cohort_ID study_ID stage platform sample_size male_percentage min_age max_age mean_age sd_age tissue cohort_name full_name description ancestry 52 ES00033 Initial 450K 239 0.85 NA NA 55.2 6.8 whole blood Cardiogenics Consortium myocardial infarction European 53 ES00033 Initial 450K 220 0.57 NA NA 55.2 6.8 whole blood Cardiogenics Consortium Healthy blood donors European 54 ES00033 Replication 450K 339 0.22 NA NA 43.8 14.2 whole blood MARTHA MARseille THrombosis Association Primary replication cohort European 55 ES00034 Initial 450K 635 0 NA NA 58.8 9.3 adipose tissue MuTHER Multiple Tissue Human Expression Resource Adipose tissue samples European 56 ES00035 Initial 450K 514 0.66 NA NA 51.9 7.5 whole blood EPICOR European Prospective Investigation into Cancer and Nutrition European 57 ES00035 Initial 450K 484 0.52 NA NA 53.2 9.6 whole blood KORA F3 Cooperative Health Research in the Region of Augsburg European 58 ES00035 Initial 450K 1709 0.49 NA NA 61 8.9 whole blood KORA F4 Cooperative Health Research in the Region of Augsburg European 59 ES00035 Initial 450K 2680 0.68 NA NA 51 10.1 whole blood LOLIPOP The London Life Sciences Prospective Population Study South Asian 60 ES00035 Replication 450K 173 0.36 NA NA 26.2 7 whole blood EGCUT Asthma Estonian Genome Centre University of Tartu European 61 ES00035 Replication 450K 96 0.5 NA NA 53 23.7 whole blood EGCUT CTG Estonian Genome Centre University of Tartu European 62 ES00035 Replication 450K 701 0 NA NA 47.8 4.3 whole blood ALSPAC Avon Longitudinal Study of Parents and Children European 63 ES00035 Replication 450K 338 0 NA NA 54.6 8.9 whole blood TwinsUK European 64 ES00035 Replication 450K 731 0.46 NA NA 59.9 8.2 whole blood RS-III Rotterdam Study European 65 ES00035 Replication 450K 656 0.43 NA NA 53.8 10.2 whole blood LOLIPOP The London Life Sciences Prospective Population Study South Asian 66 ES00035 Replication 450K 752 0.42 NA NA 45.5 13.3 whole blood LifeLines Deep European 67 ES00035 Replication 450K 642 0.48 NA NA 59 6.5 whole blood Leiden Longevity European 68 ES00035 Replication 450K 762 0.43 NA NA 67.7 5.9 whole blood RS-BIOS Rotterdam study-Biobank-based Integrative Omics Studies European 69 ES00036 Initial 450K 2377 0.45 NA NA 67 9 whole blood FHS Framingham Heart Study Not reported 70 ES00036 Initial 450K 920 0.6 NA NA 70 1 whole blood LBC1936 Lothian Birth Cohort Not reported 71 ES00036 Initial 450K 446 0.39 NA NA 79 1 whole blood LBC1921 Lothian Birth Cohort Not reported 72 ES00036 Replication 450K 2096 NA NA NA NA NA whole blood ARIC Atherosclerosis Risk in Communities African American or Afro-Caribbean 73 ES00036 Replication 450K 992 NA NA NA NA NA CD4+ T cell GOLDN Genetics of Lipid Lowering Drugs and Diet Network European 74 ES00036 Replication 450K 967 NA NA NA NA NA whole blood PIVUS Prospective Investigation of the Vasculature in Uppsala Seniors European 75 ES00037 Initial 450K 24 0.5 NA NA 10.7 0.4 leukocyte GENOI Grupo Navarro de Obesidad Infantil European 76 ES00037 Replication 450K 91 0.51 10.5 10.8 10.6 NA leukocyte GENOI Grupo Navarro de Obesidad Infantil European 77 ES00038 Initial 450K 547 0.42 49.7 51.3 50.5 NA whole blood RODAM Research on Obesity and Diabetes among African Migrants Sub-Saharan African 78 ES00039 Initial 450K 547 0.42 49.7 51.3 50.5 NA whole blood RODAM Research on Obesity and Diabetes among African Migrants Sub-Saharan African 79 ES00041 Initial 450K 2097 0.36 47 70 56.2 5.7 leukocyte ARIC Atherosclerosis Risk in Communities African American or Afro-Caribbean 80 ES00043 Initial 450K 2097 0.36 47 70 56.2 5.7 leukocyte ARIC Atherosclerosis Risk in Communities African American or Afro-Caribbean 83 ES00041 Replication 450K 2377 0.44 NA NA 67 NA whole blood FHS Offspring Framingham Heart Study Offspring Cohort European 84 ES00041 Replication 450K 991 0.48 NA NA 49 NA CD4+ T cell GOLDN Genetics of Lipid Lowering Drugs and Diet Network Study European 85 ES00043 Replication 450K 2377 0.44 NA NA 67 NA whole blood FHS Offspring Framingham Heart Study Offspring Cohort European 86 ES00043 Replication 450K 991 0.48 NA NA 49 NA CD4+ T cell GOLDN Genetics of Lipid Lowering Drugs and Diet Network Study European 87 ES00045 Replication 450K 648 0 NA NA 60 NA adipose tissue MuTHER Multiple Tissue Human Expression Resource cohort 97 MZ pairs, 162 DZ pairs and 130 singletons European 88 ES00046 Replication 450K 648 0 NA NA 60 NA adipose tissue MuTHER Multiple Tissue Human Expression Resource cohort 97 MZ pairs, 162 DZ pairs and 130 singletons European 89 ES00047 Initial 27K 148 0 52 78 NA NA whole blood UKOPS United Kingdom Ovarian Cancer Population Study Healthy women Not reported 90 ES00047 Initial 27K 113 0 50 84 NA NA whole blood UKOPS United Kingdom Ovarian Cancer Population Study Ovarian cancer before treatment Not reported 91 ES00047 Replication 27K 108 0 52 78 NA NA whole blood UKOPS United Kingdom Ovarian Cancer Population Study Healthy women Not reported 92 ES00047 Replication 27K 122 0 49 91 NA NA whole blood UKOPS United Kingdom Ovarian Cancer Population Study Ovarian cancer after treatment Not reported 93 ES00047 Replication 27K 188 0.49 24 74 NA NA whole blood Type-1 diabetics Not reported 94 ES00047 Replication 27K 177 0 24 88 NA NA ovarian cancer cell Women with ovarian cancer Not reported 95 ES00047 Replication 27K 8 0 21 85 NA NA mesenchymal stem cell Bone marrow from healthy donors Not reported 96 ES00047 Replication 27K 48 0 26 43 NA NA cervix LBC samples Not reported 97 ES00048 Initial 450K 2743 NA NA NA 56.6 5.9 leukocyte ARIC Atherosclerosis Risk in Communities African American or Afro-Caribbean 98 ES00048 Initial 450K 196 NA NA NA 73 5.4 blood CHS Cardiovascular Health Study African American or Afro-Caribbean 99 ES00048 Initial 450K 189 NA NA NA 76 5.1 blood CHS Cardiovascular Health Study European 100 ES00048 Initial 450K 2645 NA NA NA 66.4 8.9 whole blood FHS Offspring Framingham Heart Study Offspring cohort family European 101 ES00048 Initial 450K 239 NA NA NA 60.1 8.4 leukocyte GENOA Genetic Epidemiology Network of Atherosclerosis African American or Afro-Caribbean 102 ES00048 Initial 450K 822 NA NA NA 48.8 15.9 CD4+ T cell GOLDN Genetics of Lipid Lowering Drugs and Diet Network family European 103 ES00048 Initial 450K 903 NA NA NA 69.5 0.8 whole blood LBC1936 Lothian Birth Cohort 1936 European 104 ES00048 Initial 450K 674 NA NA NA 72.5 6.8 buffy coat NAS The Normative Aging Study European 105 ES00048 Initial 450K 727 NA NA NA 59.7 8.2 whole blood RS-III Rotterdam Study European 106 ES00048 Initial 450K 690 NA NA NA 58.4 9.3 whole blood TwinsUK twins European 107 ES00048 Replication 450K 192 NA NA NA 46.3 13.6 whole blood Amish The Amish Complex Disease Research Studies family European 108 ES00048 Replication 450K 1058 NA NA NA 59.8 5.4 leukocyte ARIC Atherosclerosis Risk in Communities European 109 ES00048 Replication 450K 236 NA NA NA 60.6 9.2 monocyte MESA Multi-Ethnic Study of Atherosclerosis African American or Afro-Caribbean 110 ES00048 Replication 450K 566 NA NA NA 60.8 9.6 monocyte MESA Multi-Ethnic Study of Atherosclerosis European 111 ES00048 Replication 450K 381 NA NA NA 59 9.5 monocyte MESA Multi-Ethnic Study of Atherosclerosis Hispanic or Latin American 112 ES00048 Replication 450K 711 NA NA NA 67.5 6 whole blood RS-III Rotterdam Study European 113 ES00048 Replication 450K 111 NA NA NA 47.2 4.9 whole blood SYS adults Saguenay Youth Study European 114 ES00048 Replication 450K 666 0 NA NA 62.8 6.7 blood WHI-BAA23 Women’s Health Initiative – Broad Agency Award 23 African American or Afro-Caribbean 115 ES00048 Replication 450K 965 0 NA NA 68.4 6.2 blood WHI-BAA23 Women’s Health Initiative – Broad Agency Award 23 European 116 ES00048 Replication 450K 333 0 NA NA 62.3 6.8 blood WHI-BAA23 Women’s Health Initiative – Broad Agency Award 23 Hispanic or Latin American 117 ES00048 Replication 450K 556 0 NA NA 62.8 7 blood WHI-EPMC Women’s Health Initiative - Epigenetic Mechanisms of PM-Mediated CVD African American or Afro-Caribbean 118 ES00048 Replication 450K 1092 0 NA NA 64.7 7.1 blood WHI-EMPC Women’s Health Initiative - Epigenetic Mechanisms of PM-Mediated CVD European 119 ES00048 Replication 450K 315 0 NA NA 61.6 6.2 blood WHI-EMPC Women’s Health Initiative - Epigenetic Mechanisms of PM-Mediated CVD Hispanic or Latin American 120 ES00164 Initial 450K 2743 NA NA NA 56.6 5.9 leukocyte ARIC Atherosclerosis Risk in Communities African American or Afro-Caribbean 121 ES00164 Initial 450K 196 NA NA NA 73 5.4 blood CHS Cardiovascular Health Study African American or Afro-Caribbean 122 ES00164 Initial 450K 189 NA NA NA 76 5.1 blood CHS Cardiovascular Health Study European 123 ES00164 Initial 450K 2645 NA NA NA 66.4 8.9 whole blood FHS Offspring Framingham Heart Study Offspring cohort family European 124 ES00164 Initial 450K 239 NA NA NA 60.1 8.4 leukocyte GENOA Genetic Epidemiology Network of Atherosclerosis African American or Afro-Caribbean 125 ES00164 Initial 450K 822 NA NA NA 48.8 15.9 CD4+ T cell GOLDN Genetics of Lipid Lowering Drugs and Diet Network family European 126 ES00164 Initial 450K 903 NA NA NA 69.5 0.8 whole blood LBC1936 Lothian Birth Cohort 1936 European 127 ES00164 Initial 450K 674 NA NA NA 72.5 6.8 buffy coat NAS The Normative Aging Study European 128 ES00164 Initial 450K 727 NA NA NA 59.7 8.2 whole blood RS-III Rotterdam Study European 129 ES00164 Initial 450K 690 NA NA NA 58.4 9.3 whole blood TwinsUK twins European 130 ES00164 Replication 450K 192 NA NA NA 46.3 13.6 whole blood Amish The Amish Complex Disease Research Studies family European 131 ES00164 Replication 450K 1058 NA NA NA 59.8 5.4 leukocyte ARIC Atherosclerosis Risk in Communities European 132 ES00164 Replication 450K 236 NA NA NA 60.6 9.2 monocyte MESA Multi-Ethnic Study of Atherosclerosis African American or Afro-Caribbean 133 ES00164 Replication 450K 566 NA NA NA 60.8 9.6 monocyte MESA Multi-Ethnic Study of Atherosclerosis European 134 ES00164 Replication 450K 381 NA NA NA 59 9.5 monocyte MESA Multi-Ethnic Study of Atherosclerosis Hispanic or Latin American 135 ES00164 Replication 450K 711 NA NA NA 67.5 6 whole blood RS-III Rotterdam Study European 136 ES00164 Replication 450K 111 NA NA NA 47.2 4.9 whole blood SYS adults Saguenay Youth Study European 137 ES00164 Replication 450K 666 0 NA NA 62.8 6.7 blood WHI-BAA23 Women’s Health Initiative – Broad Agency Award 23 African American or Afro-Caribbean 138 ES00164 Replication 450K 965 0 NA NA 68.4 6.2 blood WHI-BAA23 Women’s Health Initiative – Broad Agency Award 23 European 139 ES00164 Replication 450K 333 0 NA NA 62.3 6.8 blood WHI-BAA23 Women’s Health Initiative – Broad Agency Award 23 Hispanic or Latin American 140 ES00164 Replication 450K 556 0 NA NA 62.8 7 blood WHI-EPMC Women’s Health Initiative - Epigenetic Mechanisms of PM-Mediated CVD African American or Afro-Caribbean 141 ES00164 Replication 450K 1092 0 NA NA 64.7 7.1 blood WHI-EMPC Women’s Health Initiative - Epigenetic Mechanisms of PM-Mediated CVD European 142 ES00164 Replication 450K 315 0 NA NA 61.6 6.2 blood WHI-EMPC Women’s Health Initiative - Epigenetic Mechanisms of PM-Mediated CVD Hispanic or Latin American 143 ES00049 Initial 27K 93 0 49 75 NA NA peripheral blood mononuclear cell 31 twin pairs and 31 singletons Not reported 144 ES00049 Replication 27K 25 0.2 16 68 35.2 12.4 CD14+ monocyte Not reported 145 ES00052 Initial 27K 172 0 32 80 57.2 8.2 whole blood TwinsUK 33 MZ pairs, 43 DZ pairs, and 20 singletons European 146 ES00052 Replication 27K 44 NA 20 61 28 NA whole blood MZ twins discordant for psychosis Not reported 147 ES00053 Initial 450K 64 NA 9 83 NA NA whole blood mother– offspring Not reported 149 ES00054 Initial 450K 656 0.48 19 101 NA NA whole blood 426 Caucasian and 230 Hispanic individuals European,Hispanic or Latin American 150 ES00054 Replication 450K 40 NA 0 103 NA NA peripheral blood mononuclear cell Not reported 151 ES00055 Initial 27K 715 0.62 16 88 33 NA whole blood Not reported 152 ES00055 Initial 450K 94 0.72 18 65 29 NA whole blood Not reported 153 ES00055 Initial 450K 656 0.48 19 100 65 NA whole blood Not reported 154 ES00055 Initial 450K 70 1 1 16 3.1 NA peripheral blood mononuclear cell Not reported 155 ES00055 Initial 450K 48 0.48 3.5 76 15 NA peripheral blood mononuclear cell Not reported 156 ES00055 Initial 27K 216 0.49 0 0 0 0 cord blood Not reported 157 ES00055 Initial 27K 168 NA 20 70 45 NA cerebellum Not reported 158 ES00055 Initial 27K 114 0.7 16 96 44 NA cerebellum Not reported 159 ES00055 Initial 27K 133 0.68 16 100 43 NA frontal cortex Not reported 160 ES00055 Initial 27K 125 0.7 15 100 43 NA caudal pons Not reported 161 ES00055 Initial 27K 108 0.52 0 84 19 NA prefrontal cortex Cerebrotendinous xanthomatosis Not reported 162 ES00055 Initial 450K 145 0.52 13 79 35 NA brain Not reported 163 ES00055 Initial 27K 127 0.67 15 100 44 NA frontal cortex Not reported 164 ES00055 Initial 27K 23 0 19 75 46 NA breast Not reported 165 ES00055 Initial 27K 109 0.39 15 15 15 0 buccal epithelium Not reported 166 ES00055 Initial 27K 8 0.25 16 68 43 NA buccal epithelium Not reported 167 ES00055 Initial 450K 53 0.55 0 1.5 0 NA buccal epithelium Not reported 168 ES00055 Initial 27K 41 0.51 40 79 66 NA cartilage Not reported 169 ES00055 Initial 27K 35 0.37 43 90 74 NA colon Not reported 170 ES00055 Initial 450K 24 0.46 3.5 19 14 NA colon Not reported 171 ES00055 Initial 27K 14 0 6 73 20 NA dermal fibroblast Not reported 172 ES00055 Initial 27K 10 1 26 71 50 NA epidermis Not reported 173 ES00055 Initial 27K 52 NA 25 88 68 NA gastric tissue Not reported 174 ES00055 Initial 450K 50 0.76 26 87 62 NA head and neck Not reported 175 ES00055 Initial 27K 17 0.59 16 68 55 NA apical left ventricular Not reported 176 ES00055 Initial 450K 43 0.7 31 83 66 NA kidney Not reported 177 ES00055 Initial 450K 160 0.66 38 90 63 NA kidney Not reported 178 ES00055 Initial 27K 57 0.86 20 79 51 NA liver Not reported 179 ES00055 Initial 27K 27 0.85 52 83 69 NA lung Not reported 180 ES00055 Initial 27K 24 0.42 51 77 66 NA lung Not reported 181 ES00055 Initial 450K 40 0.68 40 85 73 NA lung Not reported 182 ES00055 Initial 27K 16 0.62 21 85 52 NA bone marrow Not reported 183 ES00055 Initial 27K 28 0 0 0 0 0 placenta Not reported 184 ES00055 Initial 27K 69 1 44 73 61 NA prostate Not reported 185 ES00055 Initial 450K 44 1 44 72 63 NA prostate Not reported 186 ES00055 Initial 27K 131 0.99 21 55 29 NA saliva Not reported 187 ES00055 Initial 27K 69 1 21 55 35 NA saliva Not reported 188 ES00055 Initial 27K 41 0.49 43 87 69 NA stomach Not reported 189 ES00055 Initial 450K 25 0.2 18 76 40 NA thyroid Not reported 190 ES00055 Replication 27K 191 0.49 24 74 43 NA whole blood Not reported 191 ES00055 Replication 27K 93 0 49 74 63 NA whole blood Not reported 192 ES00055 Replication 27K 262 0 49 91 67 NA whole blood Not reported 193 ES00055 Replication 27K 269 0 52 78 64 NA whole blood Not reported 194 ES00055 Replication 450K 689 0.29 17 70 54 NA whole blood Not reported 196 ES00055 Replication 27K 386 1 3.6 18 9.3 NA peripheral blood mononuclear cell Not reported 197 ES00055 Replication 450K 38 0.26 0 100 44 NA peripheral blood mononuclear cell Not reported 198 ES00055 Replication 27K 92 NA 24 45 33 NA peripheral blood mononuclear cell Not reported 199 ES00055 Replication 27K 48 0.98 0 0 0 0 cord blood Not reported 200 ES00055 Replication 27K 84 0.48 0 0 0 0 cord blood Not reported 201 ES00055 Replication 27K 53 0.55 0 0 0 0 cord blood Not reported 202 ES00055 Replication 450K 48 NA 0 1 0.5 NA CD4+ T cell Not reported 203 ES00055 Replication 27K 26 0.27 16 69 36.5 NA CD14+ monocyte Not reported 204 ES00055 Replication 450K 16 0.38 17 60 32 NA blood Not reported 205 ES00055 Replication 27K 20 1 1 60 22 NA cerebellar Not reported 206 ES00055 Replication 27K 16 1 1 60 25 NA occipital cortex Not reported 207 ES00055 Replication 450K 81 0 28 90 55 NA breast Not reported 208 ES00055 Replication 27K 27 0 35 88 51 NA breast Not reported 209 ES00055 Replication 450K 51 0.55 0 1.5 0 NA buccal cell Not reported 210 ES00055 Replication 450K 38 0.55 40 90 72 NA colon Not reported 211 ES00055 Replication 27K 10 0.6 73 78 75 NA subcutaneous adipose tissue Not reported 212 ES00055 Replication 27K 6 1 55 71 60 NA heart Not reported 213 ES00055 Replication 27K 198 0.65 33 86 60 NA kidney Not reported 214 ES00055 Replication 450K 37 0.65 20 81 68 NA liver Not reported 215 ES00055 Replication 450K 26 0.54 42 86 66 NA lung Not reported 216 ES00055 Replication 27K 22 0.45 53 78 66 NA vastus lateralis muscle Not reported 217 ES00055 Replication 27K 44 1 25 25 25 0 vastus lateralis muscle Not reported 218 ES00055 Replication 450K 40 NA 0 0 0 0 placenta Not reported 219 ES00055 Replication 27K 52 0.08 21 55 27 NA saliva Not reported 220 ES00055 Replication 27K 152 0 19 55 25 NA uterine cervix Not reported 221 ES00055 Replication 450K 28 0 35 90 62 NA uterus Not reported 222 ES00055 Replication 27K 44 0.59 0 83 71 NA various tissues Not reported 223 ES00056 Initial 450K 400 0.47 50 75 62 NA whole blood ESTHER Not reported 224 ES00056 Replication 450K 498 0.52 50 75 62 NA whole blood ESTHER Not reported 225 ES00056 Replication 450K 67 0.5 50 75 61 NA whole blood ESTHER Longitudinal Not reported 226 ES00057 Initial 27K 1006 0 35 76 NA NA whole blood Sister Study Sister Study Not reported 227 ES00057 Replication 27K 507 0 49 91 NA NA whole blood 262 healthy women, 120 ovarian cancer cases before treatment and 125 ovarian cancer cases after treatment Not reported 228 ES00057 Replication 27K 146 0.5 27 74 NA NA whole blood Type-1 diabetics Not reported 229 ES00057 Replication 27K 93 0 49 74 NA NA whole blood Not reported 230 ES00058 Initial 450K 261 0 52 78 64 NA leukocyte Not reported 231 ES00058 Initial 450K 22 0.27 16 69 34 NA CD14+ monocyte Not reported 232 ES00058 Initial 450K 18 0.28 16 69 29.5 NA CD4+ T cell Not reported 233 ES00058 Initial 450K 23 0.52 2 35 12 NA lymphocyte Not reported 234 ES00058 Initial 450K 88 0 49 74 63 NA leukocyte Not reported 235 ES00058 Initial 450K 163 0.52 0 0 0 0 cord blood Not reported 236 ES00059 Initial 450K 87 0.61 26 74 56.7 10.5 pancreatic islet Nordic Network for Islet Transplantation Not reported 237 ES00059 Replication 450K 112 NA 20 73 NA NA blood Danish Family Study Danish Family Study Not reported 238 ES00060 Initial 450K 24 0 24 47 36 NA whole blood NIHS Norfolk Island Health Study Norfolk Island European 239 ES00060 Replication 450K 2316 NA 0 103 54 NA whole blood MARMAL?AID Not reported 240 ES00061 Initial 450K 48 0.6 6 15 NA NA whole blood East Asian 241 ES00062 Initial 450K 2029 0.31 NA NA 36.4 12.4 whole blood NTR Netherlands Twin Register Not reported 242 ES00062 Replication 450K 40 0.85 NA NA 36.6 13.5 whole blood pairs of monozygotic (MZ) twins highly discordant for aggression Not reported 243 ES00063 Initial 450K 500 0.52 NA NA 53.1 9.6 whole blood KORA F3 Cooperative Health Research in the Region of Augsburg Not reported 244 ES00063 Initial 450K 1799 0.49 NA NA 60.92 8.9 whole blood KORA F4 Cooperative Health Research in the Region of Augsburg Not reported 245 ES00063 Initial 450K 657 1 NA NA 72.44 6.9 whole blood NAS baseline Normative Aging Study NAS baseline Not reported 246 ES00064 Initial 450K 280 0.55 NA NA NA NA cord blood MeDALL Mechanisms of the Development of ALLergy European 247 ES00064 Initial 450K 809 0.53 0 0 0 0 cord blood Generation R Study European 248 ES00064 Initial 450K 226 0.41 0 0 0 0 cord blood CHS Children’s Health Study European 249 ES00064 Initial 450K 733 0.54 4 5 NA NA whole blood MeDALL Mechanisms of the Development of ALLergy Hispanic or Latin American,European 250 ES00064 Initial 450K 193 0.52 0 0 0 0 cord blood MoBa Mother and Child Cohort Study European 251 ES00064 Initial 450K 444 0.52 8 8 8 0 whole blood MeDALL Mechanisms of the Development of ALLergy European 252 ES00064 Initial 450K 342 0.53 8 8 8 0 whole blood BAMSE EpiGene European 253 ES00065 Initial 450K 1207 0.48 NA NA 69.6 9.4 CD14+ monocyte MESA Multi-Ethnic Study of Atherosclerosis African American or Afro-Caribbean,Hispanic or Latin American,European 254 ES00066 Initial 450K 646 1 NA NA 73.7 6.8 whole blood NAS Normative Aging Study 97% Caucasians European,Not reported 255 ES00067 Initial 450K 646 1 NA NA 73.7 6.8 whole blood NAS Normative Aging Study 97% Caucasians Not reported,European 256 ES00068 Initial 450K 646 1 NA NA 73.7 6.8 whole blood NAS Normative Aging Study 97% Caucasians European,Not reported 257 ES00069 Initial 450K 454 0.29 NA NA 54.2 7.1 leukocyte EPIC-Italy European Prospective Investigation into Cancer and Nutrition European 259 ES00070 Initial 450K 454 0.29 NA NA 54.2 7.1 leukocyte EPIC-Italy European Prospective Investigation into Cancer and Nutrition European 261 ES00070 Initial 450K 159 0 NA NA 58.8 5.6 leukocyte EPIC-Netherlands European Prospective Investigation into Cancer and Nutrition European 263 ES00072 Initial 450K 159 0 NA NA 58.8 5.6 leukocyte EPIC-Netherlands European Prospective Investigation into Cancer and Nutrition European 264 ES00072 Initial 450K 454 0.29 NA NA 54.2 7.1 leukocyte EPIC-Italy European Prospective Investigation into Cancer and Nutrition European 267 ES00074 Initial 450K 159 0 NA NA 58.8 5.6 leukocyte EPIC-Netherlands European Prospective Investigation into Cancer and Nutrition European 268 ES00167 Initial 450K 159 0 NA NA 58.8 5.6 leukocyte EPIC-Netherlands European Prospective Investigation into Cancer and Nutrition European 269 ES00076 Initial 450K 185 0.45 NA NA 76 5 whole blood CHS Cardiovascular Health Study European 270 ES00076 Initial 450K 1275 0.51 NA NA 60 9 whole blood EPIC-Norfolk European Prospective Investigation into Cancer and Nutrition European 271 ES00076 Initial 450K 2427 0.45 NA NA 66 9 whole blood FHS Framingham Heart Study European 272 ES00076 Initial 450K 499 0.45 NA NA 63 16 whole blood InCHIANTI Invecchiare in Chianti European 273 ES00076 Initial 450K 1797 0.49 NA NA 60 9 whole blood KORA F4 Cooperative Health Research in the Region of Augsburg European 274 ES00076 Initial 450K 920 0.51 NA NA 70 1 whole blood LBC1936 Lothian Birth Cohort 1936 European 275 ES00076 Initial 450K 623 1 NA NA 72 7 whole blood NAS Normative Aging Study European 276 ES00076 Initial 450K 818 0.5 NA NA 70 0.2 whole blood PIVUS Prospective Investigation of the Vasculature in Uppsala Seniors Study European 277 ES00076 Initial 450K 502 0.48 NA NA 58 7 whole blood RS Rotterdam Study European 278 ES00076 Initial 450K 597 0 NA NA 56 9 whole blood TwinsUK European 279 ES00077 Initial 450K 2003 0.36 NA NA 56 6 whole blood ARIC Atherosclerosis Risk in Communities African American or Afro-Caribbean 280 ES00077 Initial 450K 190 0.35 NA NA 73 5 whole blood CHS Cardiovascular Health Study African American or Afro-Caribbean 281 ES00077 Initial 450K 230 0.33 NA NA 42 12 whole blood GTP Grady Trauma Project African American or Afro-Caribbean 282 ES00075 Initial 450K 1251 0.48 NA NA 60 9 CD14+ monocyte MESA Multi-Ethnic Study of Atherosclerosis EA (n = 588), AA (n = 263) and Hispanic ancestry (n = 400) Hispanic or Latin American,European,African American or Afro-Caribbean 283 ES00078 Initial 450K 40 0 NA NA 47 8 lymphoblast IAS Iowa Adoptions Studies abstinent (no use in the past 6 months) European,Not reported 285 ES00080 Initial 27K 65 0.54 50 60 54 3 peripheral blood ESTHER Heavy smoker: smoking >= 20 cigarettes per day at ages 30 and 40 and at enrollment Not reported 286 ES00080 Replication 27K 95 0.57 NA NA 55 3 peripheral blood Heavy smoker: smoking >= 20 cigarettes per day at ages 30 and 40 and at enrollment Not reported 287 ES00081 Initial 450K 1085 0.54 45 65 57.3 8.1 whole blood ICGN International COPD Genetics Network European 288 ES00081 Replication 450K 369 0.36 NA 53 47.5 7.1 whole blood EOCOPD Early-Onset COPD Not reported 289 ES00082 Initial 450K 1085 0.54 45 65 57.3 8.1 whole blood ICGN International COPD Genetics Network European 290 ES00082 Replication 450K 369 0.36 NA 53 47.5 7.1 whole blood EOCOPD Early-Onset COPD Not reported 291 ES00083 Initial 450K 1085 0.54 45 65 57.3 8.1 whole blood ICGN International COPD Genetics Network European 292 ES00083 Replication 450K 369 0.36 NA 53 47.5 7.1 whole blood EOCOPD Early-Onset COPD Not reported 293 ES00084 Initial 450K 181 1 NA NA 19.2 0.7 lymphocyte Strong African- American Healthy Adults project African American or Afro-Caribbean 294 ES00085 Initial 450K 218 0 NA NA 19.3 0.7 lymphocyte Strong African- American Healthy Adults project African American or Afro-Caribbean 295 ES00086 Initial 450K 374 0.18 NA NA NA NA leukocyte EPIC-Turin European Prospective Investigation into Cancer and Nutrition Not reported 296 ES00087 Initial 27K 972 0.29 NA NA 66.3 7.6 leukocyte GENOA Genetic Epidemiology Network of Arteriopathy African American or Afro-Caribbean 297 ES00087 Replication 450K 239 0.28 NA NA 41 13 leukocyte GTP Grady Trauma Project African American or Afro-Caribbean 298 ES00088 Initial 450K 262 0.54 46 76 57 NA whole blood KORA F4 Kooperative Gesundheitsforschung in der Region Augsburg Current smokers Not reported 299 ES00088 Initial 450K 749 0.35 31 81 62.1 NA whole blood KORA F4 Kooperative Gesundheitsforschung in der Region Augsburg Never smokers Not reported 300 ES00089 Initial 450K 782 0.6 35 81 61 NA whole blood KORA F4 Kooperative Gesundheitsforschung in der Region Augsburg Former smokers Not reported 301 ES00089 Initial 450K 749 0.35 31 81 62.1 NA whole blood KORA F4 Kooperative Gesundheitsforschung in der Region Augsburg Never smokers Not reported 305 ES00093 Initial 450K 421 0.47 14 94 NA NA whole blood NSPHS Northern Sweden population Health Study Not reported 306 ES00094 Initial 450K 64 1 NA NA 48.3 4.3 peripheral blood SABRE Southall And Brent REvisited Never smokers South Asian 308 ES00095 Initial 450K 50 0 NA NA 48.1 7 peripheral blood mononuclear cell FACHS Family and Community Health Study Smoker African American or Afro-Caribbean 309 ES00096 Initial 27K 496 0 NA NA 55.1 9.1 whole blood Sister Study National Institute of Environmental Health Sciences (NIEHS) Sister Study Never-smoker European 310 ES00096 Initial 27K 344 0 NA NA 57.1 8.8 whole blood Sister Study National Institute of Environmental Health Sciences (NIEHS) Sister Study Former smoker European 311 ES00096 Initial 27K 68 0 NA NA 53.2 9.6 whole blood Sister Study National Institute of Environmental Health Sciences (NIEHS) Sister Study Current smoker European 312 ES00097 Initial 450K 464 0.7 38 67 55.4 6.7 peripheral blood CARDIOGENICS European 313 ES00097 Replication 450K 356 0 34 84 60.1 8.8 peripheral blood EPITWIN Not reported 314 ES00098 Initial 450K 30 0.67 NA NA 60.4 8.8 buccal mucosa COPDGene Current Smokers African American or Afro-Caribbean,European 322 ES00102 Initial 450K 72 0 NA NA 36.3 17.2 whole blood Greater Middle Eastern 326 ES00106 Initial 450K 42 NA NA NA NA NA whole blood Not reported 327 ES00107 Initial 450K 400 0 53 53 53 0 buccal cell NSHD National Survey of Health and Development Not reported 328 ES00107 Replication 450K 390 0 53 53 53 0 buccal cell NSHD National Survey of Health and Development Not reported 331 ES00109 Initial 27K 19 0.54 NA NA 60.1 7.9 whole blood COPDGene Current smokers European 332 ES00110 Initial 450K 137 0.78 NA NA 46.5 8.9 whole blood COW-1 East Asian 333 ES00110 Initial 450K 101 0.8 NA NA 59 10.2 whole blood ACS-1 East Asian 334 ES00110 Initial 450K 97 0.8 NA NA 59.4 11.5 whole blood ACS-2 East Asian 335 ES00110 Initial 450K 261 0.79 NA NA 53.8 13.1 whole blood WHZH East Asian 336 ES00111 Initial 450K 175 0.45 NA NA 57.9 6.6 whole blood RS Rotterdam Study Current smokers European 337 ES00112 Initial 450K 500 0.49 50 75 NA NA whole blood ESTHER Not reported 338 ES00112 Replication 450K 500 0.51 50 75 NA NA whole blood ESTHER Not reported 340 ES00113 Initial 450K 107 0.43 NA NA 56.5 10.4 whole blood REGICOR EWAS nested in the Girona Heart Registry Current Smokers European 341 ES00114 Initial 450K 528 0 NA NA 54 8.5 whole blood EPIC European Prospective Investigation into Cancer and Nutrition Never-smokers European 342 ES00115 Initial 450K 139 1 NA NA 55.7 3.3 whole blood ETS Emory Twin Study European 343 ES00115 Replication 450K 78 1 NA NA 55.4 3.3 whole blood ETS Emory Twin Study European 344 ES00115 Replication 450K 327 1 NA NA 54.6 6.8 whole blood Not reported 345 ES00115 Replication 450K 137 0 NA NA 57.3 5.9 whole blood Not reported 346 ES00115 Replication 450K 95 1 NA NA 55.5 10.5 whole blood Not reported 347 ES00115 Replication 450K 238 0 NA NA 51.7 11.7 whole blood Not reported 348 ES00116 Initial 450K 173 0.53 58 74 66.4 NA lung TCGA Light smoking Not reported 349 ES00116 Initial 450K 153 0.62 61 73 70 NA lung TCGA Heavy smoking Not reported 382 ES00119 Initial 450K 39 0.15 NA NA 72.9 6.1 whole blood COPD Chronic Obstructive Pulmonary Disease cohort Never smokers East Asian 383 ES00120 Initial 450K 8 0.75 55 69 62.62 1.87 lung Non-smokers Not reported 384 ES00121 Initial 450K 20 1 NA NA NA NA sperm nonsmokers Not reported 385 ES00122 Initial 450K 78 1 NA NA 32.4 0.9 sperm smokers Not reported 386 ES00123 Initial 450K 280 0.57 NA NA 50.8 7.8 whole blood KORA F4 Kooperative Gesundheitsforschung in der Region Augsburg Current smokers baseline Not reported 387 ES00124 Initial 27K 10 0.4 NA NA 29.7 29.7 alveolar macrophage never smokers Not reported 388 ES00125 Initial 450K 192 0.42 5 14 10.2 NA saliva 96 were maltreated children European,African American or Afro-Caribbean,Other admixed ancestry,Hispanic or Latin American 389 ES00126 Initial 450K 23 1 NA NA 37.3 4.4 adipose tissue Baseline Not reported 390 ES00127 Initial 450K 23 0.52 NA NA 27 0.8 skeletal muscle Not reported 391 ES00128 Initial 450K 12 1 18 24 21.1 2.7 leukocyte 4 wk (thrice weekly) of sprint interval training Not reported 392 ES00129 Initial 450K 13 1 NA NA 24.4 5.19 sperm control Not reported 393 ES00130 Initial 450K 8 1 NA NA 21.1 2.2 leukocyte 8 weeks of resistance exercise training Not reported 394 ES00131 Initial 450K 20 0 NA NA 63.1 4.8 peripheral blood mononuclear cell control Not reported 395 ES00169 Initial 450K 27 0.44 0 0 0 0 frontal cortex Not reported 404 ES00136 Initial 450K 1522 0.48 32 72 58.6 7.5 whole blood KORA F4 Cooperative Health Research in the Region of Augsburg classified according to mild, moderate, or severe levels of anxiety (29.4%/6.0%/1.5%, respectively) European 405 ES00136 Replication 450K 300 NA NA NA NA NA whole blood European 406 ES00137 Initial 450K 380 0 14 94 50 NA whole blood NSPHS Northern Sweden Population Health Study European 407 ES00137 Initial 450K 399 0 69.8 70.7 70.1 NA whole blood PIVUS The prospective investigation of the Vasculature in Uppsala Seniors European 408 ES00137 Initial 450K 520 0 36.5 76.8 58.4 NA whole blood HWFS Dutch Hunger Winter Families Study European 409 ES00137 Initial 450K 398 0 29.6 74.9 52.1 NA whole blood EGM EnivroGenoMarkers project European 410 ES00138 Initial 450K 40 1 NA NA NA NA subcutaneous adipose tissue Danish National Birth Registry Not reported 412 ES00139 Initial 450K 2519 0.31 NA NA 36.79 13.01 whole blood Not reported 413 ES00140 Initial 450K 109 1 0 7 NA NA whole blood ARIES Accessible Resource for Integrated Epigenomics Studies Not reported 414 ES00141 Initial 450K 48 0.46 45.1 11.2 NA NA whole blood European,African American or Afro-Caribbean 416 ES00142 Replication 450K 142 0.51 NA NA 62.6 7.2 whole blood BLITZ Evaluierung innovativer Testverfahren zur Darmkrebsfr€uherkennung European 417 ES00142 Initial 450K 99 0.5 NA NA 65.4 7.1 whole blood ESTHER Epidemiologische Studie zu Chancen der Verh€utung, Früherkennung und optimierten Therapie chronischer Erkrankungen in der älteren Bevölkerung European 418 ES00142 Initial 450K 1000 0.5 NA NA 62.1 6.5 whole blood ESTHER Epidemiologische Studie zu Chancen der Verh€utung, Früherkennung und optimierten Therapie chronischer Erkrankungen in der älteren Bevölkerung European 423 ES00145 Initial 450K 348 0.46 NA NA 58.9 0.5 whole blood Dutch Hunger Winter Families study European 424 ES00145 Initial 450K 160 0.45 NA NA 59.2 2 whole blood Dutch Hunger Winter Families study European 425 ES00145 Initial 450K 303 0.42 NA NA 2 6.4 whole blood Dutch Hunger Winter Families study European 426 ES00146 Initial 450K 44 0.43 NA NA 70.8 2.9 leukocyte B-PROOF Folic acid and vitamin B12 intervention Not reported 430 ES00150 Initial 450K 2148 0.46 40 92 65 NA peripheral blood mononuclear cell FHS offspring Framingham Heart Study Offspring Cohort European 431 ES00151 Initial 450K 2148 0.46 40 92 65 NA peripheral blood mononuclear cell FHS offspring Framingham Heart Study Offspring Cohort European 432 ES00152 Initial 450K 46 0.52 0 0 0 0 cord blood Controls Not reported,European 433 ES00152 Initial 450K 48 0.5 0 0 0 0 cord blood ICSI Not reported,European 435 ES00154 Initial 450K 1062 0.53 0 0 0 0 cord blood MoBa Norwegian Mother and Child Cohort Study European 438 ES00157 Initial 450K 20 0.3 NA NA 26.5 6.7 whole blood Controls European 439 ES00157 Initial 450K 20 0.4 NA NA 36.6 6.6 whole blood Case Group I European 440 ES00158 Initial 450K 367 0.33 18 18 18 0 whole blood IoW Isle of Wight birth cohort Not reported 441 ES00159 Initial 450K 15 0.53 22 58 NA NA peripheral blood mononuclear cell Allergic participants Not reported 445 ES00161 Initial 450K 21 1 NA NA NA NA ascending aortic tissue Not reported 446 ES00162 Initial 450K 21 1 NA NA NA NA ascending aortic tissue Not reported 451 ES00174 Initial 450K 860 NA 0 0 0 0 cord blood ALSPAC Avon Longitudinal Study of Parents and Children ALSPAC European 452 ES00174 Initial 450K 378 NA 0 0 0 0 cord blood CHAMACOS Center for Health Assessment of Mothers and Children of Salinas Hispanic or Latin American 453 ES00174 Initial 450K 85 NA 0 0 0 0 blood spot CHS Children’s Health Study CHS European 454 ES00174 Initial 450K 255 NA 0 0 0 0 cord blood GECKO GECKO European 455 ES00174 Initial 450K 883 NA 0 0 0 0 cord blood Generation R Study European 456 ES00174 Initial 450K 90 NA 0 0 0 0 cord blood IOW Isle of Wight birth cohort European 457 ES00174 Initial 450K 362 NA 0 0 0 0 cord blood MeDALL Mechanisms of the Development of ALLergy European 458 ES00174 Initial 450K 1063 NA 0 0 0 0 cord blood MoBa1 Norwegian Mother and Child Cohort Study European 459 ES00174 Initial 450K 671 NA 0 0 0 0 cord blood MoBa2 Norwegian Mother and Child Cohort Study European 460 ES00174 Initial 450K 252 NA 0 0 0 0 cord blood MoBa3 Norwegian Mother and Child Cohort Study European 461 ES00174 Initial 450K 413 NA 0 0 0 0 cord blood NEST Newborn Epigenetics Study European,African American or Afro-Caribbean,Other 462 ES00174 Initial 450K 889 NA 0 0 0 0 heel stick blood NFCS Norway Facial Clefts Study European 463 ES00174 Initial 450K 485 NA 0 0 0 0 cord blood Project Viva European,Asian unspecified,Other,African American or Afro-Caribbean,Hispanic or Latin American 464 ES00174 Initial 450K 840 NA 7 7 7 0 whole blood ALSPAC Avon Longitudinal Study of Parents and Children European 465 ES00174 Initial 450K 347 NA 4 8 NA NA whole blood BAMSE Children’s Allergy Environment Stockholm Epidemiology study European 466 ES00174 Initial 450K 569 NA 8 21 NA NA whole blood GALA II Genes-environments and Admixture in Latino Americans Hispanic or Latin American 467 ES00174 Initial 450K 851 NA NA NA NA NA whole blood MeDALL European 468 ES00174 Initial 450K 584 NA NA NA NA NA whole blood SEED Study to Explore Early Development European,African American or Afro-Caribbean,Other 473 ES00179 Initial 450K 17 0.71 NA NA 26.9 4.7 adipose tissue LIPOGAIN SFA group Baseline Not reported 474 ES00180 Initial 450K 144 0 NA NA NA NA whole blood controls African American or Afro-Caribbean 475 ES00180 Initial 450K 146 0 NA NA NA NA whole blood Early sPTBs African American or Afro-Caribbean 476 ES00181 Initial 450K 5 0.6 0 0 0 0 T cell preterm (GA range 26– 30 weeks) Not reported 480 ES00185 Initial 450K 11 1 3 6 NA NA buccal epithelium 6 FASD patients and 5 matched controls European 481 ES00185 Replication 450K 12 1 NA NA NA NA buccal epithelium 6 FASD children and 6 matched controls European 482 ES00186 Initial 450K 134 0.5 0 0 0 0 cord blood NHBCS New Hampshire Birth Cohort Study Not reported 483 ES00187 Initial 450K 44 NA NA NA NA NA cord blood Not reported 485 ES00189 Initial 450K 62 1 NA NA NA NA cord blood Not reported 486 ES00190 Initial 450K 65 0 NA NA NA NA cord blood Not reported 487 ES00191 Initial 450K 38 NA 0 0 0 0 cord blood BEAR Biomarkers of Exposure to ARsenic Not reported 488 ES00192 Initial 450K 138 0.49 0 0 0 0 cord blood NHBCS New Hampshire Birth Cohort Study European,Not reported 489 ES00193 Initial 450K 138 0.49 0 0 0 0 cord blood NHBCS New Hampshire Birth Cohort Study Not reported,European 490 ES00194 Initial 450K 37 0.64 0 0 0 0 placenta Not reported 491 ES00195 Initial 450K 45 0.64 0 0 0 0 artery Not reported 492 ES00196 Initial 450K 52 0.64 0 0 0 0 umbilical vein endothelial cell Not reported 494 ES00198 Initial 450K 20 1 NA NA 28.9 1.3 sperm Low motility Not reported 495 ES00200 Initial 450K 244 0.46 0 7 NA NA whole blood ALSPAC Avon Longitudinal Study of Parents and Children Not reported 497 ES00202 Initial 450K 20 1 21 51 35.3 8.9 peripheral blood mononuclear cell European,Asian unspecified,African American or Afro-Caribbean,Other admixed ancestry 498 ES00203 Initial 450K 20 1 21 51 35.3 8.9 peripheral blood mononuclear cell Asian unspecified,African American or Afro-Caribbean,Other admixed ancestry,European 499 ES00204 Initial 450K 23 0.52 NA NA 41.2 2.6 leukocyte CARDIA Coronary Artery Risk Development in Young Adults high exposed European 500 ES00205 Initial 450K 10 0.7 NA NA 37.4 10.2 whole blood case South Asian 501 ES00206 Initial 450K 400 0.53 25 65 NA NA whole blood South Asian 502 ES00207 Initial 450K 400 0.53 25 65 NA NA whole blood South Asian 503 ES00208 Initial 450K 93 0 12 62 32 NA whole blood Hispanic or Latin American 505 ES00210 Initial 450K 127 0.49 0 0 0 0 cord blood South Asian 506 ES00211 Initial 450K 65 0 0 0 0 0 cord blood South Asian 507 ES00212 Initial 450K 62 1 1 1 1 1 cord blood South Asian 509 ES00216 Initial 450K 775 NA 0 0 0 0 cord blood ALSPAC Avon Longitudinal Study of Parents and Children Not reported 510 ES00216 Initial 450K 136 NA 0 0 0 0 cord blood GECKO Groningen Expert Center for Kids with Obesity Not reported 511 ES00216 Initial 450K 723 NA 0 0 0 0 cord blood Generation R Study Not reported 512 ES00216 Initial 450K 873 NA 0 0 0 0 cord blood MoBa1 Norwegian Mother and Child Cohort Study Not reported 513 ES00216 Initial 450K 157 NA 0 0 0 0 cord blood MoBa2 Norwegian Mother and Child Cohort Study Not reported 514 ES00217 Initial 450K 637 NA 0 0 0 0 cord blood ALSPAC Avon Longitudinal Study of Parents and Children Not reported 515 ES00217 Initial 450K 69 NA 0 0 0 0 cord blood GECKO Groningen Expert Center for Kids with Obesity Not reported 516 ES00217 Initial 450K 579 NA 0 0 0 0 cord blood Generation R Study Not reported 517 ES00217 Initial 450K 962 NA 0 0 0 0 cord blood MoBa1 Norwegian Mother and Child Cohort Study Not reported 518 ES00217 Initial 450K 624 NA 0 0 0 0 cord blood MoBa2 Norwegian Mother and Child Cohort Study Not reported 519 ES00218 Initial 450K 813 NA 0 0 0 0 cord blood ALSPAC Avon Longitudinal Study of Parents and Children Not reported 520 ES00218 Initial 450K 838 NA 0 0 0 0 cord blood Generation R Study Not reported 521 ES00218 Initial 450K 1049 NA 0 0 0 0 cord blood MoBa1 Norwegian Mother and Child Cohort Study Not reported 522 ES00218 Initial 450K 666 NA 0 0 0 0 cord blood MoBa2 Norwegian Mother and Child Cohort Study Not reported 523 ES00218 Initial 450K 311 NA 0 0 0 0 cord blood VIVA Project Viva Not reported 524 ES00219 Initial 450K 8413 NA 0 0 0 0 cord blood ALSPAC Avon Longitudinal Study of Parents and Children Not reported 525 ES00219 Initial 450K 866 NA 0 0 0 0 cord blood Generation R Study Not reported 526 ES00219 Initial 450K 1019 NA 0 0 0 0 cord blood MoBa1 Norwegian Mother and Child Cohort Study Not reported 527 ES00219 Initial 450K 639 NA 0 0 0 0 cord blood MoBa2 Norwegian Mother and Child Cohort Study Not reported 529 ES00220 Initial 450K 792 NA 0 0 0 0 cord blood ALSPAC Avon Longitudinal Study of Parents and Children Not reported 530 ES00220 Initial 450K 851 NA 0 0 0 0 cord blood Generation R Study Not reported 531 ES00220 Initial 450K 1053 NA 0 0 0 0 cord blood MoBa1 Norwegian Mother and Child Cohort Study Not reported 532 ES00220 Initial 450K 242 NA 0 0 0 0 cord blood MoBa2 Norwegian Mother and Child Cohort Study Not reported 534 ES00221 Initial 450K 74 0.3 NA NA 39.1 12.9 airway epithelial cell Asthma Not reported 539 ES00223 Initial 450K 8 NA NA NA 49.7 6.6 whole blood LVAD Impact of Left Ventricular Assist Devices Implantation on Micro- and Macrovascular Function Healthy Not reported 540 ES00223 Initial 450K 8 NA NA NA 78 8.4 whole blood LVAD Impact of Left Ventricular Assist Devices Implantation on Micro- and Macrovascular Function Not reported 541 ES00223 Replication 450K 15 NA NA NA NA NA aorta Not reported 542 ES00223 Replication 450K 19 NA NA NA NA NA carotid plaque Not reported 543 ES00224 Initial 450K 817 0.49 0 0 0 0 cord blood ALSPAC Avon Longitudinal Study of Parents and Children European 547 ES00227 Initial 450K 53 1 2 15 6.8 3.4 whole blood ASD Not reported 548 ES00227 Initial 450K 656 1 19 101 NA NA whole blood control European 551 ES00231 Initial 450K 23 0.57 NA NA 21.7 2.8 whole blood BFS Scottish Bipolar Family Study well high-risk individuals who remained well Not reported 553 ES00233 Initial 450K 5 NA 0 0 0 0 placenta 1st Trimester control Not reported 554 ES00234 Initial 450K 24 0.79 0 0 0 0 peripheral blood lymphocyte Control Not reported 555 ES00235 Initial 450K 84 0.45 NA NA 1.4 NA leukocyte Cases European 556 ES00236 Initial 450K 195 0.5 NA NA 58.1 6.7 whole blood Rotterdam Study Current smokers European 563 ES00242 Initial 450K 18 0.72 NA NA 54.9 4 left ventricle case Not reported 566 ES00245 Initial 450K 5 0 NA NA NA NA endometrium control Not reported 568 ES00248 Initial 450K 110 0.41 NA NA 11.6 3.4 buccal epithelial cell NeuroDevNet FASD cohort FASD cases European,Other 569 ES00249 Initial 450K 18 0.44 0 0 0 0 cord blood Array cohort A Controls European 570 ES00250 Initial 450K 6 0.5 42 55 48.7 4.7 gastric mucosa successfully eradicated East Asian 572 ES00252 Initial 450K 261 0.97 NA NA 48.8 8 whole blood VACS Veteran Aging Cohort Study HIV-infected European,African American or Afro-Caribbean,Other 573 ES00253 Initial 450K 19 1 NA NA 51.1 NA peripheral blood mononuclear cell HIV-infected Not reported 574 ES00255 Initial 450K 12 0.75 0 0 0 0 CD4+ T cell Food Allergy Not reported 575 ES00256 Initial 450K 5 1 35 49 40 5.6 sperm control Not reported 576 ES00257 Initial 450K 19 1 19 36 26 4.8 sperm control Not reported 578 ES00259 Initial 450K 28 0.39 35 78 55.3 10 white matter multiple sclerosis Not reported 579 ES00260 Initial 450K 30 0.13 18 55 NA NA CD4+ T cell multiple sclerosis Not reported 580 ES00261 Initial 450K 22 0 NA NA 38.2 11.1 CD4+ T cell control Not reported 581 ES00262 Initial 450K 13 0 21 66 49.8 14.3 CD14+ monocyte Myasthenia gravis European 582 ES00263 Initial 450K 14 0.33 0 0 0 0 chorionic villi Anencephaly European 583 ES00264 Initial 450K 16 1 NA NA NA NA sperm nonobstructive azoospermia Not reported 586 ES00267 Initial 450K 23 1 NA NA 62.2 12.6 peripheral blood mononuclear cell control Not reported 587 ES00267 Initial 450K 17 0.52 NA NA 61.4 11.4 peripheral blood mononuclear cell Parkinson's disease Not reported 588 ES00267 Initial 450K 12 0.42 NA NA 69 9.1 peripheral blood mononuclear cell MZ twins Control Not reported 591 ES00270 Initial 450K 5 0.6 NA NA 37.6 7.6 saliva RA Not reported 593 ES00272 Initial 450K 12 0 NA NA 64.6 7.5 T-lymphocyte RA European 595 ES00274 Initial 450K 23 0.35 NA NA 58.9 15.8 T-lymphocyte Early RA European 597 ES00276 Initial 450K 12 0.25 23 57 40.8 11.5 CD4+ T cell RA East Asian 598 ES00277 Initial 450K 46 0.35 NA NA 57.7 13.9 T-lymphocyte treatment-naive patients with early rheumatoid arthritis European 599 ES00278 Initial 450K 42 1 NA NA 51.8 6.7 leukocyte schizophrenia East Asian 602 ES00281 Initial 450K 18 0.44 NA NA 29.8 9 muscle Kwashiorkor Not reported 604 ES00284 Initial 450K 196 NA NA NA NA NA whole blood diabetic kidney disease European 605 ES00285 Initial 450K 12 0.42 4 30 16.3 8.4 whole blood type 1 diabetes Not reported 607 ES00287 Initial 27K 11 1 NA NA 57.2 15.2 pancreatic islet control European 608 ES00288 Initial 450K 12 0.5 NA NA 68.3 7.7 subcutaneous adipose tissue Non-diabetic European 610 ES00290 Initial 450K 34 0.65 NA NA 56 9 pancreatic islet Non-diabetics Not reported 611 ES00291 Initial 450K 14 0.64 NA NA 67.6 7.7 adipose tissue Nondiabetic Not reported 612 ES00291 Initial 450K 14 0.64 NA NA 67.6 7.7 adipose tissue Type 2 diabetes Not reported 613 ES00291 Replication 450K 70 0.46 NA NA 53.4 7.4 adipose tissue normal glucose tolerance Not reported 614 ES00291 Replication 450K 50 0.52 NA NA 55.5 6.3 adipose tissue Type 2 diabetes Not reported 616 ES00293 Initial 450K 1074 0.67 NA NA 52.5 10.2 whole blood LOLIPOP The London Life Sciences Prospective Population Study Incident T2D Asian unspecified 617 ES00293 Initial 450K 749 0.68 NA NA 49.9 9.8 whole blood LOLIPOP The London Life Sciences Prospective Population Study Controls Asian unspecified 618 ES00293 Replication 450K 181 0.75 NA NA 60.7 8.7 whole blood LOLIPOP The London Life Sciences Prospective Population Study Incident T2D European 619 ES00294 Initial 450K 850 0.37 NA NA NA NA whole blood Hispanic or Latin American 620 ES00295 Initial 450K 60 0.28 NA NA 48.9 7.9 liver Nondiabetics Not reported 621 ES00296 Initial 450K 835 0.49 NA NA 62 NA whole blood ESTHER Nondiabetic Not reported 622 ES00296 Initial 450K 84 0.56 NA NA 64 NA whole blood ESTHER Diabetic, controlled Not reported 623 ES00297 Initial 450K 204 0.57 NA NA 75 11.4 whole blood BASICMAR_1 control European 624 ES00297 Initial 450K 151 0.6 NA NA 72.6 4.5 whole blood BASICMAR_1 type 2 diabetes mellitus European 625 ES00297 Replication 450K 108 0.51 NA NA 74.7 13.3 whole blood BASICMAR_ 2 control European 626 ES00298 Initial 450K 123 0.41 NA NA NA NA whole blood Greater Middle Eastern 627 ES00298 Replication 450K 877 0 NA NA NA NA whole blood European 628 ES00299 Initial 450K 123 0.41 NA NA NA NA whole blood Greater Middle Eastern 629 ES00299 Replication 450K 877 0 NA NA NA NA whole blood European 657 ES00300 Initial 450K 7 1 36.2 59.1 42.7 7.8 liver Non-Obese Controls European 658 ES00300 Initial 450K 7 1 36.4 59.8 45.8 7.6 liver Obese Non-Diabetic European 665 ES00303 Initial 450K 100 0.52 53 69 62 NA whole blood Lifelines Type 2 diabetic individuals European 666 ES00303 Initial 450K 98 0.449 46 63 50 NA whole blood Lifelines Control individuals European 669 ES00305 Initial 450K 14 0.64 2.3 10.3 4.65 2.42 bone marrow Hyperdiploidy (HHD) European 670 ES00305 Initial 450K 1 1 12.92 12.92 12.92 0 bone marrow Trisomy 5 European 671 ES00305 Initial 450K 1 1 11.75 11.75 11.75 0 bone marrow Hypodiploidy European 672 ES00305 Initial 450K 13 0.15 2.3 7 4.28 1.39 bone marrow t(12;21) European 673 ES00305 Initial 450K 1 0 11.8 11.8 11.8 0 bone marrow t(12;21) and trisomy 21 European 674 ES00305 Initial 450K 2 0.5 11.5 14.3 12.9 1.97 bone marrow t(9;22) European 675 ES00305 Initial 450K 1 1 3.8 3.8 3.8 0 bone marrow t(1;19) European 676 ES00305 Initial 450K 1 0 10.6 10.6 10.6 0 bone marrow t(4;11) European 677 ES00305 Initial 450K 1 1 2.6 2.6 2.6 0 bone marrow t(9;12) and monosomy 7 European 678 ES00305 Initial 450K 11 0.64 2.7 14 7.5 3.7 bone marrow No abnormal finding (NAF) European 679 ES00306 Initial 450K 20 NA NA NA NA NA bone marrow ETV6-RUNX1 Not reported 680 ES00306 Initial 450K 20 NA NA NA NA NA bone marrow high hyperdiploidy (51–65 chromosomes) Not reported 681 ES00306 Initial 450K 6 NA NA NA NA NA bone marrow TCF3-PBX1 Not reported 682 ES00306 Initial 450K 6 NA NA NA NA NA bone marrow dic(9;20)(p11–13; q11) Not reported 683 ES00306 Replication 450K 66 NA NA NA NA NA bone marrow high hyperdiploidy Not reported 684 ES00306 Replication 450K 57 NA NA NA NA NA bone marrow ETV6-RUNX1 Not reported 685 ES00307 Initial 450K 20 NA NA NA NA NA bone marrow ETV6-RUNX1 Not reported 686 ES00307 Initial 450K 20 NA NA NA NA NA bone marrow high hyperdiploidy (51–65 chromosomes) Not reported 687 ES00307 Initial 450K 6 NA NA NA NA NA bone marrow TCF3-PBX1 Not reported 688 ES00307 Initial 450K 6 NA NA NA NA NA bone marrow dic(9;20)(p11–13; q11) Not reported 689 ES00307 Replication 450K 66 NA NA NA NA NA bone marrow high hyperdiploidy Not reported 690 ES00307 Replication 450K 57 NA NA NA NA NA bone marrow ETV6-RUNX1 Not reported 691 ES00308 Initial 450K 20 NA NA NA NA NA bone marrow ETV6-RUNX1 Not reported 692 ES00308 Initial 450K 20 NA NA NA NA NA bone marrow high hyperdiploidy (51–65 chromosomes) Not reported 693 ES00308 Initial 450K 6 NA NA NA NA NA bone marrow TCF3-PBX1 Not reported 694 ES00308 Initial 450K 6 NA NA NA NA NA bone marrow dic(9;20)(p11–13; q11) Not reported 695 ES00308 Replication 450K 66 NA NA NA NA NA bone marrow high hyperdiploidy Not reported 696 ES00308 Replication 450K 57 NA NA NA NA NA bone marrow ETV6-RUNX1 Not reported 697 ES00309 Initial 450K 20 NA NA NA NA NA bone marrow ETV6-RUNX1 Not reported 698 ES00309 Initial 450K 20 NA NA NA NA NA bone marrow high hyperdiploidy (51–65 chromosomes) Not reported 699 ES00309 Initial 450K 6 NA NA NA NA NA bone marrow TCF3-PBX1 Not reported 700 ES00309 Initial 450K 6 NA NA NA NA NA bone marrow dic(9;20)(p11–13; q11) Not reported 701 ES00309 Replication 450K 66 NA NA NA NA NA bone marrow high hyperdiploidy Not reported 702 ES00309 Replication 450K 57 NA NA NA NA NA bone marrow ETV6-RUNX1 Not reported 707 ES00311 Initial 450K 40 0.53 NA NA NA NA bone marrow East Asian 714 ES00033 Replication 450K 1789 0.49 NA NA 60.9 8.9 whole blood KORA F4 Cooperative Health Research in the Region of Augsburg Second replication cohort European 715 ES00049 Replication 27K 25 0.2 16 68 35.2 12.4 CD4+ T cell Not reported 719 ES00055 Replication 27K 24 0.25 16 69 35 NA CD4+ T cell Not reported 720 ES00165 Initial 450K 500 0.52 NA NA 53.1 9.6 whole blood KORA F3 Cooperative Health Research in the Region of Augsburg Not reported 721 ES00165 Initial 450K 1799 0.49 NA NA 60.92 8.9 whole blood KORA F4 Cooperative Health Research in the Region of Augsburg Not reported 722 ES00165 Initial 450K 657 1 NA NA 72.44 6.9 whole blood NAS baseline Normative Aging Study NAS baseline Not reported 723 ES00166 Initial 450K 500 0.52 NA NA 53.1 9.6 whole blood KORA F3 Cooperative Health Research in the Region of Augsburg Not reported 724 ES00166 Initial 450K 1799 0.49 NA NA 60.92 8.9 whole blood KORA F4 Cooperative Health Research in the Region of Augsburg Not reported 725 ES00166 Initial 450K 657 1 NA NA 72.44 6.9 whole blood NAS baseline Normative Aging Study NAS baseline Not reported 726 ES00078 Initial 450K 47 0 NA NA 46 8 lymphoblast IAS Iowa Adoptions Studies mild (use of alcohol in between 1 and 8 weeks the past 6 months) Not reported,European 727 ES00078 Initial 450K 50 0 NA NA 44 8 lymphoblast IAS Iowa Adoptions Studies moderate users (use of alcohol in between 9 and 25 weeks in the past 6 months) European,Not reported 728 ES00078 Initial 450K 28 0 NA NA 46 8 lymphoblast IAS Iowa Adoptions Studies heavy users (alcohol use in every week in the past 6 months) Not reported,European 729 ES00079 Initial 450K 40 0 NA NA 47 8 lymphoblast IAS Iowa Adoptions Studies abstinent (no use in the past 6 months) European,Not reported 730 ES00079 Initial 450K 47 0 NA NA 46 8 lymphoblast IAS Iowa Adoptions Studies mild (use of alcohol in between 1 and 8 weeks the past 6 months) Not reported,European 731 ES00079 Initial 450K 50 0 NA NA 44 8 lymphoblast IAS Iowa Adoptions Studies moderate users (use of alcohol in between 9 and 25 weeks in the past 6 months) Not reported,European 732 ES00079 Initial 450K 28 0 NA NA 46 8 lymphoblast IAS Iowa Adoptions Studies heavy users (alcohol use in every week in the past 6 months) European,Not reported 733 ES00080 Initial 27K 56 0.5 50 60 54 3 peripheral blood ESTHER Former smoker: abstinent for past 10+ years, but smoking >= 20 cigarettes per day before Not reported 734 ES00080 Initial 27K 56 0.48 50 60 54 3 peripheral blood ESTHER Never smoker: lifetime smoking <= 100 cigarettes, never regularly smoking Not reported 735 ES00080 Replication 27K 97 0.63 NA NA 55 3 peripheral blood Not reported 736 ES00080 Replication 27K 124 0.59 NA NA 55 3 peripheral blood Not reported 737 ES00086 Initial 450K 180 0 NA NA NA NA leukocyte EPIC-Turin European Prospective Investigation into Cancer and Nutrition Not reported 738 ES00088 Replication 450K 236 0.51 35 80 52.8 NA whole blood KORA F3 Kooperative Gesundheitsforschung in der Region Augsburg Current smokers Not reported 739 ES00088 Replication 450K 232 0.5 34 83 53.2 NA whole blood KORA F3 Kooperative Gesundheitsforschung in der Region Augsburg Never smokers Not reported 741 ES00095 Initial 450K 61 0 NA NA 48.7 11 peripheral blood mononuclear cell FACHS Family and Community Health Study non-smoker African American or Afro-Caribbean 742 ES00096 Initial 450K 118 0 NA NA 50.3 4.8 whole blood Sister Study National Institute of Environmental Health Sciences (NIEHS) Sister Study Never-smoker European 743 ES00096 Initial 450K 70 0 NA NA 51.2 5 whole blood Sister Study National Institute of Environmental Health Sciences (NIEHS) Sister Study Former smoker European 744 ES00096 Initial 450K 12 0 NA NA 50.5 3.6 whole blood Sister Study National Institute of Environmental Health Sciences (NIEHS) Sister Study Current smoker European 753 ES00094 Initial 450K 10 1 NA NA 46.6 4.4 peripheral blood SABRE Southall And Brent REvisited Former smokers South Asian 754 ES00094 Initial 450K 20 1 NA NA 47.8 4.3 peripheral blood SABRE Southall And Brent REvisited Current smokers South Asian 755 ES00094 Initial 450K 65 1 NA NA 48.5 4.6 peripheral blood SABRE Southall And Brent REvisited Never smokers European 756 ES00094 Initial 450K 14 1 NA NA 47.9 4.2 peripheral blood SABRE Southall And Brent REvisited Former smokers European 757 ES00094 Initial 450K 16 1 NA NA 46.9 3.9 peripheral blood SABRE Southall And Brent REvisited Current smokers European 758 ES00098 Initial 450K 52 0.48 NA NA 66.8 8.4 buccal mucosa COPDGene Former Smokers European,African American or Afro-Caribbean 759 ES00098 Replication 450K 43 0.44 NA NA 59.7 8.1 buccal mucosa COPDGene Current Smokers European,African American or Afro-Caribbean 760 ES00098 Replication 450K 87 0.47 NA NA 65.3 8.1 buccal mucosa COPDGene Former Smokers European,African American or Afro-Caribbean 765 ES00100 Initial 450K 270 0 NA NA 54.2 7.1 whole blood EPIC-Italy European Prospective Investigation into Cancer and Nutrition Never smokers European 766 ES00100 Initial 450K 86 0 NA NA 52.9 7.2 whole blood EPIC-Italy European Prospective Investigation into Cancer and Nutrition Former smokers European 767 ES00100 Initial 450K 95 0 NA NA 50.4 7.5 whole blood EPIC-Italy European Prospective Investigation into Cancer and Nutrition Current smokers European 768 ES00100 Initial 450K 135 0 NA NA 55.8 4.2 whole blood NOWAC Never smokers European 769 ES00100 Initial 450K 77 0 NA NA 56 4.6 whole blood NOWAC Former smokers European 770 ES00100 Initial 450K 82 0 NA NA 54.2 4.2 whole blood NOWAC Current smokers European 771 ES00101 Initial 450K 270 0 NA NA 54.2 7.1 whole blood EPIC-Italy European Prospective Investigation into Cancer and Nutrition Never smokers European 772 ES00101 Initial 450K 86 0 NA NA 52.9 7.2 whole blood EPIC-Italy European Prospective Investigation into Cancer and Nutrition Former smokers European 773 ES00101 Initial 450K 95 0 NA NA 50.4 7.5 whole blood EPIC-Italy European Prospective Investigation into Cancer and Nutrition Current smokers European 774 ES00101 Initial 450K 135 0 NA NA 55.8 4.2 whole blood NOWAC Never smokers European 775 ES00101 Initial 450K 77 0 NA NA 56 4.6 whole blood NOWAC Former smokers European 776 ES00101 Initial 450K 82 0 NA NA 54.2 4.2 whole blood NOWAC Current smokers European 777 ES00352 Initial 450K 270 0 NA NA 54.2 7.1 whole blood EPIC-Italy European Prospective Investigation into Cancer and Nutrition Never smokers European 778 ES00352 Initial 450K 86 0 NA NA 52.9 7.2 whole blood EPIC-Italy European Prospective Investigation into Cancer and Nutrition Former smokers European 779 ES00352 Initial 450K 95 0 NA NA 50.4 7.5 whole blood EPIC-Italy European Prospective Investigation into Cancer and Nutrition Current smokers European 780 ES00352 Initial 450K 135 0 NA NA 55.8 4.2 whole blood NOWAC Never smokers European 781 ES00352 Initial 450K 77 0 NA NA 56 4.6 whole blood NOWAC Former smokers European 782 ES00352 Initial 450K 82 0 NA NA 54.2 4.2 whole blood NOWAC Current smokers European 789 ES00102 Initial 450K 51 1 NA NA 36.3 17.2 whole blood Greater Middle Eastern 790 ES00103 Initial 450K 72 0 NA NA 36.3 17.2 whole blood Greater Middle Eastern 791 ES00103 Initial 450K 51 1 NA NA 36.3 17.2 whole blood Greater Middle Eastern 792 ES00104 Initial 450K 72 0 NA NA 36.3 17.2 whole blood Greater Middle Eastern 793 ES00104 Initial 450K 51 1 NA NA 36.3 17.2 whole blood Greater Middle Eastern 795 ES00109 Initial 27K 66 0.35 NA NA 66.6 7.6 whole blood COPDGene Former smokers European 796 ES00111 Initial 450K 271 0.47 NA NA 60.9 8.5 whole blood RS Rotterdam Study Former smokers European 797 ES00111 Initial 450K 184 0.72 NA NA 59 8.1 whole blood RS Rotterdam Study Never smokers European 798 ES00113 Initial 450K 31 0.26 NA NA 62 10.7 whole blood REGICOR EWAS nested in the Girona Heart Registry Former Smokers, 1 to 5 y European 799 ES00113 Initial 450K 165 0.28 NA NA 63.8 10.7 whole blood REGICOR EWAS nested in the Girona Heart Registry Former Smokers, > 5 y European 800 ES00113 Initial 450K 342 0.67 NA NA 65.1 11.9 whole blood REGICOR EWAS nested in the Girona Heart Registry Never Smokers European 801 ES00113 Replication 450K 172 0.78 NA NA 70 17 whole blood BAsicMAR Current Smokers Not reported 802 ES00113 Replication 450K 205 0.28 NA NA 79 9 whole blood BAsicMAR Never Smokers Not reported 805 ES00114 Initial 450K 189 0 NA NA 51.6 8.9 whole blood EPIC European Prospective Investigation into Cancer and Nutrition Former smokers European 806 ES00114 Initial 450K 193 0 NA NA 48.6 8.8 whole blood EPIC European Prospective Investigation into Cancer and Nutrition Current smokers European 807 ES00116 Replication 450K 97 0.56 59 72 66 NA lung TCGA Light smoking Not reported 808 ES00116 Replication 450K 88 0.69 62 72.2 67 NA lung TCGA Heavy smoking Not reported 809 ES00117 Initial 450K 720 0.5 NA NA 56.2 5.8 buffy coat Current smokers African American or Afro-Caribbean 810 ES00117 Initial 450K 866 0.48 NA NA 57.2 5.9 buffy coat Former smokers African American or Afro-Caribbean 811 ES00117 Initial 450K 1262 0.21 NA NA 56.5 5.8 buffy coat Never smokers African American or Afro-Caribbean 812 ES00117 Initial 450K 94 0.37 NA NA 43.4 11.7 whole blood Current smokers African American or Afro-Caribbean 813 ES00117 Initial 450K 64 0.27 NA NA 44.6 13.1 whole blood Former smokers African American or Afro-Caribbean 814 ES00117 Initial 450K 128 0.24 NA NA 38.4 12.9 whole blood Never smokers African American or Afro-Caribbean 815 ES00117 Initial 450K 30 0.47 NA NA 70.4 4.9 whole blood Current smokers African American or Afro-Caribbean 816 ES00117 Initial 450K 66 0.53 NA NA 72.7 5.2 whole blood Former smokers African American or Afro-Caribbean 817 ES00117 Initial 450K 96 0.19 NA NA 74.1 5.6 whole blood Never smokers African American or Afro-Caribbean 818 ES00117 Initial 450K 77 0.51 NA NA 58.7 79 buffy coat Current smokers African American or Afro-Caribbean 819 ES00117 Initial 450K 111 0.42 NA NA 61.7 7.7 buffy coat Former smokers African American or Afro-Caribbean 820 ES00117 Initial 450K 232 0.15 NA NA 61 7.4 buffy coat Never smokers African American or Afro-Caribbean 821 ES00117 Initial 450K 274 0.52 NA NA 62.5 7.8 whole blood Current smokers European 822 ES00117 Initial 450K 1538 0.51 NA NA 67.4 8.5 whole blood Former smokers European 823 ES00117 Initial 450K 836 0.34 NA NA 65.8 9.6 whole blood Never smokers European 824 ES00117 Initial 450K 262 0.54 NA NA 57 7 whole blood Current smokers European 825 ES00117 Initial 450K 782 0.61 NA NA 61.1 9 whole blood Former smokers European 826 ES00117 Initial 450K 753 0.35 NA NA 62.1 8.9 whole blood Never smokers European 827 ES00117 Initial 450K 73 0.49 NA NA 44 13 CD4+ T cell Current smokers European 828 ES00117 Initial 450K 216 0.58 NA NA 56 14 CD4+ T cell Former smokers European 829 ES00117 Initial 450K 703 0.45 NA NA 47 17 CD4+ T cell Never smokers European 830 ES00117 Initial 450K 31 0.36 NA NA 79.2 0.5 whole blood Current smokers European 831 ES00117 Initial 450K 213 0.46 NA NA 79.1 0.6 whole blood Former smokers European 832 ES00117 Initial 450K 201 0.33 NA NA 79.1 0.6 whole blood Never smokers European 833 ES00117 Initial 450K 103 0.46 NA NA 69.5 0.7 whole blood Current smokers European 834 ES00117 Initial 450K 385 0.58 NA NA 69.6 0.8 whole blood Former smokers European 835 ES00117 Initial 450K 432 0.45 NA NA 69.5 0.8 whole blood Never smokers European 836 ES00117 Initial 450K 26 1 NA NA 68.2 6.1 whole blood Current smokers European 837 ES00117 Initial 450K 431 1 NA NA 72.3 6.6 whole blood Former smokers European 838 ES00117 Initial 450K 187 1 NA NA 73.8 7.3 whole blood Never smokers European 839 ES00117 Initial 450K 169 0.45 NA NA 58 6.8 whole blood Current smokers European 840 ES00117 Initial 450K 307 0.47 NA NA 61.6 8.6 whole blood Former smokers European 841 ES00117 Initial 450K 210 0.37 NA NA 59.2 8.4 whole blood Never smokers European 842 ES00117 Initial 450K 50 0.52 NA NA 58.9 58.9 whole blood Current smokers European 843 ES00117 Initial 450K 170 0.72 NA NA 74.3 12.2 whole blood Former smokers European 844 ES00117 Initial 450K 288 0.28 NA NA 72.6 16.6 whole blood Never smokers European 845 ES00117 Initial 450K 23 0.35 NA NA 74.1 4.2 whole blood Current smokers European 846 ES00117 Initial 450K 76 0.58 NA NA 75.6 5.1 whole blood Former smokers European 847 ES00117 Initial 450K 85 0.34 NA NA 76.8 5.2 whole blood Never smokers European 848 ES00117 Initial 450K 191 0.54 NA NA 58.3 8.4 buffy coat Current smokers European 849 ES00117 Initial 450K 463 0.65 NA NA 61.4 8.7 buffy coat Former smokers European 850 ES00117 Initial 450K 529 0.35 NA NA 59.9 8.9 buffy coat Never smokers European 851 ES00117 Initial 450K 114 0.55 NA NA 65 8 CD14+ monocyte Current smokers Hispanic or Latin American,European,African American or Afro-Caribbean 852 ES00117 Initial 450K 640 0.56 NA NA 70 9 CD14+ monocyte Former smokers Hispanic or Latin American,European,African American or Afro-Caribbean 853 ES00117 Initial 450K 502 0.38 NA NA 70 10 CD14+ monocyte Never smokers African American or Afro-Caribbean,Hispanic or Latin American,European 854 ES00117 Initial 450K 196 0 NA NA 48.9 8.8 buffy coat Current smokers European 855 ES00117 Initial 450K 190 0 NA NA 51.3 8.9 buffy coat Former smokers European 856 ES00117 Initial 450K 512 0 NA NA 54 8.6 buffy coat Never smokers European 857 ES00118 Initial 450K 720 0.5 NA NA 56.2 5.8 buffy coat Current smokers African American or Afro-Caribbean 858 ES00118 Initial 450K 866 0.48 NA NA 57.2 5.9 buffy coat Former smokers African American or Afro-Caribbean 859 ES00118 Initial 450K 1262 0.21 NA NA 56.5 5.8 buffy coat Never smokers African American or Afro-Caribbean 860 ES00118 Initial 450K 94 0.37 NA NA 43.4 11.7 whole blood Current smokers African American or Afro-Caribbean 861 ES00118 Initial 450K 64 0.27 NA NA 44.6 13.1 whole blood Former smokers African American or Afro-Caribbean 862 ES00118 Initial 450K 128 0.24 NA NA 38.4 12.9 whole blood Never smokers African American or Afro-Caribbean 863 ES00118 Initial 450K 30 0.47 NA NA 70.4 4.9 whole blood Current smokers African American or Afro-Caribbean 864 ES00118 Initial 450K 66 0.53 NA NA 72.7 5.2 whole blood Former smokers African American or Afro-Caribbean 865 ES00118 Initial 450K 96 0.19 NA NA 74.1 5.6 whole blood Never smokers African American or Afro-Caribbean 866 ES00118 Initial 450K 77 0.51 NA NA 58.7 79 buffy coat Current smokers African American or Afro-Caribbean 867 ES00118 Initial 450K 111 0.42 NA NA 61.7 7.7 buffy coat Former smokers African American or Afro-Caribbean 868 ES00118 Initial 450K 232 0.15 NA NA 61 7.4 buffy coat Never smokers African American or Afro-Caribbean 869 ES00118 Initial 450K 274 0.52 NA NA 62.5 7.8 whole blood Current smokers European 870 ES00118 Initial 450K 1538 0.51 NA NA 67.4 8.5 whole blood Former smokers European 871 ES00118 Initial 450K 836 0.34 NA NA 65.8 9.6 whole blood Never smokers European 872 ES00118 Initial 450K 262 0.54 NA NA 57 7 whole blood Current smokers European 873 ES00118 Initial 450K 782 0.61 NA NA 61.1 9 whole blood Former smokers European 874 ES00118 Initial 450K 753 0.35 NA NA 62.1 8.9 whole blood Never smokers European 875 ES00118 Initial 450K 73 0.49 NA NA 44 13 CD4+ T cell Current smokers European 876 ES00118 Initial 450K 216 0.58 NA NA 56 14 CD4+ T cell Former smokers European 877 ES00118 Initial 450K 703 0.45 NA NA 47 17 CD4+ T cell Never smokers European 878 ES00118 Initial 450K 31 0.36 NA NA 79.2 0.5 whole blood Current smokers European 879 ES00118 Initial 450K 213 0.46 NA NA 79.1 0.6 whole blood Former smokers European 880 ES00118 Initial 450K 201 0.33 NA NA 79.1 0.6 whole blood Never smokers European 881 ES00118 Initial 450K 103 0.46 NA NA 69.5 0.7 whole blood Current smokers European 882 ES00118 Initial 450K 385 0.58 NA NA 69.6 0.8 whole blood Former smokers European 883 ES00118 Initial 450K 432 0.45 NA NA 69.5 0.8 whole blood Never smokers European 884 ES00118 Initial 450K 26 1 NA NA 68.2 6.1 whole blood Current smokers European 885 ES00118 Initial 450K 431 1 NA NA 72.3 6.6 whole blood Former smokers European 886 ES00118 Initial 450K 187 1 NA NA 73.8 7.3 whole blood Never smokers European 887 ES00118 Initial 450K 169 0.45 NA NA 58 6.8 whole blood Current smokers European 888 ES00118 Initial 450K 307 0.47 NA NA 61.6 8.6 whole blood Former smokers European 889 ES00118 Initial 450K 210 0.37 NA NA 59.2 8.4 whole blood Never smokers European 890 ES00118 Initial 450K 50 0.52 NA NA 58.9 58.9 whole blood Current smokers European 891 ES00118 Initial 450K 170 0.72 NA NA 74.3 12.2 whole blood Former smokers European 892 ES00118 Initial 450K 288 0.28 NA NA 72.6 16.6 whole blood Never smokers European 893 ES00118 Initial 450K 23 0.35 NA NA 74.1 4.2 whole blood Current smokers European 894 ES00118 Initial 450K 76 0.58 NA NA 75.6 5.1 whole blood Former smokers European 895 ES00118 Initial 450K 85 0.34 NA NA 76.8 5.2 whole blood Never smokers European 896 ES00118 Initial 450K 191 0.54 NA NA 58.3 8.4 buffy coat Current smokers European 897 ES00118 Initial 450K 463 0.65 NA NA 61.4 8.7 buffy coat Former smokers European 898 ES00118 Initial 450K 529 0.35 NA NA 59.9 8.9 buffy coat Never smokers European 899 ES00118 Initial 450K 114 0.55 NA NA 65 8 CD14+ monocyte Current smokers Hispanic or Latin American,European,African American or Afro-Caribbean 900 ES00118 Initial 450K 640 0.56 NA NA 70 9 CD14+ monocyte Former smokers African American or Afro-Caribbean,Hispanic or Latin American,European 901 ES00118 Initial 450K 502 0.38 NA NA 70 10 CD14+ monocyte Never smokers African American or Afro-Caribbean,Hispanic or Latin American,European 902 ES00118 Initial 450K 196 0 NA NA 48.9 8.8 buffy coat Current smokers European 903 ES00118 Initial 450K 190 0 NA NA 51.3 8.9 buffy coat Former smokers European 904 ES00118 Initial 450K 512 0 NA NA 54 8.6 buffy coat Never smokers European 905 ES00119 Initial 450K 30 1 NA NA 74.1 7.4 whole blood COPD Chronic Obstructive Pulmonary Disease cohort Former smokers East Asian 906 ES00119 Initial 450K 31 0.97 NA NA 71.5 5.3 whole blood COPD Chronic Obstructive Pulmonary Disease cohort Current smokers East Asian 910 ES00120 Initial 450K 8 0.88 52 71 61 2.33 lung Smokers Not reported 911 ES00355 Initial 450K 8 0.75 55 69 62.6 1.87 lung Non-smokers Not reported 912 ES00355 Initial 450K 8 0.63 45 63 56.1 2.6 lung COPD Not reported 913 ES00356 Initial 450K 8 0.88 52 71 61 2.3 lung Smokers Not reported 914 ES00356 Initial 450K 8 0.63 45 63 56.1 2.6 lung COPD Not reported 915 ES00121 Initial 450K 19 1 NA NA NA NA sperm heavy smokers Not reported 916 ES00122 Initial 450K 78 1 NA NA 31.2 0.6 sperm non-smokers Not reported 917 ES00123 Initial 450K 449 0.64 NA NA 54.7 8.8 whole blood KORA F4 Kooperative Gesundheitsforschung in der Region Augsburg Former smokers baseline Not reported 918 ES00123 Initial 450K 615 0.35 NA NA 55.1 9 whole blood KORA F4 Kooperative Gesundheitsforschung in der Region Augsburg Never smokers baseline Not reported 919 ES00357 Initial 450K 280 0.57 NA NA 50.8 7.8 whole blood KORA F4 Kooperative Gesundheitsforschung in der Region Augsburg Current smokers baseline Not reported 920 ES00357 Initial 450K 449 0.64 NA NA 54.7 8.8 whole blood KORA F4 Kooperative Gesundheitsforschung in der Region Augsburg Former smokers baseline Not reported 921 ES00357 Initial 450K 615 0.35 NA NA 55.1 9 whole blood KORA F4 Kooperative Gesundheitsforschung in der Region Augsburg Never smokers baseline Not reported 922 ES00357 Initial 450K 207 0.55 NA NA 57.1 7 whole blood KORA F4 Kooperative Gesundheitsforschung in der Region Augsburg Current smokers follow-up Not reported 923 ES00357 Initial 450K 523 0.64 NA NA 61.5 8.9 whole blood KORA F4 Kooperative Gesundheitsforschung in der Region Augsburg Former smokers follow-up Not reported 924 ES00357 Initial 450K 614 0.35 NA NA 62.2 9 whole blood KORA F4 Kooperative Gesundheitsforschung in der Region Augsburg Never smokers follow-up Not reported 925 ES00124 Initial 27K 12 0.58 NA NA 39.3 3.81 alveolar macrophage heavy smokers Not reported,African American or Afro-Caribbean 926 ES00126 Initial 450K 23 1 NA NA 37.3 4.4 adipose tissue After exercise Not reported 927 ES00129 Initial 450K 11 1 NA NA 22.45 4.74 sperm 3 months of exercise training Not reported 928 ES00130 Initial 450K 8 1 NA NA 21.1 2.2 leukocyte control Not reported 929 ES00131 Initial 450K 12 0 NA NA 64.8 4.6 peripheral blood mononuclear cell six-month self-management intervention Not reported 932 ES00132 Initial 450K 190 0.42 5 14 10.2 NA saliva 94 maltreated children and 96 healthy control children African American or Afro-Caribbean,Other admixed ancestry,Hispanic or Latin American,European 950 ES00363 Initial 450K 88 0.47 21 85 54.7 14.8 brain TCGA The Cancer Genome Atlas Not reported 952 ES00365 Initial 450K 30 0.57 0 0 0 0 cord blood Gestational diabetes East Asian 953 ES00365 Initial 450K 33 0.52 0 0 0 0 cord blood Normal pregnancy East Asian 955 ES00367 Initial 450K 30 0.63 0 0 0 0 cord blood 15 monozygotic twin pairs who later became discordant for CP Aboriginal Australian 958 ES00138 Initial 450K 17 1 NA NA NA NA subcutaneous adipose tissue LIPOGAIN Not reported 963 ES00374 Initial 450K 348 0.46 NA NA 58.9 0.5 whole blood Dutch Hunger Winter Families study European 964 ES00374 Initial 450K 160 0.45 NA NA 59.2 2 whole blood Dutch Hunger Winter Families study European 965 ES00374 Initial 450K 303 0.42 NA NA 2 6.4 whole blood Dutch Hunger Winter Families study European 966 ES00146 Initial 450K 43 0.49 NA NA 71.1 3 leukocyte B-PROOF Placebo Not reported 967 ES00147 Initial 450K 44 0.43 NA NA 70.8 2.9 leukocyte B-PROOF Folic acid and vitamin B12 intervention Not reported 968 ES00147 Initial 450K 43 0.49 NA NA 71.1 3 leukocyte B-PROOF Placebo Not reported 969 ES00148 Initial 450K 44 0.43 NA NA 70.8 2.9 leukocyte B-PROOF Folic acid and vitamin B12 intervention Not reported 970 ES00148 Initial 450K 43 0.49 NA NA 71.1 3 leukocyte B-PROOF Placebo Not reported 971 ES00149 Initial 450K 44 0.43 NA NA 70.8 2.9 leukocyte B-PROOF Folic acid and vitamin B12 intervention Not reported 972 ES00149 Initial 450K 43 0.49 NA NA 71.1 3 leukocyte B-PROOF Placebo Not reported 994 ES00154 Replication 450K 36 NA 0 0 0 0 cord blood NEST Newborn Epigenetics Study European 1002 ES00157 Replication 450K 14 0.21 NA NA 37.2 12.5 whole blood Case Group II European,Not reported 1003 ES00159 Initial 450K 8 0.5 21 61 NA NA peripheral blood mononuclear cell Controls Not reported 1013 ES00179 Initial 450K 17 0.76 NA NA 26.9 4.7 adipose tissue LIPOGAIN SFA group Overfeeding Not reported 1014 ES00179 Initial 450K 14 0.64 NA NA 27 4 adipose tissue LIPOGAIN PUFA group Baseline Not reported 1015 ES00179 Initial 450K 14 0.64 NA NA 27 4 adipose tissue LIPOGAIN Not reported 1018 ES00389 Initial 450K 66 0.47 NA NA 66 9.2 lung TCGA The Cancer Genome Atlas tumor Not reported 1019 ES00389 Initial 450K 65 0.49 NA NA 65 8.4 lung TCGA The Cancer Genome Atlas normal Not reported 1020 ES00180 Replication 450K 54 0 NA NA NA NA whole blood control African American or Afro-Caribbean 1021 ES00180 Replication 450K 41 0 NA NA NA NA whole blood spontaneous PTB African American or Afro-Caribbean 1022 ES00180 Initial 450K 14 0 NA NA NA NA whole blood medically-indicated PTB African American or Afro-Caribbean 1023 ES00181 Initial 450K 5 0.8 0 0 0 0 T cell term (GA 38 weeks) Not reported 1024 ES00182 Initial 450K 5 0.6 0 0 0 0 granulocyte preterm (GA range 26– 30 weeks) Not reported 1025 ES00182 Initial 450K 5 0.8 0 0 0 0 granulocyte term (GA 38 weeks) Not reported 1026 ES00183 Initial 450K 5 0.6 0 0 0 0 monocyte preterm (GA range 26– 30 weeks) Not reported 1027 ES00183 Initial 450K 5 0.8 0 0 0 0 monocyte term (GA 38 weeks) Not reported 1028 ES00184 Initial 450K 5 0.6 0 0 0 0 nucleated red blood cell preterm (GA range 26– 30 weeks) Not reported 1029 ES00184 Initial 450K 5 0.8 0 0 0 0 nucleated red blood cell term (GA 38 weeks) Not reported 1032 ES00198 Initial 450K 38 1 NA NA 27.9 0.9 sperm Normal motility Not reported 1033 ES00199 Initial 450K 23 1 NA NA 29.1 1.2 sperm Low viability Not reported 1034 ES00199 Initial 450K 35 1 NA NA 27.6 0.9 sperm Normal viability Not reported 1041 ES00204 Initial 450K 22 0.5 NA NA 41.6 2.8 leukocyte CARDIA Coronary Artery Risk Development in Young Adults European 1042 ES00205 Initial 450K 10 0.7 NA NA 37 9.8 whole blood Controls South Asian 1044 ES00214 Initial 450K 6 NA NA NA NA NA B lymphoblastoid cell Not reported 1045 ES00215 Initial 450K 6 NA NA NA NA NA B lymphoblastoid cell Not reported 1051 ES00221 Initial 450K 41 0.33 NA NA 37.56 11.4 airway epithelial cell Control Not reported 1066 ES00223 Replication 450K 24 NA NA NA NA NA whole blood AWHS Aragon Workers’ Health Study Not reported 1074 ES00227 Replication 27K 415 1 NA NA NA NA whole blood ASD Not reported 1075 ES00227 Replication 27K 405 1 NA NA NA NA whole blood control Not reported 1087 ES00229 Initial 450K 20 0.6 NA NA NA NA whole blood carriers of the linked haplotye (LH) Not reported 1088 ES00229 Initial 450K 9 0.33 NA NA NA NA whole blood m Not reported 1089 ES00230 Initial 450K 10 0.5 NA NA NA NA whole blood Bipolar disorder and major depressive disorder patientsaffected carriers of the linked haplotye(ALH) Not reported 1090 ES00230 Initial 450K 9 0.33 NA NA NA NA whole blood married-in controls Not reported 1091 ES00231 Initial 450K 22 0.46 NA NA 21.4 3.2 whole blood BFS Scottish Bipolar Family Study well high-risk individuals who developed a mood disorder Not reported 1096 ES00233 Initial 450K 5 NA 0 0 0 0 placenta 1st Trimester T16 Not reported 1097 ES00233 Initial 450K 10 NA 0 0 0 0 placenta 3rd Trimester control Not reported 1098 ES00233 Initial 450K 10 NA 0 0 0 0 placenta 3rd Trimester CPM16 Not reported 1099 ES00234 Initial 450K 24 0.83 0 0 0 0 peripheral blood lymphocyte Case Not reported 1100 ES00235 Initial 450K 196 0.45 NA NA 1.4 NA leukocyte Controls Not reported 1101 ES00236 Initial 450K 319 0.49 NA NA 61.5 8.6 whole blood Rotterdam Study Former smokers European 1102 ES00236 Initial 450K 210 0.37 NA NA 59.2 8.4 whole blood Rotterdam Study Never smokers European 1111 ES00240 Initial 450K 18 0.71 12.2 14.1 11.9 NA leukocyte BISCUIT Scottish Children Undergoing Investigation before Treatment study patients Not reported 1112 ES00240 Initial 450K 18 0.71 11 14.3 12.7 NA leukocyte BISCUIT Scottish Children Undergoing Investigation before Treatment study controls Not reported 1113 ES00240 Replication 450K 18 0.78 8.4 12.8 11.7 NA leukocyte PICTS Paediatric-onset IBD Cohort and Treatment Study patients Not reported 1114 ES00240 Replication 450K 18 0.78 8.6 12.9 11.3 NA leukocyte BISCUIT Scottish Children Undergoing Investigation before Treatment study controls Not reported 1117 ES00241 Initial 450K 18 0 22 43 NA NA whole blood case Not reported 1118 ES00241 Initial 450K 25 0 21 43 NA NA whole blood control Not reported 1119 ES00242 Initial 450K 9 0.67 NA NA 57.2 6.5 right ventricle control Not reported 1120 ES00413 Initial 450K 788 NA NA NA 29.7 4.4 cord blood ALSPAC European 1121 ES00413 Initial 450K 132 NA NA NA 27.2 5.7 whole blood CBC Hispanic or Latin American 1122 ES00413 Initial 450K 155 NA NA NA 32 5.7 cord blood CBC European 1123 ES00413 Initial 450K 368 NA NA NA 25.3 5 cord blood CHAMACOS Hispanic or Latin American 1124 ES00413 Initial 450K 211 NA NA NA 34 4.7 cord blood EARLI European,Other admixed ancestry 1125 ES00413 Initial 450K 176 NA NA NA 30.4 4 cord blood GECKO European 1126 ES00413 Initial 450K 170 NA NA NA 28 4.1 cord blood GEN3G European 1127 ES00413 Initial 450K 875 NA NA NA 31.5 4.2 cord blood Generation R European 1128 ES00413 Initial 450K 545 NA NA NA 29.5 4.1 cord blood GOYA European 1129 ES00413 Initial 450K 53 NA NA NA 21.5 1.4 cord blood IOW F2 European 1130 ES00413 Initial 450K 330 NA NA NA 30.6 4.5 cord blood MEDALL European 1131 ES00413 Initial 450K 1034 NA NA NA 29.9 4.3 cord blood MoBa1 European 1132 ES00413 Initial 450K 647 NA NA NA 30 4.5 cord blood MoBa2 European 1133 ES00413 Initial 450K 231 NA NA NA 29.6 4.4 cord blood MoBa3 European 1134 ES00413 Initial 450K 384 NA NA NA 28.8 6.4 cord blood NEST Other 1135 ES00413 Initial 450K 867 NA NA NA 29.1 4.9 cord blood NFCS European 1136 ES00413 Initial 450K 118 NA NA NA 31 4.4 cord blood NHBCS European 1137 ES00413 Initial 450K 96 NA NA NA 28.3 5.5 cord blood RICHS European 1138 ES00413 Initial 450K 343 NA NA NA 33.1 4.5 cord blood Project Viva European 1139 ES00413 Replication 450K 221 NA NA NA 31.2 4.3 cord blood BAMSE European 1140 ES00413 Replication 450K 279 NA NA NA 37.3 5.2 cord blood OW F1 European 1141 ES00413 Replication 450K 583 NA NA NA 30.9 3.7 cord blood PIAMA European 1142 ES00413 Replication 450K 734 NA NA NA 29.1 5.8 cord blood RAINE European 1143 ES00413 Replication 450K 734 NA NA NA 29.1 5.8 cord blood RAINE European 1144 ES00370 Initial 450K 700 0.45 NA NA 59.8 8 leukocyte RS Rotterdam Study European 1145 ES00370 Initial 450K 550 0.48 NA NA 58.7 6.6 leukocyte LLS Leiden Longevity Study European 1146 ES00370 Initial 450K 186 0.45 NA NA 65.3 7 leukocyte CODAM Cohort on Diabetes and Atherosclerosis Maastricht European 1147 ES00370 Initial 450K 293 0.2 NA NA 43.5 14.3 leukocyte MARTHA MARseille Thrombosis Association Study European 1148 ES00370 Initial 450K 96 0.5 NA NA 52.4 23.7 leukocyte EGCUT Estonian Biobank European 1149 ES00370 Initial 450K 210 0.48 NA NA 39.8 16.8 leukocyte FrenchCanadian family study on F5L thrombophilia European 1153 ES00420 Initial 450K 41 1 NA NA 56.4 0.6 leukocyte LLSLFH Leuven Longitudinal Study on Lifestyle, Fitness and Health European 1154 ES00414 Initial 450K 66 0 29 75 54.1 9.1 whole blood monozygotic female twin pairs European 1155 ES00422 Initial 450K 423 NA 56 66 61 NA prostate TCGA Prostate cancer Not reported,European,Asian unspecified,African American or Afro-Caribbean 1156 ES00422 Initial 450K 39 NA 55 66 61 NA prostate Adjacent Not reported,European,African American or Afro-Caribbean 1171 ES00428 Initial 450K 64 0 NA NA 28.9 4.8 cord blood TMICS Taiwan Maternal and Infant Cohort Study East Asian 1176 ES00434 Initial 450K 16 0.56 0 0 0 0 placenta control Not reported 1177 ES00435 Initial 450K 132 0.76 NA NA 59.5 14.6 liver pairs of HCC tumor and adjacent non-tumor tissues Asian unspecified,Other,African American or Afro-Caribbean,Hispanic or Latin American,European 1180 ES00437 Initial 450K 10 0.5 0 0 0 0 cord blood Exposed Not reported 1181 ES00437 Initial 450K 10 0.5 0 0 0 0 cord blood Non-exposed Not reported 1182 ES00438 Initial 450K 100 0 18 82 37.2 NA breast cancer-free women European,African American or Afro-Caribbean,Hispanic or Latin American 1183 ES00438 Replication 450K 18 0 13 80 49 NA breast NDRI National Disease Research Interchange ductal carcinoma Not reported 1184 ES00438 Replication 450K 97 0 28 90 57.57 NA breast TCGA The Cancer Genome Atlas invasive ductal carcinoma Not reported 1185 ES00439 Initial 450K 171 1 NA NA 49.5 7.6 whole blood Current (Case) European,Other 1186 ES00439 Initial 450K 100 1 NA NA 48.3 7.8 whole blood Past Other,European 1187 ES00439 Initial 450K 202 1 NA NA 50 8.4 whole blood Never (Control) Other,European 1188 ES00440 Initial 450K 116 1 NA NA 50 8 whole blood Current (Case) Other,European 1189 ES00440 Initial 450K 60 1 NA NA 49.2 8.2 whole blood Past Other,European 1190 ES00440 Initial 450K 282 1 NA NA 49.2 8 whole blood Never (Control) European,Other 1191 ES00441 Initial 450K 8 0.5 48 55 NA NA peripheral blood mononuclear cell CLSA Canadian Longitudinal Study on Aging Not reported 1192 ES00441 Initial 450K 6 66.7 72 78 NA NA peripheral blood mononuclear cell CLSA Canadian Longitudinal Study on Aging Not reported 1193 ES00442 Initial 450K 49 0.61 0.3 0.4 0.3 NA whole blood CLO Not reported,European 1194 ES00442 Initial 450K 49 0.84 0.4 0.5 0.5 NA whole blood CLP Not reported,European 1195 ES00442 Initial 450K 49 0.53 0.9 1 0.9 NA whole blood CPO Not reported,European 1196 ES00443 Initial 450K 15 1 NA NA NA NA sperm Current smokers Not reported 1197 ES00443 Initial 450K 15 1 NA NA NA NA sperm Never smokers Not reported 1198 ES00443 Replication 450K 36 1 NA NA 40.4 7.3 sperm Current smokers Not reported 1199 ES00443 Replication 450K 42 1 NA NA 38.4 8.3 sperm Never smokers Not reported 1207 ES00449 Initial 450K 479 0 NA NA 56.4 7.9 blood spot Aboriginal Australian 1208 ES00450 Initial 27K 279 NA NA NA NA NA blood TCGA Asian unspecified 1220 ES00245 Initial 450K 5 0 NA NA NA NA endometrium Endometriosis Not reported 1222 ES00248 Initial 450K 96 0.47 NA NA 11.3 3.4 buccal epithelial cell NeuroDevNet FASD cohort Controls Other,European 1223 ES00249 Initial 450K 20 0.55 0 0 0 0 cord blood Array cohort A insulin-treated GDM European 1224 ES00249 Initial 450K 46 0.48 0 0 0 0 cord blood Array cohort B Controls European 1225 ES00249 Initial 450K 24 0.5 0 0 0 0 cord blood Array cohort B dietetically treated GDM European 1226 ES00249 Initial 450K 24 0.5 0 0 0 0 cord blood Array cohort B insulin-treated GDM European 1228 ES00249 Replication 450K 64 0.39 0 0 0 0 cord blood dietetically treated GDM European 1229 ES00249 Replication 450K 61 0.56 0 0 0 0 cord blood insulin-treated GDM European 1230 ES00250 Initial 450K 2 1 43 55 49 8.5 gastric mucosa unsuccessfully eradicated East Asian 1231 ES00250 Replication 450K 8 NA NA NA NA NA gastric mucosa successfully eradicated East Asian 1232 ES00250 Replication 450K 8 NA NA NA NA NA gastric mucosa unsuccessfully eradicated East Asian 1233 ES00250 Replication 450K 25 0.56 NA NA NA NA gastric mucosa case-control validation H. pylori negative East Asian 1234 ES00250 Replication 450K 25 0.48 NA NA NA NA gastric mucosa case-control validation H. pylori positive East Asian 1235 ES00250 Replication 450K 13 0.69 NA NA 52.2 5.6 gastric mucosa self-comparison validation Unsuccessful eradication East Asian 1236 ES00250 Replication 450K 37 0.65 NA NA 51.9 6.4 gastric mucosa self-comparison validation Successful eradication East Asian 1237 ES00452 Initial 450K 6 0.5 42 55 48.7 4.7 leukocyte successfully eradicated East Asian 1238 ES00452 Initial 450K 2 1 43 55 49 8.5 leukocyte unsuccessfully eradicated East Asian 1239 ES00452 Replication 450K 8 NA NA NA NA NA leukocyte successfully eradicated East Asian 1240 ES00452 Replication 450K 8 NA NA NA NA NA leukocyte unsuccessfully eradicated East Asian 1241 ES00452 Replication 450K 25 0.56 NA NA NA NA leukocyte case-control validation H. pylori negative East Asian 1242 ES00452 Replication 450K 25 0.48 NA NA NA NA leukocyte case-control validation H. pylori positive East Asian 1243 ES00452 Replication 450K 13 0.69 NA NA 52.2 5.6 leukocyte self-comparison validation Unsuccessful eradication East Asian 1244 ES00452 Replication 450K 37 0.65 NA NA 51.9 6.4 leukocyte self-comparison validation Successful eradication East Asian 1245 ES00252 Initial 450K 117 0.89 NA NA 50.2 8.7 whole blood VACS Veteran Aging Cohort Study HIV-uninfected European,African American or Afro-Caribbean,Other 1246 ES00253 Initial 450K 19 1 NA NA 51.1 NA peripheral blood mononuclear cell HIV-uninfected Not reported 1247 ES00254 Initial 450K 3 NA NA NA NA NA Molt-3 cell HHV-6B-infected Not reported 1248 ES00254 Initial 450K 3 NA NA NA NA NA Molt-3 cell HHV-6B-uninfected Not reported 1249 ES00255 Initial 450K 12 0.33 0 0 0 0 CD4+ T cell Healthy Not reported 1250 ES00255 Initial 450K 12 0.75 1 1 1 0 CD4+ T cell Food Allergy Not reported 1251 ES00255 Initial 450K 12 0.33 1 1 1 0 CD4+ T cell Healthy Not reported 1252 ES00256 Initial 450K 7 1 36 54 40.6 6.3 sperm Patient Not reported 1253 ES00257 Initial 450K 42 1 30 50 38.4 5.3 sperm infertile Not reported 1254 ES00259 Initial 450K 19 0.63 53 81 66.3 8.5 white matter control Not reported 1255 ES00260 Initial 450K 28 0.46 18 55 NA NA CD4+ T cell control Not reported 1256 ES00453 Initial 450K 30 0.13 18 55 NA NA CD8+ T cell multiple sclerosis Not reported 1257 ES00453 Initial 450K 28 0.46 18 55 NA NA CD8+ T cell control Not reported 1258 ES00261 Initial 450K 28 0 NA NA 38.6 12.7 CD4+ T cell multiple sclerosis Not reported 1261 ES00262 Initial 450K 10 0 21 52 36.4 10.6 CD14+ monocyte control European 1262 ES00263 Initial 450K 16 0.37 0 0 0 0 chorionic villi control European 1263 ES00264 Initial 450K 5 1 NA NA NA NA sperm control Not reported 1266 ES00267 Initial 450K 12 0.42 NA NA 69 9.1 peripheral blood mononuclear cell MZ twins Parkinson's disease Not reported 1268 ES00267 Replication 450K 221 0.38 NA NA 65.1 10.2 peripheral blood mononuclear cell Parkinson's disease Not reported 1275 ES00270 Initial 450K 5 0.4 NA NA 37.6 7.6 saliva control Not reported 1276 ES00271 Initial 450K 5 0.6 NA NA 37.6 7.6 peripheral blood mononuclear cell RA Not reported 1277 ES00271 Initial 450K 5 0.4 NA NA 37.6 7.6 peripheral blood mononuclear cell control Not reported 1278 ES00272 Initial 450K 12 0 NA NA 52.6 4.9 T-lymphocyte control European 1279 ES00273 Initial 450K 12 0 NA NA 64.6 7.5 B-lymphocyte RA European 1280 ES00273 Initial 450K 12 0 NA NA 52.6 4.9 B-lymphocyte control European 1281 ES00274 Initial 450K 11 0 NA NA 52.6 4.9 T-lymphocyte control European 1282 ES00275 Initial 450K 23 0.35 NA NA 58.9 15.8 B-lymphocyte Early RA European 1283 ES00275 Initial 450K 11 0 NA NA 52.6 4.9 B-lymphocyte control European 1284 ES00276 Initial 450K 12 0.25 23 57 40.6 11.4 CD4+ T cell control East Asian 1285 ES00281 Initial 450K 19 0.47 NA NA 25 5.7 muscle Marasmus Not reported 1286 ES00284 Initial 450K 246 NA NA NA NA NA whole blood control European 1288 ES00365 Replication 450K 103 0.54 0 0 0 0 cord blood Normal pregnancy East Asian 1292 ES00415 Initial 450K 66 0 29 75 54.1 9.1 whole blood monozygotic female twin pairs European 1293 ES00416 Initial 450K 66 0 29 75 54.1 9.1 whole blood monozygotic female twin pairs European 1294 ES00417 Initial 450K 66 0 29 75 54.1 9.1 whole blood monozygotic female twin pairs European 1310 ES00469 Initial 450K 438 0.51 0 0 0 0 cord blood Not reported 1313 ES00472 Initial 450K 438 0.51 0 0 0 0 cord blood Not reported 1317 ES00432 Initial 450K 30 0.67 45 88 65.5 11.7 carotid donor-paired aortic samples Not reported 1318 ES00432 Initial 450K 19 0.68 58 76 67.9 5.4 carotid Carotid atherosclerotic samples Not reported 1321 ES00434 Initial 450K 8 0.5 0 0 0 0 placenta preeclampsia Not reported 1324 ES00475 Initial 450K 8 0.5 48 55 NA NA peripheral blood mononuclear cell CLSA Canadian Longitudinal Study on Aging Not reported 1325 ES00475 Initial 450K 6 66.7 72 78 NA NA peripheral blood mononuclear cell CLSA Canadian Longitudinal Study on Aging Not reported 1326 ES00476 Initial 450K 8 0.5 48 55 NA NA peripheral blood mononuclear cell CLSA Canadian Longitudinal Study on Aging Not reported 1327 ES00476 Initial 450K 6 66.7 72 78 NA NA peripheral blood mononuclear cell CLSA Canadian Longitudinal Study on Aging Not reported 1328 ES00477 Initial 450K 8 0.5 48 55 NA NA peripheral blood mononuclear cell CLSA Canadian Longitudinal Study on Aging Not reported 1329 ES00477 Initial 450K 6 66.7 72 78 NA NA peripheral blood mononuclear cell CLSA Canadian Longitudinal Study on Aging Not reported 1330 ES00478 Initial 450K 8 0.5 48 55 NA NA peripheral blood mononuclear cell CLSA Canadian Longitudinal Study on Aging Not reported 1331 ES00478 Initial 450K 6 66.7 72 78 NA NA peripheral blood mononuclear cell CLSA Canadian Longitudinal Study on Aging Not reported 1332 ES00479 Initial 450K 49 0.61 0.3 0.4 0.3 NA whole blood CLO Not reported,European 1333 ES00479 Initial 450K 49 0.84 0.4 0.5 0.5 NA whole blood CLP Not reported,European 1334 ES00479 Initial 450K 49 0.53 0.9 1 0.9 NA whole blood CPO European,Not reported 1353 ES00485 Initial 450K 24 0.39 NA NA 7.9 7.3 peripheral blood patients Not reported 1354 ES00485 Initial 450K 216 0.39 NA NA 8.2 9.1 peripheral blood controls Not reported 1364 ES00448 Initial 450K 244 0.54 NA NA 4.26 0.19 whole blood BAMSE Children’s Allergy Environment Stockholm Epidemiology study European 1365 ES00448 Initial 450K 147 0.59 NA NA 5.6 0.1 whole blood EDEN Etude des D eterminants pr e et post natals du d eveloppement et de la sant e de l’ Enfant European 1366 ES00448 Initial 450K 212 0.52 NA NA 4.4 0.2 whole blood INMA-SAB Infancia y Medio Ambiente European 1367 ES00448 Initial 450K 214 0.54 NA NA 4.1 0.2 whole blood PIAMA Prevention and Incidence of Asthma and Mite Allergy European 1368 ES00448 Initial 450K 232 0.53 NA NA 8.3 0.4 whole blood BAMSE Children’s Allergy Environment Stockholm Epidemiology study European 1369 ES00448 Initial 450K 308 0.52 NA NA 8.3 0.5 whole blood BAMSE-epi Children’s Allergy Environment Stockholm Epidemiology study European 1370 ES00448 Initial 450K 191 0.5 NA NA 8.1 0.3 whole blood PIAMA Prevention and Incidence of Asthma and Mite Allergy European 1372 ES00448 Replication 450K 127 0.49 4 4 4 0 whole blood INMA-GIP Infancia y Medio Ambiente European 1373 ES00448 Replication 450K 359 0.49 4 4 4 0 whole blood INMA-MEN Infancia y Medio Ambiente European 1374 ES00448 Replication 450K 521 0.53 NA NA 4.3 0.3 whole blood Rhea Mother-Child Cohort in Crete European 1375 ES00448 Replication 450K 213 0.53 NA NA 10.9 0.8 whole blood ECA Environment and Childhood Asthma study in Oslo European 1376 ES00448 Replication 450K 59 0.53 NA NA 7.5 0.2 whole blood INMA-VAL Infancia y Medio Ambiente European 1377 ES00448 Replication 450K 709 0.5 NA NA 8.3 0.4 whole blood PIAMA Prevention and Incidence of Asthma and Mite Allergy European 1378 ES00448 Replication 450K 126 0.52 NA NA 8.7 0.3 whole blood Robbic-Bologna Rome and Bologna Birth Cohorts European 1379 ES00448 Replication 450K 214 0.51 NA NA 7.8 0.5 whole blood Robbic-Rome Rome and Bologna Birth Cohorts European 1380 ES00448 Replication 450K 101 0.4 NA NA 15.7 1.6 whole blood Karelia European 1381 ES00448 Replication 450K 389 0.5 NA NA 16.3 0.2 whole blood PIAMA Prevention and Incidence of Asthma and Mite Allergy European 1382 ES00496 Initial 450K 20 NA 19.7 42.9 33.5 NA chorionic villi EOPET Not reported 1383 ES00496 Initial 450K 20 NA 25 37.3 31.8 NA chorionic villi control Not reported 1384 ES00497 Initial 450K 12 0 NA NA 26.8 2.2 peripheral blood mononuclear cell Fetal Intolerance African American or Afro-Caribbean 1385 ES00497 Initial 450K 45 0 NA NA 27.3 2.3 peripheral blood mononuclear cell Control African American or Afro-Caribbean 1386 ES00497 Replication 450K 43 0 NA NA 31.3 NA peripheral blood mononuclear cell African American or Afro-Caribbean,European 1387 ES00498 Initial 450K 35 0.46 0 0 0 0 prefrontal cortex fetal control Not reported,European 1388 ES00498 Initial 450K 60 0.7 NA NA 6.6 6.3 prefrontal cortex child control Not reported,European 1389 ES00498 Initial 450K 240 0.69 NA NA 42.3 16 prefrontal cortex adult control Not reported,European 1390 ES00498 Initial 450K 191 0.62 NA NA 50.1 14.4 prefrontal cortex schizophrenia European,Not reported 1399 ES00502 Initial 450K 8 1 21.4 62.1 41.2 11.3 liver Obese Type 2 Diabetic European 1400 ES00502 Initial 450K 7 1 36.2 59.1 42.7 7.8 liver Non-Obese Controls European 1401 ES00297 Replication 450K 59 0.48 NA NA 75 11 whole blood BASICMAR_ 2 type 2 diabetes mellitus European 1402 ES00297 Replication 450K 582 0.48 NA NA 62.6 11.7 whole blood REGICOR control European 1403 ES00297 Replication 450K 63 0.57 NA NA 69.1 10 whole blood REGICOR type 2 diabetes mellitus European 1405 ES00297 Replication 450K 131 0.6 NA NA 73.4 10.2 whole blood BASICMAR_1 type 2 diabetes mellitus European 1406 ES00503 Initial 450K 204 0.57 NA NA 75 11.4 whole blood BASICMAR_1 control European 1407 ES00503 Initial 450K 151 0.6 NA NA 72.6 4.5 whole blood BASICMAR_1 type 2 diabetes mellitus European 1408 ES00503 Replication 450K 108 0.51 NA NA 74.7 13.3 whole blood BASICMAR_ 2 control European 1409 ES00503 Replication 450K 59 0.48 NA NA 75 11 whole blood BASICMAR_ 2 type 2 diabetes mellitus European 1410 ES00503 Replication 450K 582 0.48 NA NA 62.6 11.7 whole blood REGICOR control European 1411 ES00503 Replication 450K 63 0.57 NA NA 69.1 10 whole blood REGICOR type 2 diabetes mellitus European 1413 ES00503 Replication 450K 131 0.6 NA NA 73.4 10.2 whole blood BASICMAR_1 type 2 diabetes mellitus European 1414 ES00296 Initial 450K 69 0.59 NA NA 64 NA whole blood ESTHER Diabetic, poorly controlled Not reported 1415 ES00296 Replication 450K 440 0.39 NA NA 62 NA whole blood ESTHER Nondiabetic Not reported 1416 ES00296 Replication 450K 48 0.4 NA NA 64 NA whole blood ESTHER Diabetic, controlled Not reported 1417 ES00296 Replication 450K 39 0.33 NA NA 63 NA whole blood ESTHER Diabetic, poorly controlled Not reported 1418 ES00295 Initial 450K 35 0.49 NA NA 50.5 7.3 liver Type 2 Diabetics Not reported 1419 ES00293 Replication 450K 568 0.73 NA NA 60.4 9.7 whole blood LOLIPOP The London Life Sciences Prospective Population Study control European 1420 ES00293 Replication 450K 196 0.54 NA NA 57.8 8.9 whole blood KORA Cooperative Health Research in the Region of Augsburg Incident T2D European 1421 ES00293 Replication 450K 196 0.54 NA NA 57.6 8.9 whole blood KORA Kooperative Gesundheitsforschung in der Region Augsburg controls European 1424 ES00291 Replication 450K 28 0.54 NA NA 74.3 4.3 adipose tissue normal glucose tolerance Not reported 1425 ES00291 Replication 450K 28 0.53 NA NA 74.5 4.2 adipose tissue Type 2 diabetes Not reported 1426 ES00290 Initial 450K 15 0.67 NA NA 59.5 10.7 pancreatic islet Type 2 diabetes Not reported 1429 ES00289 Initial 450K 12 0.5 NA NA 68.3 7.7 skeletal muscle Type 2 diabetic European 1430 ES00287 Initial 27K 5 1 NA NA 64.4 5.3 pancreatic islet Type 2 diabetes European 1434 ES00285 Initial 450K 12 0.42 2 30 16.1 8.5 whole blood control Not reported 1435 ES00505 Initial 450K 20 0.6 NA NA 11.8 4.8 whole blood EuroPrevall study cow’s milk allergy European 1436 ES00505 Initial 450K 20 0.5 NA NA 17.2 7.1 whole blood EuroPrevall study Controls European 1437 ES00505 Initial 450K 10 1 NA NA 18 5.5 whole blood Tolerant European 1438 ES00505 Initial 450K 13 1 NA NA 17.2 4.3 whole blood EuroPrevall study Tolerant control boys European 1439 ES00506 Initial 450K 127 0.51 0 0 0 0 cord blood Not reported 1441 ES00508 Replication 450K 142 0.51 NA NA 62.6 7.2 whole blood BLITZ Evaluierung innovativer Testverfahren zur Darmkrebsfr€uherkennung European 1442 ES00508 Initial 450K 99 0.5 NA NA 65.4 7.1 whole blood ESTHER Epidemiologische Studie zu Chancen der Verh€utung, Früherkennung und optimierten Therapie chronischer Erkrankungen in der älteren Bevölkerung European 1443 ES00508 Initial 450K 1000 0.5 NA NA 62.1 6.5 whole blood ESTHER Epidemiologische Studie zu Chancen der Verh€utung, Früherkennung und optimierten Therapie chronischer Erkrankungen in der älteren Bevölkerung European 1444 ES00509 Initial 450K 262 0.54 46 76 57 NA whole blood KORA F4 Kooperative Gesundheitsforschung in der Region Augsburg Current smokers Not reported 1445 ES00509 Replication 450K 236 0.51 35 80 52.8 NA whole blood KORA F3 Kooperative Gesundheitsforschung in der Region Augsburg Current smokers Not reported 1446 ES00509 Initial 450K 782 0.6 35 81 61 NA whole blood KORA F4 Kooperative Gesundheitsforschung in der Region Augsburg Former smokers Not reported 1447 ES00510 Initial 450K 142 1 NA NA NA NA whole blood KORA F4 Kooperative Gesundheitsforschung in der Region Augsburg Current smokers Not reported 1448 ES00510 Initial 450K 259 1 NA NA NA NA whole blood KORA F4 Kooperative Gesundheitsforschung in der Region Augsburg Never smokers Not reported 1449 ES00510 Replication 450K 120 1 NA NA NA NA whole blood KORA F3 Kooperative Gesundheitsforschung in der Region Augsburg Current smokers Not reported 1450 ES00510 Replication 450K 117 1 NA NA NA NA whole blood KORA F3 Kooperative Gesundheitsforschung in der Region Augsburg Never smokers Not reported 1451 ES00511 Initial 450K 120 0 NA NA NA NA whole blood KORA F4 Kooperative Gesundheitsforschung in der Region Augsburg Current smokers Not reported 1452 ES00511 Initial 450K 490 0 NA NA NA NA whole blood KORA F4 Kooperative Gesundheitsforschung in der Region Augsburg Never smokers Not reported 1453 ES00511 Replication 450K 116 0 NA NA NA NA whole blood KORA F3 Kooperative Gesundheitsforschung in der Region Augsburg Current smokers Not reported 1454 ES00511 Replication 450K 115 0 NA NA NA NA whole blood KORA F3 Kooperative Gesundheitsforschung in der Region Augsburg Never smokers Not reported 1455 ES00515 Initial 450K 172 1 57 79 66 NA whole blood MADT Middle Aged Danish Twins Study Male European 1456 ES00515 Initial 450K 166 0 56 78 66 NA whole blood MADT Middle Aged Danish Twins Study Female European 1457 ES00516 Initial 450K 172 1 57 79 66 NA whole blood MADT Middle Aged Danish Twins Study Male European 1458 ES00516 Initial 450K 166 0 56 78 66 NA whole blood MADT Middle Aged Danish Twins Study Female European 1459 ES00517 Initial 450K 172 1 57 79 66 NA whole blood MADT Middle Aged Danish Twins Study Male European 1460 ES00517 Initial 450K 166 0 56 78 66 NA whole blood MADT Middle Aged Danish Twins Study Female European 1461 ES00520 Initial 450K 7 1 59 84 71.4 9.3 bladder not recurred Not reported 1462 ES00520 Initial 450K 14 0.64 45 92 73.3 12.6 bladder recurred Not reported 1465 ES00519 Initial 450K 5 NA NA 45 NA NA NR early onset Not reported 1466 ES00519 Initial 450K 7 NA NA NA NA NA NR elderly onset Not reported 1467 ES00519 Replication 450K 327 NA NA NA NA NA gastric tissue TCGA The Cancer Genome Atlas Not reported 1469 ES00523 Initial 450K 24 0.63 3.5 18 9.1 NA buccal epithelial cell NeuroDevNet Kids Brain Health Network FASD cases European,Asian unspecified,Not reported 1470 ES00523 Initial 450K 24 0.46 5 17 11.6 NA buccal epithelial cell NeuroDevNet Kids Brain Health Network Controls Not reported,European,Asian unspecified 1473 ES00525 Initial 450K 23 0.43 NA NA NA NA peripheral blood mononuclear cell Responders Not reported 1474 ES00525 Initial 450K 21 0.48 NA NA NA NA peripheral blood mononuclear cell Non-responders Not reported 1475 ES00527 Initial 450K 6 0.33 0 0 0 0 umbilical cord blood healthy control Not reported 1476 ES00527 Initial 450K 6 0.66 0 0 0 0 umbilical cord blood polycystic ovary syndrome Not reported 1477 ES00526 Initial 450K 11 NA NA NA 64.1 12.5 peripheral blood mononuclear cell Responders Not reported 1478 ES00526 Initial 450K 12 NA NA NA 63.2 7.4 peripheral blood mononuclear cell Non-responders Not reported 1479 ES00528 Initial 450K 12 NA NA NA 28.4 8 peripheral blood mononuclear cell Responders Not reported 1480 ES00528 Initial 450K 9 NA NA NA 33.4 6.6 peripheral blood mononuclear cell Non-responders Not reported 1489 ES00533 Initial 450K 343 0.54 0 0 0 0 placenta NHBCS New Hampshire Birth Cohort Study Not reported,European 1490 ES00533 Initial 450K 141 0.52 0 0 0 0 placenta RICHS Rhode Island Child Health Study European,Not reported 1491 ES00534 Initial 450K 24 0.42 NA NA 42.5 6.9 whole blood Cases European 1492 ES00534 Initial 450K 24 0.42 NA NA 42.4 7.7 whole blood Controls European 1493 ES00535 Initial 450K 121 0 17 76 38 NA breast European,African American or Afro-Caribbean 1494 ES00536 Initial 450K 1017 NA NA NA 47.3 11 whole blood LifeLines European 1495 ES00536 Replication 450K 422 0.51 NA NA 53.2 9.6 whole blood KORA F3 Not reported 1496 ES00536 Replication 450K 971 0.39 NA NA 60.9 8.8 whole blood KORA F4 Not reported 1497 ES00537 Initial 850K 8 0 35 62 43.5 NA urine IC/BPS Cases Not reported,European 1498 ES00537 Initial 450K 8 0 34 61 40 NA urine Controls European,Not reported 1499 ES00538 Initial 450K 8 1 NA NA 27.6 2.4 skeletal muscle 7 weeks loading Not reported 1500 ES00538 Initial 450K 8 1 NA NA 27.6 2.4 skeletal muscle baseline Not reported 1501 ES00539 Initial 450K 8 1 NA NA 27.6 2.4 skeletal muscle 7 weeks unloading Not reported 1502 ES00539 Initial 450K 8 1 NA NA 27.6 2.4 skeletal muscle baseline Not reported 1503 ES00540 Initial 450K 8 1 NA NA 27.6 2.4 skeletal muscle 7 weeks reloading Not reported 1504 ES00540 Initial 450K 8 1 NA NA 27.6 2.4 skeletal muscle baseline Not reported 1505 ES00541 Initial 450K 14 1 25 50 NA NA sperm nonsmoker Not reported 1506 ES00541 Initial 450K 14 1 25 50 NA NA sperm smoker Not reported 1507 ES00541 Replication 450K 45 1 25 50 NA NA sperm smoker Not reported 1508 ES00541 Replication 450K 33 1 25 50 NA NA sperm nonsmoker Not reported 1509 ES00542 Initial 450K 150 0.51 57 74 NA NA buffy coat BWD European 1510 ES00542 Initial 450K 238 0.24 73 90 NA NA buffy coat LSADT Longitudinal Study of Aging Danish Twins European 1511 ES00542 Initial 450K 482 0.54 55 79 NA NA buffy coat MADT Middle Aged Danish Twins Study European 1512 ES00542 Initial 450K 550 NA NA NA NA NA whole blood LBC1921 Lothian Birth Cohort 1921 Not reported 1513 ES00542 Initial 450K 1091 NA NA NA NA NA whole blood LBC1936 Lothian Birth Cohort 1936 Not reported 1514 ES00542 Initial 450K 385 NA 48 99 NA NA whole blood SATSA Swedish Adoption/Twin Study of Aging twins Not reported 1515 ES00543 Initial 27K 26 NA NA NA NA NA whole blood narcoleptic patients East Asian 1516 ES00543 Initial 450K 20 NA NA NA NA NA whole blood healthy individuals East Asian 1517 ES00544 Initial 450K 12 0.58 52 68 62 4.7 gastric mucosa individuals with gastric atrophy Not reported 1518 ES00544 Initial 450K 12 0.58 47 65 60 4.9 gastric mucosa gastric cancer patients Not reported 1519 ES00544 Replication 450K 63 0.65 41 69 60.4 7.2 gastric mucosa healthy individuals with gastric atrophy Not reported 1520 ES00544 Replication 450K 82 0.89 47 68 62.2 4.7 gastric mucosa gastric cancer patients Not reported 1521 ES00545 Initial 450K 64 0.73 41 95 75.8 12.9 intima tissue atheromatous plaque lesions East Asian 1522 ES00545 Initial 450K 64 0.73 41 95 75.8 12.9 intima tissue plaque?free intima East Asian 1523 ES00546 Initial 450K 347 0.15 NA NA 47 17.2 whole blood Patients Not reported 1524 ES00546 Initial 450K 400 0.12 NA NA 47.1 13.2 whole blood Controls Not reported 1525 ES00546 Replication 450K 201 0.13 NA NA 48.7 14.8 whole blood Patients Not reported 1526 ES00546 Replication 450K 187 0.07 NA NA 48.8 14.9 whole blood Controls Not reported 1527 ES00547 Initial 450K 7 1 NA NA 21.2 14.3 peripheral blood Claes-Jensen syndrome Not reported 1528 ES00547 Initial 450K 56 1 NA NA 19.3 12.2 peripheral blood healthy control Not reported 1529 ES00548 Initial 450K 678 0 18 80 46 NA whole blood Not reported 1530 ES00549 Initial 450K 903 0.56 18 80 46 NA whole blood Never- smokers Not reported 1531 ES00550 Initial 450K 658 0.57 22 79 46 NA whole blood Current- smokers Not reported 1532 ES00551 Initial 450K 595 0.5 26 80 49 NA whole blood Subjects with airway obstruction Not reported 1533 ES00552 Initial 450K 81 0.49 NA NA 9.6 1.7 whole blood EPOCH Exploring Perinatal Outcomes in Children study gestational diabetes-exposed Not reported 1534 ES00552 Initial 450K 204 0.5 NA NA 10.3 1.3 whole blood EPOCH Exploring Perinatal Outcomes in Children study gestational diabetes-unexposed Not reported 1535 ES00552 Initial 450K 31 NA 0 0 0 0 cord blood Colorado Healthy Start cohort gestational diabetes-exposed Not reported 1536 ES00552 Initial 450K 64 NA 0 0 0 0 cord blood Colorado Healthy Start cohort gestational diabetes-unexposed Not reported 1537 ES00553 Initial 450K 23 0.3 NA NA 41 6.2 subcutaneous adipose tissue Non-diabetic individuals with obesity Not reported 1538 ES00553 Initial 450K 23 0.3 NA NA 41.8 9.9 subcutaneous adipose tissue Diabetic individuals with obesity Not reported 1539 ES00554 Initial 450K 23 0.3 NA NA 41 6.2 visceral adipose tissue Non-diabetic individuals with obesity Not reported 1540 ES00554 Initial 450K 23 0.3 NA NA 41.8 9.9 visceral adipose tissue Diabetic individuals with obesity Not reported 1541 ES00555 Initial 450K 23 0.3 NA NA 41 6.2 liver Non-diabetic individuals with obesity Not reported 1542 ES00555 Initial 450K 23 0.3 NA NA 41.8 9.9 liver Diabetic individuals with obesity Not reported 1543 ES00558 Initial 450K 17 0.47 NA NA NA NA placenta Control Hispanic or Latin American,Native American 1544 ES00558 Initial 450K 17 0.47 0 0 0 0 placenta diabetes during pregnancy Native American,Hispanic or Latin American 1545 ES00559 Initial 450K 8 1 0 0 0 0 placenta Control Hispanic or Latin American,Native American 1546 ES00559 Initial 450K 8 1 0 0 0 0 placenta diabetes during pregnancy Native American,Hispanic or Latin American 1547 ES00560 Initial 450K 9 0 0 0 0 0 placenta Control Native American,Hispanic or Latin American 1548 ES00560 Initial 450K 9 0 0 0 0 0 placenta diabetes during pregnancy Native American,Hispanic or Latin American 1549 ES00557 Initial 450K 92 0.5 14 20.9 17.7 1.7 leukocyte EpiGO Epigenetic Basis of Obesity-Induced Cardiovascular Disease and Type 2 Diabetes lean African American or Afro-Caribbean 1550 ES00557 Initial 450K 96 0.49 14.1 21 17.7 1.8 leukocyte EpiGO Epigenetic Basis of Obesity-Induced Cardiovascular Disease and Type 2 Diabetes obese African American or Afro-Caribbean 1551 ES00557 Initial 450K 284 0.5 13.8 19 16.2 1.3 leukocyte LACHY Lifestyle, Adiposity, and Cardiovascular Health in Youth African American or Afro-Caribbean 1552 ES00561 Initial 450K 25 0.56 0 0 0 0 placenta ELGAN Extremely Low for Gestational Age Newborns Indicated EPTB European,Other,African American or Afro-Caribbean 1553 ES00557 Initial 450K 228 0.43 18.9 35.6 27.8 3.3 leukocyte BP stress Blood Pressure (BP) stress African American or Afro-Caribbean 1554 ES00561 Initial 450K 59 0.75 0 0 0 0 placenta ELGAN Extremely Low for Gestational Age Newborns Spontaneous EPTB Other,European,African American or Afro-Caribbean 1555 ES00562 Initial 450K 80 0 50 84 NA NA bone postmenopausal women Not reported 1556 ES00557 Replication 450K 2097 NA 47 70 NA NA leukocyte ARIC Atherosclerosis Risk in Communities African American or Afro-Caribbean 1557 ES00563 Initial 450K 8 0.25 NA NA 44.6 3.6 peripheral blood mononuclear cell Phlegm-dampness Constitution Not reported 1558 ES00563 Initial 450K 4 0.25 NA NA 35.3 2.7 peripheral blood mononuclear cell Balanced Constitution Not reported 1559 ES00564 Initial 450K 12 0.42 0 0 0 0 umbilical cord blood Infected Not reported 1560 ES00564 Initial 450K 12 0.42 0 0 0 0 umbilical cord blood Non-infected Not reported 1561 ES00565 Initial 450K 23 0.43 NA NA 47.1 10.7 leukocyte Low folate (<300 ?g/d) European 1562 ES00565 Initial 450K 24 0.63 NA NA 49.6 8.9 leukocyte High folate (?300 ?g/d) European 1563 ES00566 Initial 450K 440 0 NA NA 65.1 7 whole blood bladder cancer Asian unspecified,Not reported,African American or Afro-Caribbean,Hispanic or Latin American,European,Other 1564 ES00566 Initial 450K 440 0 NA NA 65.1 7 whole blood Controls European,Asian unspecified,Other,African American or Afro-Caribbean,Hispanic or Latin American 1565 ES00567 Initial 450K 190 0.44 0 0 0 0 cord blood East Asian 1566 ES00567 Replication 450K 37 0.62 0 0 0 0 cord blood East Asian 1567 ES00568 Initial 450K 190 0.44 0 0 0 0 cord blood East Asian 1568 ES00568 Replication 450K 37 0.62 0 0 0 0 cord blood East Asian 1569 ES00569 Initial 450K 43 0 NA NA 47 NA saliva Placebo Not reported 1570 ES00569 Initial 450K 20 0 NA NA 47 NA saliva Folic acid 200µg/day Not reported 1571 ES00569 Initial 450K 23 0 NA NA 47 NA saliva Folic acid 5 mg/day Not reported 1572 ES00570 Initial 450K 43 0 NA NA 47 NA saliva Placebo Not reported 1573 ES00570 Initial 450K 23 0 NA NA 47 NA saliva Folic acid 5 mg/day Not reported 1574 ES00571 Initial 450K 43 0 NA NA 47 NA saliva Placebo Not reported 1575 ES00571 Initial 450K 20 0 NA NA 47 NA saliva Folic acid 200µg/day Not reported 1576 ES00572 Initial 450K 17 0.47 NA NA 49 NA whole blood t(1;11) Carriers Not reported 1577 ES00572 Initial 450K 24 0.5 NA NA 37 NA whole blood t(1;11) Non-carriers Not reported 1578 ES00573 Initial 450K 42 0.86 NA NA 52 11.1 gastric mucosa Gastric Cancer patients (normal gastric mucosa ) East Asian 1579 ES00573 Initial 450K 42 0.86 NA NA 52.2 9.5 gastric mucosa Controls East Asian 1580 ES00573 Replication 450K 60 0.6 NA NA 53.5 9.7 gastric mucosa Gastric Cancer patients (normal gastric mucosa ) East Asian 1581 ES00573 Replication 450K 120 0.6 NA NA 53.6 8.5 gastric mucosa Controls East Asian 1582 ES00574 Initial 450K 42 0.86 NA NA 52 11.1 gastric mucosa Gastric Cancer patients (normal gastric mucosa ) East Asian 1583 ES00574 Initial 450K 42 0.86 NA NA 52.2 9.5 gastric mucosa Controls East Asian 1584 ES00574 Replication 450K 60 0.6 NA NA 53.5 9.7 gastric mucosa Gastric Cancer patients (normal gastric mucosa ) East Asian 1585 ES00574 Replication 450K 120 0.6 NA NA 53.6 8.5 gastric mucosa Controls East Asian 1588 ES00576 Initial 450K 629 0.52 0 0 0 0 blood spot MINERvA ASD European 1589 ES00576 Initial 450K 634 0.5 0 0 0 0 blood spot MINERvA Controls European 1590 ES00577 Initial 450K 780 45 0 0 0 0 cord blood ALSPAC European 1591 ES00577 Initial 450K 197 0.51 0 0 0 0 cord blood ENVIRONAGE European 1592 ES00577 Initial 450K 84 0.48 0 0 0 0 cord blood INMA European 1593 ES00577 Initial 450K 99 0.55 0 0 0 0 cord blood Piccolipiù European 1594 ES00577 Initial 450K 75 0.52 0 0 0 0 cord blood Rhea European 1595 ES00578 Initial 450K 10 0.7 0 0 0 0 whole blood Down syndrome Not reported 1596 ES00578 Initial 450K 5 NA NA NA NA NA whole blood Controls Not reported 1597 ES00579 Initial 450K 1730 0.48 NA NA 67 9 whole blood FHS Framingham Heart Study European 1598 ES00579 Initial 450K 970 0.48 NA NA 47.8 16.3 CD4+ T cell GOLDN Genetics of Lipid Lowering Drugs and Diet Network European 1599 ES00579 Initial 450K 498 0.45 NA NA 62.8 15.8 whole blood InCHIANTI Invecchiare in Chianti Study European 1600 ES00579 Initial 450K 800 0.51 NA NA 69 4.3 whole blood KORA Kooperative Gesundheitsforschung in der Region Augsburg European 1601 ES00579 Initial 450K 165 0.46 NA NA 86.7 0.4 whole blood LBC1921 Lothian Birth Cohort 1921 European 1602 ES00579 Initial 450K 631 1 NA NA 74.6 6.8 whole blood NAS Normative Aging Study European 1603 ES00579 Replication 450K 667 0.44 NA NA 31 0.3 whole blood NFBC66 Northern Finland Birth Cohort 1966 European 1604 ES00579 Replication 450K 149 1 NA NA 63.3 2.7 whole blood HBCS Helsinki Birth Cohort European 1605 ES00580 Initial 450K 124 0.42 0 0 0 0 cord blood Never-smokers East Asian 1606 ES00580 Initial 450K 46 0.35 0 0 0 0 cord blood Sustained smokers during pregnancy East Asian 1607 ES00581 Initial 450K 44 0.61 0 0 0 0 cord blood Stopped smokers before pregnancy East Asian 1608 ES00581 Initial 450K 77 0.47 0 0 0 0 cord blood Stopped smokers afer confrming pregnancy East Asian 1609 ES00581 Initial 450K 124 0.42 0 0 0 0 cord blood Never-smokers East Asian 1610 ES00582 Initial 450K 44 0.61 0 0 0 0 cord blood Stopped smokers before pregnancy East Asian 1611 ES00582 Initial 450K 77 0.47 0 0 0 0 cord blood Stopped smokers afer confrming pregnancy East Asian 1612 ES00582 Initial 450K 46 0.35 0 0 0 0 cord blood Sustained smokers during pregnancy East Asian 1613 ES00583 Initial 450K 30 0.5 0 0 0 0 cord blood ROLO Intervention Not reported 1614 ES00583 Initial 450K 30 0.5 0 0 0 0 cord blood Control Not reported 1615 ES00584 Initial 450K 284 0.33 NA NA 52 10 buffy coat HyperGen Hypertension Genetic Epidemiology Network MetS+ African American or Afro-Caribbean 1616 ES00584 Initial 450K 330 0.33 NA NA 46 11 buffy coat HyperGen Hypertension Genetic Epidemiology Network MetS? African American or Afro-Caribbean 1617 ES00584 Replication 450K 37 0.45 NA NA 59.7 4.8 buffy coat REGARDS REasons for Geographic and Racial Differences in Stroke MetS+ African American or Afro-Caribbean 1618 ES00584 Replication 450K 32 0.45 NA NA 59.3 4.2 cord blood REGARDS REasons for Geographic and Racial Differences in Stroke MetS- African American or Afro-Caribbean 1619 ES00585 Initial 450K 284 0.5 NA NA 16.2 1.27 leukocyte African American or Afro-Caribbean 1620 ES00586 Initial 450K 24 0.13 NA NA 55 15 whole blood pSS high fatigue European 1621 ES00586 Initial 450K 24 0.17 NA NA 57 13 whole blood pSS low fatigue European 1622 ES00587 Initial 450K 100 0.11 NA NA 56.1 13.6 whole blood Patients with pSS European 1623 ES00587 Initial 450K 400 0.12 NA NA 47.1 13.2 whole blood Controls European 1624 ES00588 Initial 450K 24 0 NA NA 56.6 13.8 CD19+ B cell Patients with pSS European 1625 ES00588 Initial 450K 47 0.26 NA NA 48.8 17.7 CD19+ B cell Controls European 1626 ES00589 Initial 450K 26 0 NA NA 58 14 CD19+ B cell pSS patients European 1627 ES00589 Initial 450K 22 0 NA NA 58 19.13 CD19+ B cell Healthy controls European 1628 ES00590 Initial 450K 26 0 NA NA 58 14 CD19+ B cell pSS patients European 1629 ES00590 Initial 450K 22 0 NA NA 58 19.13 CD19+ B cell Healthy controls European 1630 ES00591 Initial 450K 11 0 23 69 45.9 15.5 CD4+ T cell pSS cases European 1631 ES00591 Initial 450K 11 0 23 64 45.5 12.9 CD4+ T cell Controls European 1632 ES00592 Initial 450K 16 NA 0 0 0 0 placenta European 1633 ES00593 Initial 450K 669 NA NA NA NA NA breast TCGA The Cancer Genome Atlas Not reported 1634 ES00594 Initial 450K 54 0.63 NA NA 12 2.9 nasal epithelial cell ESS Exposure Sibling Study Asthmatics Other admixed ancestry,African unspecified 1635 ES00594 Initial 450K 54 0.43 NA NA 11.3 3.7 nasal epithelial cell ESS Exposure Sibling Study Nonasthmatics Other admixed ancestry,African unspecified 1636 ES00595 Initial 450K 70 0 NA NA 50 1.5 peripheral blood mononuclear cell myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) European 1637 ES00596 Initial 450K 24 NA NA NA NA NA peripheral blood mononuclear cell cognitively impaired participants (MoCA <26) Not reported 1638 ES00596 Initial 450K 24 NA NA NA NA NA peripheral blood mononuclear cell Controls Not reported 1639 ES00597 Initial 450K 5 1 NA NA 65.2 3.8 periprostatic adipose tissue normal weight Not reported 1640 ES00597 Initial 450K 5 1 NA NA 63.2 2.5 periprostatic adipose tissue obese/overweight Not reported 1641 ES00598 Initial 450K 242 0.52 0 0 0 0 cord blood Not reported 1642 ES00599 Initial 450K 25 0.52 0 0 0 0 cord blood POSEIDON Smoking subgroup Not reported 1643 ES00599 Initial 450K 257 0.54 0 0 0 0 cord blood POSEIDON Non-smoking subgroup Not reported 1644 ES00600 Initial 450K 14 0.64 NA NA 21.9 3.6 whole blood Converters Not reported 1645 ES00600 Initial 450K 25 0.52 NA NA 23.8 4.1 whole blood Non-converters Not reported 1646 ES00601 Initial 450K 33 0.76 NA NA 45.5 7.8 whole blood Case European,African American or Afro-Caribbean 1647 ES00601 Initial 450K 33 0.76 NA NA 46.7 7.8 whole blood Control European,African American or Afro-Caribbean 1648 ES00601 Initial 450K 47 0.89 NA NA 45.7 14.5 whole blood Case European,African American or Afro-Caribbean 1649 ES00601 Initial 450K 47 0.64 NA NA 45.9 14.2 whole blood Control African American or Afro-Caribbean,European 1650 ES00602 Initial 850K 74 0 NA NA 32.4 6 saliva mother African American or Afro-Caribbean 1651 ES00602 Initial 850K 74 0.35 NA NA 3.7 0.7 saliva Child African American or Afro-Caribbean 1652 ES00603 Initial 450K 301 0 NA NA 54.1 10.4 leukocyte EPIC-Italy Post-Menopausal Breast Cancer European 1653 ES00603 Initial 450K 303 0.53 NA NA 56.3 9.4 leukocyte EPIC-Italy Colorectal Cancer European 1654 ES00603 Initial 450K 485 0.15 NA NA 52.3 12.4 leukocyte EPIC-Italy EPICOR European 1655 ES00603 Initial 450K 154 0.15 NA NA 52.3 12.4 leukocyte EnviroGenoMarkers EPIC-Italy European 1656 ES00603 Initial 450K 224 0.35 NA NA 50.1 10.1 leukocyte EnviroGenoMarkers NSHDS European 1657 ES00603 Initial 450K 144 0 NA NA 57.7 7.1 leukocyte EPIC Netherlands European 1658 ES00603 Initial 450K 330 0 NA NA 55.6 6.4 leukocyte NOWAC European 1659 ES00603 Replication 450K 358 0.35 NA NA 49.3 12.1 leukocyte EPIC-Italy European 1660 ES00604 Initial 450K 301 0 NA NA 54.1 10.4 leukocyte EPIC-Italy Post-Menopausal Breast Cancer European 1661 ES00604 Initial 450K 303 0.53 NA NA 56.3 9.4 leukocyte EPIC-Italy Colorectal Cancer European 1662 ES00604 Initial 450K 485 0.15 NA NA 52.3 12.4 leukocyte EPIC-Italy EPICOR European 1663 ES00604 Initial 450K 154 0.15 NA NA 52.3 12.4 leukocyte EnviroGenoMarkers EPIC-Italy European 1664 ES00604 Initial 450K 224 0.35 NA NA 50.1 10.1 leukocyte EnviroGenoMarkers NSHDS European 1665 ES00604 Initial 450K 144 0 NA NA 57.7 7.1 leukocyte EPIC Netherlands European 1666 ES00604 Initial 450K 330 0 NA NA 55.6 6.4 leukocyte NOWAC European 1667 ES00604 Replication 450K 358 0.35 NA NA 49.3 12.1 leukocyte EPIC-Italy European 1668 ES00605 Initial 450K 301 0 NA NA 54.1 10.4 leukocyte EPIC-Italy Post-Menopausal Breast Cancer European 1669 ES00605 Initial 450K 303 0.53 NA NA 56.3 9.4 leukocyte EPIC-Italy Colorectal Cancer European 1670 ES00605 Initial 450K 485 0.15 NA NA 52.3 12.4 leukocyte EPIC-Italy EPICOR European 1671 ES00605 Initial 450K 154 0.15 NA NA 52.3 12.4 leukocyte EnviroGenoMarkers EPIC-Italy European 1672 ES00605 Initial 450K 224 0.35 NA NA 50.1 10.1 leukocyte EnviroGenoMarkers NSHDS European 1673 ES00605 Initial 450K 144 0 NA NA 57.7 7.1 leukocyte EPIC Netherlands European 1674 ES00605 Initial 450K 330 0 NA NA 55.6 6.4 leukocyte NOWAC European 1675 ES00605 Replication 450K 358 0.35 NA NA 49.3 12.1 leukocyte EPIC-Italy European 1676 ES00606 Initial 450K 301 0 NA NA 54.1 10.4 leukocyte EPIC-Italy Post-Menopausal Breast Cancer European 1677 ES00606 Initial 450K 303 0.53 NA NA 56.3 9.4 leukocyte EPIC-Italy Colorectal Cancer European 1678 ES00606 Initial 450K 485 0.15 NA NA 52.3 12.4 leukocyte EPIC-Italy EPICOR European 1679 ES00606 Initial 450K 154 0.15 NA NA 52.3 12.4 leukocyte EnviroGenoMarkers EPIC-Italy European 1680 ES00606 Initial 450K 224 0.35 NA NA 50.1 10.1 leukocyte EnviroGenoMarkers NSHDS European 1681 ES00606 Initial 450K 144 0 NA NA 57.7 7.1 leukocyte EPIC Netherlands European 1682 ES00606 Initial 450K 330 0 NA NA 55.6 6.4 leukocyte NOWAC European 1683 ES00606 Replication 450K 358 0.35 NA NA 49.3 12.1 leukocyte EPIC-Italy European 1684 ES00607 Initial 450K 11 0.64 NA NA 65.3 12.6 tumor tissue Non-obese Not reported 1685 ES00607 Initial 450K 17 0.71 NA NA 65.7 8.1 tumor tissue Obese Not reported 1686 ES00607 Replication 450K 8 0.63 NA NA 69.7 13.1 tumor tissue Non-obese Not reported 1687 ES00607 Replication 450K 20 0.7 NA NA 68.3 9.6 tumor tissue Obese Not reported 1688 ES00608 Initial 450K 36 0 34 81 61 NA tumor tissue 18 responder and 18 non-responder Not reported 1689 ES00608 Initial 450K 80 0 29 86 60 NA tumor tissue Not reported 1690 ES00608 Initial 450K 15 0 49 86 62 NA tumor tissue Not reported 1691 ES00609 Initial 450K 408 0.52 0 0 0 0 cord blood LINA Not reported 1692 ES00610 Initial 450K 31 1 NA NA 55.2 9.9 tumor tissue prostate adenocarcinoma Not reported 1693 ES00610 Initial 450K 16 1 NA NA 55.7 7.3 prostate gland tissue adjacent normal tissues Not reported 1694 ES00611 Initial 450K 2468 0.48 NA NA 67 9 whole blood FHS Framingham Heart Study Not reported 1695 ES00612 Initial 450K 2775 0.68 39 70 60 NA whole blood MCCS Melbourne Collaborative Cohort Study European 1696 ES00612 Initial 450K 2586 0.67 40 76 61 NA whole blood MCCS Melbourne Collaborative Cohort Study European 1697 ES00612 Initial 450K 1088 0.68 49 82 68 NA whole blood MCCS Melbourne Collaborative Cohort Study European 1698 ES00613 Initial 450K 29 NA NA NA NA NA prefrontal cortex Major Depressive Disorder European 1699 ES00613 Initial 450K 29 NA NA NA NA NA prefrontal cortex Controls European 1700 ES00614 Initial 450K 60 NA NA NA NA NA bronchi Controls Not reported 1701 ES00614 Initial 450K 76 0.78 NA NA 59 10 bronchi Bronchial washing Lung cancer Not reported 1702 ES00615 Initial 450K 31 0.55 NA NA 76.4 6.3 buccal epithelial cell European 1703 ES00616 Initial 450K 147 0 30 39 NA NA saliva African American or Afro-Caribbean 1704 ES00617 Initial 450K 27 0.62 1 12 NA NA whole blood Kabuki syndrome samples Not reported 1705 ES00617 Initial 450K 9 NA NA NA NA NA whole blood non-Kabuki syndrome controls Not reported 1706 ES00618 Initial 450K 76 0.37 NA NA 37 7.5 whole blood Controls European 1707 ES00618 Initial 450K 89 0.45 NA NA 36 10.4 whole blood Cases European 1708 ES00618 Replication 450K 169 0.28 NA NA 38 7.2 whole blood Controls European 1709 ES00618 Replication 450K 131 0.37 NA NA 38 11.6 whole blood Cases European 1710 ES00619 Initial 450K 15 0.47 0 0 0 0 cord blood T lymphocyte Current European,Other 1711 ES00619 Initial 450K 14 0.57 0 0 0 0 cord blood T lymphocyte Past depression group Other,European 1712 ES00619 Initial 450K 15 0.47 0 0 0 0 cord blood T lymphocyte Control group Other,European 1713 ES00620 Initial 450K 84 0.68 0 0 0 0 placenta ELGANs European,Not reported 1714 ES00621 Initial 450K 84 0.68 0 0 0 0 placenta ELGANs Not reported,European 1715 ES00622 Initial 450K 84 0.68 0 0 0 0 placenta ELGANs European,Not reported 1716 ES00623 Initial 450K 84 0.68 0 0 0 0 placenta ELGANs Not reported,European 1717 ES00624 Initial 450K 84 0.68 0 0 0 0 placenta ELGANs European,Not reported 1718 ES00625 Initial 450K 84 0.68 0 0 0 0 placenta ELGANs Not reported,European 1719 ES00626 Initial 450K 84 0.68 0 0 0 0 placenta ELGANs Not reported,European 1720 ES00627 Initial 450K 84 0.68 0 0 0 0 placenta ELGANs Not reported,European 1721 ES00628 Initial 450K 84 0.68 0 0 0 0 placenta ELGANs Not reported,European 1722 ES00629 Initial 450K 84 0.68 0 0 0 0 placenta ELGANs European,Not reported 1723 ES00630 Initial 450K 84 0.68 0 0 0 0 placenta ELGANs Not reported,European 1724 ES00631 Initial 450K 84 0.68 0 0 0 0 placenta ELGANs European,Not reported 1725 ES00632 Initial 450K 84 0.68 0 0 0 0 placenta ELGANs Not reported,European 1726 ES00633 Initial 450K 84 0.68 0 0 0 0 placenta ELGANs Not reported,European 1729 ES00635 Initial 450K 10 0 NA NA 48.2 9.2 visceral adipose tissue No Type 2 Diabetes Not reported 1730 ES00635 Initial 450K 8 0 NA NA 50.3 7.7 visceral adipose tissue Type 2 diabetes Not reported 1732 ES00635 Replication 450K 36 0.44 NA NA 46.5 11.5 adipose tissue Type 2 diabetes Not reported 1733 ES00637 Initial 850K 448 0.53 0 0 0 0 placenta Gen3G Gestation and Growth prospective cohort European 1734 ES00638 Initial 850K 4 0.75 34 44 NA NA synovial fibroblast BEACON Birmingham early arthritis cohort non-arthritic patients Not reported 1735 ES00638 Initial 450K 5 0 42 70 NA NA synovial fibroblast BEACON Birmingham early arthritis cohort Early RA Not reported 1736 ES00639 Initial 850K 4 0.75 34 44 NA NA synovial fibroblast BEACON Birmingham early arthritis cohort non-arthritic patients Not reported 1737 ES00640 Initial 850K 4 0.75 34 44 NA NA synovial fibroblast BEACON Birmingham early arthritis cohort non-arthritic patients Not reported 1738 ES00639 Initial 450K 3 0 54 70 NA NA synovial fibroblast BEACON Birmingham early arthritis cohort established, long-standing rheumatoid arthritis Not reported 1739 ES00640 Initial 450K 7 0.71 32 72 NA NA synovial fibroblast BEACON Birmingham early arthritis cohort patients with resolving arthritis Not reported 1740 ES00641 Initial 450K 227 0.43 15 17 NA NA whole blood ALSPAC European 1741 ES00642 Initial 450K 524 0.49 15 17 NA NA whole blood ALSPAC European 1742 ES00643 Initial 450K 364 0.4 15 17 NA NA whole blood ALSPAC European 1743 ES00644 Initial 450K 575 0.48 15 17 NA NA whole blood ALSPAC European 1744 ES00645 Initial 450K 319 0.41 0 0 0 0 cord blood ALSPAC European 1745 ES00645 Initial 450K 319 0.41 7 7 7 0 whole blood ALSPAC European 1746 ES00646 Initial 450K 575 0.48 0 0 0 0 cord blood ALSPAC European 1747 ES00646 Initial 450K 575 0.48 7 7 7 0 whole blood ALSPAC European 1748 ES00647 Initial 450K 934 0.47 NA NA 69 9 CD14+ monocyte MESA Multi-Ethnic Study of Atherosclerosis Hispanic or Latin American,European,African unspecified 1749 ES00647 Replication 450K 128 NA NA NA NA NA CD14+ monocyte Not reported 1750 ES00648 Initial 450K 40 0 NA NA NA NA lymphocyte Pre-guadecitabine Not reported 1751 ES00648 Initial 450K 9 0 NA NA NA NA leukocyte post-treatment Not reported 1752 ES00650 Initial 450K 486 0.54 55 79 65.9 6.1 whole blood MADT Middle Aged Danish Twins Study European 1753 ES00649 Initial 450K 12 0.58 10.7 10.9 10.7 NA whole blood PMNS Pune Maternal Nutrition Study Placebo Not reported 1754 ES00649 Initial 450K 12 0.5 8.8 9.2 9 NA whole blood PMNS Pune Maternal Nutrition Study B12 Supplementation Not reported 1755 ES00651 Initial 450K 12 0.58 8.9 9.2 9.1 NA whole blood PMNS Pune Maternal Nutrition Study Placebo Not reported 1756 ES00651 Initial 450K 12 0.6 8.9 9.2 8.9 NA whole blood PMNS Pune Maternal Nutrition Study B12 + folic acid Supplementation Not reported 1757 ES00651 Replication 450K 55 0.33 10.9 12.2 11.4 NA whole blood B12 with multiple micronutrients supplementation Not reported 1758 ES00651 Replication 450K 55 0.55 11 12 11.3 NA whole blood Control Not reported 1759 ES00653 Initial 450K 574 0.49 NA NA 60.9 10.2 whole blood REGICOR REgistre GIroní del COR European 1760 ES00653 Initial 450K 1823 0.47 NA NA 63.5 7.3 whole blood FHS Offspring Framingham Offspring Study European 1761 ES00654 Initial 450K 10 0.5 NA NA 52.7 18.5 whole blood best responders East Asian 1762 ES00654 Initial 450K 10 0.2 NA NA 47 11 whole blood worst responders East Asian 1763 ES00655 Initial 450K 53 0.64 NA NA 64.7 8.2 whole blood Control Not reported 1764 ES00655 Initial 450K 74 0.64 NA NA 69 13.6 whole blood stable coronary artery disease Not reported 1765 ES00655 Initial 450K 81 0.52 NA NA 72.7 12.9 whole blood acute coronary syndrome Not reported 1766 ES00656 Initial 450K 19 0 NA NA 38 0.2 peripheral blood mononuclear cell smoking within 5 years European 1767 ES00656 Initial 450K 22 0 NA NA 38 0.2 peripheral blood mononuclear cell never-smokers European 1768 ES00657 Initial 450K 9 0 NA NA 38 0.2 peripheral blood mononuclear cell smoking beyond 5 years European 1769 ES00657 Initial 450K 19 0 NA NA 38 0.2 peripheral blood mononuclear cell smoking within 5 years European 1770 ES00658 Initial 450K 20 1 NA NA 36.4 3.2 sperm m proven fertile males Not reported 1771 ES00658 Initial 450K 20 1 NA NA 36.4 3.2 sperm oligospermic males Not reported 1772 ES00659 Initial 450K 22 0.5 NA NA 38.1 5.6 whole blood Controls African American or Afro-Caribbean,Other,European 1773 ES00659 Initial 450K 22 0.55 NA NA 36.3 9.3 whole blood Intermittent explosive disorder African American or Afro-Caribbean,Other,European 1774 ES00660 Initial 450K 641 0.49 NA NA 63.2 11.7 whole blood REGICOR Not reported 1775 ES00660 Replication 450K 2515 0.46 NA NA 66.2 8.9 whole blood FHS Offspring Framingham Offspring Study Not reported 1776 ES00661 Initial 450K 641 0.49 NA NA 63.2 11.7 whole blood REGICOR Not reported 1777 ES00661 Replication 450K 2515 0.46 NA NA 66.2 8.9 whole blood FHS Offspring Framingham Offspring Study Not reported 1778 ES00662 Initial 450K 18 0.61 NA NA 5.8 1.4 leukocyte Siblings exposed to GDM in utero Not reported 1779 ES00662 Initial 450K 18 0.56 NA NA 9.4 2.5 leukocyte Siblings not exposed to GDM in utero Not reported 1780 ES00663 Initial 450K 2264 0.37 NA NA 56.2 5.8 whole blood ARIC Atherosclerosis Risk in Communities African American or Afro-Caribbean 1781 ES00663 Initial 450K 2595 0.46 NA NA 66.3 8.9 whole blood FHS Framingham Heart Study European 1782 ES00664 Initial 450K 2264 0.37 NA NA 56.2 5.8 whole blood ARIC Atherosclerosis Risk in Communities African American or Afro-Caribbean 1783 ES00664 Initial 450K 2595 0.46 NA NA 66.3 8.9 whole blood FHS Framingham Heart Study European 1784 ES00665 Initial 450K 2264 0.37 NA NA 56.2 5.8 whole blood ARIC Atherosclerosis Risk in Communities African American or Afro-Caribbean 1785 ES00665 Initial 450K 2595 0.46 NA NA 66.3 8.9 whole blood FHS Framingham Heart Study European 1786 ES00666 Initial 450K 21 0.43 0 0 0 0 cord blood ALSPAC Avon Longitudinal Study of Parents and Children Active ED Not reported 1787 ES00666 Initial 450K 126 0.45 0 0 0 0 cord blood ALSPAC Avon Longitudinal Study of Parents and Children Controls Not reported 1788 ES00667 Initial 450K 43 0.49 0 0 0 0 cord blood ALSPAC Avon Longitudinal Study of Parents and Children Past ED Not reported 1789 ES00667 Initial 450K 126 0.45 0 0 0 0 cord blood ALSPAC Avon Longitudinal Study of Parents and Children Controls Not reported 1790 ES00668 Initial 450K 22 0.64 0 0 0 0 placenta early-onset preeclampsia Other,European,Asian unspecified 1791 ES00668 Initial 450K 24 0.67 0 0 0 0 placenta Pre-term Control Asian unspecified,Other,European 1792 ES00668 Replication 450K 22 0.41 0 0 0 0 placenta early-onset preeclampsia Asian unspecified,African unspecified,Other,European 1793 ES00668 Replication 450K 6 0.67 0 0 0 0 placenta Pre-term Control African unspecified,Other,European,Asian unspecified 1794 ES00669 Initial 450K 374 0.48 5.5 5.5 5.5 0 whole blood European 1795 ES00670 Initial 450K 374 0.48 5.5 5.5 5.5 0 whole blood European 1796 ES00671 Initial 450K 374 0.48 5.5 5.5 5.5 0 whole blood European 1797 ES00672 Initial 450K 374 0.48 5.5 5.5 5.5 0 whole blood European 1798 ES00673 Initial 450K 374 0.48 5.5 5.5 5.5 0 whole blood European 1799 ES00674 Initial 450K 374 0.48 5.5 5.5 5.5 0 whole blood European 1800 ES00675 Initial 450K 729 0.46 NA NA 59.9 8.2 whole blood RS-III-I European 1801 ES00675 Initial 450K 436 0.4 NA NA 79.1 0.6 whole blood LBC1921 European 1802 ES00675 Initial 450K 905 0.51 NA NA 69.6 0.8 whole blood LBC1936 European 1803 ES00675 Initial 450K 1799 0.49 NA NA 61 8.9 whole blood KORA European 1804 ES00675 Initial 450K 2408 0.46 NA NA 66.4 8.9 whole blood FHS European 1805 ES00675 Initial 450K 722 0.42 NA NA 67.6 6 whole blood RS-II-3/ RS-III-2 European 1806 ES00675 Initial 450K 739 0.48 NA NA 59 6.7 whole blood LLS European 1807 ES00675 Initial 450K 744 0.42 NA NA 45.6 13.3 whole blood LLD European 1808 ES00675 Initial 450K 691 0.31 NA NA 34 12.1 whole blood NTR European 1809 ES00675 Initial 450K 161 0.55 NA NA 65.4 6.8 whole blood CODAM European 1810 ES00675 Initial 450K 349 0.22 NA NA 43.8 14.1 whole blood MARTHA European 1811 ES00675 Initial 450K 211 0.48 NA NA 39.7 16.8 whole blood F5L European 1812 ES00676 Initial 450K 729 0.46 NA NA 59.9 8.2 whole blood RS-III-I European 1813 ES00676 Initial 450K 436 0.4 NA NA 79.1 0.6 whole blood LBC1921 European 1814 ES00676 Initial 450K 905 0.51 NA NA 69.6 0.8 whole blood LBC1936 European 1815 ES00676 Initial 450K 1799 0.49 NA NA 61 8.9 whole blood KORA European 1816 ES00676 Initial 450K 2408 0.46 NA NA 66.4 8.9 whole blood FHS European 1817 ES00676 Initial 450K 722 0.42 NA NA 67.6 6 whole blood RS-II-3/ RS-III-2 European 1818 ES00676 Initial 450K 739 0.48 NA NA 59 6.7 whole blood LLS European 1819 ES00676 Initial 450K 744 0.42 NA NA 45.6 13.3 whole blood LLD European 1820 ES00676 Initial 450K 691 0.31 NA NA 34 12.1 whole blood NTR European 1821 ES00676 Initial 450K 161 0.55 NA NA 65.4 6.8 whole blood CODAM European 1822 ES00676 Initial 450K 349 0.22 NA NA 43.8 14.1 whole blood MARTHA European 1823 ES00676 Initial 450K 211 0.48 NA NA 39.7 16.8 whole blood F5L European 1824 ES00677 Initial 450K 2 0.5 NA NA NA NA metastatic tumor metastatic tumors East Asian 1825 ES00677 Initial 450K 2 0.5 NA NA NA NA primary tumor primary tumor East Asian 1826 ES00678 Initial 450K 179 0.56 6 17 10.7 NA whole blood CNTR Chinese National Twin Registry East Asian 1827 ES00679 Initial 450K 1450 0.44 NA NA 63.7 8.1 whole blood RS Rotterdam Study European 1828 ES00679 Replication 450K 2097 0.36 NA NA 56.2 5.7 whole blood ARIC Atherosclerosis Risk in Communities Study African American or Afro-Caribbean 1829 ES00680 Initial 450K 1450 0.44 NA NA 63.7 8.1 whole blood RS Rotterdam Study European 1830 ES00680 Replication 450K 2097 0.36 NA NA 56.2 5.7 whole blood ARIC Atherosclerosis Risk in Communities Study African American or Afro-Caribbean 1831 ES00681 Initial 450K 25 1 14 14 14 0 peripheral blood mononuclear cell COAST post-puberty European,African American or Afro-Caribbean 1832 ES00681 Initial 450K 25 1 8 8 8 0 peripheral blood mononuclear cell COAST pre-puberty African American or Afro-Caribbean,European 1833 ES00682 Initial 450K 30 0 14 14 14 0 peripheral blood mononuclear cell COAST post-puberty Hispanic or Latin American,European,African American or Afro-Caribbean 1834 ES00682 Initial 450K 30 0 8 8 8 0 peripheral blood mononuclear cell COAST pre-puberty Hispanic or Latin American,European,African American or Afro-Caribbean 1835 ES00683 Initial 450K 25 1 14 14 14 0 peripheral blood mononuclear cell COAST post-puberty African American or Afro-Caribbean,European 1836 ES00683 Initial 450K 25 1 8 8 8 0 peripheral blood mononuclear cell COAST pre-puberty European,African American or Afro-Caribbean 1837 ES00683 Initial 450K 30 0 14 14 14 0 peripheral blood mononuclear cell COAST post-puberty Hispanic or Latin American,European,African American or Afro-Caribbean 1838 ES00683 Initial 450K 30 0 8 8 8 0 peripheral blood mononuclear cell COAST pre-puberty African American or Afro-Caribbean,Hispanic or Latin American,European 1839 ES00684 Initial 450K 58 0.59 NA NA 45 13 airway epithelial cell IL-13 treated Not reported 1840 ES00684 Initial 450K 58 0.59 NA NA 45 13 airway epithelial cell untreated Not reported 1841 ES00686 Initial 450K 1 NA NA NA NA NA lymphoblastoid cell line ICF patients Not reported 1842 ES00686 Initial 450K 1 NA NA NA NA NA untrasformed fibroblast ICF patients Not reported 1843 ES00686 Initial 450K 1 NA NA NA NA NA fibroblast healthy control Not reported 1844 ES00686 Initial 450K 2 NA NA NA NA NA lymphoblastoid cell line healthy control Not reported 1845 ES00687 Initial 27K 123 0.5 8 78 43 17.2 tumor tissue ENS@T European Network for the Study of Adrenal Tumors 24 metastatic European 1846 ES00687 Replication 27K 154 0.37 7 82 42.5 16.3 tumor tissue ENS@T European Network for the Study of Adrenal Tumors European 1847 ES00687 Replication 27K 33 0.52 9 74 50.9 18.1 tumor tissue ENS@T European Network for the Study of Adrenal Tumors European 1848 ES00690 Initial 450K 257 0.5 NA NA 50.4 NA whole blood RODAM Research on Obesity and Diabetes among African Migrants No obesity Sub-Saharan African 1849 ES00690 Initial 450K 290 0.5 NA NA 50.7 NA whole blood RODAM Research on Obesity and Diabetes among African Migrants Obesity Sub-Saharan African 1850 ES00691 Initial 450K 422 0.15 NA NA 50.4 NA whole blood RODAM Research on Obesity and Diabetes among African Migrants Abdominal obesity Sub-Saharan African 1851 ES00691 Initial 450K 164 0.85 NA NA 50.6 NA whole blood RODAM Research on Obesity and Diabetes among African Migrants No abdominal obesity Sub-Saharan African 1855 ES00693 Initial 450K 34 1 49.2 65.5 57.3 NA leukocyte European 1856 ES00694 Initial 450K 34 1 49.2 65.5 57.3 NA leukocyte European 1857 ES00695 Initial 450K 34 1 49.2 65.5 57.3 NA leukocyte European 1858 ES00688 Initial 450K 20 0.8 10 NA 6 15 nasal epithelial cell African unspecified,Other admixed ancestry,European 1859 ES00688 Replication 450K 13 0.46 6 NA 5 8 nasal epithelial cell European,African unspecified,Other admixed ancestry 1860 ES00689 Initial 450K 20 0.8 10 NA 6 15 nasal epithelial cell European,African unspecified,Other admixed ancestry 1861 ES00689 Replication 450K 13 0.46 6 NA 5 8 nasal epithelial cell Other admixed ancestry,European,African unspecified 1862 ES00696 Initial 450K 22 0.5 0 0 0 0 cord blood PELS Prenatal Early Life Stress cohort Low pregnancy anxiety European 1863 ES00696 Initial 450K 23 0.57 0 0 0 0 cord blood PELS Prenatal Early Life Stress cohort High pregnancy anxiety European 1864 ES00697 Initial 450K 479 0 NA NA 56.4 7.9 whole blood Aboriginal Australian 1865 ES00698 Initial 450K 479 0 NA NA 56.4 7.9 whole blood Aboriginal Australian 1866 ES00699 Initial 450K 479 0 NA NA 56.4 7.9 whole blood Aboriginal Australian 1867 ES00700 Initial 450K 9 NA 50 83 61.4 10.2 CD3+ T cell Controls Not reported 1868 ES00700 Initial 450K 28 NA 43 85 64.1 10.2 CD3+ T cell breast cancer Not reported 1869 ES00701 Initial 450K 56 0.2 NA NA 6.1 4 CD4+ T cell Case Not reported 1870 ES00701 Initial 450K 57 0.25 NA NA 6.4 4.2 CD4+ T cell control Not reported 1871 ES00702 Initial 450K 13 0.23 0 0 0 0 umbilical cord leukocyte EOPE Not reported 1872 ES00702 Initial 450K 36 0.58 0 0 0 0 umbilical cord leukocyte uncomplicated pregnancies Not reported 1873 ES00702 Initial 450K 27 0.56 0 0 0 0 umbilical cord leukocyte normotensive fetal growth restricted Not reported 1874 ES00702 Initial 450K 20 0.5 0 0 0 0 umbilical cord leukocyte normotensive preterm birth Not reported 1875 ES00703 Initial 450K 13 0.23 0 0 0 0 placenta EOPE Not reported 1876 ES00703 Initial 450K 36 0.58 0 0 0 0 placenta uncomplicated pregnancies Not reported 1877 ES00703 Initial 450K 27 0.56 0 0 0 0 placenta normotensive fetal growth restricted Not reported 1878 ES00703 Initial 450K 20 0.5 0 0 0 0 placenta normotensive preterm birth Not reported 1879 ES00704 Initial 450K 17 NA NA NA NA NA thyroid benign thyroid lesions Not reported 1880 ES00704 Initial 450K 50 NA NA NA NA NA thyroid nonneoplastic thyroid tissues Not reported 1881 ES00705 Initial 450K 60 NA NA NA NA NA thyroid papillary thyroid carcinoma Not reported 1882 ES00705 Initial 450K 50 NA NA NA NA NA thyroid nonneoplastic thyroid tissues Not reported 1883 ES00706 Initial 450K 8 NA NA NA NA NA thyroid follicular thyroid carcinoma Not reported 1884 ES00706 Initial 450K 50 NA NA NA NA NA thyroid nonneoplastic thyroid tissues Not reported 1885 ES00707 Initial 450K 671 0.49 0 0 0 0 cord blood ALSPAC Avon Longitudinal Study of Parents and Children European 1886 ES00708 Initial 450K 671 0.49 0 0 0 0 cord blood ALSPAC Avon Longitudinal Study of Parents and Children European 1887 ES00709 Initial 450K 3 1 70 75 NA NA whole blood Normal East Asian 1888 ES00709 Initial 450K 3 1 60 75 NA NA whole blood LA Type I East Asian 1889 ES00710 Initial 450K 3 1 60 75 NA NA whole blood LA Type I East Asian 1890 ES00710 Initial 450K 3 1 60 85 NA NA whole blood LA Type II East Asian 1891 ES00711 Initial 450K 6 1 60 85 NA NA whole blood LA East Asian 1892 ES00711 Initial 450K 3 1 70 75 NA NA whole blood Normal European 1893 ES00712 Initial 450K 754 0 0 0 0 0 whole blood ALSPAC Avon Longitudinal Study of Parents and Children Not reported 1894 ES00712 Replication 450K 656 0 18 18 18 0 leukocyte ALSPAC Avon Longitudinal Study of Parents and Children Not reported 1895 ES00712 Replication 450K 230 1 18 18 18 0 leukocyte ALSPAC Avon Longitudinal Study of Parents and Children Not reported 1896 ES00713 Initial 450K 96 0.51 NA NA 49.8 7.4 whole blood European,African American or Afro-Caribbean 1897 ES00713 Replication 450K 166 0.64 NA NA 43.9 12 whole blood European,African American or Afro-Caribbean 1898 ES00714 Initial 450K 375 NA NA NA NA NA liver HCC Not reported 1899 ES00714 Initial 450K 132 NA NA NA NA NA liver paired HCC and adjacent normal Not reported 1900 ES00714 Initial 450K 184 NA NA NA NA NA whole blood European 1901 ES00714 Initial 450K 37 NA NA NA NA NA liver paired HCC and adjacent normal Not reported 1902 ES00714 Initial 450K 243 NA NA NA NA NA liver 224 HCC, nine cirrhotic, and ten normal Not reported 1903 ES00715 Initial 850K 3 NA NA NA NA NA whole blood Werner syndrome Not reported 1904 ES00715 Initial 850K 3 NA NA NA NA NA whole blood control Not reported 1905 ES00716 Initial 450K 268 0.49 0 0 0 0 cord blood Project Viva Project Viva Not reported,European 1906 ES00717 Initial 450K 130 1 0 0 0 0 whole blood Not reported,European 1907 ES00718 Initial 450K 138 0 0 0 0 0 cord blood European,Not reported 1908 ES00719 Initial 450K 116 0.81 NA NA NA NA lung EAGLE Environment And Genetics in Lung cancer Etiology study Current nonsmokers Not reported 1909 ES00719 Initial 450K 121 0.89 NA NA NA NA lung EAGLE Environment And Genetics in Lung cancer Etiology study Current smokers Not reported 1910 ES00720 Initial 450K 313 0.66 19 90 61 NA tumor tissue Not reported 1911 ES00720 Replication 450K 82 0.44 23 85 58 NA tumor tissue Not reported 1912 ES00720 Replication 450K 53 0.21 28 79 45 NA tumor tissue Not reported 1913 ES00721 Initial 450K 508 0.55 35 92 70 NA whole blood PEG1 Parkinson’s Environment and Genes study 289 PD European 1914 ES00721 Initial 450K 64 0.64 35 86 65 NA whole blood PEG1 Parkinson’s Environment and Genes study 46 PD Hispanic or Latin American 1915 ES00722 Initial 450K 166 0.54 40 88 69 NA saliva PEG2 Parkinson’s Environment and Genes study 82 PD European 1916 ES00722 Initial 450K 93 0.6 36 88 68 NA saliva PEG2 Parkinson’s Environment and Genes study 46 PD Hispanic or Latin American 1917 ES00723 Initial 450K 48 0.56 0 0 0 0 neonatal blood Psychiatric Not reported 1918 ES00723 Initial 450K 116 0.49 0 0 0 0 neonatal blood control Not reported 1919 ES00724 Initial 450K 116 0.49 0 0 0 0 neonatal blood control Not reported 1920 ES00725 Initial 450K 116 0.49 0 0 0 0 neonatal blood control Not reported 1921 ES00726 Initial 450K 116 0.49 0 0 0 0 neonatal blood control Not reported 1922 ES00727 Initial 450K 116 0.49 0 0 0 0 neonatal blood control Not reported 1923 ES00724 Initial 450K 23 0.52 0 0 0 0 neonatal blood Intellectual Disability Not reported 1924 ES00725 Initial 450K 12 0.75 0 0 0 0 neonatal blood Behavioral Disorders Not reported 1925 ES00726 Initial 450K 16 0.75 0 0 0 0 neonatal blood Psychological Development Not reported 1926 ES00727 Initial 450K 4 NA 0 0 0 0 neonatal blood schizophrenia Not reported 1929 ES00728 Initial 450K 41 1 NA NA 56.4 0.6 leukocyte LLSLFH Leuven Longitudinal Study on Lifestyle, Fitness and Health European 1930 ES00729 Initial 450K 41 1 NA NA 56.4 0.6 leukocyte LLSLFH Leuven Longitudinal Study on Lifestyle, Fitness and Health European 1931 ES00730 Initial 450K 788 NA NA NA 29.7 4.4 cord blood ALSPAC European 1932 ES00730 Initial 450K 132 NA NA NA 27.2 5.7 whole blood CBC Hispanic or Latin American 1933 ES00730 Initial 450K 155 NA NA NA 32 5.7 cord blood CBC European 1934 ES00730 Initial 450K 368 NA NA NA 25.3 5 cord blood CHAMACOS Hispanic or Latin American 1935 ES00730 Initial 450K 211 NA NA NA 34 4.7 cord blood EARLI Other admixed ancestry,European 1936 ES00730 Initial 450K 176 NA NA NA 30.4 4 cord blood GECKO European 1937 ES00730 Initial 450K 170 NA NA NA 28 4.1 cord blood GEN3G European 1938 ES00730 Initial 450K 875 NA NA NA 31.5 4.2 cord blood Generation R European 1939 ES00730 Initial 450K 545 NA NA NA 29.5 4.1 cord blood GOYA European 1940 ES00730 Initial 450K 53 NA NA NA 21.5 1.4 cord blood IOW F2 European 1941 ES00730 Initial 450K 330 NA NA NA 30.6 4.5 cord blood MEDALL European 1942 ES00730 Initial 450K 1034 NA NA NA 29.9 4.3 cord blood MoBa1 European 1943 ES00730 Initial 450K 647 NA NA NA 30 4.5 cord blood MoBa2 European 1944 ES00730 Initial 450K 231 NA NA NA 29.6 4.4 cord blood MoBa3 European 1945 ES00730 Initial 450K 384 NA NA NA 28.8 6.4 cord blood NEST Other 1946 ES00730 Initial 450K 867 NA NA NA 29.1 4.9 cord blood NFCS European 1947 ES00730 Initial 450K 118 NA NA NA 31 4.4 cord blood NHBCS European 1948 ES00730 Initial 450K 96 NA NA NA 28.3 5.5 cord blood RICHS European 1949 ES00730 Initial 450K 343 NA NA NA 33.1 4.5 cord blood Project Viva European 1950 ES00730 Replication 450K 221 NA NA NA 31.2 4.3 cord blood BAMSE European 1951 ES00730 Replication 450K 279 NA NA NA 37.3 5.2 cord blood OW F1 European 1952 ES00730 Replication 450K 583 NA NA NA 30.9 3.7 cord blood PIAMA European 1953 ES00730 Replication 450K 734 NA NA NA 29.1 5.8 cord blood RAINE European 1954 ES00730 Replication 450K 734 NA NA NA 29.1 5.8 cord blood RAINE European 1955 ES00732 Initial 450K 162 0 NA NA NA NA breast EPIC European Prospective Investigation into Cancer and Nutrition Cases European 1956 ES00732 Initial 450K 162 0 NA NA NA NA breast EPIC European Prospective Investigation into Cancer and Nutrition Control European 1957 ES00733 Initial 450K 1669 NA NA NA 18.4 0.36 whole blood E-Risk Environmental Risk Longitudinal Twin Study Not reported 1958 ES00734 Initial 450K 1669 NA NA NA 18.4 0.36 whole blood E-Risk Environmental Risk Longitudinal Twin Study Not reported 1959 ES00735 Initial 450K 1669 NA NA NA 18.4 0.36 whole blood E-Risk Environmental Risk Longitudinal Twin Study Not reported 1960 ES00736 Initial 450K 486 0.54 55 79 65.9 6.1 whole blood MADT Middle Aged Danish Twins Study European 1961 ES00737 Initial 450K 486 0.54 55 79 65.9 6.1 whole blood MADT Middle Aged Danish Twins Study European 1962 ES00738 Initial 450K 486 0.54 55 79 65.9 6.1 whole blood MADT Middle Aged Danish Twins Study European 1963 ES00739 Initial 450K 486 0.54 55 79 65.9 6.1 whole blood MADT Middle Aged Danish Twins Study European 1964 ES00740 Initial 450K 2307 0.35 NA NA 56.2 5.7 whole blood ARIC Atherosclerosis Risk in Communities African American or Afro-Caribbean 1965 ES00740 Initial 450K 2249 0.46 NA NA 66 8.8 whole blood FHS Framingham Heart Study European 1966 ES00740 Initial 450K 219 0.26 NA NA 65.9 6.4 whole blood GENOA Genetic Epidemiology Network of Arteriopathy African American or Afro-Caribbean 1967 ES00740 Initial 450K 437 0.48 NA NA 61 16.1 whole blood InCHIANTI European 1968 ES00740 Initial 450K 435 0.39 NA NA 79.1 0.6 whole blood LBC1921 Lothian Birth Cohort 1921 European 1969 ES00740 Initial 450K 920 0.51 NA NA 69.6 0.8 whole blood LBC1936 Lothian Birth Cohort 1936 European 1970 ES00740 Initial 450K 464 0.39 NA NA 78 5.5 whole blood MOBILZE European 1971 ES00740 Initial 450K 538 0 NA NA 72.6 6.4 whole blood NAS Normative Aging Study European 1972 ES00740 Initial 450K 689 0.45 NA NA 59.5 8 whole blood RS-III Rotterdam Study European 1973 ES00740 Initial 450K 728 0.42 NA NA 67.5 5.9 whole blood RS-Bios Rotterdam Bios European 1974 ES00740 Initial 450K 332 1 NA NA 58.9 8.6 whole blood TwinsUK European 1975 ES00741 Initial 450K 2307 0.35 NA NA 56.2 5.7 whole blood ARIC Atherosclerosis Risk in Communities African American or Afro-Caribbean 1976 ES00741 Initial 450K 2249 0.46 NA NA 66 8.8 whole blood FHS Framingham Heart Study European 1977 ES00741 Initial 450K 219 0.26 NA NA 65.9 6.4 whole blood GENOA Genetic Epidemiology Network of Arteriopathy African American or Afro-Caribbean 1978 ES00741 Initial 450K 437 0.48 NA NA 61 16.1 whole blood InCHIANTI European 1979 ES00741 Initial 450K 435 0.39 NA NA 79.1 0.6 whole blood LBC1921 Lothian Birth Cohort 1921 European 1980 ES00741 Initial 450K 920 0.51 NA NA 69.6 0.8 whole blood LBC1936 Lothian Birth Cohort 1936 European 1981 ES00741 Initial 450K 464 0.39 NA NA 78 5.5 whole blood MOBILZE European 1982 ES00741 Initial 450K 538 0 NA NA 72.6 6.4 whole blood NAS Normative Aging Study European 1983 ES00741 Initial 450K 689 0.45 NA NA 59.5 8 whole blood RS-III Rotterdam Study European 1984 ES00741 Initial 450K 728 0.42 NA NA 67.5 5.9 whole blood RS-Bios Rotterdam Bios European 1985 ES00741 Initial 450K 332 1 NA NA 58.9 8.6 whole blood TwinsUK European 1986 ES00742 Initial 450K 2307 0.35 NA NA 56.2 5.7 whole blood ARIC Atherosclerosis Risk in Communities African American or Afro-Caribbean 1987 ES00742 Initial 450K 2249 0.46 NA NA 66 8.8 whole blood FHS Framingham Heart Study European 1988 ES00742 Initial 450K 219 0.26 NA NA 65.9 6.4 whole blood GENOA Genetic Epidemiology Network of Arteriopathy African American or Afro-Caribbean 1989 ES00742 Initial 450K 437 0.48 NA NA 61 16.1 whole blood InCHIANTI European 1990 ES00742 Initial 450K 435 0.39 NA NA 79.1 0.6 whole blood LBC1921 Lothian Birth Cohort 1921 European 1991 ES00742 Initial 450K 920 0.51 NA NA 69.6 0.8 whole blood LBC1936 Lothian Birth Cohort 1936 European 1992 ES00742 Initial 450K 464 0.39 NA NA 78 5.5 whole blood MOBILZE European 1993 ES00742 Initial 450K 538 0 NA NA 72.6 6.4 whole blood NAS Normative Aging Study European 1994 ES00742 Initial 450K 689 0.45 NA NA 59.5 8 whole blood RS-III Rotterdam Study European 1995 ES00742 Initial 450K 728 0.42 NA NA 67.5 5.9 whole blood RS-Bios Rotterdam Bios European 1996 ES00742 Initial 450K 332 1 NA NA 58.9 8.6 whole blood TwinsUK European 1997 ES00743 Initial 450K 2307 0.35 NA NA 56.2 5.7 whole blood ARIC Atherosclerosis Risk in Communities African American or Afro-Caribbean 1998 ES00743 Initial 450K 2249 0.46 NA NA 66 8.8 whole blood FHS Framingham Heart Study European 1999 ES00743 Initial 450K 219 0.26 NA NA 65.9 6.4 whole blood GENOA Genetic Epidemiology Network of Arteriopathy African American or Afro-Caribbean 2000 ES00743 Initial 450K 437 0.48 NA NA 61 16.1 whole blood InCHIANTI European 2001 ES00743 Initial 450K 435 0.39 NA NA 79.1 0.6 whole blood LBC1921 Lothian Birth Cohort 1921 European 2002 ES00743 Initial 450K 920 0.51 NA NA 69.6 0.8 whole blood LBC1936 Lothian Birth Cohort 1936 European 2003 ES00743 Initial 450K 464 0.39 NA NA 78 5.5 whole blood MOBILZE European 2004 ES00743 Initial 450K 538 0 NA NA 72.6 6.4 whole blood NAS Normative Aging Study European 2005 ES00743 Initial 450K 689 0.45 NA NA 59.5 8 whole blood RS-III Rotterdam Study European 2006 ES00743 Initial 450K 728 0.42 NA NA 67.5 5.9 whole blood RS-Bios Rotterdam Bios European 2007 ES00743 Initial 450K 332 1 NA NA 58.9 8.6 whole blood TwinsUK European 2008 ES00652 Initial 450K 27 0.33 NA NA 40 NA leukocyte without depressive symptoms Not reported 2009 ES00652 Initial 450K 20 0.35 NA NA 36.2 NA leukocyte with depressive symptoms Not reported 2010 ES00744 Initial 450K 28 0.64 NA NA 52 8.1 whole blood Cases European 2011 ES00744 Initial 450K 319 0.37 NA NA 52.3 7.7 whole blood Controls European 2012 ES00745 Initial 450K 767 NA NA NA NA NA breast European,African unspecified 2013 ES00746 Initial 450K 733 0 35 60 47.4 4.5 whole blood ALSPAC Avon Longitudinal Study of Parents and Children European 2014 ES00746 Initial 450K 120 0.48 34 75 46.7 5.8 whole blood BSGS Brisbane Systems Genetics Study European 2015 ES00746 Initial 450K 48 0.33 25 40 31.8 4.6 whole blood EGCUT1 European 2016 ES00746 Initial 450K 93 0.51 25 84 53.4 23.5 whole blood EGCUT2 European 2017 ES00746 Initial 450K 305 0.5 25 81 51 16.5 whole blood EGCUT3 European 2018 ES00746 Initial 450K 155 0 36 70 52.6 7 whole blood EPIC European Prospective Investigation into Cancer and Nutrition European 2019 ES00746 Initial 450K 155 0.53 35 71 54.7 6.9 whole blood EPIC European Prospective Investigation into Cancer and Nutrition European 2020 ES00746 Initial 450K 194 0.56 36 70 54.4 6.4 whole blood EPIC European Prospective Investigation into Cancer and Nutrition European 2021 ES00746 Initial 450K 501 0.41 21 72 26.6 11 whole blood FTC Finnish Twin Cohort European 2022 ES00746 Initial 450K 472 0.53 25 74 51.9 13.8 whole blood FINRISK The National FINRISK Study European 2023 ES00746 Initial 450K 160 1 58 69 63.5 2.8 whole blood HBCS Helsinki Birth Cohort Study European 2024 ES00746 Initial 450K 1658 0.49 32 81 61 8.9 whole blood KORA F4 Cooperative Health Research in the Region of Augsburg European 2025 ES00746 Initial 450K 444 0.39 78 81 79.1 0.6 whole blood LBC1921 Lothian Birth Cohort 1921 European 2026 ES00746 Initial 450K 918 0.51 68 71 69.5 0.8 whole blood LBC1936 Lothian Birth Cohort 1936 European 2027 ES00746 Initial 450K 751 0.42 18 81 45.5 13.3 whole blood LLD LifeLines-DEEP European 2028 ES00746 Initial 450K 315 0 38 70 55.5 7.9 whole blood MCCS Melbourne Collaborative Cohort Study European 2029 ES00746 Initial 450K 528 0.46 40 70 58.3 7.9 whole blood MCCS Melbourne Collaborative Cohort Study European 2030 ES00746 Initial 450K 91 0.59 41 69 56.2 8.7 whole blood MCCS Melbourne Collaborative Cohort Study European 2031 ES00746 Initial 450K 215 0.59 40 70 58.1 7.5 whole blood MCCS Melbourne Collaborative Cohort Study European 2032 ES00746 Initial 450K 283 0.49 40 70 57.5 8.2 whole blood MCCS Melbourne Collaborative Cohort Study European 2033 ES00746 Initial 450K 600 1 40 70 58.2 7.7 whole blood MCCS Melbourne Collaborative Cohort Study European 2034 ES00746 Initial 450K 159 0.75 41 70 61 7.1 whole blood MCCS Melbourne Collaborative Cohort Study European 2035 ES00746 Initial 450K 111 0.38 65 90 71 5.9 whole blood OATS Older Australian Twins Study European 2036 ES00746 Initial 450K 671 0.43 52 80 67.2 6.1 whole blood RS-BIOS Rotterdam study-Biobank-based Integrative Omics Studies European 2037 ES00746 Initial 450K 728 0.46 46 89 59.9 8.2 whole blood RS3 Rotterdam Study European 2038 ES00746 Initial 450K 178 0.44 48 94 67.6 9.5 whole blood SATSA The Swedish Adoption/Twin Study of Aging European 2039 ES00746 Initial 450K 181 0.39 33 49 43.2 3.9 whole blood YFS Young Finns Study European 2040 ES00747 Initial 450K 19 0.74 0 0 0 0 cord blood MoBa Norwegian Mother and Child Cohort Study prenatal exposure to paracetamol for more than 20 days in children diagnosed with attention-deficit/hyperactivity disorder European 2041 ES00747 Initial 450K 96 0.54 0 0 0 0 cord blood MoBa Norwegian Mother and Child Cohort Study unexposed without attention-deficit/hyperactivity disorder European 2042 ES00748 Initial 450K 19 0.74 0 0 0 0 cord blood MoBa Norwegian Mother and Child Cohort Study prenatal exposure to paracetamol for more than 20 days in children diagnosed with attention-deficit/hyperactivity disorder European 2043 ES00748 Initial 450K 77 0.74 0 0 0 0 cord blood MoBa Norwegian Mother and Child Cohort Study sporadically exposed with attention-deficit/hyperactivity disorder European 2044 ES00749 Initial 450K 19 0.74 0 0 0 0 cord blood MoBa Norwegian Mother and Child Cohort Study prenatal exposure to paracetamol for more than 20 days in children diagnosed with attention-deficit/hyperactivity disorder European 2045 ES00749 Initial 450K 96 0.69 0 0 0 0 cord blood MoBa Norwegian Mother and Child Cohort Study unexposed with attention-deficit/hyperactivity disorder European 2046 ES00750 Initial 450K 49 0.49 34 82 63.7 11.8 colorectal mucosa Never smokers Not reported 2047 ES00750 Initial 450K 64 0.75 38 89 65.5 10.9 colorectal mucosa Former smokers Not reported 2048 ES00750 Initial 450K 18 0.56 22 79 56.6 12.5 colorectal mucosa Active smokers Not reported 2049 ES00750 Initial 450K 36 0.58 41 82 63.9 11.5 colorectal tumour Never smokers Not reported 2050 ES00750 Initial 450K 47 0.49 38 89 65.1 10.3 colorectal tumour Former smokers Not reported 2051 ES00750 Initial 450K 13 0.46 35 79 59.6 9.8 colorectal tumour Active smokers Not reported 2052 ES00751 Initial 450K 37 1 NA NA 69.4 0.6 whole blood GTP Grady Trauma Project Non-PTSD Aboriginal Australian 2053 ES00751 Initial 450K 42 1 NA NA 67.9 0.6 whole blood GTP Grady Trauma Project PTSD Aboriginal Australian 2054 ES00752 Initial 450K 24 0.34 NA NA 13 2.6 saliva IPV+ Not reported 2055 ES00752 Initial 450K 97 0.49 NA NA 13.8 2.5 saliva IPV ? Not reported 2056 ES00753 Initial 450K 27 0.74 NA NA 14 3 saliva CDV+ Not reported 2057 ES00753 Initial 450K 94 0.39 NA NA 13.5 2.3 saliva CDV ? Not reported 2058 ES00754 Initial 450K 112 0 NA NA 59.9 7.3 whole blood AMDTSS Australian Mammographic Density Twins and Sisters Study BT siblings Not reported 2059 ES00754 Initial 450K 103 0 NA NA 52.9 7.1 whole blood AMDTSS Australian Mammographic Density Twins and Sisters Study AT siblings Not reported 2060 ES00754 Replication 450K 27 0.41 NA NA 46.2 6.1 whole blood KHTS Korean Healthy Twin Study BT siblings Not reported 2061 ES00754 Replication 450K 15 0.4 NA NA 42.5 5 whole blood KHTS Korean Healthy Twin Study AT siblings Not reported 2062 ES00755 Initial 450K 229 0 0 0 0 0 cord blood Girls Hispanic or Latin American,European,African unspecified,Other 2063 ES00755 Initial 450K 249 1 0 0 0 0 cord blood Boys Hispanic or Latin American,European,African unspecified,Other 2064 ES00756 Initial 450K 229 0 0 0 0 0 cord blood Girls European,African unspecified,Other,Hispanic or Latin American 2065 ES00756 Initial 450K 249 1 0 0 0 0 cord blood Boys European,African unspecified,Other,Hispanic or Latin American 2066 ES00757 Initial 450K 229 0 0 0 0 0 cord blood Girls African unspecified,Other,Hispanic or Latin American,European 2067 ES00757 Initial 450K 249 1 0 0 0 0 cord blood Boys African unspecified,Other,Hispanic or Latin American,European 2068 ES00758 Initial 450K 5 0.6 51 69 57.4 7.1 articular cartilage KBD East Asian 2069 ES00758 Initial 450K 5 0.6 47 62 51 7.3 articular cartilage Normal East Asian 2070 ES00759 Initial 450K 5 0.6 58 72 64.6 5.2 articular cartilage OA East Asian 2072 ES00759 Initial 450K 5 0.6 47 62 51 7.3 articular cartilage Normal East Asian 2073 ES00760 Initial 450K 12 NA NA NA NA NA cartilage knee OA patients Not reported 2074 ES00760 Replication 450K 17 NA NA NA NA NA cartilage knee OA patients Not reported 2075 ES00760 Initial 450K 9 NA NA NA NA NA cartilage hip OA patients Not reported 2076 ES00761 Initial 450K 8 0 25 37 34.4 3.9 whole blood GDM East Asian 2077 ES00761 Initial 450K 8 0 27 38 33.3 3.2 whole blood Non-GDM East Asian 2078 ES00762 Initial 450K 8 0 25 37 34.4 3.9 cord blood GDM East Asian 2079 ES00762 Initial 450K 8 0 27 38 33.3 3.2 cord blood Non-GDM East Asian 2080 ES00763 Initial 450K 750 0.5 NA NA 48.9 16 buffy coat GOLDN Genetics of Lipid Lowering Drugs and Diet Network Study Baseline European 2081 ES00763 Initial 450K 750 0.5 NA NA 48.9 16 buffy coat GOLDN Genetics of Lipid Lowering Drugs and Diet Network Study After 3 weeks European 2082 ES00764 Initial 450K 750 0.5 NA NA 48.9 16 buffy coat GOLDN Genetics of Lipid Lowering Drugs and Diet Network Study Baseline European 2083 ES00764 Initial 450K 750 0.5 NA NA 48.9 16 buffy coat GOLDN Genetics of Lipid Lowering Drugs and Diet Network Study After 3 weeks European 2084 ES00765 Initial 450K 750 0.5 NA NA 48.9 16 buffy coat GOLDN Genetics of Lipid Lowering Drugs and Diet Network Study Baseline European 2085 ES00765 Initial 450K 750 0.5 NA NA 48.9 16 buffy coat GOLDN Genetics of Lipid Lowering Drugs and Diet Network Study After 3 weeks European 2086 ES00766 Initial 450K 41 0.76 NA NA 54.1 12.3 cardiac tissue Cases Not reported 2087 ES00766 Initial 450K 41 0.76 NA NA 54.1 12.3 whole blood Cases Not reported 2088 ES00766 Initial 450K 31 0.77 NA NA 54.1 11.7 cardiac tissue symptom-free patients after heart transplantation Not reported 2089 ES00766 Initial 450K 31 0.61 NA NA 65.7 0.1 whole blood Clinical Controls Not reported 2090 ES00767 Initial 450K 336 0.52 0 0 0 0 cord blood CHAMACOS Center of Health Assessment of Mothers and Children of Salinas Hispanic or Latin American 2091 ES00768 Initial 450K 336 0.52 0 0 0 0 cord blood CHAMACOS Center of Health Assessment of Mothers and Children of Salinas Hispanic or Latin American 2092 ES00769 Initial 450K 336 0.52 0 0 0 0 cord blood CHAMACOS Center of Health Assessment of Mothers and Children of Salinas Hispanic or Latin American 2093 ES00770 Initial 450K 336 0.52 0 0 0 0 cord blood CHAMACOS Center of Health Assessment of Mothers and Children of Salinas Hispanic or Latin American 2094 ES00771 Initial 450K 336 0.52 0 0 0 0 cord blood CHAMACOS Center of Health Assessment of Mothers and Children of Salinas Hispanic or Latin American 2095 ES00772 Initial 450K 336 0.52 0 0 0 0 cord blood CHAMACOS Center of Health Assessment of Mothers and Children of Salinas Hispanic or Latin American 2096 ES00773 Initial 450K 336 0.52 0 0 0 0 cord blood CHAMACOS Center of Health Assessment of Mothers and Children of Salinas Hispanic or Latin American 2097 ES00774 Initial 450K 336 0.52 0 0 0 0 cord blood CHAMACOS Center of Health Assessment of Mothers and Children of Salinas Hispanic or Latin American 2098 ES00775 Initial 450K 336 0.52 0 0 0 0 cord blood CHAMACOS Center of Health Assessment of Mothers and Children of Salinas Hispanic or Latin American 2099 ES00776 Initial 450K 336 0.52 0 0 0 0 cord blood CHAMACOS Center of Health Assessment of Mothers and Children of Salinas Hispanic or Latin American 2100 ES00777 Initial 450K 336 0.52 0 0 0 0 cord blood CHAMACOS Center of Health Assessment of Mothers and Children of Salinas Hispanic or Latin American 2101 ES00778 Initial 450K 336 0.52 0 0 0 0 cord blood CHAMACOS Center of Health Assessment of Mothers and Children of Salinas Hispanic or Latin American 2102 ES00779 Initial 450K 336 0.52 0 0 0 0 cord blood CHAMACOS Center of Health Assessment of Mothers and Children of Salinas Hispanic or Latin American 2103 ES00780 Initial 450K 336 0.52 0 0 0 0 cord blood CHAMACOS Center of Health Assessment of Mothers and Children of Salinas Hispanic or Latin American 2104 ES00781 Initial 450K 336 0.52 0 0 0 0 cord blood CHAMACOS Center of Health Assessment of Mothers and Children of Salinas Hispanic or Latin American 2105 ES00782 Initial 450K 336 0.52 0 0 0 0 cord blood CHAMACOS Center of Health Assessment of Mothers and Children of Salinas Hispanic or Latin American 2106 ES00783 Initial 450K 336 0.52 0 0 0 0 cord blood CHAMACOS Center of Health Assessment of Mothers and Children of Salinas Hispanic or Latin American 2107 ES00784 Initial 450K 336 0.52 0 0 0 0 cord blood CHAMACOS Center of Health Assessment of Mothers and Children of Salinas Hispanic or Latin American 2108 ES00785 Initial 450K 336 0.52 0 0 0 0 cord blood CHAMACOS Center of Health Assessment of Mothers and Children of Salinas Hispanic or Latin American 2109 ES00786 Initial 450K 336 0.52 0 0 0 0 cord blood CHAMACOS Center of Health Assessment of Mothers and Children of Salinas Hispanic or Latin American 2110 ES00787 Initial 450K 336 0.52 0 0 0 0 cord blood CHAMACOS Center of Health Assessment of Mothers and Children of Salinas Hispanic or Latin American 2111 ES00788 Initial 450K 336 0.52 0 0 0 0 cord blood CHAMACOS Center of Health Assessment of Mothers and Children of Salinas Hispanic or Latin American 2112 ES00789 Initial 450K 336 0.52 0 0 0 0 cord blood CHAMACOS Center of Health Assessment of Mothers and Children of Salinas Hispanic or Latin American 2113 ES00790 Initial 450K 336 0.52 0 0 0 0 cord blood CHAMACOS Center of Health Assessment of Mothers and Children of Salinas Hispanic or Latin American 2114 ES00791 Initial 450K 336 0.52 0 0 0 0 cord blood CHAMACOS Center of Health Assessment of Mothers and Children of Salinas Hispanic or Latin American 2115 ES00792 Initial 450K 336 0.52 0 0 0 0 cord blood CHAMACOS Center of Health Assessment of Mothers and Children of Salinas Hispanic or Latin American 2116 ES00793 Initial 450K 336 0.52 0 0 0 0 cord blood CHAMACOS Center of Health Assessment of Mothers and Children of Salinas Hispanic or Latin American 2117 ES00794 Initial 450K 336 0.52 0 0 0 0 cord blood CHAMACOS Center of Health Assessment of Mothers and Children of Salinas Hispanic or Latin American 2118 ES00795 Initial 450K 336 0.52 0 0 0 0 cord blood CHAMACOS Center of Health Assessment of Mothers and Children of Salinas Hispanic or Latin American 2119 ES00796 Initial 450K 336 0.52 0 0 0 0 cord blood CHAMACOS Center of Health Assessment of Mothers and Children of Salinas Hispanic or Latin American 2120 ES00797 Initial 450K 336 0.52 0 0 0 0 cord blood CHAMACOS Center of Health Assessment of Mothers and Children of Salinas Hispanic or Latin American 2121 ES00798 Initial 450K 336 0.52 0 0 0 0 cord blood CHAMACOS Center of Health Assessment of Mothers and Children of Salinas Hispanic or Latin American 2122 ES00799 Initial 450K 336 0.52 0 0 0 0 cord blood CHAMACOS Center of Health Assessment of Mothers and Children of Salinas Hispanic or Latin American 2123 ES00800 Initial 450K 336 0.52 0 0 0 0 cord blood CHAMACOS Center of Health Assessment of Mothers and Children of Salinas Hispanic or Latin American 2124 ES00801 Initial 450K 336 0.52 0 0 0 0 cord blood CHAMACOS Center of Health Assessment of Mothers and Children of Salinas Hispanic or Latin American 2125 ES00802 Initial 450K 91 0.35 14 83 47.2 NA tumor tissue Not reported 2126 ES00803 Initial 27K 51 0.24 15 81 43 NA tumor tissue Carcinomas Not reported 2127 ES00803 Initial 27K 84 0.08 22 78 48 NA tumor tissue Adenomas Not reported 2128 ES00804 Initial 450K 18 NA NA NA NA NA tumor tissue Adrenocortical carcinomas Not reported 2129 ES00804 Initial 450K 6 NA NA NA NA NA adrenal gland normal Not reported 2130 ES00805 Initial 450K 164 0.29 NA NA 15.4 0.6 whole blood Low-risk group Not reported 2131 ES00805 Initial 450K 55 0.13 NA NA 15.7 0.7 whole blood High-risk group Not reported 2132 ES00806 Initial 450K 127 0.57 NA NA 55.3 16.1 whole blood TCGA The Cancer Genome Atlas Training group European,Asian unspecified,African unspecified,Not reported 2133 ES00806 Replication 450K 55 0.47 NA NA 55.7 16.5 whole blood TCGA The Cancer Genome Atlas Validation group Asian unspecified,African unspecified,Not reported,European 2134 ES00807 Initial 450K 127 0.57 NA NA 55.3 16.1 whole blood TCGA The Cancer Genome Atlas Training group Asian unspecified,African unspecified,Not reported,European 2135 ES00807 Replication 450K 55 0.47 NA NA 55.7 16.5 whole blood TCGA The Cancer Genome Atlas Validation group African unspecified,Not reported,European,Asian unspecified 2136 ES00808 Initial 450K 22 0 52 85 NA NA peripheral blood mononuclear cell CaMos Canadian Multicenter Osteoporosis Study normal subjects Not reported 2137 ES00808 Initial 450K 22 0 51 89 NA NA peripheral blood mononuclear cell CaMos Canadian Multicenter Osteoporosis Study osteoporosis subjects Not reported 2138 ES00809 Initial 450K 668 0.52 0 0 0 0 placenta EDEN European 2139 ES00810 Initial 450K 668 0.52 0 0 0 0 placenta EDEN European 2140 ES00811 Initial 450K 476 0.66 NA NA 44.8 13.2 whole blood East Asian 2141 ES00812 Initial 450K 476 0.66 NA NA 44.8 13.2 whole blood East Asian 2142 ES00813 Initial 450K 476 0.66 NA NA 44.8 13.2 whole blood East Asian 2143 ES00814 Initial 450K 476 0.66 NA NA 44.8 13.2 whole blood East Asian 2144 ES00815 Initial 450K 464 NA NA NA NA NA tumor tissue endometrial cancer Not reported 2145 ES00815 Initial 450K 46 NA NA NA NA NA uterine normal Not reported 2146 ES00815 Initial 450K 422 NA NA NA NA NA tumor tissue endometrial cancer Not reported 2147 ES00816 Initial 450K 464 NA NA NA NA NA tumor tissue endometrial cancer Not reported 2148 ES00816 Initial 450K 46 NA NA NA NA NA uterine normal Not reported 2149 ES00816 Initial 450K 422 NA NA NA NA NA tumor tissue endometrial cancer Not reported 2150 ES00817 Initial 450K 23 1 NA NA 46.9 10.3 CD3+ T cell Controls Not reported 2151 ES00817 Initial 450K 24 1 NA NA 47.5 10.1 CD3+ T cell pre-treatment alcohol dependent patients Not reported 2152 ES00817 Replication 450K 12 1 NA NA 45.3 16.2 CD3+ T cell Controls Not reported 2153 ES00817 Replication 450K 13 1 NA NA 50.9 9.1 CD3+ T cell pre-treatment alcohol dependent patients Not reported 2154 ES00818 Initial 450K 24 1 NA NA 47.5 10.1 CD3+ T cell pre-treatment alcohol dependent patients Not reported 2155 ES00818 Initial 450K 24 1 NA NA 47.5 10.1 CD3+ T cell post-treatment alcohol dependent patients Not reported 2156 ES00818 Replication 450K 13 1 NA NA 50.9 9.1 CD3+ T cell pre-treatment alcohol dependent patients Not reported 2157 ES00818 Replication 450K 13 1 NA NA 50.9 9.1 CD3+ T cell post-treatment alcohol dependent patients Not reported 2158 ES00819 Initial 450K 5 1 22 31 NA NA whole blood Ankylosing spondylitis East Asian 2159 ES00819 Initial 450K 5 1 23 34 NA NA whole blood Healthy controls East Asian 2160 ES00820 Initial 450K 765 0 NA NA NA NA tumor tissue breast cancer Not reported 2161 ES00824 Initial 450K 199 0.47 NA NA 39.6 16.9 whole blood F5L The French-Canadian Family study on Factor V Leiden Not reported 2162 ES00824 Replication 450K 324 0.23 NA NA 44.1 14.3 whole blood MARTHA MARseille Thrombosis Association Study Not reported 2163 ES00825 Initial 450K 1 NA NA NA NA NA MCF10A cell line Not reported 2164 ES00826 Initial 450K 3 NA 4 6 NA NA leukocyte obese subjects East Asian 2165 ES00826 Initial 450K 4 NA 4 6 NA NA leukocyte matched controls East Asian 2166 ES00827 Initial 450K 53 0.55 NA NA 55 12 tissue from bronchial washings Controls Not reported 2167 ES00827 Initial 450K 70 0.74 NA NA 64 9 tissue from bronchial washings Cases Not reported 2168 ES00829 Initial 450K 48 0.43 NA NA 83 14 whole blood CRELES Costa Rican Study on Longevity and Healthy Aging Nicoya Hispanic or Latin American 2169 ES00829 Initial 450K 47 0.45 NA NA 85 16 whole blood CRELES Costa Rican Study on Longevity and Healthy Aging Non-Nicoya Hispanic or Latin American 2170 ES00830 Initial 450K 49 0.1 NA NA 55.6 14.4 CD19+ B cell Cases Not reported 2171 ES00830 Initial 450K 73 0.25 NA NA 51.7 13.9 CD19+ B cell Controls Not reported 2172 ES00830 Replication 450K 15 0.29 NA NA 52.1 9.3 CD19+ B cell Cases Hispanic or Latin American 2173 ES00830 Replication 450K 15 0.33 NA NA 52.5 11.4 CD19+ B cell Controls Hispanic or Latin American 2174 ES00831 Initial 450K 432 0.74 NA NA 68.6 10.6 tumor tissue and adjacent normal tissue bladder carcinoma Not reported 2175 ES00831 Initial 450K 876 0.12 NA NA 58.6 13.1 tumor tissue and adjacent normal tissue breast carcinoma Not reported 2176 ES00831 Initial 450K 321 0.54 NA NA 65.4 13.2 tumor tissue and adjacent normal tissue colon adenocarcinoma Not reported 2177 ES00831 Initial 450K 201 0.85 NA NA 63 11.9 tumor tissue and adjacent normal tissue esophageal carcinoma Not reported 2178 ES00831 Initial 450K 577 0.73 NA NA 61.4 11.9 tumor tissue and adjacent normal tissue head and neck squamous cell carcinoma Not reported 2179 ES00831 Initial 450K 479 0.64 NA NA 61.9 11.8 tumor tissue and adjacent normal tissue renal clear cell carcinoma Not reported 2180 ES00831 Initial 450K 320 0.74 NA NA 62.2 12.1 tumor tissue and adjacent normal tissue renal papillary cell carcinoma Not reported 2181 ES00831 Initial 450K 424 0.68 NA NA 59.8 13.3 tumor tissue and adjacent normal tissue hepatocellular carcinoma Not reported 2182 ES00831 Initial 450K 489 0.47 NA NA 65.5 10.2 tumor tissue and adjacent normal tissue lung adenocarcinoma Not reported 2183 ES00831 Initial 450K 412 0.74 NA NA 68.1 8.7 tumor tissue and adjacent normal tissue lung squamous cell carcinoma Not reported 2184 ES00831 Initial 450K 193 0.55 NA NA 65.3 11 tumor tissue and adjacent normal tissue pancreatic adenocarcinoma Not reported 2185 ES00831 Initial 450K 547 1 NA NA 61.6 6.8 tumor tissue and adjacent normal tissue prostate adenocarcinoma Not reported 2186 ES00831 Initial 450K 560 0.27 NA NA 47.8 15.8 tumor tissue and adjacent normal tissue thyroid carcinoma Not reported 2187 ES00831 Initial 450K 463 0 NA NA 64.6 11.2 tumor tissue and adjacent normal tissue endometrial carcinoma Not reported 2188 ES00832 Initial 450K 14 0 NA NA 26.2 1.4 CD4+ T cell Normal BMI European 2189 ES00832 Initial 450K 8 0 NA NA 30.9 1.7 CD4+ T cell Obese BMI European 2190 ES00833 Initial 450K 14 0 NA NA 26.2 1.4 CD8+ T cell Normal BMI European 2191 ES00833 Initial 450K 8 0 NA NA 30.9 1.7 CD8+ T cell Obese BMI European 2192 ES00834 Initial 450K 14 0 NA NA 26.2 1.4 CD4+ T cell Normal BMI European 2193 ES00834 Initial 450K 8 0 NA NA 30.9 1.7 CD4+ T cell Obese BMI European 2196 ES00836 Initial 450K 113 0.44 NA NA 8.9 0.1 leukocyte South Asian 2197 ES00837 Initial 450K 50 1 NA NA 8.9 0.1 leukocyte South Asian 2198 ES00838 Initial 450K 63 0 NA NA 8.9 0.2 leukocyte South Asian 2199 ES00839 Initial 450K 300 0.57 0 0 0 0 cord blood Unexposed group African American or Afro-Caribbean 2200 ES00839 Initial 450K 39 0.56 0 0 0 0 cord blood Exposed group African American or Afro-Caribbean 2201 ES00840 Initial 27K 355 0.52 2 61 28 NA leukocyte MRCA Medical Research Council Asthma Not reported 2202 ES00840 Initial 27K 149 0.52 18 30 21 NA leukocyte PAPA Poblogaeth Asthma Prifysgol Abertawe European 2203 ES00840 Initial 27K 160 0.5 5 79 29 NA leukocyte SLSJ Saguenay–Lac-SaintJean region European 2204 ES00841 Initial 450K 645 0.42 NA NA 39.5 NA whole blood Controls African American or Afro-Caribbean,European 2205 ES00841 Initial 450K 689 0.62 NA NA 37.7 NA whole blood Cases European,African American or Afro-Caribbean 2206 ES00841 Replication 450K 250 0.76 NA NA 35.1 NA whole blood Controls European 2207 ES00841 Replication 450K 247 0.76 NA NA 35 NA whole blood Cases European 2208 ES00842 Initial 450K 491 0.47 NA NA 47.4 20.9 whole blood NSPHS northern Sweden population health study control European 2209 ES00842 Initial 450K 77 0.47 NA NA 47.4 20.9 whole blood NSPHS Northern Sweden population Health Study Myocardial infarction European 2210 ES00843 Initial 450K 92 0.77 22 87 65 NA whole blood Not reported 2211 ES00843 Replication 450K 93 0.53 22 97 69 NA whole blood Not reported 2212 ES00844 Initial 450K 991 0.48 NA NA 48.8 16 CD4+ T cell GOLDN Genetics of Lipid Lowering Drugs and Diet Network European 2213 ES00844 Replication 450K 1261 0.4 NA NA 64.8 9 buffy coat FHS Framingham Heart Study Not reported 2214 ES00845 Initial 450K 991 0.48 NA NA 48.8 16 CD4+ T cell GOLDN Genetics of Lipid Lowering Drugs and Diet Network European 2215 ES00845 Replication 450K 1261 0.4 NA NA 64.8 9 buffy coat FHS Framingham Heart Study Not reported 2216 ES00846 Initial 450K 76 0.41 NA NA 5.5 4 whole blood Chicago Food Allergy Study Normal controls European 2217 ES00846 Initial 450K 106 0.63 NA NA 4.2 2.7 whole blood Chicago Food Allergy Study CMA cases European 2218 ES00847 Initial 450K 66 0.5 NA NA 15.6 1.5 buffy coat SYS Saguenay Youth Study Nonexposed European 2219 ES00847 Initial 450K 66 0.5 NA NA 15.5 1.4 buffy coat SYS Saguenay Youth Study Exposed European 2220 ES00848 Initial 450K 306 0.57 6 15 9 NA leukocyte PR-GOAL African American or Afro-Caribbean,European 2221 ES00848 Initial 450K 573 0.5 8 22 13 NA leukocyte GALA II European,African American or Afro-Caribbean 2222 ES00848 Replication 27K 355 0.52 2 61 28 NA leukocyte MRCA African American or Afro-Caribbean,European 2223 ES00848 Replication 450K 149 0.52 21 NA 18 30 leukocyte PAPA European,African American or Afro-Caribbean 2224 ES00848 Replication 450K 160 0.5 5 79 29 NA leukocyte SLSJ European,African American or Afro-Caribbean 2225 ES00849 Initial 450K 192 1 62 71 66 NA whole blood KING European,African American or Afro-Caribbean,Hispanic or Latin American 2226 ES00849 Initial 450K 287 0.47 58 68 63 NA whole blood Fukuoka Hispanic or Latin American,European,African American or Afro-Caribbean 2227 ES00849 Initial 450K 1202 0.49 52 68 60 NA whole blood MESA Hispanic or Latin American,European,African American or Afro-Caribbean 2228 ES00850 Initial 450K 850 0.37 NA NA 46.8 14.5 whole blood Hispanic or Latin American 2229 ES00851 Initial 450K 653 0.48 NA NA 48 16.2 CD4+ T cell GOLDN Genetics of Lipid Lowering Drugs and Diet Network European 2230 ES00851 Replication 450K 326 0.48 NA NA 48.8 16.9 CD4+ T cell GOLDN Genetics of Lipid Lowering Drugs and Diet Network European 2231 ES00852 Initial 450K 192 0.55 NA NA 36.2 18.8 peripheral blood mononuclear cell European 2232 ES00852 Replication 450K 1052 0.41 NA NA 39 19 peripheral blood mononuclear cell European 2233 ES00853 Initial 450K 725 0.46 NA NA 59.9 8.2 leukocyte Not reported 2234 ES00853 Replication 450K 760 0.42 NA NA 67.7 5.9 leukocyte Not reported 2235 ES00854 Initial 450K 725 0.46 NA NA 59.9 8.2 leukocyte Not reported 2236 ES00854 Replication 450K 760 0.42 NA NA 67.7 5.9 leukocyte Not reported 2237 ES00855 Initial 450K 60 0.7 NA NA 73.5 5.8 whole blood COPD COPD cases East Asian 2238 ES00855 Initial 450K 40 0.6 NA NA 71.8 6.9 whole blood COPD Controls East Asian 2239 ES00856 Initial 450K 60 0.7 NA NA 73.5 5.8 whole blood COPD COPD cases East Asian 2240 ES00856 Initial 450K 40 0.6 NA NA 71.8 6.9 whole blood COPD Controls East Asian 2241 ES00857 Initial 450K 60 0.7 NA NA 73.5 5.8 whole blood COPD COPD cases East Asian 2242 ES00857 Initial 450K 40 0.6 NA NA 71.8 6.9 whole blood COPD Controls East Asian 2243 ES00858 Initial 450K 991 0.48 NA NA 49 16 whole blood GOLDN European 2244 ES00858 Initial 450K 2106 0.37 NA NA 56 6 whole blood ARIC African American or Afro-Caribbean 2245 ES00858 Initial 450K 1935 0.39 NA NA 65 9 whole blood FHS European 2246 ES00858 Initial 450K 442 0.7 NA NA 71 8 whole blood FHS European 2247 ES00859 Initial 450K 991 0.48 NA NA 49 16 whole blood GOLDN European 2248 ES00859 Initial 450K 2106 0.37 NA NA 56 6 whole blood ARIC African American or Afro-Caribbean 2249 ES00859 Initial 450K 1935 0.39 NA NA 65 9 whole blood FHS European 2250 ES00859 Initial 450K 442 0.7 NA NA 71 8 whole blood FHS European 2251 ES00860 Initial 450K 39 0.56 0 0 0 0 placenta Nicotine Exposed Not reported 2252 ES00860 Initial 450K 41 0.58 0 0 0 0 placenta Controls Not reported 2253 ES00861 Initial 450K 48 0.35 NA NA 38.1 NA leukocyte PD Not reported 2254 ES00861 Initial 450K 48 0.35 NA NA 38.2 NA leukocyte control Not reported 2255 ES00862 Initial 450K 241 1 NA NA 42.5 14 whole blood NTR Netherlands Twin Register 30 cases and 211 controls Not reported 2256 ES00862 Initial 450K 680 0 NA NA 40.6 12.1 whole blood NTR Netherlands Twin Register 74 cases and 606 controls Not reported 2257 ES00862 Initial 450K 213 1 NA NA 37.6 10.1 whole blood NTR Netherlands Twin Register 31 cases and 182 controls Not reported 2258 ES00862 Initial 450K 404 0 NA NA 38.5 11 whole blood NTR Netherlands Twin Register 38 cases and 366 controls Not reported 2259 ES00862 Initial 450K 63 1 NA NA 42.8 14.1 whole blood NTR Netherlands Twin Register 8 cases and 55 controls Not reported 2260 ES00862 Initial 450K 77 0 NA NA 42 12.5 whole blood NTR Netherlands Twin Register 7 cases and 70 controls Not reported 2261 ES00863 Initial 450K 715 0 34 60 47.5 4.3 whole blood ALSPAC European 2262 ES00863 Initial 450K 135 1 30 70 47 15 whole blood DTR European 2263 ES00863 Initial 450K 132 0 30 74 49 15.5 whole blood DTR European 2264 ES00863 Initial 450K 294 1 47.5 84.5 59.2 7.9 whole blood RS European 2265 ES00863 Initial 450K 356 0 47.7 90.1 60.8 8.2 whole blood RS European 2266 ES00863 Initial 450K 775 0 18.7 83.1 58 10.3 whole blood TUK European 2267 ES00864 Initial 450K 126 0.52 0 0 0 0 cord blood GECKO Unexposed European 2268 ES00864 Initial 450K 129 0.54 0 0 0 0 cord blood GECKO European 2269 ES00865 Initial 450K 68 0.5 NA NA 70.5 5.9 whole blood MCC-Sp THM <= 85 ?g/L Not reported 2270 ES00865 Initial 450K 70 0.59 NA NA 70.1 5.6 whole blood MCC-Sp THM > 85 ?g/L Not reported 2271 ES00866 Initial 450K 912 0.52 0 0 0 0 cord blood Generation R European 2272 ES00866 Initial 450K 828 0.51 0 0 0 0 cord blood ALSPAC European 2273 ES00867 Initial 450K 343 0.54 0 0 0 0 placenta New Hampshire Birth Cohort Study Not reported 2274 ES00868 Initial 450K 192 1 NA NA 65.8 6 whole blood Controls East Asian 2275 ES00868 Initial 450K 192 1 NA NA 65.9 6.4 whole blood Cases East Asian 2276 ES00869 Initial 450K 15 NA NA NA NA NA whole blood PD + anxiety Not reported 2277 ES00869 Initial 450K 15 NA NA NA NA NA whole blood PD + no anxiety Not reported 2278 ES00869 Initial 450K 15 NA NA NA NA NA whole blood No PD Not reported 2279 ES00870 Initial 450K 1275 NA 0 0 0 0 cord blood MoBa Norwegian Mother and Child Cohort Study European 2280 ES00870 Initial 450K 713 NA 0 0 0 0 cord blood Generation R European 2281 ES00871 Initial 450K 308 0.47 NA NA 5.5 0.07 buffy coat CHOP not exposed European 2282 ES00871 Initial 450K 58 0.57 NA NA 5.6 0.07 buffy coat CHOP exposed European 2283 ES00872 Initial 450K 75 1 21.6 71.2 41.6 12.8 whole blood European 2284 ES00873 Initial 450K 75 1 21.6 71.2 41.6 12.8 whole blood European 2285 ES00874 Initial 450K 871 0 NA NA 55.2 9.1 whole blood Sister Study Not reported 2286 ES00874 Initial 450K 187 0 NA NA 50.5 4.8 whole blood Sister Study Not reported 2287 ES00875 Initial 450K 25 1 NA NA 40 15.1 skin paird PP / PN Not reported 2288 ES00875 Initial 450K 16 0 NA NA 33.9 15.7 skin paird PP / PN Not reported 2289 ES00875 Initial 450K 41 1 NA NA 37.6 12.4 skin PP Not reported 2290 ES00875 Initial 450K 32 0 NA NA 36.4 15.8 skin PP Not reported 2291 ES00875 Initial 450K 25 1 NA NA 41.6 13.2 skin NN Not reported 2292 ES00875 Initial 450K 37 0 NA NA 40.3 15.3 skin NN Not reported 2293 ES00875 Initial 450K 12 1 NA NA 43.8 17.6 skin PP Not reported 2294 ES00875 Initial 450K 9 0 NA NA 42.3 18.9 skin PP Not reported 2295 ES00875 Initial 450K 10 1 NA NA 31.9 15.1 skin NN Not reported 2296 ES00875 Initial 450K 14 0 NA NA 43.4 13.5 skin NN Not reported 2297 ES00876 Initial 450K 645 0.49 NA NA 63.2 11.7 whole blood REGICOR European 2298 ES00876 Initial 450K 2542 0.46 NA NA 66.3 8.9 whole blood FHS Framingham Offspring Study European 2299 ES00877 Initial 450K 645 0.49 NA NA 63.2 11.7 whole blood REGICOR European 2300 ES00877 Initial 450K 2542 0.46 NA NA 66.3 8.9 whole blood FHS Framingham Offspring Study European 2301 ES00878 Initial 450K 728 0.47 14 94 50.4 NA leukocyte NSPHS Not reported 2302 ES00878 Replication 450K 355 0.52 2 61 28 NA leukocyte MRCA Not reported 2303 ES00878 Replication 450K 367 0.33 18 18 18 0 leukocyte IOW Not reported 2304 ES00879 Initial 450K 731 0.46 46.4 89.3 59.6 NA whole blood RS European 2305 ES00879 Replication 450K 719 0.43 51.5 79.9 67.5 NA whole blood RS 40 hepatic steatosis patients European 2306 ES00880 Initial 450K 731 0.46 46.4 89.3 59.6 NA whole blood RS European 2307 ES00880 Replication 450K 719 0.43 51.5 79.9 67.5 NA whole blood RS 40 hepatic steatosis patients European 2308 ES00881 Replication 450K 719 0.43 51.5 79.9 67.5 NA whole blood RS 40 hepatic steatosis patients European 2309 ES00882 Initial 450K 121 0.52 24.9 50.7 32.4 NA leukocyte Crohn’s disease Not reported 2310 ES00882 Initial 450K 119 0.57 25.5 47.8 34.3 NA leukocyte Ulcerative colitis Not reported 2311 ES00882 Initial 450K 74 0.47 26.4 45.5 32.8 NA leukocyte Symptomatic controls Not reported 2312 ES00882 Initial 450K 117 0.5 26.4 40.6 32.3 NA leukocyte Healthy volunteers Not reported 2313 ES00883 Initial 450K 132 0.49 NA NA 32.2 9.8 whole blood Obese Not reported 2314 ES00883 Initial 450K 378 0.42 NA NA 27.9 8.3 whole blood Control (BMI < 30) Not reported 2315 ES00884 Initial 450K 200 1 58 67 62 NA whole blood ESTHER European 2316 ES00884 Replication 450K 202 1 57 67 62 NA whole blood ESTHER European 2317 ES00885 Initial 450K 544 0.48 NA NA 48 15.8 CD4+ T cell GOLDN European 2318 ES00885 Replication 450K 293 0.53 NA NA 49 17 CD4+ T cell GOLDN European 2319 ES00886 Initial 450K 544 0.48 NA NA 4848 15.8 CD4+ T cell GOLDN European 2320 ES00886 Replication 450K 293 0.53 NA NA 49 17 CD4+ T cell GOLDN European 2321 ES00887 Initial 450K 1814 NA 32 81 NA NA whole blood KORA F4 Not reported 2322 ES00888 Initial 450K 1814 NA 32 81 NA NA whole blood KORA F4 Not reported 2323 ES00889 Initial 450K 1814 NA 32 81 NA NA whole blood KORA F4 Not reported 2324 ES00890 Initial 450K 1814 NA 32 81 NA NA whole blood KORA F4 Not reported 2325 ES00891 Initial 450K 1814 NA 32 81 NA NA whole blood KORA F4 Not reported 2326 ES00892 Initial 450K 1814 NA 32 81 NA NA whole blood KORA F4 Not reported 2327 ES00893 Initial 450K 1814 NA 32 81 NA NA whole blood KORA F4 Not reported 2328 ES00894 Initial 450K 1814 NA 32 81 NA NA whole blood KORA F4 Not reported 2329 ES00895 Initial 450K 1814 NA 32 81 NA NA whole blood KORA F4 Not reported 2330 ES00896 Initial 450K 298 0 NA NA 12.5 1.4 whole blood NIEHS National Institute of Environmenal Health Sciences Case subjects European 2331 ES00896 Initial 450K 612 0 NA NA 12.7 1.5 whole blood NIEHS National Institute of Environmenal Health Sciences Noncase subjects European 2332 ES00897 Initial 450K 16 1 NA NA NA NA CD14+ monocyte BD patients Not reported 2333 ES00897 Initial 450K 16 1 NA NA NA NA CD14+ monocyte healthy controls Not reported 2334 ES00898 Initial 450K 16 1 NA NA NA NA CD4+ T cell BD patients Not reported 2335 ES00898 Initial 450K 16 1 NA NA NA NA CD4+ T cell healthy controls Not reported 2336 ES00899 Initial 450K 323 0.4 NA NA 75.6 5.2 whole blood CHS European 2337 ES00899 Initial 450K 2722 0.47 NA NA 58.5 11.6 whole blood FHS European 2338 ES00899 Initial 450K 122 0.8 NA NA 65.2 2.7 whole blood HBCS European 2339 ES00899 Initial 450K 1727 0.49 NA NA 61 8.9 whole blood KORA European 2340 ES00899 Initial 450K 432 0.4 NA NA 79.1 0.6 whole blood LBC1921 European 2341 ES00899 Initial 450K 916 0.51 NA NA 69.6 0.8 whole blood LBC1936 European 2342 ES00899 Initial 450K 722 0.46 NA NA 59.8 8.1 whole blood RS-III European 2343 ES00899 Initial 450K 757 0.58 NA NA 67.6 5.9 whole blood RS-BIOS European 2344 ES00899 Initial 450K 227 0.36 NA NA 52.4 8.1 whole blood GS European 2345 ES00899 Replication 450K 2297 0.37 NA NA 56.1 5.7 whole blood ARIC African unspecified 2346 ES00899 Replication 450K 1011 0 NA NA 64.6 7.1 whole blood WHI-EMPC European 2347 ES00900 Initial 450K 22 0 9 12 10.9 1.26 saliva Not reported,European 2348 ES00901 Initial 450K 903 0.56 18 80 46 NA whole blood Not reported 2349 ES00902 Initial 450K 658 0.57 22 79 46 NA whole blood Not reported 2350 ES00903 Initial 450K 21 0.38 2 31 9 NA whole blood 17q12 deletion Not reported 2351 ES00903 Initial 450K 21 0.38 2 29 9 NA whole blood Control Not reported 2352 ES00904 Initial 450K 17 0.47 NA NA 65.2 7.5 buffy coat Non-exposure group (Generation 1) East Asian 2353 ES00904 Initial 450K 9 0.44 NA NA 40 7 buffy coat Non-exposure group (Generation 2) East Asian 2354 ES00904 Initial 450K 9 0.44 NA NA 13.1 6.3 buffy coat Non-exposure group (Generation 3) East Asian 2355 ES00904 Initial 450K 31 0.52 NA NA 58.8 8 buffy coat Exposure group (Generation 1) East Asian 2356 ES00904 Initial 450K 18 0.89 NA NA 33.6 5.2 buffy coat Exposure group (Generation 2) East Asian 2357 ES00904 Initial 450K 18 0.44 NA NA 10.8 3.5 buffy coat Exposure group (Generation 3) East Asian 2358 ES00905 Initial 450K 336 0.52 0 0 0 0 cord blood CHAMACOS Center of Health Assessment of Mothers and Children of Salinas Hispanic or Latin American 2359 ES00906 Initial 850K 3 NA 60 74 69 NA blood COPD Chronic Obstructive Pulmonary Disease cohort 2 years before lung cancer detection Not reported 2360 ES00906 Initial 850K 3 NA 60 74 69 NA blood COPD Chronic Obstructive Pulmonary Disease cohort 1 years before lung cancer detection Not reported 2361 ES00906 Initial 850K 3 NA 60 74 69 NA blood COPD Chronic Obstructive Pulmonary Disease cohort 1 years after lung cancer detection Not reported 2362 ES00907 Initial 450K 57 NA NA NA 49.4 2 peripheral blood mononuclear cell SLE patients European,African American or Afro-Caribbean 2363 ES00907 Initial 450K 33 NA NA NA 55.6 2.1 peripheral blood mononuclear cell Non-SLE patients European,African American or Afro-Caribbean 2364 ES00908 Initial 450K 26 NA NA NA 49.4 2 peripheral blood mononuclear cell SLE patients (disease activity index<=6) European,African American or Afro-Caribbean 2365 ES00908 Initial 450K 33 NA NA NA 55.6 2.1 peripheral blood mononuclear cell Non-SLE patients African American or Afro-Caribbean,European 2366 ES00909 Initial 450K 31 NA NA NA 49.4 2 peripheral blood mononuclear cell SLE patients (disease activity index>6) European,African American or Afro-Caribbean 2367 ES00909 Initial 450K 33 NA NA NA 55.6 2.1 peripheral blood mononuclear cell Non-SLE patients African American or Afro-Caribbean,European 2368 ES00910 Initial 450K 18 NA NA NA 49.4 2 peripheral blood mononuclear cell SLE patients European 2369 ES00910 Initial 450K 16 NA NA NA 55.6 2.1 peripheral blood mononuclear cell Non-SLE patients European 2370 ES00911 Initial 450K 39 NA NA NA 49.4 2 peripheral blood mononuclear cell SLE patients African American or Afro-Caribbean 2371 ES00911 Initial 450K 17 NA NA NA 55.6 2.1 peripheral blood mononuclear cell Non-SLE patients African American or Afro-Caribbean 2372 ES00912 Initial 450K 1 NA NA NA NA NA cardiomyocyte control group Not reported 2373 ES00912 Initial 450K 1 NA NA NA NA NA cardiomyocyte 24h PM2.5 exposure Not reported 2374 ES00913 Initial 450K 12 1 24 28 26.3 NA sperm GUTS Growing Up Today Study childhood abuse (None) European 2375 ES00913 Initial 450K 5 1 23 27 25.4 NA sperm GUTS Growing Up Today Study childhood abuse (Medium) European 2376 ES00913 Initial 450K 17 1 23 29 25.2 NA sperm GUTS Growing Up Today Study childhood abuse (High) European 2377 ES00914 Initial 450K 35 0.771 NA NA 37.7 12.4 leukocyte NAFLD East Asian 2378 ES00914 Initial 450K 30 0.6 NA NA 46.6 7.2 leukocyte Control East Asian 2379 ES00915 Initial 450K 18 0.167 NA NA 37.7 12.5 leukocyte Simple hepatic steatosis East Asian 2380 ES00915 Initial 450K 30 0.6 NA NA 46.6 7.2 leukocyte Control East Asian 2381 ES00916 Initial 450K 1011 NA NA NA 69 NA whole blood SATSA Swedish Adoption/Twin Study of Aging European 2382 ES00916 Replication 450K 390 NA 70 80 NA NA whole blood Prospective Investigation of the Vasculature in Uppsala Seniors PIVUS European 2383 ES00916 Replication 450K 3018 NA 70 79 NA NA whole blood LBC Lothian Birth Cohort European 2384 ES00918 Initial 450K 580 0.56 NA NA 69.1 11.4 whole blood PEG Parkinson's Environment and Genes Study European,Not reported 2385 ES00918 Replication 450K 259 0.56 NA NA 68.8 9.7 saliva PEG Parkinson's Environment and Genes Study Not reported,European 2386 ES00919 Initial 450K 379 0.613 NA NA NA NA primary tumor TCGA The Cancer Genome Atlas Not reported 2387 ES00920 Initial 450K 24 0.875 NA NA NA NA peripheral blood mononuclear cell COPD patients Not reported 2388 ES00920 Initial 450K 12 NA NA NA NA NA peripheral blood mononuclear cell non-COPD age-matched subjects Not reported 2389 ES00921 Initial 450K 6 1 24 38 30 NA sperm control Not reported 2390 ES00921 Initial 450K 6 1 28 32 30.16 NA sperm oligozoospermic infertile patients Not reported 2391 ES00922 Initial 450K 76 0.61 42 84 62.16 10.17 whole blood African American or Afro-Caribbean 2392 ES00922 Initial 450K 104 0.55 40 87 68.63 11.01 whole blood European 2393 ES00923 Initial 450K 76 0.61 42 84 62.16 10.17 whole blood African American or Afro-Caribbean 2394 ES00923 Initial 450K 104 0.55 40 87 68.63 11.01 whole blood European 2395 ES00924 Initial 450K 482 0.52 0 0 0 0 leukocyte Project viva Other,European,African unspecified 2396 ES00924 Initial 450K 482 0.52 7.4 11.3 8.7 NA leukocyte 482 Other,European,African unspecified 2397 ES00924 Replication 450K 641 0.52 0 0 0 0 leukocyte Generation R Study European 2398 ES00925 Initial 450K 338 0.518 NA NA 5.32 0.32 buccal epithelium PAWS Peers and Wellness Study Other,African American or Afro-Caribbean,Hispanic or Latin American,European,Asian unspecified 2399 ES00926 Initial 450K 338 0.518 NA NA 5.32 0.32 buccal epithelium PAWS Peers and Wellness Study European,Asian unspecified,Other,African American or Afro-Caribbean,Hispanic or Latin American 2400 ES00927 Initial 450K 338 0.518 NA NA 5.32 0.32 buccal epithelium PAWS Peers and Wellness Study Asian unspecified,Other,African American or Afro-Caribbean,Hispanic or Latin American,European 2401 ES00929 Initial 450K 16 0.313 26 82 57 NA lung Never smokers Not reported 2402 ES00929 Initial 450K 16 0.563 42 71 56 NA lung Current smokers Not reported 2403 ES00928 Initial 450K 658 0.57 22 79 46 NA whole blood Not reported 2404 ES00930 Initial 850K 22 0.5 0 0 0 0 chorionic villi aCA case Not reported 2405 ES00930 Initial 850K 22 0.59 0 0 0 0 chorionic villi Non-aCA case Not reported 2406 ES00931 Initial 450K 698 0.47 14 94 50.4 NA whole blood NSPHS Northern Sweden population Health Study Not reported 2415 ES00932 Initial 450K 698 0.47 14 94 50.4 NA whole blood NSPHS Northern Sweden population Health Study Not reported 2416 ES00933 Initial 450K 698 0.47 14 94 50.4 NA whole blood NSPHS Northern Sweden population Health Study Not reported 2417 ES00934 Initial 450K 698 0.47 14 94 50.4 NA whole blood NSPHS Northern Sweden population Health Study Not reported 2418 ES00935 Initial 450K 698 0.47 14 94 50.4 NA whole blood NSPHS Northern Sweden population Health Study Not reported 2419 ES00936 Initial 450K 698 0.47 14 94 50.4 NA whole blood NSPHS Northern Sweden population Health Study Not reported 2420 ES00937 Initial 450K 698 0.47 14 94 50.4 NA whole blood NSPHS Northern Sweden population Health Study Not reported 2421 ES00938 Initial 450K 698 0.47 14 94 50.4 NA whole blood NSPHS Northern Sweden population Health Study Not reported 2422 ES00939 Initial 450K 698 0.47 14 94 50.4 NA whole blood NSPHS Northern Sweden population Health Study Not reported 2423 ES00940 Initial 450K 698 0.47 14 94 50.4 NA whole blood NSPHS Northern Sweden population Health Study Not reported 2424 ES00941 Initial 450K 698 0.47 14 94 50.4 NA whole blood NSPHS Northern Sweden population Health Study Not reported 2425 ES00942 Initial 450K 698 0.47 14 94 50.4 NA whole blood NSPHS Northern Sweden population Health Study Not reported 2426 ES00943 Initial 450K 698 0.47 14 94 50.4 NA whole blood NSPHS Northern Sweden population Health Study Not reported 2427 ES00944 Initial 450K 698 0.47 14 94 50.4 NA whole blood NSPHS Northern Sweden population Health Study Not reported 2428 ES00945 Initial 450K 698 0.47 14 94 50.4 NA whole blood NSPHS Northern Sweden population Health Study Not reported 2429 ES00946 Initial 450K 698 0.47 14 94 50.4 NA whole blood NSPHS Northern Sweden population Health Study Not reported 2430 ES00947 Initial 450K 698 0.47 14 94 50.4 NA whole blood NSPHS Northern Sweden population Health Study Not reported 2431 ES00948 Initial 450K 698 0.47 14 94 50.4 NA whole blood NSPHS Northern Sweden population Health Study Not reported 2432 ES00949 Initial 450K 698 0.47 14 94 50.4 NA whole blood NSPHS Northern Sweden population Health Study Not reported 2433 ES00950 Initial 450K 698 0.47 14 94 50.4 NA whole blood NSPHS Northern Sweden population Health Study Not reported 2434 ES00951 Initial 450K 698 0.47 14 94 50.4 NA whole blood NSPHS Northern Sweden population Health Study Not reported 2435 ES00952 Initial 450K 698 0.47 14 94 50.4 NA whole blood NSPHS Northern Sweden population Health Study Not reported 2436 ES00953 Initial 450K 698 0.47 14 94 50.4 NA whole blood NSPHS Northern Sweden population Health Study Not reported 2437 ES00954 Initial 450K 698 0.47 14 94 50.4 NA whole blood NSPHS Northern Sweden population Health Study Not reported 2438 ES00955 Initial 450K 698 0.47 14 94 50.4 NA whole blood NSPHS Northern Sweden population Health Study Not reported 2439 ES00956 Initial 450K 698 0.47 14 94 50.4 NA whole blood NSPHS Northern Sweden population Health Study Not reported 2440 ES00957 Initial 450K 698 0.47 14 94 50.4 NA whole blood NSPHS Northern Sweden population Health Study Not reported 2441 ES00958 Initial 450K 698 0.47 14 94 50.4 NA whole blood NSPHS Northern Sweden population Health Study Not reported 2442 ES00959 Initial 450K 698 0.47 14 94 50.4 NA whole blood NSPHS Northern Sweden population Health Study Not reported 2443 ES00960 Initial 450K 698 0.47 14 94 50.4 NA whole blood NSPHS Northern Sweden population Health Study Not reported 2444 ES00961 Initial 450K 698 0.47 14 94 50.4 NA whole blood NSPHS Northern Sweden population Health Study Not reported 2445 ES00962 Initial 450K 698 0.47 14 94 50.4 NA whole blood NSPHS Northern Sweden population Health Study Not reported 2446 ES00963 Initial 450K 698 0.47 14 94 50.4 NA whole blood NSPHS Northern Sweden population Health Study Not reported 2447 ES00964 Initial 450K 698 0.47 14 94 50.4 NA whole blood NSPHS Northern Sweden population Health Study Not reported 2448 ES00965 Initial 450K 698 0.47 14 94 50.4 NA whole blood NSPHS Northern Sweden population Health Study Not reported 2449 ES00966 Initial 450K 698 0.47 14 94 50.4 NA whole blood NSPHS Northern Sweden population Health Study Not reported 2450 ES00967 Initial 450K 698 0.47 14 94 50.4 NA whole blood NSPHS Northern Sweden population Health Study Not reported 2451 ES00968 Initial 450K 698 0.47 14 94 50.4 NA whole blood NSPHS Northern Sweden population Health Study Not reported 2452 ES00969 Initial 450K 698 0.47 14 94 50.4 NA whole blood NSPHS Northern Sweden population Health Study Not reported 2453 ES00970 Initial 450K 698 0.47 14 94 50.4 NA whole blood NSPHS Northern Sweden population Health Study Not reported 2454 ES00971 Initial 450K 698 0.47 14 94 50.4 NA whole blood NSPHS Northern Sweden population Health Study Not reported 2455 ES00972 Initial 450K 698 0.47 14 94 50.4 NA whole blood NSPHS Northern Sweden population Health Study Not reported 2456 ES00973 Initial 450K 698 0.47 14 94 50.4 NA whole blood NSPHS Northern Sweden population Health Study Not reported 2457 ES00974 Initial 450K 453 0.81 2 5 NA NA whole blood SEED Study to Explore Early Development ASD cases Asian unspecified,African unspecified,Other,European 2458 ES00974 Initial 450K 515 0.53 2 5 NA NA whole blood SEED Study to Explore Early Development healthy controls Asian unspecified,African unspecified,Other,European 2459 ES00974 Initial 450K 343 0.98 4 18 NA NA whole blood SSC Simons Simplex Collection ASD cases African unspecified,Other,European,Asian unspecified 2460 ES00974 Initial 450K 343 1 4 18 NA NA whole blood SSC Simons Simplex Collection unaffected siblings African unspecified,Other,European,Asian unspecified 2461 ES00975 Initial 450K 361 NA NA NA NA NA tumor tissue tumor tissue Not reported 2462 ES00975 Initial 450K 41 NA NA NA NA NA liver adjacent normal tissues Not reported 2463 ES00976 Initial 450K 79 0.14 NA NA 54.2 12.2 whole blood TwinsUK RA European 2464 ES00976 Initial 450K 79 0.14 NA NA 54.2 12.2 whole blood TwinsUK Non-RA European 2465 ES00977 Initial 450K 79 0.14 NA NA 54.2 12.2 whole blood TwinsUK RA European 2466 ES00977 Initial 450K 79 0.14 NA NA 54.2 12.2 whole blood TwinsUK Non-RA European 2467 ES00978 Initial 450K 60 0 23 31 27.17 NA whole blood HUNT Study Lean Not reported 2468 ES00978 Initial 450K 60 0 23 31 27.17 NA whole blood HUNT Study Obese Not reported 2469 ES00979 Initial 450K 1630 0.48 NA NA 60.99 8.89 whole blood KORA F4 European 2470 ES00979 Initial 450K 619 0.48 NA NA 59.22 6.5 whole blood LLS European 2471 ES00979 Initial 450K 148 0.57 NA NA 64.77 9.44 whole blood EGCUT European 2472 ES00979 Initial 450K 609 0 NA NA 58.28 9.96 whole blood TwinsUK European 2473 ES00980 Initial 450K 9 0.56 47.7 83.9 64 10.98 corneal endothelial FECD Not reported 2474 ES00980 Initial 450K 4 0.5 46.2 75 70.56 9.96 corneal endothelial Control Not reported 2475 ES00981 Initial 450K 2 NA NA NA NA NA BEAS-2B cell Not reported 2476 ES00982 Initial 450K 54 0 NA NA 54.17 8.31 adipose tissue TwinsUK current smokers European 2477 ES00982 Initial 450K 291 0 NA NA 59.18 9.58 adipose tissue TwinsUK non-smokers European 2478 ES00982 Initial 450K 104 0.52 NA NA 47 1.7 adipose tissue LEAP New England Family Study 46 current smokers and 58 non-smokers Not reported,European 2479 ES00982 Initial 450K 69 0.449 NA NA 31.1 4.43 adipose tissue Finnish Twin Cohort Not reported 2480 ES00982 Initial 450K 195 0 NA NA 59.1 9.71 skin TwinsUK 37 current smokers and 158 non-smokers cancer-free female subjects European 2481 ES00982 Initial 450K 168 NA NA NA 65.1 10.66 lung lung cancer female subjects Not reported 2482 ES00983 Initial 450K 235 0.57 NA NA 79.1 0.55 whole blood LBC1921 Lothian Birth Cohort 1921 Not reported 2483 ES00984 Initial 450K 50 0.26 NA NA 45.66 NA whole blood Depression European 2484 ES00984 Initial 450K 50 0.26 NA NA 45.48 NA whole blood Dep-Inflam European 2485 ES00984 Initial 450K 50 0.26 NA NA 45.58 NA whole blood Inflammation European 2486 ES00984 Initial 450K 50 0.26 NA NA 45.42 NA whole blood Healthy Controls European 2487 ES00828 Initial 450K 41 0.268 20 77 39 NA tumor tissue papillary thyroid carcinoma Not reported 2488 ES00828 Initial 450K 41 0.268 20 77 39 NA thyroid non-neoplastic adjacent tissues (NT) Not reported 2489 ES00985 Initial 450K 144 NA 30 36 33 NA whole blood 26 PTB Not reported 2490 ES00985 Initial 450K 350 0.55 56 80 66 NA whole blood 40 PTB Not reported 2491 ES00986 Initial 450K 207 0.54 0 0 0 0 placenta Other admixed ancestry,Hispanic or Latin American,African unspecified 2492 ES00987 Initial 450K 387 0.367 NA NA 79 7 prefrontal cortex ROS Religious Orders Study Not reported 2493 ES00987 Initial 450K 321 0.368 NA NA 84.1 5.8 prefrontal cortex MAP Memory and Aging Project Not reported 2494 ES00987 Replication 450K 29 0.448 NA NA 77.6 12.8 prefrontal cortex Braak 0-II Not reported 2495 ES00987 Replication 450K 18 0.389 NA NA 88.5 5.2 prefrontal cortex Braak III-IV Not reported 2496 ES00987 Initial 450K 66 0.394 NA NA 85.5 8 prefrontal cortex Braak V-VI Not reported 2497 ES00989 Initial 450K 256 0.465 50.6 53.2 51.9 NA whole blood T2D cases Sub-Saharan African 2498 ES00989 Initial 450K 457 0.404 49.8 51.5 50.7 NA whole blood T2D controls Sub-Saharan African 2499 ES00990 Initial 450K 256 0.465 50.6 53.2 51.9 NA whole blood T2D cases Sub-Saharan African 2500 ES00990 Initial 450K 457 0.404 49.8 51.5 50.7 NA whole blood T2D controls Sub-Saharan African 2501 ES00988 Initial 450K 265 0.506 NA NA 7.7 0.7 whole blood Project Viva European,Asian unspecified,Other,African unspecified,Hispanic or Latin American 2503 ES00991 Initial 450K 265 0.506 NA NA 7.7 0.7 whole blood Project Viva Asian unspecified,Other,African unspecified,Hispanic or Latin American,European 2504 ES00992 Initial 450K 24 NA 0 0 0 0 cord blood Hispanic or Latin American,European,African American or Afro-Caribbean,Other 2505 ES00994 Initial 450K 24 NA 0 0 0 0 cord blood European,African American or Afro-Caribbean,Other,Hispanic or Latin American 2506 ES00993 Initial 450K 24 0 19 35 26.83 5.34 whole blood Hispanic or Latin American,European,African American or Afro-Caribbean,Other 2507 ES00995 Initial 450K 131 0 NA NA 56.55 4.01 buffy coat NOWAC Norwegian Women and Cancer Study Cases Not reported 2508 ES00995 Initial 450K 129 0 NA NA 56.57 3.98 buffy coat NOWAC Norwegian Women and Cancer Study Controls Not reported 2509 ES00996 Initial 450K 14 NA NA NA 12 7.5 whole blood patients with mutations in ARID1B Not reported 2510 ES00996 Initial 450K 84 NA NA NA 13 9.7 whole blood matched controls Not reported 2511 ES00997 Initial 450K 5 NA NA NA 3 3.9 whole blood patients with mutations in SMARCB1 Not reported 2512 ES00997 Initial 450K 30 NA NA NA 3 3.3 whole blood matched controls Not reported 2513 ES00998 Initial 450K 7 NA NA NA 11.5 11.3 whole blood NCBRS subjects Not reported 2514 ES00998 Initial 450K 42 NA NA NA 11.9 11 whole blood matched controls Not reported 2515 ES00999 Initial 450K 8 0 22 54 42.5 13 whole blood European 2516 ES00999 Initial 450K 12 0.66 20 50 37 10.9 whole blood European 2517 ES00999 Initial 450K 14 0.71 19 39 30.3 7.3 whole blood European 2518 ES01000 Initial 450K 24 NA NA NA 40.7 8.5 CD19+ B cell MS participant Not reported 2519 ES01000 Initial 450K 24 NA NA NA 43.3 16.4 CD19+ B cell Control Not reported 2520 ES01001 Initial 450K 257 0.51 0 0 0 0 cord blood Project Viva Hispanic or Latin American,European,African unspecified,Other 2521 ES01002 Initial 450K 6 1 NA NA 49.17 3.25 whole blood Cases Not reported 2522 ES01002 Initial 450K 6 1 NA NA 51.17 3.61 whole blood Controls Not reported 2523 ES01003 Initial 450K 10 0.5 28 67 44 13 neutrophil primary APS European 2524 ES01003 Initial 450K 12 0.5 NA NA 43 13 neutrophil control European 2525 ES01004 Initial 450K 15 0 NA NA 37 10 neutrophil SLE European 2526 ES01004 Initial 450K 13 0 NA NA 40 9 whole blood control European 2527 ES01005 Initial 450K 663 0.47 NA NA 48.6 16.4 CD4+ T cell GOLDN Genetics of Lipid Lowering Drugs and Diet Network European 2528 ES01005 Replication 450K 331 0.492 NA NA 47.7 16.2 CD4+ T cell GOLDN Genetics of Lipid Lowering Drugs and Diet Network European 2529 ES01006 Initial 450K 663 0.47 NA NA 48.6 16.4 CD4+ T cell GOLDN Genetics of Lipid Lowering Drugs and Diet Network European 2530 ES01006 Replication 450K 331 0.492 NA NA 47.7 16.2 CD4+ T cell GOLDN Genetics of Lipid Lowering Drugs and Diet Network European 2531 ES01007 Initial 450K 663 0.47 NA NA 48.6 16.4 CD4+ T cell GOLDN Genetics of Lipid Lowering Drugs and Diet Network European 2532 ES01007 Replication 450K 331 0.492 NA NA 47.7 16.2 CD4+ T cell GOLDN Genetics of Lipid Lowering Drugs and Diet Network European 2533 ES01008 Initial 450K 663 0.47 NA NA 48.6 16.4 CD4+ T cell GOLDN Genetics of Lipid Lowering Drugs and Diet Network European 2534 ES01008 Replication 450K 331 0.492 NA NA 47.7 16.2 CD4+ T cell GOLDN Genetics of Lipid Lowering Drugs and Diet Network European 2535 ES01009 Initial 450K 663 0.47 NA NA 48.6 16.4 CD4+ T cell GOLDN Genetics of Lipid Lowering Drugs and Diet Network European 2536 ES01009 Replication 450K 331 0.492 NA NA 47.7 16.2 CD4+ T cell GOLDN Genetics of Lipid Lowering Drugs and Diet Network European 2537 ES01010 Initial 450K 663 0.47 NA NA 48.6 16.4 CD4+ T cell GOLDN Genetics of Lipid Lowering Drugs and Diet Network European 2538 ES01010 Replication 450K 331 0.492 NA NA 47.7 16.2 CD4+ T cell GOLDN Genetics of Lipid Lowering Drugs and Diet Network European 2539 ES01011 Initial 450K 365 0.485 NA NA 57.7 12.6 CD4+ T cell GOLDN Genetics of Lipid Lowering Drugs and Diet Network MetS+ European 2540 ES01011 Initial 450K 481 0.485 NA NA 49.9 12.8 CD4+ T cell GOLDN Genetics of Lipid Lowering Drugs and Diet Network MetS- European 2541 ES01011 Replication 450K 249 NA NA NA 44.1 4.1 whole blood BHS Bogalusa Heart Study MetS+ European 2542 ES01011 Replication 450K 354 NA NA NA 43.1 4.6 whole blood BHS Bogalusa Heart Study MetS- European 2543 ES01011 Initial 450K 117 NA NA NA 43.5 4.5 whole blood BHS Bogalusa Heart Study MetS+ African American or Afro-Caribbean 2544 ES01011 Initial 450K 152 NA NA NA 43.1 4.5 whole blood BHS Bogalusa Heart Study MetS- African American or Afro-Caribbean 2545 ES01012 Initial 450K 164 0.5 NA NA 65.6 6.8 whole blood BIOS Biobank-based Integrative Omics Study Not reported 2546 ES01012 Initial 450K 748 0.42 NA NA 45.6 13.3 whole blood BIOS Biobank-based Integrative Omics Study Not reported 2547 ES01012 Initial 450K 785 0.48 NA NA 58.4 7.5 whole blood BIOS Biobank-based Integrative Omics Study Not reported 2548 ES01012 Initial 450K 692 0.32 NA NA 34 12.1 whole blood BIOS Biobank-based Integrative Omics Study Not reported 2549 ES01012 Initial 450K 184 0.6 NA NA 62.4 9.4 whole blood BIOS Biobank-based Integrative Omics Study Not reported 2550 ES01012 Initial 450K 723 0.42 NA NA 67.6 6 whole blood BIOS Biobank-based Integrative Omics Study Not reported 2551 ES01013 Initial 450K 164 0.5 NA NA 65.6 6.8 whole blood BIOS Biobank-based Integrative Omics Study Not reported 2552 ES01013 Initial 450K 748 0.42 NA NA 45.6 13.3 whole blood BIOS Biobank-based Integrative Omics Study Not reported 2553 ES01013 Initial 450K 785 0.48 NA NA 58.4 7.5 whole blood BIOS Biobank-based Integrative Omics Study Not reported 2554 ES01013 Initial 450K 692 0.32 NA NA 34 12.1 whole blood BIOS Biobank-based Integrative Omics Study Not reported 2555 ES01013 Initial 450K 184 0.6 NA NA 62.4 9.4 whole blood BIOS Biobank-based Integrative Omics Study Not reported 2556 ES01013 Initial 450K 723 0.42 NA NA 67.6 6 whole blood BIOS Biobank-based Integrative Omics Study Not reported 2557 ES01014 Initial 450K 164 0.5 NA NA 65.6 6.8 whole blood BIOS Biobank-based Integrative Omics Study Not reported 2558 ES01014 Initial 450K 748 0.42 NA NA 45.6 13.3 whole blood BIOS Biobank-based Integrative Omics Study Not reported 2559 ES01014 Initial 450K 785 0.48 NA NA 58.4 7.5 whole blood BIOS Biobank-based Integrative Omics Study Not reported 2560 ES01014 Initial 450K 692 0.32 NA NA 34 12.1 whole blood BIOS Biobank-based Integrative Omics Study Not reported 2561 ES01014 Initial 450K 184 0.6 NA NA 62.4 9.4 whole blood BIOS Biobank-based Integrative Omics Study Not reported 2562 ES01014 Initial 450K 723 0.42 NA NA 67.6 6 whole blood BIOS Biobank-based Integrative Omics Study Not reported 2563 ES01017 Initial 450K 991 0.48 NA NA 49 16 CD4+ T cell GOLDN Genetics of Lipid Lowering Drugs and Diet Network European 2564 ES01017 Replication 450K 474 0.53 NA NA 44 14 whole blood HAPI Phenotype Intervention Heart Study Not reported 2565 ES01017 Replication 450K 592 0.46 NA NA 43 5 whole blood BHS Bogalusa Heart Study European 2566 ES01017 Initial 450K 243 0.35 NA NA 43 5 whole blood BHS Bogalusa Heart Study African unspecified 2567 ES01018 Initial 450K 545 0.54 NA NA 46.6 NA whole blood African unspecified,Other,European 2568 ES01019 Initial 450K 633 1 NA NA 72 NA whole blood NAS Normative Aging Study Not reported 2569 ES01019 Initial 450K 868 0.47 41 63 NA NA whole blood KORA Cooperative Health Research in the Region of Augsburg Not reported 2570 ES01020 Initial 450K 6 1 24 38 30 NA sperm Control Not reported 2571 ES01020 Initial 450K 6 1 28 32 30.16 NA sperm Patient Not reported 2572 ES01021 Initial 450K 780 0 NA NA 47.14 4.61 buccal cell ALSPAC Avon Longitudinal Study of Parents and Children Not reported 2573 ES01021 Replication 450K 552 0 NA NA 53.45 0.5 buccal cell NSHD National Survey of Health and Development Not reported 2574 ES01022 Initial 450K 780 0 NA NA 47.14 4.61 buccal cell ALSPAC Avon Longitudinal Study of Parents and Children Not reported 2575 ES01022 Replication 450K 552 0 NA NA 53.45 0.5 buccal cell NSHD National Survey of Health and Development Not reported 2576 ES01023 Initial 450K 780 0 NA NA 47.14 4.61 buccal cell ALSPAC Avon Longitudinal Study of Parents and Children Not reported 2577 ES01023 Replication 450K 552 0 NA NA 53.45 0.5 buccal cell NSHD National Survey of Health and Development Not reported 2578 ES01024 Initial 450K 61 0.25 NA NA NA NA peripheral blood mononuclear cell ME/CFS diagnosed patients Not reported 2579 ES01024 Initial 450K 48 0.25 NA NA NA NA peripheral blood mononuclear cell healthy control Not reported 2580 ES01025 Initial 850K 4 0.25 20 33 26 NA right upper lobe controls Not reported 2581 ES01025 Initial 850K 4 0.25 20 33 26 NA right lower lobe controls Not reported 2582 ES01025 Initial 850K 4 0.5 18 28 21 NA right upper lobe CF subjects Not reported 2583 ES01025 Initial 850K 4 0.5 18 28 21 NA right lower lobe CF subjects Not reported 2584 ES01026 Initial 450K 100 1 NA NA 49.2 6.74 leukocyte Smokers African American or Afro-Caribbean 2585 ES01026 Initial 450K 100 1 NA NA 49.7 8.7 leukocyte Non-smokers African American or Afro-Caribbean 2586 ES01026 Replication 850K 309 1 NA NA 48 6.55 leukocyte smokers African American or Afro-Caribbean 2587 ES01026 Replication 850K 220 1 NA NA 48.3 9.2 leukocyte Non-smokers African American or Afro-Caribbean 2588 ES01027 Initial 450K 100 1 NA NA 49.2 6.74 leukocyte Smokers African American or Afro-Caribbean 2589 ES01027 Initial 450K 100 1 NA NA 49.7 8.7 leukocyte Non-smokers African American or Afro-Caribbean 2590 ES01027 Replication 850K 309 1 NA NA 48 6.55 leukocyte smokers African American or Afro-Caribbean 2591 ES01027 Replication 850K 220 1 NA NA 48.3 9.2 leukocyte Non-smokers African American or Afro-Caribbean 2592 ES01028 Initial 450K 12 0.42 NA NA 31.4 6.7 leukocyte before starting a metformin therapy Not reported 2594 ES01028 Initial 450K 12 0.42 NA NA 31.4 6.7 leukocyte 10?h after the first metformin intake Not reported 2595 ES01028 Initial 450K 12 0.42 NA NA 31.4 6.7 leukocyte time point after 7?days of metformin administration Not reported 2596 ES01029 Initial 450K 688 0.49 0 0 0 0 cord blood ALSPAC European 2597 ES01029 Initial 450K 229 0.4 0 0 0 0 cord blood CHS Not reported 2598 ES01029 Initial 450K 150 0.58 0 0 0 0 cord blood EDEN European 2599 ES01029 Initial 450K 661 0.52 0 0 0 0 cord blood Generation R European 2600 ES01029 Initial 450K 507 0.49 0 0 0 0 cord blood GOYA European 2601 ES01029 Initial 450K 666 0.52 0 0 0 0 cord blood MoBa1 European 2602 ES01029 Initial 450K 458 0.4 0 0 0 0 cord blood MoBa2 European 2603 ES01029 Initial 450K 213 0.51 0 0 0 0 cord blood NEST Not reported 2604 ES01030 Initial 450K 307 0.52 8 8 8 0 whole blood BAMSE EpiGene European 2605 ES01030 Initial 450K 214 0.56 8 8 8 0 whole blood BAMSE MeDALL European 2606 ES01030 Initial 450K 382 0.48 5.5 5.5 5.5 0 whole blood CHOP European 2607 ES01030 Initial 450K 193 0.56 8 10 NA NA whole blood GALA II Not reported 2608 ES01030 Initial 450K 187 0.51 6 12 NA NA whole blood ICAC African American or Afro-Caribbean 2609 ES01030 Initial 450K 413 0.46 NA NA NA NA whole blood NFBC 1986 European 2610 ES01030 Initial 450K 197 0.5 4 16 NA NA whole blood PIAMA European 2611 ES01030 Initial 450K 509 0.49 17 17 17 0 whole blood Raine Study European 2612 ES01030 Initial 450K 460 0.53 9 14 NA NA whole blood STOPPA European 2613 ES01031 Initial 450K 312 0.55 NA NA 15 3 nasal epithelial cell EVA-PR Epigenetic Variation and Childhood Asthma in Puerto Ricans Atopy Hispanic or Latin American 2614 ES01031 Initial 450K 171 0.46 NA NA 15 3 nasal epithelial cell EVA-PR Epigenetic Variation and Childhood Asthma in Puerto Ricans No atopy Hispanic or Latin American 2615 ES01031 Replication 450K 207 0.56 NA NA 16.4 0.2 nasal epithelial cell PIAMA Prevention and Incidence of Asthma and Mite Allergy Atopy European 2616 ES01031 Replication 450K 225 0.44 NA NA 16.3 0.2 nasal epithelial cell PIAMA Prevention and Incidence of Asthma and Mite Allergy No atopy European 2617 ES01032 Initial 450K 169 0.61 NA NA 15 3 nasal epithelial cell EVA-PR Epigenetic Variation and Childhood Asthma in Puerto Ricans Atopic asthma Hispanic or Latin American 2618 ES01032 Initial 450K 104 0.41 NA NA 16 3 nasal epithelial cell EVA-PR Epigenetic Variation and Childhood Asthma in Puerto Ricans Non-atopic controls Hispanic or Latin American 2619 ES01032 Replication 450K 36 0.53 NA NA 11.1 0.8 nasal epithelial cell Atopic asthma African American or Afro-Caribbean 2620 ES01032 Replication 450K 36 0.47 NA NA 10.9 0.9 nasal epithelial cell Non-atopic controls African American or Afro-Caribbean 2621 ES01033 Initial 850K 32 0.59 0 0 0 0 placenta spontaneous preterm birth East Asian 2622 ES01033 Initial 850K 16 0.56 0 0 0 0 placenta term birth East Asian 2623 ES01034 Initial 850K 32 0.59 0 0 0 0 cord blood spontaneous preterm birth East Asian 2624 ES01034 Initial 850K 16 0.56 0 0 0 0 cord blood term brth East Asian 2625 ES01035 Initial 450K 1103 0.51 NA NA 54.5 8.87 leukocyte KORA Baseline European 2626 ES01035 Initial 450K 1103 0.51 NA NA 61.5 8.9 leukocyte KORA Follow-up European 2627 ES01035 Initial 450K 344 1 NA NA 70.9 6.6 leukocyte NAS Baseline European 2628 ES01035 Initial 450K 344 1 NA NA 74.5 6.6 leukocyte NAS Follow-up European 2629 ES01035 Initial 450K 443 0.47 NA NA 61.7 16.2 leukocyte InCHIANTI Baseline European 2630 ES01035 Initial 450K 443 0.47 NA NA 70.8 16.2 leukocyte InCHIANTI Follow-up European 2631 ES01036 Initial 450K 310 0.48 21 69 29.5 14.2 whole blood FTC Finnish Twin Cohort Not reported 2632 ES01036 Replication 450K 79 0.56 25 72 51 13.5 whole blood DILGOM Not reported 2633 ES01036 Replication 450K 446 0.42 NA NA NA NA whole blood NTR Netherlands Twin Register Not reported 2634 ES01037 Initial 450K 914 0.49 0 0 0 0 cord blood ARIES Not reported 2635 ES01038 Initial 450K 974 0.49 NA NA 15.5 NA whole blood ARIES Not reported 2636 ES01039 Initial 450K 54 NA NA NA NA NA tumor tissue OSCC Not reported 2637 ES01039 Initial 450K 29 NA NA NA NA NA oral tongue sub-site adjacent normal tissue Not reported 2638 ES01040 Initial 450K 883 0 NA NA 66.3 9 leukocyte FHS Offspring European 2639 ES01041 Initial 27K 196 0 NA NA 62.9 12.7 tumor tissue Case European 2640 ES01041 Initial 27K 202 0 NA NA 62.8 12.4 ovarian Control European 2641 ES01042 Initial 27K 153 0 NA NA 63 11.1 leukocyte European 2642 ES01042 Initial 450K 89 0 NA NA 62.7 11 leukocyte European 2643 ES01043 Initial 27K 87 0 33 85 60.2 12.1 leukocyte control European 2644 ES01043 Initial 27K 176 0 27 89 62.9 12.7 leukocyte control European 2645 ES01043 Initial 450K 135 0 33 88 62.4 11.4 leukocyte control European 2646 ES01043 Initial 27K 69 0 33 -82 60.2 12 leukocyte case European 2647 ES01043 Initial 27K 146 0 28 91 63.3 12.8 leukocyte case European 2648 ES01043 Initial 450K 121 0 28 91 62.2 11.3 leukocyte case European 2649 ES01044 Initial 27K 87 0 33 85 60.2 12.1 leukocyte control European 2650 ES01044 Initial 27K 176 0 27 89 62.9 12.7 leukocyte control European 2651 ES01044 Initial 450K 135 0 33 88 62.4 11.4 leukocyte control European 2652 ES01044 Initial 27K 69 0 33 -82 60.2 12 leukocyte case European 2653 ES01044 Initial 27K 146 0 28 91 63.3 12.8 leukocyte case European 2654 ES01044 Initial 450K 121 0 28 91 62.2 11.3 leukocyte case European 2655 ES01045 Initial 27K 132 0 33 82 60 12 whole blood Batch 1 European 2656 ES01045 Initial 27K 296 0 27 91 63 13 whole blood Batch 2 European 2657 ES01046 Initial 27K 148 0 NA NA NA NA whole blood healthy Not reported 2658 ES01046 Initial 27K 113 0 NA NA NA NA whole blood pre-treatment ovarian cancer cases Not reported 2659 ES01047 Initial 450K 1 1 52 52 52 0 neutrophil European 2660 ES01048 Initial 850K 78 1 NA NA 30.9 NA CD14+ monocyte African descent African unspecified 2661 ES01048 Initial 850K 78 1 NA NA 25.9 NA CD14+ monocyte European descent European 2662 ES01049 Initial 450K 12 1 NA NA 21.58 2.71 whole blood Congenital hypopituitarism Not reported 2663 ES01049 Initial 450K 12 1 NA NA 24 3.67 whole blood Controls Not reported 2664 ES01050 Initial 450K 12 0.75 NA NA 71 7.2 peripheral blood mononuclear cell Poor responder East Asian 2665 ES01050 Initial 450K 12 1 NA NA 68 15.5 peripheral blood mononuclear cell Good responder East Asian 2666 ES01051 Initial 450K 33 0 NA NA 49.9 1.56 peripheral blood mononuclear cell ME/CFS Cases Not reported 2667 ES01051 Initial 450K 31 0 NA NA 47.9 1.63 peripheral blood mononuclear cell Healthy Controls Not reported 2668 ES01052 Initial 850K 7 0.43 23 43 NA NA CD4+ T cell prior to the first dose of DMF Not reported 2669 ES01052 Initial 850K 7 0.43 23 43 NA NA CD4+ T cell 6 months treatment Not reported 2670 ES01053 Initial 450K 16 0.56 18 88 69.6 21.3 neuron European 2671 ES01054 Initial 450K 16 0.56 18 88 69.6 21.3 glia European 2672 ES01055 Initial 450K 31 0.45 18 94 74.8 16.8 neuron European 2673 ES01056 Initial 450K 31 0.45 18 94 74.8 16.8 glia European 2674 ES01057 Initial 850K 157 0.38 50 70 NA NA buffy coat Not reported 2675 ES01058 Initial 450K 365 0.5 NA NA 69.4 0.88 whole blood LBC1936 Not frail Not reported 2676 ES01058 Initial 450K 62 0.47 NA NA 69.5 0.7 whole blood LBC1936 Frail Not reported 2677 ES01059 Initial 850K 36 0.56 NA NA 19.8 0.9 whole blood East Asian 2678 ES01060 Initial 450K 16 NA NA NA NA NA nasal epithelial cell healthy controls Not reported 2679 ES01060 Initial 450K 32 NA NA NA NA NA nasal epithelial cell CF patients Not reported 2680 ES01061 Initial 450K 32 NA NA NA NA NA nasal epithelial cell CF patients Not reported 2681 ES01062 Initial 450K 16 NA NA NA NA NA nasal epithelial cell healthy controls Not reported 2682 ES01062 Initial 450K 32 NA NA NA NA NA nasal epithelial cell CF patients Not reported 2683 ES01063 Initial 450K 29 0 NA NA 63.28 14.83 CD19+ B cell female CLL Not reported 2684 ES01063 Initial 450K 19 0 NA NA 58.26 10.61 CD19+ B cell Female control Not reported 2685 ES01063 Initial 450K 19 1 NA NA 61.21 8.55 CD19+ B cell Male CLL Not reported 2686 ES01063 Initial 450K 9 1 NA NA 47.22 18.43 CD19+ B cell Male control Not reported 2687 ES01064 Initial 450K 391 0.49 0 0 0 0 cord blood Not reported 2688 ES01065 Initial 450K 391 0.49 0 0 0 0 cord blood Not reported 2689 ES01066 Initial 450K 391 0.49 0 0 0 0 cord blood Not reported 2690 ES01067 Initial 450K 391 0.49 0 0 0 0 cord blood Not reported 2691 ES01068 Initial 450K 391 0.49 0 0 0 0 cord blood Not reported 2692 ES01069 Initial 450K 391 0.49 0 0 0 0 cord blood Not reported 2693 ES01070 Initial 450K 391 0.49 0 0 0 0 cord blood Not reported 2694 ES01071 Initial 850K 11 0.55 10 10 10 0 whole blood Not reported 2695 ES01071 Initial 850K 11 0.55 5 5 5 0 whole blood Not reported 2696 ES01072 Initial 850K 11 0.55 0 0 0 0 cord blood Not reported 2697 ES01072 Initial 850K 11 0.55 5 5 5 0 whole blood Not reported 2698 ES01073 Initial 450K 2199 0.31 NA NA 38.2 12.6 leukocyte NTR Not reported 2699 ES01073 Initial 450K 668 0.48 NA NA 59.1 6.6 leukocyte LLS Not reported 2700 ES01073 Initial 450K 608 0.42 NA NA 68.6 5.6 leukocyte RS Not reported 2701 ES01073 Initial 450K 704 0.42 NA NA 47.3 12.5 leukocyte LLD Not reported 2702 ES01074 Initial 450K 48 0.75 12 74 37.94 14.24 skin 24 paired South Asian 2703 ES01075 Initial 450K 2690 0.69 53.8 65.4 60.7 NA peripheral blood mononuclear cell MCCS Melbourne Collaborative Cohort Study normal samples European 2704 ES01075 Initial 450K 2496 0.67 54.1 65.5 60.8 NA peripheral blood mononuclear cell MCCS Melbourne Collaborative Cohort Study European 2705 ES01076 Initial 450K 54 0.7 NA NA 44.7 12.3 leukocyte schizophrenia suicide attempters European 2706 ES01076 Initial 450K 69 0.7 NA NA 44.7 12.3 leukocyte non-suicide attempters European 2707 ES01077 Initial 450K 14 0 NA NA 29.7 5.85 skeletal muscle Controls Not reported 2708 ES01077 Initial 450K 17 0 NA NA 31.2 5.4 skeletal muscle PCOS Not reported 2709 ES01078 Initial 450K 87 0 NA NA NA NA peripheral blood mononuclear cell breast cancer cases Not reported 2710 ES01078 Initial 450K 123 0 NA NA NA NA peripheral blood mononuclear cell unaffected controls Not reported 2711 ES01078 Initial 450K 251 0 NA NA NA NA whole blood MCCS Melbourne Collaborative Cohort Study Not reported 2712 ES01079 Initial 450K 134 0.35 65 91 NA NA leukocyte Not reported 2713 ES01080 Initial 450K 203 0.5 NA NA 61 6.95 leukocyte Japanese Americans East Asian 2714 ES01081 Initial 27K 11 0.45 NA NA 58 15 whole blood symptomatic HDM Not reported 2715 ES01081 Initial 27K 15 0.47 NA NA 38.1 11.05 whole blood healthy controls Not reported 2716 ES01081 Initial 27K 9 0.44 NA NA 33.6 7.26 whole blood pre-symptomatic Not reported 2717 ES01082 Initial 27K 11 0.45 NA NA 58 15 whole blood symptomatic HDM Not reported 2718 ES01082 Initial 27K 15 0.47 NA NA 38.1 11.05 whole blood healthy controls Not reported 2719 ES01082 Initial 27K 9 0.44 NA NA 33.6 7.26 whole blood pre-symptomatic Not reported 2720 ES01083 Initial 27K 11 0.45 NA NA 58 15 whole blood symptomatic HDM Not reported 2721 ES01083 Initial 27K 15 0.47 NA NA 38.1 11.05 whole blood healthy controls Not reported 2722 ES01083 Initial 27K 9 0.44 NA NA 33.6 7.26 whole blood pre-symptomatic Not reported 2723 ES01084 Initial 27K 11 0.45 NA NA 58 15 whole blood symptomatic HDM Not reported 2724 ES01084 Initial 27K 15 0.47 NA NA 38.1 11.05 whole blood healthy controls Not reported 2725 ES01084 Initial 27K 9 0.44 NA NA 33.6 7.26 whole blood pre-symptomatic Not reported 2726 ES01085 Initial 27K 55 0.35 15 15 15 0 buccal epithelium European 2727 ES01086 Initial 450K 55 0.35 18 18 18 0 buccal epithelium European 2728 ES01087 Initial 450K 977 NA NA NA NA NA urological tumor tissue Not reported 2729 ES01087 Initial 450K 480 NA NA NA NA NA urological tumor tissue Not reported 2730 ES01087 Initial 450K 81 NA NA NA NA NA urological tumor tissue Not reported 2731 ES01088 Initial 450K 217 NA NA NA NA NA kidney Not reported 2732 ES01089 Initial 450K 280 NA NA NA NA NA bladder Not reported 2733 ES01088 Initial 450K 108 NA NA NA NA NA kidney Not reported 2734 ES01088 Initial 450K 17 NA NA NA NA NA kidney Not reported 2735 ES01089 Initial 450K 139 NA NA NA NA NA bladder Not reported 2736 ES01089 Initial 450K 25 NA NA NA NA NA bladder Not reported 2737 ES01091 Initial 450K 10 0.5 NA NA 59.6 11.9 colon colorectal laterally spreading tumor East Asian 2738 ES01091 Initial 450K 10 0.5 NA NA 59.6 11.9 colon matched normal samples Not reported 2739 ES01090 Initial 450K 88 NA NA NA NA NA colon colorectal cancer Not reported 2740 ES01090 Initial 450K 17 NA NA NA NA NA colon normal healthy individuals Not reported 2741 ES01092 Initial 450K 42 NA NA NA NA NA colon adenomas Not reported 2742 ES01092 Initial 450K 17 NA NA NA NA NA colon normal healthy individuals Not reported 2743 ES01093 Initial 450K 25 0.6 NA NA 73.6 8.9 retinal pigment epithelium AMD Not reported 2744 ES01093 Initial 450K 19 0.63 NA NA 73.6 6.6 retinal pigment epithelium normal control Not reported 2745 ES01094 Initial 450K 30 1 NA NA 21.9 0.4 peripheral blood mononuclear cell perinatal exposed to high PCBs and PCDFs East Asian 2746 ES01094 Initial 450K 30 1 NA NA 22.3 0.4 peripheral blood mononuclear cell Non-exposed referents East Asian 2747 ES01095 Initial 450K 16 0.44 NA NA 28.7 46.5 peripheral blood mononuclear cell pre-exposure South Asian,Greater Middle Eastern,European,Asian unspecified 2748 ES01095 Initial 450K 16 0.44 NA NA 28.7 46.5 peripheral blood mononuclear cell 6 hours diesel exhaust exposure Greater Middle Eastern,European,Asian unspecified,South Asian 2749 ES01095 Initial 450K 16 0.44 NA NA 28.7 46.5 peripheral blood mononuclear cell 30 hours diesel exhaust exposure Greater Middle Eastern,European,Asian unspecified,South Asian 2750 ES01095 Initial 450K 16 0.44 NA NA 28.7 46.5 peripheral blood mononuclear cell 6 hours filtered air exposure European,Asian unspecified,South Asian,Greater Middle Eastern 2751 ES01095 Initial 450K 16 0.44 NA NA 28.7 46.5 peripheral blood mononuclear cell 30 hours filtered air exposure European,Asian unspecified,South Asian,Greater Middle Eastern 2752 ES01096 Initial 450K 92 0.51 NA NA 11.7 1.55 whole blood DNBC Danish National Birth Registry GDM Not reported 2753 ES01096 Initial 450K 94 0.5 NA NA 11.7 1.51 whole blood DNBC Danish National Birth Registry Control offspring Not reported 2754 ES01097 Initial 450K 67 NA NA NA 36.4 10 leukocyte KS patients Not reported 2755 ES01097 Initial 450K 33 0 NA NA 45 10.3 leukocyte female controls Not reported 2756 ES01098 Initial 450K 67 NA NA NA 36.4 10 leukocyte KS patients Not reported 2757 ES01098 Initial 450K 67 1 NA NA 36.3 9.71 leukocyte male controls Not reported 2758 ES01099 Initial 450K 968 0.48 NA NA 17.1 1.1 whole blood ARIES Not reported 2759 ES01100 Initial 450K 968 0.48 NA NA 17.1 1.1 whole blood ARIES Not reported 2760 ES01101 Initial 450K 968 0.48 NA NA 17.1 1.1 whole blood ARIES Not reported 2761 ES01102 Initial 450K 968 0.48 NA NA 17.1 1.1 whole blood ARIES Not reported 2762 ES01103 Initial 450K 968 0.48 NA NA 17.1 1.1 whole blood ARIES Not reported 2763 ES01104 Initial 450K 149 0.59 7.5 7.5 7.5 0 whole blood ALSPAC Avon Longitudinal Study of Parents and Children Current asthma Not reported 2764 ES01104 Initial 450K 632 0.49 7.5 7.5 7.5 0 whole blood ALSPAC Avon Longitudinal Study of Parents and Children Controls Not reported 2765 ES01105 Initial 450K 111 0.6 7.5 7.5 7.5 0 whole blood ALSPAC Avon Longitudinal Study of Parents and Children Current wheeze Not reported 2766 ES01105 Initial 450K 742 0.49 7.5 7.5 7.5 0 whole blood ALSPAC Avon Longitudinal Study of Parents and Children Controls Not reported 2767 ES01107 Initial 450K 194 0.53 16.5 16.5 16.5 0 whole blood ALSPAC Avon Longitudinal Study of Parents and Children Ever asthma Not reported 2768 ES01107 Initial 450K 554 0.48 16.5 16.5 16.5 0 whole blood ALSPAC Avon Longitudinal Study of Parents and Children Controls Not reported 2769 ES01106 Initial 450K 184 0.4 16.5 16.5 16.5 16.5 whole blood ALSPAC Avon Longitudinal Study of Parents and Children Current asthma Not reported 2770 ES01106 Initial 450K 427 0.47 16.5 16.5 16.5 0 whole blood ALSPAC Avon Longitudinal Study of Parents and Children Controls Not reported 2771 ES01108 Initial 450K 204 0.53 16.5 16.5 16.5 0 whole blood ALSPAC Avon Longitudinal Study of Parents and Children Ever wheeze Not reported 2772 ES01108 Initial 450K 554 0.48 16.5 16.5 16.5 0 whole blood ALSPAC Avon Longitudinal Study of Parents and Children Controls Not reported 2773 ES01109 Initial 450K 681 1 NA NA NA NA peripheral blood mononuclear cell VACS Veterans Aging Cohort Study Not reported 2774 ES01110 Initial 450K 681 1 NA NA NA NA peripheral blood mononuclear cell VACS Veterans Aging Cohort Study Not reported 2775 ES01111 Initial 450K 13 0 NA NA 53.5 7.9 myoblast women Not reported 2776 ES01111 Initial 450K 13 1 NA NA 52.4 5.3 myoblast men Not reported 2778 ES01112 Initial 450K 13 0 NA NA 53.5 7.9 myotube women Not reported 2779 ES01112 Initial 450K 13 1 NA NA 52.4 5.3 myotube men Not reported 2780 ES01113 Initial 850K 658 0.42 NA NA 54.3 12.7 leukocyte European 2781 ES01114 Initial 450K 706 0.37 NA NA 88 6.7 dorsolateral prefrontal cortex Not reported 2782 ES01115 Initial 450K 706 0.37 NA NA 88 6.7 dorsolateral prefrontal cortex Not reported 2783 ES01118 Initial 450K 1249 0.675 NA NA 69.1 8.1 whole blood MCCS Melbourne Collaborative Cohort Study Not reported 2784 ES01119 Initial 450K 1249 0.675 NA NA 69.1 8.1 whole blood MCCS Melbourne Collaborative Cohort Study Not reported 2785 ES01120 Initial 450K 1249 0.675 NA NA 69.1 8.1 whole blood MCCS Melbourne Collaborative Cohort Study Not reported 2786 ES01121 Initial 450K 8 0.875 NA NA 58.6 6.8 lung Chronic beryllium disease European 2787 ES01121 Initial 450K 8 0.875 NA NA 56.8 8.3 lung Beryllium sensitized European 2788 ES01122 Initial 450K 51 0 NA NA 59.8 11.3 ovarian TCGA The Cancer Genome Atlas recurrence ?12 months Not reported 2789 ES01122 Initial 450K 158 0 NA NA 58.2 11.4 ovarian TCGA The Cancer Genome Atlas recurrence >12 months Not reported 2790 ES01123 Initial 450K 436 0 40 70 NA NA whole blood AMDTSS Australian Mammographic Density Twins and Sisters Study European 2791 ES01123 Initial 450K 591 0 27 76 NA NA whole blood MCCS Melbourne Collaborative Cohort Study European 2792 ES01124 Initial 450K 436 0 40 70 NA NA whole blood AMDTSS Australian Mammographic Density Twins and Sisters Study European 2793 ES01124 Initial 450K 591 0 27 76 NA NA whole blood MCCS Melbourne Collaborative Cohort Study European 2794 ES01125 Initial 450K 436 0 40 70 NA NA whole blood AMDTSS Australian Mammographic Density Twins and Sisters Study European 2795 ES01125 Initial 450K 591 0 27 76 NA NA whole blood MCCS Melbourne Collaborative Cohort Study European 2796 ES01126 Initial 450K 45 0.76 NA NA 59 12 rectal cancer tissue Not reported 2797 ES01127 Initial 450K 369 0.336 18 18 18 0 whole blood IoW Isle of Wight birth cohort Not reported 2798 ES01128 Initial 450K 1216 NA NA NA NA NA cancer tissues TCGA The Cancer Genome Atlas Not reported 2799 ES01129 Initial 450K 43 0.395 NA NA 60.63 7.04 cerebellum control Not reported 2800 ES01129 Initial 450K 24 0.458 NA NA 79.47 10.02 cerebellum symptomatic AD Not reported 2801 ES01129 Initial 450K 47 0.596 NA NA 61.54 7.71 dorsolateral prefrontal cortex control Not reported 2802 ES01129 Initial 450K 21 0.524 NA NA 79.95 9.46 dorsolateral prefrontal cortex Symptomatic AD Not reported 2803 ES01129 Initial 450K 48 0.604 NA NA 61.71 7.66 hippocampus control Not reported 2804 ES01129 Initial 450K 17 0.471 NA NA 81.54 9.16 hippocampus symptomatic AD Not reported 2805 ES01129 Initial 450K 49 0.592 NA NA 61.62 7.61 entorhinal Cortex control Not reported 2806 ES01129 Initial 450K 20 0.45 NA NA 79.69 9.64 entorhinal Cortex symptomatic AD Not reported 2807 ES01130 Initial 450K 6 0 NA NA 36.2 7.1 endometrium endometriotic lesions Not reported 2808 ES01130 Initial 450K 6 0 NA NA 36.2 7.1 endometrium adjacent normal tissues Not reported 2809 ES01131 Initial 450K 6 0 NA NA 36.2 7.1 endometrium endometriotic lesions Not reported 2810 ES01131 Initial 450K 6 0 NA NA 34.8 2.9 endometrium endometriosis?free control Not reported 2811 ES01132 Initial 450K 476 0.4 78 95 79 NA whole blood LBC1921 Lothian Birth Cohort 1921 Not reported 2812 ES01132 Initial 450K 949 0.5 67 77 70 NA whole blood LBC1936 Lothian Birth Cohort 1936 Not reported 2813 ES01133 Initial 450K 901 0.49 0 0 0 0 cord blood ALSPAC Avon Longitudinal Study of Parents and Children Not reported 2814 ES01134 Initial 450K 966 0.49 7 7 7 0 whole blood ALSPAC Avon Longitudinal Study of Parents and Children Not reported 2815 ES01135 Initial 450K 901 0.49 0 0 0 0 cord blood ALSPAC Avon Longitudinal Study of Parents and Children Not reported 2816 ES01136 Initial 450K 966 0.49 7 7 7 0 whole blood ALSPAC Avon Longitudinal Study of Parents and Children Not reported 2817 ES01137 Initial 450K 966 0.49 15 17 NA NA cord blood ALSPAC Avon Longitudinal Study of Parents and Children Not reported 2818 ES01138 Initial 450K 966 0.49 15 17 NA NA whole blood ALSPAC Avon Longitudinal Study of Parents and Children Not reported 2819 ES01139 Initial 450K 17 1 NA NA 40.1 7.5 whole blood DILGOM DIetary, Lifestyle, and Genetic determinants of Obesity and Metabolic syndrome study insufcient sleep Not reported 2820 ES01139 Initial 450K 62 1 NA NA 39 7.3 whole blood DILGOM DIetary, Lifestyle, and Genetic determinants of Obesity and Metabolic syndrome study sufcient sleep Not reported 2821 ES01139 Initial 450K 17 1 NA NA 41.8 8.8 whole blood Airline insufcient sleep Not reported 2822 ES01139 Initial 450K 9 1 NA NA 46.7 6.7 whole blood Airline sufcient sleep Not reported 2823 ES01140 Initial 450K 101 0.55 0 0 0 0 umbilical cord blood Exposed group East Asian 2824 ES01140 Initial 450K 103 0.52 0 0 0 0 umbilical cord blood Reference group East Asian 2825 ES01141 Initial 450K 108 NA 10 10 10 0 whole blood IoW Isle of Wight European 2826 ES01141 Initial 450K 176 NA 18 18 18 0 whole blood IoW Isle of Wight European 2827 ES01141 Initial 450K 267 NA 16 16 16 0 whole blood BAMSE European 2828 ES01142 Initial 450K 528 0 18.6 80.9 57.9 NA whole blood TwinsUK Not reported 2829 ES01143 Initial 450K 492 0 18.6 80.9 58 NA whole blood TwinsUK Not reported 2830 ES01144 Initial 450K 158 0.608 17.9 86 65.4 NA tumor tissue TCGA The Cancer Genome Atlas Not reported 2831 ES01144 Replication 450K 159 0.73 16.1 84.8 59.5 NA tumor tissue TCGA The Cancer Genome Atlas Not reported 2832 ES01145 Initial 450K 380 0.29 NA NA 65.6 7.3 leukocyte GENOA Genetic Epidemiology Network of Arteriopathy African American or Afro-Caribbean 2833 ES01146 Initial 450K 90 0 NA NA NA NA breast NBS Normal Breast Study Not reported 2834 ES01147 Initial 850K 30 0.33 18 58 25.6 7.7 buccal cell before glucocorticoid exposure Not reported 2835 ES01147 Initial 850K 30 0.33 18 58 25.6 7.7 buccal cell after glucocorticoid exposure Not reported 2836 ES01147 Replication 850K 18 NA NA NA NA NA whole blood before glucocorticoid exposure Not reported 2837 ES01147 Replication 850K 13 NA NA NA NA NA buccal cell before glucocorticoid exposure Not reported 2838 ES01147 Replication 850K 21 NA NA NA NA NA saliva before glucocorticoid exposure Not reported 2839 ES01147 Replication 850K 10 NA NA NA NA NA brain before glucocorticoid exposure Not reported 2840 ES01147 Replication 850K 18 NA NA NA NA NA whole blood after glucocorticoid exposure Not reported 2841 ES01147 Replication 850K 13 NA NA NA NA NA buccal cell after glucocorticoid exposure Not reported 2842 ES01147 Replication 850K 21 NA NA NA NA NA saliva after glucocorticoid exposure Not reported 2843 ES01147 Replication 850K 10 NA NA NA NA NA brain after glucocorticoid exposure Not reported 2844 ES01148 Initial 450K 100 0.66 NA NA 72.8 6.3 whole blood East Asian 2845 ES01149 Initial 450K 100 0.66 NA NA 72.8 6.3 whole blood East Asian 2846 ES01150 Initial 450K 211 0.5 NA NA 28.17 14.83 whole blood SFS STANISLAS Family Study European 2847 ES01151 Initial 850K 16 0.125 6 17 11.5 NA whole blood paediatric-onset systemic lupus erythematosus patients Not reported 2848 ES01151 Initial 850K 13 0 12 57 19 NA whole blood healthy control Not reported 2849 ES01151 Initial 850K 16 0.125 6 17 11.5 NA CD4+ T cell paediatric-onset systemic lupus erythematosus patients Not reported 2850 ES01151 Initial 850K 13 0 12 57 19 NA CD4+ T cell healthy control Not reported 2851 ES01151 Initial 850K 16 0.125 6 17 11.5 NA CD8+ T cell paediatric-onset systemic lupus erythematosus patients Not reported 2852 ES01151 Initial 850K 13 0 12 57 19 NA CD8+ T cell healthy control Not reported 2853 ES01151 Initial 850K 16 0.125 6 17 11.5 NA CD19+ B cell paediatric-onset systemic lupus erythematosus patients Not reported 2854 ES01151 Initial 850K 13 0 12 57 19 NA CD19+ B cell healthy control Not reported 2855 ES01151 Initial 850K 16 0.125 6 17 11.5 NA CD16+ neutrophil paediatric-onset systemic lupus erythematosus patients Not reported 2856 ES01151 Initial 850K 13 0 12 57 19 NA CD16+ neutrophil healthy control Not reported 2865 ES01153 Initial 450K 719 NA 7 7 7 0 leukocyte ALSPAC Avon Longitudinal Study of Parents and Children Not reported 2866 ES01154 Initial 450K 703 NA 7 7 7 0 leukocyte ALSPAC Avon Longitudinal Study of Parents and Children Not reported 2867 ES01155 Initial 450K 691 NA 7 7 7 0 leukocyte ALSPAC Avon Longitudinal Study of Parents and Children Not reported 2868 ES01156 Initial 450K 710 NA 7 7 7 0 leukocyte ALSPAC Avon Longitudinal Study of Parents and Children Not reported 2869 ES01157 Initial 450K 703 NA 7 7 7 0 leukocyte ALSPAC Avon Longitudinal Study of Parents and Children Not reported 2870 ES01158 Initial 450K 774 NA 7 7 7 0 leukocyte ALSPAC Avon Longitudinal Study of Parents and Children Not reported 2871 ES01159 Initial 450K 702 NA 7 7 7 0 leukocyte ALSPAC Avon Longitudinal Study of Parents and Children Not reported 2872 ES01160 Initial 450K 26 0.54 NA NA 13.6 0.1 whole blood Non-obese sample Not reported 2873 ES01160 Initial 450K 5 0.8 NA NA 13.6 0.1 whole blood Obese sample Not reported 2874 ES01161 Initial 450K 474 0.36 NA NA 47 14.3 leukocyte MENA Methyl Epigenome Network Association project European 2875 ES01163 Initial 850K 164 0.59 10.6 15 12.6 NA whole blood RISK Risk Stratification and Identification of Immunogenetic and Microbial Markers of Rapid Disease Progression in Children with Crohn’s Disease cohort crohn disease at diagnosis Not reported 2876 ES01163 Initial 450K 74 0.54 9.8 14.3 12.6 NA whole blood RISK Risk Stratification and Identification of Immunogenetic and Microbial Markers of Rapid Disease Progression in Children with Crohn’s Disease cohort Controls without IBD Not reported 2877 ES01164 Initial 450K 251 0.247 NA NA 53.3 8.1 leukocyte EPIC-Italy European Prospective Investigation into Cancer and Nutrition study European 2878 ES01164 Initial 450K 408 0.419 NA NA 51.5 7.5 leukocyte NSHDS European 2879 ES01165 Initial 450K 251 0.247 NA NA 53.3 8.1 leukocyte EPIC-Italy European Prospective Investigation into Cancer and Nutrition study European 2880 ES01165 Initial 450K 408 0.419 NA NA 51.5 7.5 leukocyte NSHDS European 2881 ES01166 Initial 450K 251 0.247 NA NA 53.3 8.1 leukocyte EPIC-Italy European Prospective Investigation into Cancer and Nutrition study European 2882 ES01166 Initial 450K 408 0.419 NA NA 51.5 7.5 leukocyte NSHDS European 2883 ES01167 Initial 450K 251 0.247 NA NA 53.3 8.1 leukocyte EPIC-Italy European Prospective Investigation into Cancer and Nutrition study European 2884 ES01167 Initial 450K 408 0.419 NA NA 51.5 7.5 leukocyte NSHDS European 2885 ES01168 Initial 450K 251 0.247 NA NA 53.3 8.1 leukocyte EPIC-Italy European Prospective Investigation into Cancer and Nutrition study European 2886 ES01168 Initial 450K 408 0.419 NA NA 51.5 7.5 leukocyte NSHDS European 2887 ES01169 Initial 450K 251 0.247 NA NA 53.3 8.1 leukocyte EPIC-Italy European Prospective Investigation into Cancer and Nutrition study European 2888 ES01169 Initial 450K 408 0.419 NA NA 51.5 7.5 leukocyte NSHDS European 2889 ES01170 Initial 450K 251 0.247 NA NA 53.3 8.1 leukocyte EPIC-Italy European Prospective Investigation into Cancer and Nutrition study European 2890 ES01170 Initial 450K 408 0.419 NA NA 51.5 7.5 leukocyte NSHDS European 2891 ES01171 Initial 450K 251 0.247 NA NA 53.3 8.1 leukocyte EPIC-Italy European Prospective Investigation into Cancer and Nutrition study European 2892 ES01171 Initial 450K 408 0.419 NA NA 51.5 7.5 leukocyte NSHDS European 2893 ES01172 Initial 450K 16 1 NA NA 62.25 18.18 whole blood 8 atherosclerotic patients and 8 healthy subjects Not reported 2894 ES01173 Initial 450K 124 0.516 NA NA NA NA tumor tissue Not reported 2895 ES01174 Initial 450K 436 0.55 0 0 0 0 whole blood NCL Norway Facial Cleft Study Control European 2896 ES01174 Initial 450K 92 0.55 0 0 0 0 whole blood NCL Norway Facial Cleft Study cleft lip European 2897 ES01174 Initial 450K 84 0.44 0 0 0 0 whole blood NCL Norway Facial Cleft Study cleft palate European 2898 ES01174 Initial 450K 132 0.72 0 0 0 0 whole blood NCL Norway Facial Cleft Study cleft lip and palate European 2899 ES01175 Initial 450K 436 0.55 0 0 0 0 whole blood NCL Norway Facial Cleft Study Control European 2900 ES01175 Initial 450K 92 0.55 0 0 0 0 whole blood NCL Norway Facial Cleft Study cleft lip European 2901 ES01176 Initial 450K 436 0.55 0 0 0 0 whole blood NCL Norway Facial Cleft Study Control European 2902 ES01176 Initial 450K 84 0.44 0 0 0 0 whole blood NCL Norway Facial Cleft Study cleft palate European 2903 ES01177 Initial 450K 436 0.55 0 0 0 0 whole blood NCL Norway Facial Cleft Study Control European 2904 ES01177 Initial 450K 132 0.72 0 0 0 0 whole blood NCL Norway Facial Cleft Study cleft lip and palate European 2905 ES01179 Initial 450K 58 0.43 NA NA 45.8 16.7 whole blood NKI-RS Nathan Kline Institute-Rockland Sample healthy controls Not reported 2906 ES01179 Initial 450K 52 0.44 NA NA 45.8 16.4 whole blood NKI-RS Nathan Kline Institute-Rockland Sample alcohol use disorder Not reported 2907 ES01178 Initial 450K 58 0.43 NA NA 45.8 16.7 whole blood NKI-RS Nathan Kline Institute-Rockland Sample healthy controls Not reported 2908 ES01178 Initial 450K 52 0.44 NA NA 45.8 16.4 whole blood NKI-RS Nathan Kline Institute-Rockland Sample alcohol use disorder Not reported 2909 ES01180 Initial 450K 24 0.54 0 7 1.91 1.52 peripheral blood mononuclear cell KD Not reported 2910 ES01180 Initial 450K 24 0.5 0 6 2.24 1.07 peripheral blood mononuclear cell Control Not reported 2911 ES01181 Initial 850K 18 NA 4 12 NA NA whole blood case Not reported 2912 ES01181 Initial 850K 18 NA 4 12 NA NA whole blood control Not reported 2913 ES01182 Initial 450K 383 NA NA NA NA NA whole blood cases Not reported 2914 ES01182 Initial 450K 565 NA NA NA NA NA whole blood control Not reported 2915 ES01183 Initial 450K 633 0.48 0 0 0 0 whole blood ALSPAC European 2916 ES01183 Initial 450K 127 0.58 0 0 0 0 whole blood CBC Hispanic or Latin American 2917 ES01183 Initial 450K 136 0.58 0 0 0 0 whole blood CBC European 2918 ES01183 Initial 450K 283 0.5 0 0 0 0 whole blood CHAMACOS Hispanic or Latin American 2919 ES01183 Initial 450K 199 0.4 0 0 0 0 whole blood CHS Other admixed ancestry 2920 ES01183 Initial 450K 131 0.53 0 0 0 0 whole blood EARLI Other admixed ancestry 2921 ES01183 Initial 450K 324 0.52 0 0 0 0 whole blood EXPOsOMICS European 2922 ES01183 Initial 450K 255 0.53 0 0 0 0 whole blood GECKO European 2923 ES01183 Initial 450K 162 0.46 0 0 0 0 whole blood Gen3G European 2924 ES01183 Initial 450K 717 0.52 0 0 0 0 whole blood Generation R European 2925 ES01183 Initial 450K 947 0.51 0 0 0 0 whole blood GOYA European 2926 ES01183 Initial 450K 77 0.55 0 0 0 0 whole blood Healthy Start African American or Afro-Caribbean 2927 ES01183 Initial 450K 115 0.48 0 0 0 0 whole blood Healthy Start Hispanic or Latin American 2928 ES01183 Initial 450K 240 0.52 0 0 0 0 whole blood Healthy Start European 2929 ES01183 Initial 450K 166 0.49 0 0 0 0 whole blood INMA European 2930 ES01183 Initial 450K 118 0.5 0 0 0 0 whole blood IOW F2 European 2931 ES01183 Initial 450K 1066 0.53 0 0 0 0 whole blood MoBa1 European 2932 ES01183 Initial 450K 587 0.56 0 0 0 0 whole blood MoBa2 European 2933 ES01183 Initial 450K 205 0.52 0 0 0 0 whole blood MoBa3 European 2934 ES01183 Initial 450K 792 0.57 0 0 0 0 whole blood NCL European 2935 ES01183 Initial 450K 99 0.48 0 0 0 0 whole blood NEST African American or Afro-Caribbean 2936 ES01183 Initial 450K 111 0.45 0 0 0 0 whole blood NEST European 2937 ES01183 Initial 450K 96 0.55 0 0 0 0 whole blood NHBCS European 2938 ES01183 Initial 450K 540 0.49 0 0 0 0 whole blood PREDO European 2939 ES01183 Initial 450K 138 0.55 0 0 0 0 whole blood PRISM Other admixed ancestry 2940 ES01183 Initial 450K 143 0.54 0 0 0 0 whole blood PROGRESS Hispanic or Latin American 2941 ES01183 Initial 450K 89 0.39 0 0 0 0 whole blood RICHS European 2942 ES01183 Initial 450K 329 0.51 0 0 0 0 whole blood Project Viva European 2943 ES01184 Initial 450K 2775 0 NA NA 57.8 8.8 whole blood National Institute of Environmental Health Sciences (NIEHS) Sister Study Not reported 2944 ES01184 Replication 450K 187 0 NA NA 50.5 4.8 whole blood National Institute of Environmental Health Sciences (NIEHS) Sister Study Not reported 2945 ES01185 Initial 450K 450 0 26 73 52 9 leukocyte EPIC EuropeanProspective Investigation into Cancer and Nutrition (EPIC) study European 2946 ES01186 Initial 450K 587 0.54 33 94 69.3 NA tumor tissue DACHS Non-metastatic CRC Not reported 2947 ES01186 Initial 450K 101 0.61 46 93 67.8 NA tumor tissue DACHS Metastatic CRC Not reported 2948 ES01187 Initial 450K 36 0.11 NA NA 56.2 15.5 CD4+ T cell GD Patients European 2949 ES01187 Initial 450K 31 0.1 NA NA 53.7 11.9 CD4+ T cell GD Controls European 2950 ES01187 Initial 450K 12 0.25 NA NA 40.8 11.5 CD4+ T cell RA Patients East Asian 2951 ES01187 Initial 450K 12 0.25 NA NA 40.6 11.4 CD4+ T cell RA Controls East Asian 2952 ES01187 Initial 450K 44 0.16 NA NA 31 8.4 CD4+ T cell SLE Patients European,African unspecified 2953 ES01187 Initial 450K 50 0.22 NA NA 29.2 6.3 CD4+ T cell SLE Controls African unspecified,European 2954 ES01187 Initial 450K 24 0.29 NA NA 47.4 14.1 CD4+ T cell SSc Patients East Asian 2955 ES01187 Initial 450K 24 0.21 NA NA 46.8 10 CD4+ T cell SSc Controls East Asian 2956 ES01188 Initial 450K 37 0.11 NA NA 55 16.3 CD8+ T cell GD Patients European 2957 ES01188 Initial 450K 31 0.1 NA NA 53.7 11.9 CD8+ T cell GD Controls European 2958 ES01188 Initial 450K 24 0.29 NA NA 47.4 14.1 CD8+ T cell SSc Patients East Asian 2959 ES01188 Initial 450K 24 0.21 NA NA 46.8 10 CD8+ T cell SSc Controls East Asian 2960 ES01189 Initial 450K 2775 0 NA NA 57.8 8.8 whole blood National Institute of Environmental Health Sciences (NIEHS) Sister Study Not reported 2961 ES01189 Replication 450K 171 0 NA NA NA NA breast Not reported 2962 ES01190 Initial 450K 283 0.72 NA NA 70 9 carotid plaque AEMS450K1 Athero-Express Biobank Study Former or Never Smokers Not reported 2963 ES01190 Initial 450K 194 0.68 NA NA 64.9 8.3 carotid plaque AEMS450K1 Athero-Express Biobank Study Current Smokers Not reported 2964 ES01190 Replication 450K 131 0.85 NA NA 70.2 8.7 carotid plaque AEMS450K2 Athero-Express Biobank Study Former or Never Smokers Not reported 2965 ES01190 Replication 450K 56 0.8 NA NA 65.2 9 carotid plaque AEMS450K2 Athero-Express Biobank Study Current Smokers Not reported 2966 ES01191 Initial 450K 53 0.66 NA NA 69.1 8.9 whole blood AEMS450K1 Athero-Express Biobank Study Former smokers Not reported 2967 ES01191 Initial 450K 40 0.68 NA NA 65.2 7.1 whole blood AEMS450K1 Athero-Express Biobank Study Current smokers Not reported 2968 ES01192 Initial 450K 216 0 NA NA 54.2 6.4 whole blood EPIC-Italy Not reported 2969 ES01192 Initial 450K 237 0 NA NA 53.1 7.2 whole blood EPIC-Italy Not reported 2970 ES01192 Initial 450K 65 0 NA NA 51.8 8.4 whole blood The Generations Study Not reported 2971 ES01193 Initial 450K 6 0.67 45 58 NA NA tumor tissue tumor tissue East Asian 2972 ES01193 Initial 450K 6 0.67 45 58 NA NA adjacent normal tissue adjacent normal tissue East Asian 2973 ES01194 Initial 450K 34 0.53 NA NA 14.55 2.65 saliva Adolescents - CDV+ Not reported 2974 ES01194 Initial 450K 90 0.45 NA NA 13.38 2.38 saliva Adolescents - CDV- Not reported 2975 ES01194 Initial 450K 38 0 NA NA 37.32 6.39 saliva Mothers - CDV+ Not reported 2976 ES01194 Initial 450K 87 0 NA NA 39.19 6.15 saliva Mothers - CDV- Not reported 2977 ES01194 Initial 450K 24 0 NA NA 63.24 7.8 saliva Grandmothers - CDV+ Not reported 2978 ES01194 Initial 450K 102 0 NA NA 65.02 8.25 saliva Grandmothers - CDV- Not reported 2979 ES01195 Initial 450K 23 NA NA NA 0.72 0.05 leukocyte CP Cases African American or Afro-Caribbean,Hispanic or Latin American,European 2980 ES01195 Initial 450K 21 NA NA NA 0.72 0.06 leukocyte Controls African American or Afro-Caribbean,Hispanic or Latin American,European 2981 ES01196 Initial 450K 184 0.48 0 0 0 0 placenta RICHS The Rhode Island Child Health Study Non-night shift Not reported 2982 ES01196 Initial 450K 53 0.53 0 0 0 0 placenta RICHS The Rhode Island Child Health Study Night shift Not reported 2983 ES01197 Initial 450K 100 0.84 NA NA 34.5 8.3 whole blood Patients with BD East Asian 2984 ES01197 Initial 450K 100 0.7 NA NA 37.8 6.2 whole blood Controls East Asian 2985 ES01198 Initial 450K 962 0.47 NA NA 50.5 11.3 whole blood SAPALDIA time point 1 European 2986 ES01198 Initial 450K 962 0.47 NA NA 58.8 11.3 whole blood SAPALDIA time point 2 European 2987 ES01198 Initial 850K 470 0.44 NA NA 43.6 6.8 whole blood ECRHS time point 1 European 2988 ES01198 Initial 850K 470 0.44 NA NA 54.5 6.8 whole blood ECRHS time point 2 European 2989 ES01198 Initial 450K 611 0.45 NA NA 31 0.3 whole blood NFBC1966 time point 1 European 2990 ES01198 Initial 850K 611 0.45 NA NA 46.3 0.4 whole blood NFBC1966 time point 2 European 2991 ES01198 Replication 450K 628 0.47 NA NA 53.6 4.5 whole blood KORA time point 1 European 2992 ES01198 Replication 450K 628 0.47 NA NA 60.1 4.5 whole blood KORA time point 2 European 2993 ES01198 Replication 450K 449 0.53 NA NA 69.6 0.9 whole blood LCB1936 time point 1 European 2994 ES01198 Replication 450K 449 0.53 NA NA 76.3 0.7 whole blood LCB1936 time point 2 European 2995 ES01198 Replication 450K 1622 0.57 NA NA 46.7 10.8 whole blood Lifelines time point 1 European 2996 ES01198 Replication 450K 535 0.47 NA NA 55.1 16 whole blood NSPHS time point 1 European 2997 ES01198 Replication 450K 93 0.53 NA NA 30.4 3.8 whole blood FTC time point 1 European 2998 ES01199 Initial 850K 45 0.25 NA NA 42.3 12.1 peripheral blood mononuclear cell MS-affected MZ co-twins Not reported 2999 ES01199 Initial 850K 45 0.25 NA NA 42.3 12.1 peripheral blood mononuclear cell Non-affected MZ co-twins Not reported 3000 ES01200 Initial 450K 274 0.54 0.12 1 NA NA saliva Not reported 3001 ES01201 Initial 450K 426 0.52 0 0 0 0 placenta ELGAN Other,European 3002 ES01202 Initial 450K 426 0.52 0 0 0 0 placenta ELGAN European,Other 3003 ES01203 Initial 450K 426 0.52 0 0 0 0 placenta ELGAN Other,European 3004 ES01204 Initial 450K 426 0.52 0 0 0 0 placenta ELGAN European,Other 3005 ES01205 Initial 450K 6 1 NA NA 30.5 1.7 whole blood oligo/azoospermic infertile patients Not reported 3006 ES01205 Initial 450K 6 1 NA NA 31 1.9 whole blood normozoospermic fertile controls Not reported 3007 ES01206 Initial 850K 5 0 NA NA 61.4 8 natural killer Cell before exercise Not reported 3008 ES01206 Initial 450K 5 0 NA NA 61.4 8 natural killer Cell after exercise Not reported 3009 ES01207 Initial 450K 23 1 23 29 NA NA whole blood Cases African unspecified,European 3010 ES01207 Initial 450K 24 1 23 29 NA NA whole blood Controls European,African unspecified 3011 ES01208 Initial 450K 54 0.39 NA NA 46.8 1 whole blood Unexposed East Asian 3012 ES01208 Initial 450K 25 0.4 NA NA 50.3 0.5 whole blood Exposed to maternal famine Not reported 3013 ES01209 Initial 850K 24 1 26 75 56.8 14.7 whole blood ankylosing spondylitis patients European 3014 ES01210 Initial 850K 12 1 26 75 58.1 15 whole blood HLA-B*27 + AS European 3015 ES01210 Initial 850K 12 1 29 73 55.5 14.8 whole blood HLA-B*27 - AS European 3016 ES01209 Initial 850K 12 1 26 87 57 18 whole blood osteoarthritis patients European 3017 ES01212 Initial 450K 900 0.43 NA NA 64.5 9 whole blood RS Rotterdam Study European 3018 ES01212 Initial 450K 430 0.49 NA NA 58.6 6.3 whole blood LLS Leiden Longevity Study European 3019 ES01212 Initial 450K 154 0.56 NA NA 65.5 6.9 whole blood CODAM Cohort study on Diabetes and Atherosclerosis Maastricht European 3020 ES01212 Initial 450K 484 0.46 NA NA 62.6 15.7 whole blood InCHIANTI Invecchiare in Chianti European 3021 ES01212 Initial 450K 155 0.38 NA NA 40.2 3.3 whole blood YFS Young Finns Study European 3022 ES01212 Initial 450K 568 0 NA NA 58.9 9.9 whole blood TwinsUK European 3023 ES01212 Initial 450K 1657 0.43 NA NA 64.8 8.6 whole blood FHS Framingham Heart Study European 3024 ES01212 Initial 450K 124 0.47 NA NA 49 16 CD4+ T cell GOLDN Genetics of Lipid Lowering Drugs and Diet Network European 3025 ES01212 Initial 450K 321 0.32 NA NA 59.5 5.8 whole blood ARIC Atherosclerosis Risk in Communities African American or Afro-Caribbean 3026 ES01212 Initial 450K 188 0.33 NA NA 77.3 4.9 whole blood CHS Cardiovascular Health Study European,African American or Afro-Caribbean 3027 ES01213 Initial 450K 12 0.5 31.8 80.2 NA NA whole blood Not reported 3028 ES01214 Initial 450K 80 0.58 NA NA 6.8 1.3 whole blood FEPRA FEtal Programming in Rheumatoid Arthritis born to mothers with RA European 3029 ES01214 Initial 450K 354 0.5 NA NA 6 0.4 whole blood Generation R born to mothers without RA European 3030 ES01215 Initial 450K 7 0.86 53 56 54 NA whole blood patients East Asian 3031 ES01215 Initial 450K 7 0.86 55 59 59 NA whole blood controls East Asian 3032 ES01216 Initial 450K 626 0.44 NA NA 59.8 8.1 whole blood RS-III-I European 3033 ES01216 Initial 450K 705 0.41 NA NA 67.5 6 whole blood RS-BIOS European 3034 ES01216 Initial 450K 2753 0.34 NA NA 36.3 12.8 whole blood NTR European 3035 ES01216 Initial 450K 724 0 NA NA 58.1 9.3 whole blood TwinsUK European 3036 ES01216 Replication 450K 1875 0.36 NA NA 56.1 5.8 whole blood ARIC African American or Afro-Caribbean 3037 ES01216 Replication 450K 402 0.5 NA NA 69 14.4 whole blood BLSA European 3038 ES01216 Replication 450K 142 0.4 NA NA 64.3 10.9 whole blood BLSA African American or Afro-Caribbean 3039 ES01216 Replication 450K 160 0.44 NA NA 76.2 5 whole blood CHS European 3040 ES01216 Replication 450K 147 0.33 NA NA 73.2 5.7 whole blood CHS African American or Afro-Caribbean 3041 ES01216 Replication 450K 2117 0.43 NA NA 65.7 8.9 whole blood FHS European 3042 ES01216 Replication 450K 268 0.29 NA NA 60.7 7.7 whole blood GENOA African American or Afro-Caribbean 3043 ES01216 Replication 450K 917 0.51 NA NA 48 15.8 whole blood GOLDN European 3044 ES01216 Replication 450K 469 0.4 NA NA 51 13.7 whole blood HyperGEN African American or Afro-Caribbean 3045 ES01216 Replication 450K 433 0.46 NA NA 62.1 16 whole blood inCHIANTI European 3046 ES01216 Replication 450K 1488 0.47 NA NA 60.2 8.8 whole blood KORA European 3047 ES01216 Replication 450K 836 0 NA NA 68.4 6.2 whole blood WHI-BAA23 European 3048 ES01216 Replication 450K 503 0 NA NA 62.6 6.7 whole blood WHI-BAA23 African American or Afro-Caribbean 3049 ES01216 Replication 450K 319 0 NA NA 62.4 6.8 whole blood WHI-BAA23 Hispanic or Latin American 3050 ES01216 Replication 450K 425 0 NA NA 62.1 6.9 whole blood WHI-EMPC European 3051 ES01216 Replication 450K 951 0 NA NA 64.5 7.2 whole blood WHI-EMPC African American or Afro-Caribbean 3052 ES01216 Replication 450K 258 0 NA NA 61.4 6.1 whole blood WHI-EMPC Hispanic or Latin American 3053 ES01217 Initial 450K 626 0.44 NA NA 59.8 8.1 whole blood RS-III-I European 3054 ES01217 Initial 450K 705 0.41 NA NA 67.5 6 whole blood RS-BIOS European 3055 ES01217 Initial 450K 2685 0.34 NA NA 36.3 12.8 whole blood NTR European 3056 ES01217 Initial 450K 724 0 NA NA 58.1 9.3 whole blood TwinsUK European 3058 ES01217 Replication 450K 402 0.5 NA NA 69 14.4 whole blood BLSA European 3059 ES01217 Replication 450K 142 0.4 NA NA 64.3 10.9 whole blood BLSA African American or Afro-Caribbean 3060 ES01217 Replication 450K 160 0.44 NA NA 76.2 5 whole blood CHS European 3061 ES01217 Replication 450K 147 0.33 NA NA 73.2 5.7 whole blood CHS African American or Afro-Caribbean 3062 ES01217 Replication 450K 2157 0.43 NA NA 65.7 8.9 whole blood FHS European 3063 ES01217 Replication 450K 267 0.29 NA NA 60.7 7.7 whole blood GENOA African American or Afro-Caribbean 3064 ES01217 Replication 450K 915 0.51 NA NA 48 15.8 whole blood GOLDN European 3065 ES01217 Replication 450K 466 0.4 NA NA 51 13.7 whole blood HyperGEN African American or Afro-Caribbean 3066 ES01217 Replication 450K 421 0.46 NA NA 62.1 16 whole blood inCHIANTI European 3067 ES01217 Replication 450K 1488 0.47 NA NA 60.2 8.8 whole blood KORA European 3068 ES01217 Replication 450K 817 0 NA NA 68.4 6.2 whole blood WHI-BAA23 European 3069 ES01217 Replication 450K 495 0 NA NA 62.6 6.7 whole blood WHI-BAA23 African American or Afro-Caribbean 3070 ES01217 Replication 450K 314 0 NA NA 62.4 6.8 whole blood WHI-BAA23 Hispanic or Latin American 3071 ES01217 Replication 450K 413 0 NA NA 62.1 6.9 whole blood WHI-EMPC European 3072 ES01217 Replication 450K 917 0 NA NA 64.5 7.2 whole blood WHI-EMPC African American or Afro-Caribbean 3073 ES01217 Replication 450K 246 0 NA NA 61.4 6.1 whole blood WHI-EMPC Hispanic or Latin American 3074 ES01218 Initial 450K 658 0.48 0 0 0 0 cord blood ALSPAC European 3075 ES01218 Initial 450K 838 0.52 0 0 0 0 cord blood GenR European 3076 ES01218 Initial 450K 540 0.5 0 0 0 0 cord blood GOYA European 3077 ES01218 Initial 450K 135 0.51 0 0 0 0 cord blood HS Hispanic or Latin American 3078 ES01218 Initial 450K 301 0.53 0 0 0 0 cord blood HS European 3079 ES01218 Initial 450K 124 0.48 0 0 0 0 cord blood IOW European 3080 ES01218 Initial 450K 1020 0.54 0 0 0 0 cord blood MoBa1 European 3081 ES01218 Initial 450K 644 0.53 0 0 0 0 cord blood MoBa2 European 3082 ES01218 Initial 450K 663 0.53 0 0 0 0 cord blood PREDO European 3083 ES01218 Initial 450K 319 0.5 0 0 0 0 cord blood Project Viva European 3084 ES01219 Initial 450K 658 0.48 0 0 0 0 cord blood ALSPAC European 3085 ES01219 Initial 450K 838 0.52 0 0 0 0 cord blood GenR European 3086 ES01219 Initial 450K 540 0.5 0 0 0 0 cord blood GOYA European 3087 ES01219 Initial 450K 135 0.51 0 0 0 0 cord blood HS Hispanic or Latin American 3088 ES01219 Initial 450K 301 0.53 0 0 0 0 cord blood HS European 3089 ES01219 Initial 450K 124 0.48 0 0 0 0 cord blood IOW European 3090 ES01219 Initial 450K 1020 0.54 0 0 0 0 cord blood MoBa1 European 3091 ES01219 Initial 450K 644 0.53 0 0 0 0 cord blood MoBa2 European 3092 ES01219 Initial 450K 663 0.53 0 0 0 0 cord blood PREDO European 3093 ES01219 Initial 450K 319 0.5 0 0 0 0 cord blood Project Viva European 3094 ES01220 Initial 450K 23 1 47 57 52 NA CD14+ monocyte HAHC-CVD Hawaii Aging with HIV Cohort-Cardiovascular Disease IS Not reported 3095 ES01220 Initial 450K 14 1 50 59.25 54 NA CD14+ monocyte HAHC-CVD Hawaii Aging with HIV Cohort-Cardiovascular Disease IR Not reported 3096 ES01221 Initial 850K 21 NA NA NA NA NA whole blood Werner syndrome patients Not reported 3097 ES01221 Initial 850K 24 NA NA NA NA NA whole blood control Not reported 3098 ES01222 Initial 450K 630 0.49 NA NA 63.3 11.7 whole blood REGICOR Not reported 3099 ES01222 Initial 450K 454 0.29 NA NA 54.2 7.1 whole blood EPIC-Italy Not reported 3100 ES01223 Initial 450K 630 0.49 NA NA 63.3 11.7 whole blood REGICOR Not reported 3101 ES01223 Initial 450K 454 0.29 NA NA 54.2 7.1 whole blood EPIC-Italy Not reported 3102 ES01224 Initial 850K 15 0.73 36 56 NA NA hip articular cartilage ONFH patients Not reported 3103 ES01224 Initial 850K 15 0.73 54 68 NA NA hip articular cartilage control Not reported 3104 ES01226 Initial 450K 73 0.79 NA NA 27.3 7.3 whole blood controls Not reported 3105 ES01226 Initial 450K 67 0.64 NA NA 25.5 6.8 whole blood TCE Exposed Not reported 3106 ES01227 Initial 450K 57 0 22 30 25 NA leukocyte The GEDYMET Chilean study Not reported 3107 ES01228 Initial 450K 2664 0.37 NA NA 56.6 5.9 leukocyte ARIC African American or Afro-Caribbean 3108 ES01228 Initial 450K 1100 0.42 NA NA 59.9 5.4 leukocyte ARIC European 3109 ES01228 Initial 450K 351 0 NA NA 64.7 7.1 leukocyte WHI-AS311-CT European 3110 ES01228 Initial 450K 395 0 NA NA 66.2 6.9 leukocyte WHI-AS311-OS European 3111 ES01228 Initial 450K 371 0 NA NA 61.8 6.3 leukocyte WHI-BAA23-CT African American or Afro-Caribbean 3112 ES01228 Initial 450K 926 0 NA NA 67.8 6.2 leukocyte WHI-BAA23-CT European 3113 ES01228 Initial 450K 220 0 NA NA 60.7 6.4 leukocyte WHI-BAA23-CT Hispanic or Latin American 3114 ES01228 Initial 450K 259 0 NA NA 62.8 6.8 leukocyte WHI-BAA23-OS African American or Afro-Caribbean 3115 ES01228 Initial 450K 174 0 NA NA 62.8 7.3 leukocyte WHI-BAA23-OS Hispanic or Latin American 3116 ES01228 Initial 450K 553 0 NA NA 62.7 6.9 leukocyte WHI-EMPC African American or Afro-Caribbean 3117 ES01228 Initial 450K 1072 0 NA NA 64.6 7.1 leukocyte WHI-EMPC European 3118 ES01228 Initial 450K 312 0 NA NA 61.5 6.1 leukocyte WHI-EMPC Hispanic or Latin American 3119 ES01229 Initial 850K 473 0.36 NA NA 47 14.3 leukocyte MENA Methyl Epigenome Network Association Not reported 3120 ES01230 Initial 850K 12 0.58 NA NA 63.5 4.15 tumor tissue colorectal cancer Not reported 3121 ES01230 Initial 850K 12 0.58 NA NA 63.5 4.15 adjacent normal tissue Not reported 3122 ES01230 Replication 450K 13 0.46 NA NA 59.62 5.99 tumor tissue Hyperplastic polyps Not reported 3123 ES01230 Replication 450K 129 0.61 NA NA 62.14 7.21 tumor tissue adenomas Not reported 3124 ES01230 Replication 450K 256 0.61 NA NA 63.51 9.55 tumor tissue colorectal cancer Not reported 3125 ES01231 Initial 450K 91 0.56 NA NA 81.2 9.5 entorhinal cortex Not reported 3126 ES01231 Replication 450K 104 0.4 NA NA 84.9 8.7 entorhinal cortex Not reported 3127 ES01232 Initial 450K 232 0.51 0 0 0 0 cord blood Viva Other,European,African unspecified 3128 ES01232 Initial 450K 839 0.48 0 0 0 0 cord blood GenR European 3129 ES01232 Initial 450K 396 0.5 NA NA 7.7 0.7 whole blood Viva Other,European,African unspecified 3130 ES01232 Initial 450K 343 0.54 NA NA 9.8 0.3 whole blood GenR European 3131 ES01233 Initial 450K 232 0.51 0 0 0 0 cord blood Viva Other,European,African unspecified 3132 ES01233 Initial 450K 839 0.48 0 0 0 0 cord blood GenR European 3133 ES01233 Initial 450K 396 0.5 NA NA 7.7 0.7 whole blood Viva European,African unspecified,Other 3134 ES01233 Initial 450K 343 0.54 NA NA 9.8 0.3 whole blood GenR European 3135 ES01234 Initial 450K 232 0.51 0 0 0 0 cord blood Viva European,African unspecified,Other 3136 ES01234 Initial 450K 839 0.48 0 0 0 0 cord blood GenR European 3137 ES01234 Initial 450K 396 0.5 NA NA 7.7 0.7 whole blood Viva African unspecified,Other,European 3138 ES01234 Initial 450K 343 0.54 NA NA 9.8 0.3 whole blood GenR European 3139 ES01235 Initial 450K 2567 0.36 NA NA 56.5 5.8 whole blood ARIC African American or Afro-Caribbean 3140 ES01235 Initial 450K 197 0.34 NA NA 72.9 5.4 whole blood CHS African American or Afro-Caribbean 3141 ES01235 Initial 450K 188 0.45 NA NA 76.1 5.1 whole blood CHS European 3142 ES01235 Initial 450K 584 0.64 NA NA 52.9 7.4 whole blood EPICOR European 3143 ES01235 Initial 450K 2375 0.43 NA NA 65.8 8.8 whole blood FHS European 3144 ES01235 Initial 450K 457 0.47 NA NA 62.1 15.8 whole blood InCHIANTI European 3145 ES01235 Initial 450K 1377 0.49 NA NA 54.2 8.8 whole blood KORA European 3146 ES01235 Initial 450K 484 1 NA NA 72 7.1 whole blood NAS European 3147 ES01235 Initial 450K 538 0 NA NA 62.7 7 whole blood WHI-EMPC African American or Afro-Caribbean 3148 ES01235 Initial 450K 1072 0 NA NA 64.7 7.1 whole blood WHI-EMPC European 3149 ES01235 Initial 450K 657 0 NA NA 62.9 6.7 whole blood WHI-BAA23 African American or Afro-Caribbean 3150 ES01235 Initial 450K 965 0 NA NA 68.3 6.3 whole blood WHI-BAA23 European 3151 ES01236 Initial 450K 2567 0.36 NA NA 56.5 5.8 whole blood ARIC African American or Afro-Caribbean 3152 ES01236 Initial 450K 197 0.34 NA NA 72.9 5.4 whole blood CHS African American or Afro-Caribbean 3153 ES01236 Initial 450K 188 0.45 NA NA 76.1 5.1 whole blood CHS European 3154 ES01236 Initial 450K 584 0.64 NA NA 52.9 7.4 whole blood EPICOR European 3155 ES01236 Initial 450K 2375 0.43 NA NA 65.8 8.8 whole blood FHS European 3156 ES01236 Initial 450K 457 0.47 NA NA 62.1 15.8 whole blood InCHIANTI European 3157 ES01236 Initial 450K 1377 0.49 NA NA 54.2 8.8 whole blood KORA European 3158 ES01236 Initial 450K 484 1 NA NA 72 7.1 whole blood NAS European 3159 ES01236 Initial 450K 538 0 NA NA 62.7 7 whole blood WHI-EMPC African American or Afro-Caribbean 3160 ES01236 Initial 450K 1072 0 NA NA 64.7 7.1 whole blood WHI-EMPC European 3161 ES01236 Initial 450K 657 0 NA NA 62.9 6.7 whole blood WHI-BAA23 African American or Afro-Caribbean 3162 ES01236 Initial 450K 965 0 NA NA 68.3 6.3 whole blood WHI-BAA23 European 3163 ES01237 Initial 450K 347 0.14 NA NA 47 17.2 whole blood SLE Not reported 3164 ES01237 Initial 450K 400 0.13 NA NA 47.1 13.2 whole blood healthy control Not reported 3165 ES01238 Initial 450K 100 0.11 NA NA 56.1 13.6 whole blood pSS Not reported 3166 ES01238 Initial 450K 400 0.13 NA NA 47.1 13.2 whole blood healthy control Not reported 3167 ES01239 Initial 450K 24 0 22 49 37 NA CD19+ B cell SLE African American or Afro-Caribbean 3168 ES01239 Initial 450K 25 0 24 47 37 NA CD19+ B cell Control African American or Afro-Caribbean 3169 ES01239 Replication 450K 23 0 19 49 28 NA CD19+ B cell SLE African American or Afro-Caribbean 3170 ES01239 Replication 450K 22 0 22 48 29 NA CD19+ B cell Control African American or Afro-Caribbean 3171 ES01239 Initial 450K 18 0 22 54 38 NA CD19+ B cell SLE European 3172 ES01239 Initial 450K 13 0 24 48 37 NA CD19+ B cell Control European 3173 ES01239 Replication 450K 11 0 25 47 37 NA CD19+ B cell SLE European 3174 ES01239 Initial 450K 13 0 21 65 25 NA CD19+ B cell Control European 3175 ES01240 Initial 850K 286 0.24 NA NA NA NA whole blood European 3176 ES01240 Replication 450K 124 0.22 NA NA NA NA whole blood European 3177 ES01241 Initial 450K 43 0 0 0 0 0 umbilical cord blood C-MACH Chiba study of Mother and Child Health East Asian 3178 ES01242 Initial 450K 32 1 0 0 0 0 umbilical cord blood C-MACH Chiba study of Mother and Child Health East Asian 3179 ES01243 Initial 850K 807 1 NA NA 64.7 11.96 saliva NHRVS National Health and Resilience in Veterans Study None -hazardous Alcohol consumption European 3180 ES01243 Initial 850K 328 1 NA NA 63.3 12.64 saliva NHRVS National Health and Resilience in Veterans Study European 3181 ES01244 Initial 450K 8 1 NA NA 15.93 0.86 leukocyte case Not reported 3182 ES01244 Initial 450K 9 1 NA NA 16.16 0.78 leukocyte Controls Not reported 3183 ES01245 Initial 450K 58 NA NA NA NA NA placenta African unspecified 3184 ES01245 Initial 450K 53 NA NA NA NA NA placenta Asian unspecified 3185 ES01245 Initial 450K 389 NA NA NA NA NA placenta European 3186 ES01246 Initial 850K 547 0.51 11.9 15.3 12.9 0.65 nasal epithelial cell Hispanic or Latin American,European,Asian unspecified 3187 ES01247 Initial 850K 547 0.51 11.9 15.3 12.9 0.65 nasal epithelial cell Asian unspecified,Hispanic or Latin American,European 3188 ES01248 Initial 850K 547 0.51 11.9 15.3 12.9 0.65 nasal epithelial cell Asian unspecified,Hispanic or Latin American,European 3189 ES01249 Initial 850K 547 0.51 11.9 15.3 12.9 0.65 nasal epithelial cell European,Asian unspecified,Hispanic or Latin American 3190 ES01250 Initial 850K 21 0.43 22 28 24 NA lung Non-smokers Not reported 3191 ES01250 Initial 850K 14 0.29 24.3 29.8 28 NA lung Smokers Not reported 3192 ES01251 Initial 450K 119 0.46 NA NA 6.42 1.4 whole blood HIV-infected Sub-Saharan African 3193 ES01251 Initial 450K 60 0.5 NA NA 6.43 1.4 whole blood HIV-uninfecte Sub-Saharan African 3194 ES01252 Initial 450K 70 0.27 32.1 49 40.4 NA thyroid Not reported 3195 ES01252 Initial 450K 161 0.27 32.2 52.4 43.1 NA thyroid Not reported 3196 ES01253 Initial 450K 70 0.27 32.1 49 40.4 NA thyroid Not reported 3197 ES01253 Initial 450K 161 0.27 32.2 52.4 43.1 NA thyroid Not reported 3198 ES01254 Initial 850K 10 0.2 NA NA 42.2 10.6 whole blood HighBFR Not reported 3199 ES01254 Initial 850K 10 0.2 NA NA 46.1 7.2 whole blood LowBFR Not reported 3200 ES01255 Initial 850K 10 0.2 NA NA 42.2 10.6 visceral adipose tissue HighBFR Not reported 3201 ES01255 Initial 850K 10 0.2 NA NA 46.1 7.2 visceral adipose tissue LowBFR Not reported 3202 ES01256 Initial 850K 150 0.57 NA NA 56.1 7.95 whole blood Patients Not reported 3203 ES01256 Initial 850K 150 0.57 NA NA 55.6 7.94 whole blood Controls Not reported 3204 ES01257 Initial 850K 48 0.57 NA NA 56.1 7.95 whole blood Patients Not reported 3205 ES01257 Initial 850K 150 0.57 NA NA 55.6 7.94 whole blood Controls Not reported 3206 ES01258 Initial 850K 72 0.57 NA NA 56.1 7.95 whole blood Patients Not reported 3207 ES01258 Initial 850K 150 0.57 NA NA 55.6 7.94 whole blood Controls Not reported 3208 ES01259 Initial 850K 150 0.57 NA NA 56.1 7.95 whole blood Patients Not reported 3211 ES01260 Initial 850K 150 0.57 NA NA 55.6 7.94 whole blood Controls Not reported 3212 ES01261 Initial 850K 46 0.57 NA NA 56.1 7.95 whole blood Patients Not reported 3213 ES01261 Initial 850K 150 0.57 NA NA 55.6 7.94 whole blood Controls Not reported 3214 ES01262 Initial 450K 277 0.44 0 0 0 0 cord blood East Asian 3215 ES01263 Initial 450K 123 1 0 0 0 0 cord blood East Asian 3216 ES01264 Initial 450K 154 0 0 0 0 0 cord blood East Asian 3217 ES01265 Initial 450K 442 0 33 81 57 NA leukocyte FHS European 3218 ES01265 Initial 450K 432 1 36 82 58 NA leukocyte FHS European 3219 ES01265 Initial 450K 1034 0 23 92 56 NA leukocyte JHS African unspecified 3220 ES01265 Initial 450K 603 1 22 93 55 NA leukocyte JHS African unspecified 3221 ES01265 Initial 450K 342 0 50 80 63 NA leukocyte WHI African unspecified 3222 ES01265 Initial 450K 476 0 51 80 68 NA leukocyte WHI European 3223 ES01265 Initial 450K 156 0 30 54 44 NA leukocyte BHS African unspecified 3224 ES01265 Initial 450K 94 1 33 49 44 NA leukocyte BHS African unspecified 3225 ES01265 Initial 450K 315 0 29 55 43 NA leukocyte BHS European 3226 ES01265 Initial 450K 266 1 28 52 43 NA leukocyte BHS European 3227 ES01265 Initial 450K 242 0 78 80 79 NA leukocyte LBC1921 European 3228 ES01265 Initial 450K 161 1 78 81 79 NA leukocyte LBC1921 European 3229 ES01265 Initial 450K 448 0 68 71 70 NA leukocyte LBC1936 European 3230 ES01265 Initial 450K 458 1 68 71 70 NA leukocyte LBC1936 European 3231 ES01265 Initial 450K 172 0 73 90 79 NA leukocyte LSADT European 3232 ES01265 Initial 450K 72 1 74 87 79 NA leukocyte LSADT European 3233 ES01266 Initial 450K 444 NA NA NA NA NA lung Not reported 3234 ES01267 Initial 450K 264 1 NA NA 66.2 6.1 whole blood MADT Not reported 3235 ES01267 Initial 450K 222 0 NA NA 65.6 6 whole blood MADT Not reported 3236 ES01267 Initial 450K 82 1 NA NA 78 4 whole blood LSADT Not reported 3237 ES01267 Initial 450K 156 0 NA NA 77.9 4.1 whole blood LSAD Not reported 3238 ES01268 Initial 850K 149 0.44 0 0 0 0 neonatal blood CHART ART-conceived Not reported 3239 ES01268 Initial 850K 58 0.36 0 0 0 0 neonatal blood CHART non-ART conceived Not reported 3240 ES01269 Initial 850K 158 0.45 22 35 NA NA whole blood CHART ART-conceived Not reported 3241 ES01269 Initial 850K 75 0.32 22 35 NA NA whole blood CHART non-ART conceived Not reported 3242 ES01270 Initial 450K 38 0.61 NA NA 28.6 6.5 whole blood ASD East Asian 3243 ES01270 Initial 450K 31 0.52 NA NA 26.7 6.7 whole blood Control East Asian 3244 ES01270 Replication 450K 11 1 NA NA 34.5 10.3 whole blood ASD East Asian 3245 ES01270 Initial 450K 10 1 NA NA 31.2 10 whole blood Control East Asian 3246 ES01271 Initial 850K 8 0.62 0 0 0 0 cord blood Not reported 3247 ES01271 Initial 850K 69 0 51 65 59 NA whole blood Not reported 3248 ES01271 Initial 850K 679 0.59 23 88 53 NA whole blood Not reported 3249 ES01272 Initial 450K 185 NA 35 70 NA NA whole blood EPIC-Italy Not reported 3250 ES01272 Initial 450K 367 0 27 76 NA NA whole blood MCCS Melbourne Collaborative Cohort Study Not reported 3251 ES01272 Initial 450K 132 0 NA NA NA NA whole blood NOWAC Norwegian Women and Cancer Study European 3252 ES01272 Initial 450K 234 NA NA NA NA NA whole blood NSHDS Northern Sweden Health and Disease Study European 3253 ES01273 Initial 850K 6 0.67 71 99 NA NA cerebellum control Not reported 3254 ES01273 Initial 850K 6 0.67 71 99 NA NA frontal lobe control Not reported 3255 ES01273 Initial 850K 6 0.67 71 99 NA NA occipital lobe control Not reported 3256 ES01273 Initial 850K 10 0.5 50 72 NA NA cerebellum MSA Not reported 3257 ES01273 Initial 850K 10 0.5 50 72 NA NA frontal lobe MSA Not reported 3258 ES01273 Initial 850K 10 0.5 50 72 NA NA occipital lobe MSA Not reported 3259 ES01273 Replication 850K 16 0.44 63 86 NA NA cerebellum control Not reported 3260 ES01273 Replication 850K 32 0.5 52 82 NA NA cerebellum MSA Not reported 3261 ES01274 Initial 850K 24 0 NA NA 70.5 3.3 whole blood Non-sarcopenic European 3262 ES01274 Initial 850K 24 0 NA NA 72.5 4.2 whole blood Sarcopenic European 3263 ES01275 Initial 450K 609 0.51 0 0 0 0 cord blood Project Viva Not reported 3264 ES01276 Initial 450K 786 0 NA NA 57.99 13.19 cancer tissues TCGA The Cancer Genome Atlas Not reported 3265 ES01277 Initial 450K 622 0.44 NA NA 31 NA whole blood NFBC 1966 Unexposed Not reported 3266 ES01277 Initial 450K 95 0.43 NA NA 31 NA whole blood NFBC 1966 Exposed Not reported 3267 ES01277 Initial 450K 365 0.42 NA NA 16 NA whole blood NFBC 1986 Unexposed Not reported 3268 ES01277 Initial 450K 77 0.42 NA NA 16 NA whole blood NFBC 1986 Exposed Not reported 3269 ES01277 Initial 450K 588 0.52 NA NA 17 NA whole blood ALSPAC children Unexposed Not reported 3270 ES01277 Initial 450K 79 0.49 NA NA 17 NA whole blood ALSPAC children Exposed Not reported 3271 ES01277 Initial 450K 536 0 NA NA 30 NA whole blood ALSPAC mothers Unexposed Not reported 3272 ES01277 Initial 450K 216 0 NA NA 30 NA whole blood ALSPAC mothers Exposed Not reported 3273 ES01277 Initial 450K 215 0.31 NA NA 18 NA whole blood IOWBC Unexposed European 3274 ES01277 Initial 450K 42 0.32 NA NA 18 NA whole blood IOWBC Exposed European 3275 ES01278 Initial 850K 220 0 NA NA 40 13.5 whole blood European 3276 ES01279 Initial 450K 61 0.28 NA NA 65.6 14 lung TCGA The Cancer Genome Atlas Never smokers European,Asian unspecified,African unspecified 3277 ES01280 Initial 450K 61 0.28 NA NA 65.6 14 lung TCGA The Cancer Genome Atlas Never smokers Asian unspecified,African unspecified,European 3278 ES01281 Initial 450K 61 0.28 NA NA 65.6 14 lung TCGA The Cancer Genome Atlas Never smokers European,Asian unspecified,African unspecified 3279 ES01279 Initial 450K 91 0.57 NA NA 61.4 13 lung TCGA The Cancer Genome Atlas Current smokers African unspecified,European,Asian unspecified 3280 ES01280 Initial 450K 135 0.42 NA NA 63.9 12 lung TCGA The Cancer Genome Atlas Former?15 Asian unspecified,African unspecified,European 3281 ES01281 Initial 450K 103 0.5 NA NA 70.5 10 lung TCGA The Cancer Genome Atlas Former>15 European,African unspecified 3282 ES01282 Initial 450K 39 0.67 1 18.4 7.3 4.9 whole blood FASD European 3283 ES01282 Initial 450K 64 0.38 0.1 18.3 12.3 4.8 whole blood Controls European 3284 ES01283 Initial 850K 189 0.69 NA NA NA NA whole blood Harvard Biomarker Study PD European,Asian unspecified,African American or Afro-Caribbean,Hispanic or Latin American 3285 ES01283 Initial 850K 191 0.36 NA NA NA NA whole blood Harvard Biomarker Study Control Asian unspecified,African American or Afro-Caribbean,Hispanic or Latin American,European 3286 ES01284 Initial 850K 189 0.69 NA NA NA NA whole blood Harvard Biomarker Study PD baseline Asian unspecified,African American or Afro-Caribbean,Hispanic or Latin American,European 3287 ES01284 Initial 850K 189 0.69 NA NA NA NA whole blood Harvard Biomarker Study PD follow-up Asian unspecified,African American or Afro-Caribbean,Hispanic or Latin American,European 3288 ES01285 Initial 850K 38 NA NA NA NA NA whole blood Harvard Biomarker Study PD baseline African American or Afro-Caribbean,Hispanic or Latin American,European,Asian unspecified 3289 ES01285 Initial 850K 50 NA NA NA NA NA whole blood Harvard Biomarker Study PD follow-up African American or Afro-Caribbean,Hispanic or Latin American,European,Asian unspecified 3290 ES01286 Initial 850K 82 NA NA NA NA NA whole blood Harvard Biomarker Study PD baseline African American or Afro-Caribbean,Hispanic or Latin American,European,Asian unspecified 3291 ES01286 Initial 850K 108 NA NA NA NA NA whole blood Harvard Biomarker Study PD follow-up Hispanic or Latin American,European,Asian unspecified,African American or Afro-Caribbean 3292 ES01287 Initial 450K 10140 NA NA NA NA NA cancer tissues Not reported 3293 ES01287 Initial 450K 3386 NA NA NA NA NA normal tissue Not reported 3294 ES01288 Initial 850K 95 0.41 NA NA 36 13.17 whole blood CAN-BIND-1 Canadian Biomaker Integration Network in Depression non-responders European 3295 ES01288 Initial 850K 82 0.34 NA NA 35 12.2 whole blood CAN-BIND-1 Canadian Biomaker Integration Network in Depression responders European 3296 ES01290 Initial 850K 208 0.29 NA NA 53.3 1.1 whole blood African American or Afro-Caribbean 3297 ES01290 Initial 850K 310 0.29 NA NA 55.6 1 whole blood ACHS-I European 3298 ES01290 Initial 850K 155 0.23 NA NA 61.2 0.9 whole blood African American or Afro-Caribbean 3299 ES01290 Initial 450K 144 0.28 NA NA 64.5 1.2 whole blood ACHS-II European 3300 ES01291 Initial 450K 22 NA 0 0 0 0 cord blood ALSPAC GDM European 3301 ES01291 Initial 450K 867 NA 0 0 0 0 cord blood ALSPAC Control subjects European 3302 ES01291 Initial 450K 28 NA 0 0 0 0 cord blood GOYA GDM case European 3303 ES01291 Initial 450K 404 NA 0 0 0 0 cord blood GOYA Control subjects European 3304 ES01291 Initial 450K 32 NA 0 0 0 0 cord blood Healthy Start Study GDM case European 3305 ES01291 Initial 450K 534 NA 0 0 0 0 cord blood Healthy Start Study Control subjects European 3306 ES01291 Initial 450K 12 NA 0 0 0 0 cord blood INMA GDM case European 3307 ES01291 Initial 450K 144 NA 0 0 0 0 cord blood INMA Control subjects European 3308 ES01291 Initial 450K 180 NA 0 0 0 0 cord blood PREDO GDM case European 3309 ES01291 Initial 450K 600 NA 0 0 0 0 cord blood PREDO Control subjects European 3310 ES01291 Initial 450K 20 NA 0 0 0 0 cord blood RHEA GDM case European 3311 ES01291 Initial 450K 352 NA 0 0 0 0 cord blood RHEA Control subjects European 3312 ES01291 Initial 450K 23 NA 0 0 0 0 cord blood Project Viva GDM case European 3313 ES01291 Initial 450K 459 NA 0 0 0 0 cord blood Project Viva Control subjects European 3314 ES01292 Initial 850K 16 0 NA NA 30.19 0.8 granulosa lutein cell PCOS with oligomenorrhea Not reported 3315 ES01292 Initial 850K 16 0 NA NA 34.75 0.9 granulosa lutein cell healthy women Not reported 3316 ES01293 Initial 450K 5044 0.68 53.9 65.4 60.7 NA whole blood MCCS Melbourne Collaborative Cohort Study European 3317 ES01294 Initial 450K 1024 0.68 51.1 64.1 58.5 NA whole blood MCCS Melbourne Collaborative Cohort Study Baseline data European 3318 ES01294 Initial 450K 1024 0.68 62.7 75.5 69.8 NA whole blood Melbourne Collaborative Cohort Study MCCS Wave 2 data European 3319 ES01295 Initial 450K 34 0.53 0 0 0 0 placenta SGA East Asian 3320 ES01295 Initial 450K 62 0.45 0 0 0 0 placenta AGA East Asian 3321 ES01296 Initial 450K 5648 NA 0 0 0 0 umbilical cord blood Not reported 3322 ES01297 Initial 450K 15907 NA NA NA NA NA whole blood Not reported 3323 ES01298 Initial 450K 563 0.16 NA NA 61.6 8.1 whole blood EPIC-Norfolk Incident T2DM European 3324 ES01298 Initial 450K 701 0.42 NA NA 59.1 9.2 whole blood EPIC-Norfolk Non-cases European 3325 ES01298 Replication 450K 1074 0.64 NA NA 52.5 10.2 whole blood LOLIPOP Incident T2DM South Asian 3326 ES01298 Replication 450K 1590 0.68 NA NA 49.9 9.8 whole blood LOLIPOP Non-cases South Asian 3327 ES01298 Replication 450K 403 0.57 NA NA 69.3 8.4 whole blood FHS Prevalent T2DM European 3328 ES01298 Replication 450K 2204 0.44 NA NA 65.8 8.9 whole blood FHS Non-cases European 3329 ES01299 Initial 450K 30 0.53 64.4 70.2 67.3 7.5 mucosa primary adenomas without recurrence Not reported 3330 ES01299 Initial 450K 29 0.52 55.9 70.7 64.9 11.7 mucosa primary adenomas with recurrence Not reported 3331 ES01300 Initial 450K 30 0.53 64.4 70.2 67.3 7.5 mucosa primary adenomas without recurrence Not reported 3332 ES01300 Initial 450K 29 0.52 55.9 70.7 64.9 11.7 mucosa primary adenomas with recurrence Not reported 3333 ES01301 Initial 450K 30 0.53 64.4 70.2 67.3 7.5 mucosa primary adenomas without recurrence Not reported 3334 ES01301 Initial 450K 29 0.52 55.9 70.7 64.9 11.7 mucosa primary adenomas with recurrence Not reported 3335 ES01302 Initial 450K 568 0.53 NA NA NA NA tumor tissue Not reported 3336 ES01302 Replication 450K 308 0.58 NA NA NA NA tumor tissue Not reported 3337 ES01303 Initial 450K 701 0.49 0 0 0 0 cord blood ARIES Accessible Resource for Integrated Epigenetic Studies European 3338 ES01304 Initial 450K 86 NA NA NA NA NA tumor tissue Not reported 3339 ES01305 Initial 450K 58 0.46 NA NA 60 1 peripheral blood mononuclear cell OAI US-based Osteoarthritis Initiative study Radiographic progressors European 3340 ES01305 Initial 450K 58 0.4 NA NA 60 1 peripheral blood mononuclear cell OAI US-based Osteoarthritis Initiative study Nonprogressors European 3341 ES01306 Initial 450K 275 NA NA NA NA NA tumor tissue Not reported 3342 ES01307 Initial 850K 7 0.57 7 34 15.6 NA whole blood Patients Not reported 3343 ES01307 Initial 850K 59 0.51 1 33.7 10.59 NA whole blood Controls Not reported 3344 ES01308 Initial 450K 22 NA NA NA NA NA cfDNA hepatocellular cancer Not reported 3345 ES01308 Initial 450K 22 NA NA NA NA NA cfDNA cirrhosis Not reported 3346 ES01308 Initial 450K 109 NA NA NA NA NA liver hepatocellular cancer Not reported 3347 ES01308 Initial 450K 82 NA NA NA NA NA liver non-tumor Not reported 3348 ES01308 Replication 450K 306 NA NA NA NA NA liver hepatocellular cancer Not reported 3349 ES01308 Replication 450K 45 NA NA NA NA NA liver non-tumor Not reported 3350 ES01308 Replication 450K 15 NA NA NA NA NA cfDNA hepatocellular cancer Not reported 3351 ES01308 Replication 450K 15 NA NA NA NA NA cfDNA non-tumor Not reported 3352 ES01309 Initial 450K 39 NA NA NA NA NA bronchial biopsies remission subjects Not reported 3353 ES01309 Initial 450K 26 NA NA NA NA NA bronchial biopsies persistent asthma Not reported 3354 ES01310 Initial 450K 70 NA NA NA NA NA bronchial biopsies healthy controls Not reported 3355 ES01310 Initial 450K 39 NA NA NA NA NA bronchial biopsies remission subjects Not reported 3356 ES01311 Initial 850K 265 0.52 5 12 NA NA buccal cell NTR Netherlands Twin Register Never Breastfeeding European 3357 ES01311 Initial 850K 741 0.47 5 12 NA NA buccal cell NTR Netherlands Twin Register Ever Breastfeeding European 3358 ES01312 Initial 850K 141 0.53 NA NA 7.9 1.1 buccal cell NTR Netherlands Twin Register Never Breastfeeding European 3359 ES01312 Initial 850K 378 0.48 NA NA 7.9 1.13 buccal cell NTR Netherlands Twin Register Ever Breastfeeding European 3360 ES01313 Initial 850K 124 0.51 NA NA 11.06 0.73 buccal cell NTR Netherlands Twin Register Never Breastfeeding European 3361 ES01313 Initial 850K 365 0.46 NA NA 11.2 0.72 buccal cell NTR Netherlands Twin Register Ever Breastfeeding European 3362 ES01314 Initial 450K 38 0.42 NA NA 49.89 11.18 peripheral blood mononuclear cell 19 Long-term meditators Not reported 3363 ES01314 Initial 450K 42 0.43 NA NA 50.38 8.96 peripheral blood mononuclear cell 21 meditation-naïve controls Not reported 3364 ES01315 Initial 850K 50 0.47 NA NA 51 8.4 peripheral blood mononuclear cell HANDLS Healthy Aging in Neighborhoods of Diversity across the Life Span MetS+ African American or Afro-Caribbean 3365 ES01315 Initial 850K 175 0.51 NA NA 47.6 8.7 peripheral blood mononuclear cell HANDLS Healthy Aging in Neighborhoods of Diversity across the Life Span MetS- African American or Afro-Caribbean 3366 ES01316 Initial 850K 92 0.47 NA NA 51 8.4 peripheral blood mononuclear cell HANDLS Healthy Aging in Neighborhoods of Diversity across the Life Span MetS+ European 3367 ES01316 Initial 850K 141 0.51 NA NA 47.6 8.7 peripheral blood mononuclear cell HANDLS Healthy Aging in Neighborhoods of Diversity across the Life Span MetS- European 3368 ES01323 Initial 850K 57 0.25 NA NA 33.96 9.71 whole blood PD patient group European 3369 ES01323 Initial 850K 61 0.23 NA NA 33.25 9.18 whole blood Control group European 3370 ES01317 Initial 850K 50 0.47 NA NA 51 8.4 peripheral blood mononuclear cell HANDLS Healthy Aging in Neighborhoods of Diversity across the Life Span MetS+ African American or Afro-Caribbean 3371 ES01317 Initial 850K 175 0.51 NA NA 47.6 8.7 peripheral blood mononuclear cell HANDLS Healthy Aging in Neighborhoods of Diversity across the Life Span MetS- African American or Afro-Caribbean 3372 ES01318 Initial 850K 92 0.47 NA NA 51 8.4 peripheral blood mononuclear cell HANDLS Healthy Aging in Neighborhoods of Diversity across the Life Span MetS+ European 3373 ES01318 Initial 850K 141 0.51 NA NA 47.6 8.7 peripheral blood mononuclear cell HANDLS Healthy Aging in Neighborhoods of Diversity across the Life Span MetS- European 3374 ES01319 Initial 850K 50 0.47 NA NA 51 8.4 peripheral blood mononuclear cell HANDLS Healthy Aging in Neighborhoods of Diversity across the Life Span MetS+ African American or Afro-Caribbean 3375 ES01319 Initial 850K 175 0.51 NA NA 47.6 8.7 peripheral blood mononuclear cell HANDLS Healthy Aging in Neighborhoods of Diversity across the Life Span MetS- African American or Afro-Caribbean 3376 ES01320 Initial 850K 92 0.47 NA NA 51 8.4 peripheral blood mononuclear cell HANDLS Healthy Aging in Neighborhoods of Diversity across the Life Span MetS+ European 3377 ES01320 Initial 850K 141 0.51 NA NA 47.6 8.7 peripheral blood mononuclear cell HANDLS Healthy Aging in Neighborhoods of Diversity across the Life Span MetS- European 3378 ES01321 Initial 850K 50 0.47 NA NA 51 8.4 peripheral blood mononuclear cell HANDLS Healthy Aging in Neighborhoods of Diversity across the Life Span MetS+ African American or Afro-Caribbean 3379 ES01321 Initial 850K 175 0.51 NA NA 47.6 8.7 peripheral blood mononuclear cell HANDLS Healthy Aging in Neighborhoods of Diversity across the Life Span MetS- African American or Afro-Caribbean 3380 ES01322 Initial 850K 92 0.47 NA NA 51 8.4 peripheral blood mononuclear cell HANDLS Healthy Aging in Neighborhoods of Diversity across the Life Span MetS+ European 3381 ES01322 Initial 850K 141 0.51 NA NA 47.6 8.7 peripheral blood mononuclear cell HANDLS Healthy Aging in Neighborhoods of Diversity across the Life Span MetS- European 3382 ES01324 Initial 850K 176 1 NA NA NA NA whole blood with cisplatin-based chemotherapy European 3383 ES01324 Initial 850K 103 1 NA NA NA NA whole blood without cisplatin-based chemotherapy European 3384 ES01325 Initial 850K 93 1 NA NA NA NA whole blood MetS+ European 3385 ES01325 Initial 850K 184 1 NA NA NA NA whole blood MetS- European 3386 ES01326 Initial 850K 34 0.26 26 70 43.7 NA thyroid East Asian 3387 ES01327 Initial 850K 68 0.51 NA NA 50.28 11.47 pituitary East Asian 3388 ES01328 Initial 450K 3337 NA NA NA NA NA whole blood Not reported 3389 ES01329 Initial 450K 209 0.78 NA NA 63 13.3 esophagus normal Not reported 3390 ES01329 Initial 450K 172 0.8 NA NA 64.3 12.8 esophagus Barrett’s esophagus Not reported 3391 ES01329 Initial 450K 251 0.88 NA NA 65 11.3 esophagus esophageal adenocarcinoma Not reported 3392 ES01329 Initial 450K 116 0.78 NA NA 59.8 10.5 esophagus esophageal squamous cell carcinoma Not reported 3393 ES01330 Initial 450K 68 0.69 NA NA 67 NA whole blood non-septic patients Not reported 3394 ES01330 Initial 450K 66 0.55 NA NA 66 NA whole blood septic patients Not reported 3395 ES01331 Initial 850K 11 0.64 19 34 27.9 NA whole blood Trisomy 21 patients European 3396 ES01331 Initial 850K 21 0.57 NA NA NA NA whole blood control European 3397 ES01332 Initial 850K 42 0.4 21 30 25 NA lung Never-smokers Asian unspecified,European 3398 ES01332 Initial 850K 15 0.67 21 30 27 NA lung E-cig users European 3399 ES01332 Initial 850K 16 0.75 21 30 26 NA lung Smokers European 3400 ES01333 Initial 27K 189 NA NA NA NA NA lung Tumor Not reported 3401 ES01333 Initial 27K 149 NA NA NA NA NA lung Normal Not reported 3402 ES01335 Initial 450K 16 0.56 0 0 0 0 placenta HEBC Harvard Epigenetic Birth Cohort Cases European 3403 ES01335 Initial 450K 16 0.56 0 0 0 0 placenta HEBC Harvard Epigenetic Birth Cohort Controls European 3404 ES01336 Initial 450K 9 1 0 0 0 0 placenta HEBC Harvard Epigenetic Birth Cohort Cases European 3405 ES01336 Initial 450K 9 1 0 0 0 0 placenta HEBC Harvard Epigenetic Birth Cohort European 3406 ES01337 Initial 450K 113 0 NA NA NA NA cervix normal Not reported 3407 ES01337 Initial 450K 307 0 NA NA NA NA cervix tumor Not reported 3408 ES01338 Initial 450K 114 0.53 0 0 0 0 cord blood Not reported,European 3409 ES01339 Initial 450K 36 0.19 NA NA 17.6 0.72 whole blood Controls (baseline) European 3410 ES01339 Initial 850K 36 0.19 NA NA 18.6 0.72 whole blood Controls (follow-up) European 3411 ES01339 Initial 450K 23 0.13 NA NA 17.6 0.87 whole blood Cases (baseline) European 3412 ES01339 Initial 850K 23 0.13 NA NA 18.6 0.87 whole blood follow-up European 3413 ES01340 Initial 450K 424 NA NA NA NA NA colon Not reported 3414 ES01341 Initial 450K 220 0.54 NA NA 66.6 9.9 lung European 3415 ES01341 Initial 450K 440 0.54 NA NA 65.4 10.1 lung European 3416 ES01342 Initial 450K 12 0.58 NA NA 1.1 0.38 saliva ABC European,African American or Afro-Caribbean 3417 ES01342 Initial 450K 11 0.46 NA NA 1.26 0.3 saliva Control African American or Afro-Caribbean,European 3418 ES01343 Initial 450K 164 0.51 0.25 3.08 1.31 0.004 buccal epithelium ESAM African unspecified 3419 ES01343 Initial 450K 145 0.53 0.42 3.58 1.2 0.004 buccal epithelium NESAM African unspecified 3420 ES01344 Initial 450K 429 0.52 0 0 0 0 cord blood Project Viva Project Viva Other,African unspecified,Hispanic or Latin American,European,Asian unspecified 3421 ES01345 Initial 450K 147 0.52 0 0 0 0 cord blood Project Viva Project Viva maternal BMI >= 25 European,Asian unspecified,Other,African unspecified,Hispanic or Latin American 3422 ES01346 Initial 850K 430 0.53 0 0 0 0 cord blood Genetics of Glucose regulation in Gestation and Growth prospective cohort Gen3G European 3423 ES01347 Initial 850K 346 0.49 0 0 0 0 cord blood EAGeR Effects of Aspirin in Gestation and Reproduction trial European 3424 ES01348 Initial 850K 346 0.49 0 0 0 0 cord blood EAGeR Effects of Aspirin in Gestation and Reproduction trial European 3425 ES01350 Initial 850K 346 0.49 0 0 0 0 cord blood EAGeR Effects of Aspirin in Gestation and Reproduction trial European 3426 ES01349 Initial 850K 374 0.49 0 0 0 0 cord blood EAGeR Effects of Aspirin in Gestation and Reproduction trial European 3427 ES01351 Initial 850K 374 0.49 0 0 0 0 cord blood EAGeR Effects of Aspirin in Gestation and Reproduction trial European 3428 ES01352 Initial 850K 32 NA 45 93 77 10 skin Not reported 3429 ES01353 Initial 850K 23 NA 45 93 77 10 skin Not reported 3430 ES01354 Initial 850K 23 NA 45 93 77 10 skin Not reported 3431 ES01355 Initial 450K 1311 NA NA NA NA NA colon Not reported 3432 ES01356 Initial 450K 785 0.48 0 0 0 0 cord blood European 3433 ES01357 Initial 450K 344 0.49 10 10 10 0 peripheral blood mononuclear cell European 3434 ES01358 Initial 450K 944 NA 32 81 NA NA leukocyte KORA Cooperative Health Research in the Region of Augsburg Not reported 3435 ES01358 Initial 450K 359 NA NA NA NA NA leukocyte QMDiab Qatar Metabolomics Study on Diabetes Asian unspecified 3436 ES01359 Initial 450K 944 NA 32 81 NA NA leukocyte KORA Cooperative Health Research in the Region of Augsburg Not reported 3437 ES01359 Initial 450K 359 NA NA NA NA NA leukocyte QMDiab Qatar Metabolomics Study on Diabetes Asian unspecified 3438 ES01360 Initial 450K 944 NA 32 81 NA NA leukocyte KORA Cooperative Health Research in the Region of Augsburg Not reported 3439 ES01360 Initial 450K 359 NA NA NA NA NA leukocyte QMDiab Qatar Metabolomics Study on Diabetes Asian unspecified 3440 ES01361 Initial 450K 944 NA 32 81 NA NA leukocyte KORA Cooperative Health Research in the Region of Augsburg Not reported 3441 ES01361 Initial 450K 359 NA NA NA NA NA leukocyte QMDiab Qatar Metabolomics Study on Diabetes Asian unspecified 3442 ES01362 Initial 450K 944 NA 32 81 NA NA leukocyte KORA Cooperative Health Research in the Region of Augsburg Not reported 3443 ES01362 Initial 450K 359 NA NA NA NA NA leukocyte QMDiab Qatar Metabolomics Study on Diabetes Asian unspecified 3444 ES01363 Initial 450K 944 NA 32 81 NA NA leukocyte KORA Cooperative Health Research in the Region of Augsburg Not reported 3445 ES01363 Initial 450K 359 NA NA NA NA NA leukocyte QMDiab Qatar Metabolomics Study on Diabetes Asian unspecified 3446 ES01364 Initial 450K 944 NA 32 81 NA NA leukocyte KORA Cooperative Health Research in the Region of Augsburg Not reported 3447 ES01364 Initial 450K 359 NA NA NA NA NA leukocyte QMDiab Qatar Metabolomics Study on Diabetes Asian unspecified 3448 ES01365 Initial 450K 944 NA 32 81 NA NA leukocyte KORA Cooperative Health Research in the Region of Augsburg Not reported 3449 ES01365 Initial 450K 359 NA NA NA NA NA leukocyte QMDiab Qatar Metabolomics Study on Diabetes Asian unspecified 3450 ES01366 Initial 450K 944 NA 32 81 NA NA leukocyte KORA Cooperative Health Research in the Region of Augsburg Not reported 3451 ES01366 Initial 450K 359 NA NA NA NA NA leukocyte QMDiab Qatar Metabolomics Study on Diabetes Asian unspecified 3452 ES01367 Initial 850K 2586 0.39 18 87 NA NA whole blood Not reported 3453 ES01367 Replication 850K 4450 0.44 18 93 NA NA whole blood Not reported 3454 ES01368 Initial 850K 2586 0.39 18 87 NA NA whole blood Not reported 3455 ES01368 Replication 850K 4450 0.44 18 93 NA NA whole blood Not reported 3456 ES01369 Initial 450K 459 0.53 33 90 68 NA colon TCGA The Cancer Genome Atlas colorectal cancer Not reported 3457 ES01369 Initial 450K 754 0.47 19 101 63 NA whole blood normal Not reported 3458 ES01369 Initial 450K 801 0.62 24 85 58 NA serum colorectal cancer East Asian 3459 ES01369 Initial 450K 1021 0.46 19 90 47 NA serum normal East Asian 3460 ES01369 Initial 450K 29 0.55 NA NA NA NA serum colorectal cancer East Asian 3461 ES01369 Initial 450K 78 0.62 NA NA NA NA serum advanced precancerous lesion East Asian 3462 ES01369 Initial 450K 1386 0.51 NA NA NA NA serum normal East Asian 3463 ES01370 Initial 450K 459 0.53 33 90 68 NA colon TCGA The Cancer Genome Atlas colorectal cancer NA 3464 ES01370 Initial 450K 754 0.47 19 101 63 NA whole blood normal NA 3465 ES01370 Initial 450K 801 0.62 24 85 58 NA serum colorectal cancer NA 3466 ES01370 Initial 450K 1021 0.46 19 90 47 NA serum normal NA 3467 ES01370 Initial 450K 29 0.55 NA NA NA NA serum colorectal cancer NA 3468 ES01370 Initial 450K 78 0.62 NA NA NA NA serum advanced precancerous lesion NA 3469 ES01370 Initial 450K 1386 0.51 NA NA NA NA serum normal NA 3470 ES01371 Initial 450K 459 0.53 33 90 68 NA colon TCGA The Cancer Genome Atlas colorectal cancer NA 3471 ES01371 Initial 450K 754 0.47 19 101 63 NA whole blood normal NA 3472 ES01371 Initial 450K 801 0.62 24 85 58 NA serum colorectal cancer NA 3473 ES01371 Initial 450K 1021 0.46 19 90 47 NA serum normal NA 3474 ES01371 Initial 450K 29 0.55 NA NA NA NA serum colorectal cancer NA 3475 ES01371 Initial 450K 78 0.62 NA NA NA NA serum advanced precancerous lesion NA 3476 ES01371 Initial 450K 1386 0.51 NA NA NA NA serum normal NA 3477 ES01372 Initial 850K 95 0.52 11 45 26 7.5 whole blood RHINESSA European 3478 ES01372 Initial 850K 100 0.56 31 54 44 6.2 whole blood ECRHS European Community Respiratory Health Survey European 3479 ES01373 Initial 850K 22 0.64 36.6 90.6 67.4 NA skin primary acral lentiginous melanoma European 3480 ES01373 Initial 850K 8 0.63 1.7 89.4 55.6 NA skin primary non-lentiginous melanoma European 3481 ES01374 Initial 850K 9 0.56 16 79 58.4 NA skin metastatic acral lentiginous melanoma European 3482 ES01374 Initial 850K 22 0.64 36.6 90.6 67.4 NA skin primary acral lentiginous melanoma European 3483 ES01374 Initial 850K 8 0.63 1.7 89.4 55.6 NA skin primary non-lentiginous melanoma European 3484 ES01375 Initial 850K 9 0.56 16 79 58.4 NA skin metastatic acral lentiginous melanoma European 3485 ES01375 Initial 850K 22 0.64 36.6 90.6 67.4 NA skin primary acral lentiginous melanoma European 3486 ES01376 Initial 850K 48 0.63 1.7 90.6 62.1 NA skin European 3487 ES01377 Initial 450K 45 0.5 NA NA 85 6.2 middle temporal gyrus AD Not reported 3488 ES01377 Initial 450K 35 0.5 NA NA 84 5.5 middle temporal gyrus Non-demented controls European 3489 ES01378 Initial 450K 42 0.24 NA NA 81 3 whole blood Controls Not reported 3490 ES01378 Initial 450K 54 0.31 NA NA 82 3.55 whole blood Converters Not reported 3491 ES01379 Initial 450K 5606 0.68 54 65 61 NA blood MCCS Melbourne Collaborative Cohort Study European 3492 ES01380 Initial 450K 1088 0.68 51 64 59 NA blood MCCS Melbourne Collaborative Cohort Study Baseline data European 3493 ES01380 Initial 450K 1088 0.68 63 76 70 NA blood MCCS Melbourne Collaborative Cohort Study Follow?up data European 3494 ES01381 Initial 450K 64 0 23 44 33.2 NA breast milk NHBCS New Hampshire Birth Cohort study Controls Not reported 3495 ES01381 Initial 450K 23 0 29 45 36.3 NA breast milk NHBCS New Hampshire Birth Cohort study Breast Cancer Not reported 3496 ES01382 Initial 450K 94 0.61 0 0 0 0 bloodspot Cases Hispanic or Latin American,European 3497 ES01382 Initial 450K 88 0.58 0 0 0 0 bloodspot control European,Hispanic or Latin American 3498 ES01383 Initial 450K 93 0 NA NA NA NA leukocyte post-chemotherapy European 3499 ES01383 Initial 450K 93 0 NA NA NA NA leukocyte pre-chemotherapy European 3500 ES01383 Initial 450K 48 0 NA NA NA NA leukocyte Non-cancer controls European 3501 ES01384 Initial 450K 780 NA NA NA NA NA breast TCGA The Cancer Genome Atlas cancer Not reported 3502 ES01384 Initial 450K 83 NA NA NA NA NA breast normal Not reported 3503 ES01385 Initial 450K 479 0.52 NA NA 32.1 5.4 cord blood Project Viva Not reported 3504 ES01385 Replication 450K 999 0.52 NA NA 32.2 4.3 cord blood Generation R Not reported 3505 ES01386 Initial 850K 20 1 NA NA 45.3 1.05 peripheral blood mononuclear cell GWI cases European,Asian unspecified,African American or Afro-Caribbean,Hispanic or Latin American 3506 ES01386 Initial 850K 20 1 NA NA 46.1 1.23 peripheral blood mononuclear cell Healthy controls European,Asian unspecified,African American or Afro-Caribbean,Hispanic or Latin American 3507 ES01388 Initial 850K 32 0 NA NA 30.4 NA saliva InterGEN Intergenerational Impact of Genetic and Psychological Factors on Blood Pressure Study Smokers African American or Afro-Caribbean 3508 ES01388 Initial 850K 124 0 NA NA 31.9 NA saliva GENOA Genetic Epidemiology Network of Arteriopathy Nonsmokers African American or Afro-Caribbean 3509 ES01389 Initial 450K 10 0.2 NA NA 50.1 12.22 whole blood Cold pattern East Asian 3510 ES01389 Initial 450K 10 0.3 NA NA 53.6 11.32 whole blood Hot pattern East Asian 3511 ES01390 Initial 850K 29 0.69 8 34 19.98 6.77 whole blood children raised in orphanages Not reported 3512 ES01390 Initial 850K 29 0.62 8 35 20.89 7.16 whole blood children raised in biological families Not reported 3513 ES01391 Initial 850K 45 1 NA NA 40.6 7.7 whole blood Incumbents Not reported 3514 ES01391 Initial 850K 41 1 NA NA 28.9 6.3 whole blood recruits Not reported 3515 ES01392 Initial 450K 1018 NA 0 0 0 0 cord blood Not reported 3516 ES01393 Initial 450K 10 0.6 0 0 0 0 placenta Controls European 3517 ES01393 Initial 450K 8 0.75 0 0 0 0 placenta TOF European 3518 ES01394 Initial 450K 1263 NA NA NA NA NA bloodspot MINERvA Not reported 3519 ES01395 Initial 450K 1263 NA NA NA NA NA bloodspot MINERvA Not reported 3520 ES01397 Initial 450K 1263 NA NA NA NA NA bloodspot MINERvA Not reported 3521 ES01398 Initial 450K 81 0.48 0 0 0 0 cord blood CHAMACOS Not reported 3522 ES01399 Initial 450K 54 0.04 NA NA 43 NA whole blood European 3523 ES01400 Initial 450K 42 0.04 NA NA 43 NA whole blood European 3524 ES01401 Initial 450K 12 0.04 NA NA 43 NA whole blood European 3525 ES01402 Initial 450K 3400 NA NA NA NA NA whole blood European 3526 ES01402 Initial 450K 401 NA NA NA NA NA whole blood Hispanic or Latin American 3527 ES01402 Initial 450K 724 NA NA NA NA NA whole blood African unspecified 3528 ES01403 Initial 850K 274 0.34 NA NA 53.96 13.59 whole blood GS:SFHS Generation Scotland: Scottish Family Health Study COPD cases Not reported 3529 ES01403 Initial 850K 2919 0.4 NA NA 46.98 13.37 whole blood GS:SFHS Generation Scotland: Scottish Family Health Study Controls Not reported 3530 ES01404 Initial 850K 274 0.34 NA NA 53.96 13.59 whole blood GS:SFHS Generation Scotland: Scottish Family Health Study COPD cases Not reported 3531 ES01404 Initial 850K 2919 0.4 NA NA 46.98 13.37 whole blood GS:SFHS Generation Scotland: Scottish Family Health Study Controls Not reported 3532 ES01405 Initial 850K 274 0.34 NA NA 53.96 13.59 whole blood GS:SFHS Generation Scotland: Scottish Family Health Study COPD cases Not reported 3533 ES01405 Initial 850K 2919 0.4 NA NA 46.98 13.37 whole blood GS:SFHS Generation Scotland: Scottish Family Health Study Controls Not reported 3534 ES01406 Initial 850K 274 0.34 NA NA 53.96 13.59 whole blood GS:SFHS Generation Scotland: Scottish Family Health Study COPD cases Not reported 3535 ES01406 Initial 850K 2919 0.4 NA NA 46.98 13.37 whole blood GS:SFHS Generation Scotland: Scottish Family Health Study Controls Not reported 3536 ES01407 Initial 450K 917 0.6 33 96 70 NA breast Not reported 3537 ES01407 Replication 450K 907 0.56 33 94 69 NA breast Not reported 3538 ES01408 Initial 850K 536 NA NA NA NA NA buccal cell NOVI Neonatal Neurobehavior and Outcomes in Very Preterm Infants Study Not reported 3539 ES01409 Initial 450K 712 1 NA NA 51 7.1 whole blood South Asian,European 3540 ES01410 Initial 450K 712 1 NA NA 51 7.1 whole blood South Asian,European 3541 ES01411 Initial 450K 712 1 NA NA 51 7.1 whole blood South Asian,European 3542 ES01412 Initial 450K 364 1 NA NA 52 7.2 whole blood European 3543 ES01413 Initial 450K 364 1 NA NA 52 7.2 whole blood European 3544 ES01414 Initial 450K 364 1 NA NA 52 7.2 whole blood European 3545 ES01415 Initial 450K 348 1 NA NA 51 7 whole blood South Asian 3546 ES01416 Initial 450K 348 1 NA NA 51 7 whole blood South Asian 3547 ES01417 Initial 450K 348 1 NA NA 51 7 whole blood South Asian 3548 ES01418 Initial 450K 371 0.68 NA NA NA NA liver Not reported 3549 ES01419 Initial 450K 506 0.5 NA NA 8.1 0.1 whole blood Generation R European 3550 ES01419 Initial 450K 846 0.48 NA NA 8.6 0.2 whole blood ALSPAC Avon Longitudinal Study of Parents and Children European 3551 ES01420 Initial 450K 194 0.54 18 88 55 NA whole blood Not reported 3552 ES01421 Initial 450K 136 0.69 1 13 5 NA whole blood Not reported 3553 ES01422 Initial 850K 124 0 NA NA NA NA cervix HPV positive Not reported 3554 ES01422 Initial 850K 62 0 NA NA NA NA cervix HPV negative Not reported 3555 ES01423 Initial 450K 343 0.54 0 0 0 0 placenta NHBCS New Hampshire Birth Cohort Study European 3556 ES01423 Initial 450K 141 0.52 NA NA NA NA placenta RICHS Rhode Island Child Health Study European 3557 ES01424 Initial 450K 94 0.49 NA NA 28.9 20.2 whole blood Hispanic or Latin American 3558 ES01425 Initial 450K 31 0.39 NA NA 42 15 saliva Coeliac Not reported 3559 ES01425 Initial 450K 28 0.46 NA NA 37 14 saliva Control Not reported 3560 ES01429 Initial 450K 166 1 NA NA 49.3 7.3 whole blood PEth ? 20 African American or Afro-Caribbean 3561 ES01429 Initial 450K 414 1 NA NA 49.3 8.1 whole blood PEth < 20 African American or Afro-Caribbean 3562 ES01429 Replication 850K 135 1 NA NA 47.5 7.1 whole blood PEth ? 20 African American or Afro-Caribbean 3563 ES01429 Replication 850K 332 1 NA NA 48.2 8 whole blood PEth < 20 African American or Afro-Caribbean 3564 ES01430 Initial 850K 183 0.48 58 69 64 NA whole blood REGICOR controls European 3565 ES01430 Initial 850K 218 0.66 62 78 71 NA whole blood REGICOR ischemic stroke European 3566 ES01430 Replication 850K 41 0.51 NA NA 62.8 14.2 whole blood Controls European 3567 ES01430 Replication 850K 185 0.26 NA NA 74.9 12.6 whole blood ischemic stroke European 3568 ES01430 Replication 850K 21 0.62 67 76 75 NA whole blood Controls European 3569 ES01430 Replication 850K 145 0.69 67 81 75 NA whole blood ischemic stroke European 3570 ES01431 Initial 450K 2 NA NA NA NA NA neural iPSCs Down syndrome Not reported 3571 ES01431 Initial 450K 2 NA NA NA NA NA neural iPSCs euploid donors Not reported 3572 ES01432 Initial 450K 25 0.56 0 0 0 0 cord blood ALSPAC Avon Longitudinal Study of Parents and Children With seizures European 3573 ES01432 Initial 450K 797 0.49 0 0 0 0 cord blood ALSPAC Avon Longitudinal Study of Parents and Children Without seizures European 3574 ES01433 Initial 450K 7 NA NA NA 7.69 0.36 whole blood ALSPAC Avon Longitudinal Study of Parents and Children With seizures European 3575 ES01433 Initial 450K 841 0.5 NA NA 7.44 0.13 whole blood ALSPAC Avon Longitudinal Study of Parents and Children Without seizures European 3576 ES01434 Initial 450K 12 NA NA NA 17.65 0.86 whole blood ALSPAC Avon Longitudinal Study of Parents and Children With seizures European 3577 ES01434 Initial 450K 801 0.51 NA NA 17.11 1.04 whole blood ALSPAC Avon Longitudinal Study of Parents and Children Without seizures European 3578 ES01435 Initial 450K 58 0.52 NA NA 17.16 1.01 whole blood ALSPAC Avon Longitudinal Study of Parents and Children With seizures European 3579 ES01435 Initial 450K 759 0.51 NA NA 17.1 1.05 whole blood ALSPAC Avon Longitudinal Study of Parents and Children Without seizures European 3580 ES01436 Initial 850K 120 1 55 70 64 NA whole blood PURE-SA-NW South East Asian 3581 ES01437 Initial 850K 120 1 55 70 64 NA whole blood PURE-SA-NW South Asian 3582 ES01438 Initial 850K 120 1 55 70 64 NA whole blood PURE-SA-NW South Asian 3583 ES01439 Initial 850K 120 1 55 70 64 NA whole blood PURE-SA-NW South Asian 3584 ES01440 Initial 850K 120 1 55 70 64 NA whole blood PURE-SA-NW South Asian 3585 ES01441 Initial 850K 120 1 55 70 64 NA whole blood PURE-SA-NW South Asian 3586 ES01442 Initial 850K 120 1 55 70 64 NA whole blood PURE-SA-NW South Asian 3587 ES01443 Initial 450K 309 0.65 NA NA NA NA kidney African American or Afro-Caribbean 3588 ES01444 Initial 450K 68 0.61 NA NA 67 NA whole blood Non-septic patients Not reported 3589 ES01444 Initial 450K 66 0.55 NA NA 66 NA whole blood Septic patients Not reported 3590 ES01445 Initial 450K 15 0 NA NA 30.13 4.42 decidual tissue recurrent miscarriage East Asian 3591 ES01445 Initial 450K 15 0 NA NA 29.53 6.65 decidual tissue normal pregnant East Asian 3592 ES01446 Initial 450K 15 0 NA NA 30.13 4.42 decidual tissue recurrent miscarriage East Asian 3593 ES01446 Initial 450K 15 0 NA NA 29.53 6.65 decidual tissue normal pregnant East Asian 3594 ES01447 Initial 450K 697 NA NA NA NA NA peripheral blood mononuclear cell asthma Not reported 3595 ES01447 Initial 450K 97 NA NA NA NA NA peripheral blood mononuclear cell controls Not reported 3596 ES01448 Initial 450K 15 NA NA NA NA NA nasal epithelial cells asthma Not reported 3597 ES01448 Initial 450K 14 NA NA NA NA NA nasal epithelial cells controls Not reported 3598 ES01449 Initial 450K 74 NA NA NA NA NA airway epithelial cells asthma Not reported 3599 ES01449 Initial 450K 41 NA NA NA NA NA airway epithelial cells controls Not reported 3600 ES01450 Initial 450K 63 1 NA NA 22.15 2.3 whole blood MRS US Marine Resiliency Study Cases Other,European,African unspecified 3601 ES01450 Initial 450K 63 1 NA NA 22.36 3.7 whole blood MRS US Marine Resiliency Study Controls African unspecified,Other,European 3602 ES01450 Initial 450K 31 1 NA NA 23.5 1 whole blood Army STARRS US Army Study to Assess Risk and Resilience in Servicemembers Cases European 3603 ES01450 Initial 450K 47 1 NA NA 24.6 4.8 whole blood Army STARRS US Army Study to Assess Risk and Resilience in Servicemembers Controls European 3604 ES01450 Initial 450K 29 1 NA NA 27.1 9.9 whole blood PRISMO Cases European 3605 ES01450 Initial 450K 33 1 NA NA 27.1 8.7 whole blood PRISMO Controls European 3606 ES01451 Initial 450K 455 0.48 NA NA 16.3 0.2 nasal epithelial cells PIAMA Prevention and Incidence of Asthma and Mite Allergy European 3607 ES01451 Initial 450K 72 0.5 NA NA 11 0.9 nasal epithelial cells African American or Afro-Caribbean 3608 ES01451 Initial 450K 483 0.52 NA NA 15.5 3 nasal epithelial cells EVA-PR Epigenetic Variation and Childhood Asthma in Puerto Ricans Hispanic or Latin American 3609 ES01452 Initial 450K 455 0.48 NA NA 16.3 0.2 nasal epithelial cells PIAMA Prevention and Incidence of Asthma and Mite Allergy European 3610 ES01452 Initial 450K 72 0.5 NA NA 11 0.9 nasal epithelial cells African American or Afro-Caribbean 3611 ES01452 Initial 450K 483 0.52 NA NA 15.5 3 nasal epithelial cells EVA-PR Epigenetic Variation and Childhood Asthma in Puerto Ricans Hispanic or Latin American 3612 ES01453 Initial 450K 40 0.35 NA NA 45.1 8.1 whole blood Not reported 3613 ES01454 Initial 450K 29 0.38 NA NA 84.2 10.8 entorhinal cortex AD+P Not reported 3614 ES01454 Initial 450K 18 0.5 NA NA 88.4 6.4 entorhinal Cortex Not reported 3615 ES01454 Initial 450K 29 0.38 NA NA 84.2 10.8 prefrontal cortex AD+P Not reported 3616 ES01454 Initial 450K 18 0.5 NA NA 88.4 6.4 prefrontal cortex Not reported 3617 ES01454 Initial 450K 29 0.38 NA NA 84.2 10.8 superior temporal gyrus AD+P Not reported 3618 ES01454 Initial 450K 18 0.5 NA NA 88.4 6.4 superior temporal gyrus Not reported 3619 ES01455 Initial 450K 766 0 NA NA NA NA breast breast cancer Not reported 3620 ES01455 Initial 450K 97 0 NA NA NA NA breast normal Not reported 3621 ES01456 Initial 450K 16 0.56 0 0 0 0 blood spot Controls European 3622 ES01456 Initial 450K 24 0.67 0 0 0 0 blood spot CoA Not reported 3623 ES01457 Initial 850K 96 0.52 NA NA 45.2 12.4 whole blood PsyCourse Baseline Not reported 3624 ES01457 Initial 850K 95 0.53 NA NA 46.17 12.4 whole blood PsyCourse 1-year follow-up Not reported 3625 ES01458 Initial 450K 340 0.54 NA NA 49.8 NA whole blood RODAM Research on Obesity and Diabetes among African Migrants study Sub-Saharan African 3626 ES01459 Initial 850K 24 0.29 NA NA 66.8 5.3 whole blood Not reported 3627 ES01459 Initial 850K 24 0.71 NA NA 69.2 4.3 whole blood Not reported 3628 ES01460 Initial 450K 42 0.55 NA NA NA NA whole blood case Hispanic or Latin American,European 3629 ES01460 Initial 450K 39 0.67 NA NA NA NA whole blood control Hispanic or Latin American,European 3630 ES01460 Initial 850K 45 0.44 NA NA NA NA whole blood Case Hispanic or Latin American,European 3631 ES01460 Initial 850K 45 0.53 NA NA NA NA whole blood Control Hispanic or Latin American,European 3632 ES01463 Initial 450K 38 0.42 21 68 43.8 12.7 colon Inflamed tissue Not reported 3633 ES01463 Initial 450K 39 0.36 21 68 42.6 13 colon Noninflamed tissue Not reported 3634 ES01464 Initial 850K 5 0.4 NA NA 38 4.6 adipose-derived stem cells Control Not reported 3635 ES01464 Initial 850K 7 0.57 NA NA 36.1 9.4 adipose-derived stem cells CD Not reported 3636 ES01465 Initial 850K 9 0 32 66 49 10 breast ipsilateral-normal Not reported 3637 ES01465 Initial 850K 9 0 32 66 49 10 breast contralateral-normal Not reported 3638 ES01466 Initial 850K 137 0 10 10 10 0 whole blood IOW Isle of Wight Not reported 3639 ES01466 Initial 850K 241 0 18 18 18 0 whole blood IoW Isle of Wight Not reported 3640 ES01466 Initial 450K 966 0 7 7 7 0 whole blood ALSPAC Avon Longitudinal Study of Parents and Children Not reported 3641 ES01466 Initial 450K 966 0 15 15 15 0 whole blood ALSPAC Avon Longitudinal Study of Parents and Children Not reported 3642 ES01466 Initial 450K 1838 NA 8 8 8 0 whole blood BAMSE The Swedish Children, Allergy, Milieu, Stockholm, Epidemiology Not reported 3643 ES01466 Initial 450K 2063 NA 16 16 16 0 whole blood BAMSE The Swedish Children, Allergy, Milieu, Stockholm, Epidemiology Not reported 3644 ES01467 Initial 450K 81 NA NA NA NA NA intestinal mucosal cells control Not reported 3645 ES01467 Initial 450K 204 NA NA NA NA NA intestinal mucosal cells IBD Not reported 3646 ES01468 Initial 450K 168 0.42 63 94 76.4 6.8 whole blood Control European 3647 ES01468 Initial 450K 290 0.41 59 99 79.7 7.17 whole blood AD European 3648 ES01469 Initial 850K 203 0.5 NA NA 34.64 12.54 whole blood Controls European,African American or Afro-Caribbean 3649 ES01469 Initial 850K 336 0.59 NA NA 44.29 10.92 whole blood AUD African American or Afro-Caribbean,European 3650 ES01469 Replication 850K 43 0.44 NA NA 38.85 11.78 whole blood Healthy Controls Not reported 3651 ES01469 Replication 850K 43 0.67 NA NA 45.95 11.07 whole blood AUD Not reported 3652 ES01469 Replication 850K 4301 NA NA NA NA NA whole blood GS Generation Scotland: Scottish Family Health Study Not reported 3653 ES01469 Replication 450K 391 0.7 NA NA NA NA whole blood GTP Grady Trauma Project Not reported 3654 ES01471 Initial 450K 11 0 NA NA 36.9 10.3 leukocyte before diet Not reported 3655 ES01471 Initial 450K 11 0 NA NA 36.9 10.3 leukocyte after diet Not reported 3656 ES01470 Initial 450K 24 0 NA NA 36.9 11.8 leukocyte normal-weight women Not reported 3657 ES01470 Initial 450K 11 0 NA NA 36.9 10.3 leukocyte obesity Not reported 3658 ES01472 Initial 450K 378 0.54 NA NA NA NA colorectal tumour TCGA The Cancer Genome Atlas Asian unspecified,African unspecified,European 3659 ES01473 Initial 450K 40 1 NA NA 58.2 1.3 whole blood KoGES-ASAS Korean Genome and Epidemiology Study Ansan-Ansung never smokers East Asian 3660 ES01473 Initial 450K 91 1 NA NA 58 0.8 whole blood KoGES-ASAS Korean Genome and Epidemiology Study Ansan-Ansung current smokers East Asian 3661 ES01474 Initial 450K 100 1 NA NA 51.89 9.23 buffy coat Korean National Health and Nutrition Examination Survey Non-smokers East Asian 3662 ES01474 Initial 450K 100 1 NA NA 51.4 8.23 buffy coat Korean National Health and Nutrition Examination Survey Smokers East Asian 3663 ES01475 Initial 850K 358 NA NA NA NA NA cord blood EAGeR The Effects of Aspirin in Gestation and Reproduction tria Not reported 3664 ES01476 Initial 850K 673 0.45 55 7 62 NA whole blood Non-atopic asthma European,African American or Afro-Caribbean 3665 ES01476 Initial 850K 1157 0.54 55 72 63 NA whole blood Non-cases European,African American or Afro-Caribbean 3666 ES01477 Initial 850K 1157 0.54 55 72 63 NA whole blood Non-cases European,African American or Afro-Caribbean 3667 ES01477 Initial 850K 271 0.51 52 68 60 NA whole blood Atopic asthma European 3668 ES01478 Initial 850K 48 0.77 NA NA 28 0 whole blood CHDS Christchurch Health and Development Study heavy cannabis users European 3669 ES01478 Initial 850K 48 0.77 NA NA 28 0 whole blood CHDS Christchurch Health and Development Study control European 3670 ES01479 Initial 450K 20 NA NA NA NA NA colon normal Not reported 3671 ES01479 Initial 450K 18 NA NA NA NA NA colon low-grade adenoma Not reported 3672 ES01479 Initial 450K 22 NA NA NA NA NA colon high-grade adenoma Not reported 3673 ES01480 Initial 450K 28 0.57 NA NA 18.5 6.5 CD4+ T cell patients with CAH Not reported 3674 ES01480 Initial 450K 37 0.51 NA NA 17 6.1 CD4+ T cell controls Not reported 3675 ES01481 Initial 450K 30 0.53 NA NA 52.34 12.74 whole blood Leukocytopenia East Asian 3676 ES01481 Initial 450K 30 0.5 NA NA 55.76 11.84 whole blood controls East Asian 3677 ES01482 Initial 450K 30 0.63 NA NA 53.62 13.08 whole blood Leukocytosis East Asian 3678 ES01482 Initial 450K 30 0.5 NA NA 55.76 11.84 whole blood control East Asian 3679 ES01483 Initial 450K 544 NA NA NA NA NA lung Not reported 3680 ES01484 Initial 450K 158 NA NA NA NA NA whole blood disease-discordant monozygotic twin pairs Not reported 3681 ES01485 Initial 450K 24 0 NA NA 36.9 11.8 peripheral blood mononuclear cell normal weight Not reported 3682 ES01485 Initial 450K 24 0 NA NA 36.9 10.2 peripheral blood mononuclear cell severe obese Not reported 3683 ES01486 Initial 450K 48 0 NA NA 36.9 10.2 peripheral blood mononuclear cell Not reported 3684 ES01487 Initial 450K 17 NA NA NA NA NA placenta COCOA Cohort for Childhood Origin of Asthma and Allergic Diseases Not reported 3685 ES01488 Initial 450K 370 NA NA NA NA NA lung lung squamous cell carcinoma Not reported 3686 ES01489 Initial 850K 24 1 NA NA NA NA skin normal Not reported 3687 ES01489 Initial 850K 24 1 NA NA NA NA skin wart Not reported 3688 ES01490 Initial 850K 150 0.23 NA NA 60.9 0.9 whole blood ACHS-II Anniston Community Health Survey Phase II African American or Afro-Caribbean 3689 ES01490 Initial 850K 142 0.28 NA NA 64.3 1.2 whole blood ACHS-II Anniston Community Health Survey Phase II European 3690 ES01491 Initial 450K 120 0 NA NA 54.7 12.3 breast breast cancer European,Not reported 3691 ES01491 Replication 450K 38 0 NA NA 57.2 12.5 breast breast cancer Not reported,European 3692 ES01491 Initial 450K 98 0 NA NA 57.6 15.3 breast normal European 3693 ES01491 Initial 450K 158 0 NA NA 55.3 12.5 breast breast cancer Not reported,European 3694 ES01492 Initial 450K 4 NA NA NA NA NA brain Exposure 10+ years East Asian 3695 ES01492 Initial 450K 13 NA NA NA NA NA brain Exposure 0 years East Asian 3696 ES01493 Initial 450K 4 NA NA NA NA NA whole blood Exposure 10+ years East Asian 3697 ES01493 Initial 450K 14 NA NA NA NA NA whole blood Exposure 0 years East Asian 3698 ES01494 Initial 850K 27 0.45 NA NA 53.4 12.2 bufy coat Non-DCI Not reported 3699 ES01494 Initial 850K 13 0.23 NA NA 53.2 6.7 buffy coat DCI Not reported 3700 ES01495 Initial 450K 260 0.5 0 0 0 0 placenta National Institute of Child Health and Human Development’s Fetal Growth Study Hispanic or Latin American,European,Asian unspecified,African unspecified 3701 ES01496 Initial 450K 260 0.5 0 0 0 0 placenta National Institute of Child Health and Human Development’s Fetal Growth Study European,Asian unspecified,African unspecified,Hispanic or Latin American 3702 ES01497 Initial 850K 641 0.42 NA NA 54.3 12.8 buffy coat PBB Michigan Polybrominated Biphenyl (PBB) Registry Hispanic or Latin American,European 3703 ES01498 Initial 450K 19 0.63 NA NA 44.58 9.14 leukocyte Suicidal ideators European 3704 ES01498 Initial 450K 88 0.65 NA NA 45.13 12.96 leukocyte Non-suicidal ideators European 3705 ES01499 Initial 850K 96 0.54 NA NA NA NA cord blood European 3706 ES01500 Initial 850K 32 0.06 NA NA 48.5 NA gallbladder tissue 32 Not reported 3707 ES01500 Initial 850K 13 0.15 NA NA 53 NA gallbladder tissue Low-grade dysplasia Not reported 3708 ES01500 Initial 850K 9 0.22 NA NA 67.5 NA gallbladder tissue High-grade dysplasia Not reported 3709 ES01500 Initial 850K 27 0.18 NA NA 62 NA gallbladder tissue 27 Not reported 3710 ES01503 Initial 450K 714 NA 0 0 NA NA cord blood ALSPAC European 3711 ES01503 Initial 450K 1191 NA 0 0 NA NA cord blood GenR European 3712 ES01503 Initial 450K 325 NA 0 0 NA NA cord blood INMA European 3713 ES01503 Initial 450K 55 NA 0 0 0 NA cord blood NEST African unspecified 3714 ES01503 Initial 450K 56 NA 0 0 0 NA cord blood NEST European 3715 ES01503 Initial 450K 136 NA 5 5 5 NA cord blood PREDO European 3716 ES01505 Initial 450K 221 0.754 NA NA 46 NA nucleus accumbens Other 3717 ES01506 Initial 450K 651 NA NA NA 7 NA blood ALSPAC European 3718 ES01506 Initial 450K 395 NA NA NA 10 NA blood GENR European 3719 ES01506 Initial 450K 215 NA NA NA 12 NA blood GLAKU European 3720 ES01506 Initial 450K 1034 NA NA NA NA NA blood HELIX European 3721 ES01506 Initial 450K 79 NA NA NA NA NA blood HELIX Asian unspecified 3722 ES01507 Initial 850K 22 0 22 37.5 25.54 NA bronchoalveolar cells Other 3723 ES01508 Initial 850K 17 0 27 49.3 40.35 NA bronchoalveolar cells Not reported 3724 ES01509 Initial 850K 19 0 NA NA 32.74 NA bronchoalveolar cells Not reported 3725 ES01510 Initial 850K 20 0 NA NA 31.3 NA bronchoalveolar cells Not reported 3726 ES01511 Initial 450K 890 NA NA NA NA NA tumor TCGA-BRCA Not reported 3727 ES01511 Replication 450K 295 NA NA NA NA NA tumor GEO-BRCA Not reported 3728 ES01512 Initial 450K 120 91.6 NA NA 49 9.3 blood CENTRAL subgroup Not reported 3729 ES01516 Initial 450K 99 38.8 NA NA 38.8 NA blood Not reported 3730 ES01517 Initial 450K 40 NA NA NA 38 10.3 B lymphoblastoid cell Other 3731 ES01518 Initial 850K 94 1 NA NA NA NA sperm blood Not reported 3732 ES01519 Initial 850K 8 NA NA NA 57.1 NA blood Not reported 3733 ES01520 Initial 450K 2893 51 NA NA NA NA blood ESTHER European 3734 ES01521 Initial 450K 11 1 NA NA 54 NA hepatocyte Not reported 3735 ES01522 Initial 850K 24 0 NA NA 73 4 blood Sarcopenic European 3736 ES01522 Initial 850K 24 NA NA NA 70 3 blood Non?sarcopenic European 3737 ES01524 Initial 450K 4010 NA NA NA NA NA nasal epithelial cells Other 3738 ES01523 Initial 850K 127 NA NA NA NA NA brain STG Superior temporal gyrus Native American 3739 ES01523 Initial 450K 117 NA NA NA NA NA brain IFG Inferior frontal gyrus Native American 3740 ES01525 Initial 450K 20 NA NA NA NA NA skin homing CD4+CLA+ T cells Not reported 3741 ES01526 Initial 850K 136 1 NA NA NA NA whole blood Not reported 3742 ES01527 Initial 450K 961 0.685 NA NA 68.7 NA blood African American or Afro-Caribbean 3743 ES01528 Initial 450K 11 0 NA NA NA NA neutrophils African American or Afro-Caribbean 3744 ES01530 Initial 450K 40 0 NA NA NA NA breast Not reported 3745 ES01531 Initial 850K 45 NA NA NA NA NA cord blood ELBW ELBW participants Other 3746 ES01531 Initial 850K 47 46.5 NA NA NA NA cord blood Other 3747 ES01533 Initial 850K 29 NA NA NA NA NA blood Other admixed ancestry 3748 ES01534 Initial 450K 532 NA NA NA NA NA blood Other 3749 ES01535 Initial 450K 2476 NA NA NA NA NA blood Central Asian 3750 ES01537 Initial 850K 1395 NA NA NA NA NA Peripheral whole blood Other 3751 ES01537 Replication 850K 392 NA NA NA NA NA blood Other 3752 ES01539 Initial 850K 824 NA NA NA NA NA leukocytes Not reported 3753 ES01541 Initial 450K 320 NA NA NA 60 NA FFPE tissue Other 3754 ES01542 Initial 450K 1697 NA NA NA NA NA peripheral blood Not reported 3755 ES01543 Initial 450K 32 NA NA NA NA NA breast Hispanic or Latin American 3756 ES01544 Initial 450K 275 NA NA NA NA NA blood Not reported 3757 ES01545 Initial 850K 557 NA NA NA NA NA blood Not reported 3758 ES01546 Initial 450K 250 NA NA NA NA NA blood European 3759 ES01547 Initial 450K 483 NA NA NA NA NA renal tissue Not reported 3760 ES01548 Initial 850K 92 NA NA NA NA NA cord blood Other admixed ancestry,European 3761 ES01548 Replication 850K 15 NA NA NA NA NA cord blood Not reported 3762 ES01549 Initial 450K 335 NA NA NA NA NA buccal swabs Other 3763 ES01550 Initial NA 179 NA NA NA NA NA breast tissue East Asian 3764 ES01550 Replication 450K 656 NA NA NA NA NA breast tissue East Asian 3765 ES01551 Initial 850K 3004 NA NA NA NA NA cord blood COCOA COCOA birth cohort Other 3766 ES01552 Initial NA 64 NA NA NA NA NA blood Other 3767 ES01553 Initial 450K 17 88 21 33 15.4 NA blood Other admixed ancestry 3768 ES01554 Initial 450K 38 NA NA NA NA NA blood KhoeSan Other 3769 ES01554 Initial 450K 48 NA NA NA NA NA blood Bantu & European Other 3770 ES01555 Initial 850K 8 NA NA NA NA NA left posterior mandible Not reported 3771 ES01557 Initial 450K 2372 NA NA NA NA NA whole blood Other 3772 ES01558 Initial 850K 9 NA NA NA NA NA heterogenous muscle?derived human primary cells Not reported 3773 ES01559 Initial 850K 378 0.92 31 45 37 NA CD4+ T cell Other admixed ancestry 3774 ES01559 Initial 850K 34 0.65 45 48 46 NA CD4+ T cell Other admixed ancestry 3775 ES01560 Initial 450K 935 NA NA NA 31.7 NA blood Not reported 3776 ES01562 Initial 450K 145 NA 6 17 NA NA buccal cell Other 3777 ES01561 Initial 450K 2684 38 NA NA NA NA blood ARIC Not reported 3778 ES01563 Replication 450K 5743 NA NA NA NA NA blood European,African American or Afro-Caribbean 3779 ES01566 Initial 450K 36 NA NA NA NA NA cord blood Not reported 3780 ES01567 Initial 450K 910 NA NA NA NA NA buffy coat Enroll-HD data 1 Not reported 3781 ES01567 Initial 850K 714 NA NA NA 45 NA Buffy coat Enroll-HD data 2a Not reported 3782 ES01567 Initial 450K 376 NA NA NA NA NA whole blood Registry-HD Not reported 3783 ES01567 Initial 450K 100 NA NA NA NA NA lymphoblastoid Registry-HD Not reported 3784 ES01567 Initial 450K 64 NA NA NA NA NA fibroblast CHDI Not reported 3785 ES01568 Initial 450K 622 NA NA NA NA NA urine DEEP Lifelines DEEP cohort Not reported 3786 ES01569 Initial 850K 25 72 NA NA 48.2 NA main renal artery Not reported 3787 ES01569 Initial 850K 7 0.71 NA NA 51.14 NA main renal artery Not reported 3788 ES01570 Initial 450K 219 NA NA NA NA NA blood Not reported 3789 ES01570 Initial 450K 186 NA NA NA NA NA blood Not reported 3790 ES01571 Initial 850K 60 NA NA NA NA NA blood Not reported 3791 ES01571 Replication 850K 63 NA NA NA NA NA blood Not reported 3792 ES01572 Initial 450K 1595 NA NA NA NA NA blood FHS FHS Offspring Cohort Not reported 3793 ES01573 Initial 450K 111 NA NA NA NA NA peripheral blood Other 3794 ES01573 Initial 450K 39 NA NA NA NA NA peripheral blood Other 3795 ES01574 Initial 850K 10 NA NA NA NA NA cord blood mononuclear leukocytes Not reported 3796 ES01575 Initial 450K 618 NA NA NA 80 NA blood Not reported 3797 ES01576 Initial 450K 1438 NA NA NA NA NA breast tissue Other admixed ancestry 3798 ES01577 Initial 850K 89 NA NA NA NA NA blood ELEMENT Other admixed ancestry 3799 ES01578 Initial 850K 11 NA NA NA NA NA gastric cardiac mucosal biopsies Not reported 3800 ES01579 Initial 450K 320 NA NA NA NA NA peripheral blood Not reported 3801 ES01580 Initial 450K 467 NA NA NA NA NA lung Not reported 3802 ES01581 Initial 450K 284 NA NA NA NA NA blood European 3803 ES01583 Initial 850K 18 NA NA NA 57.4 8.4 blood WTC EHC Native American 3804 ES01582 Initial 450K 24 NA NA NA NA NA myocardium samples from left ventricles Not reported 3805 ES01583 Initial 850K 24 NA NA NA 56 8.3 blood NYUWHS Native American 3806 ES01584 Initial 850K 991 NA NA NA NA NA peripheral blood Not reported 3807 ES01585 Initial 450K 542 52 NA NA NA NA cord blood F2 F2-Generation of Isle of Wight Cohort Not reported 3808 ES01585 Initial 450K 107 NA NA NA NA NA cord blood Not reported 3809 ES01586 Initial 450K 29 NA NA NA NA NA blood Not reported 3810 ES01587 Initial 450K 45 NA NA NA NA NA preputial tissue Not reported 3811 ES01588 Initial 450K 21 NA NA NA NA NA preputial tissue Not reported 3812 ES01590 Initial 450K 823 NA NA NA NA NA lung Not reported 3813 ES01591 Initial 450K 290 NA NA NA NA NA renal tissue Not reported 3814 ES01591 Initial 450K 160 NA NA NA NA NA renal tissue Not reported 3815 ES01592 Initial 850K 18 NA NA NA NA NA blood Not reported 3816 ES01593 Initial 450K 178 NA NA NA NA NA esophagus Not reported 3817 ES01594 Initial 450K 5 0 NA NA 39 NA peripheral blood mononuclear cell Not reported 3818 ES01595 Initial 450K 433 NA NA NA NA NA bladder Not reported 3819 ES01596 Initial 450K 522 NA NA NA NA NA lung Not reported 3820 ES01599 Initial 450K 80 NA NA NA NA NA liver tissue Not reported 3821 ES01600 Initial 450K 153 NA NA NA NA NA cancer tissues Not reported 3822 ES01601 Initial 450K 1136 NA 6 20 NA NA white blood cells Hispanic or Latin American 3823 ES01602 Initial 450K 414 NA NA NA NA NA hepatocyte Not reported 3824 ES01603 Initial 450K 9773 NA NA NA NA NA whole blood Not reported 3825 ES01604 Initial 450K 2780 37 NA NA 57 6 blood ARIC Not reported 3826 ES01605 Initial 850K 902 NA NA NA NA NA whole blood Not reported 3827 ES01606 Initial 450K 192 NA NA NA 68.89 8.58 blood same?sex aging twins Not reported 3828 ES01606 Initial 450K 106 47 NA NA NA NA blood SATSA Swedish Adoption Twin Study of Aging European 3829 ES01606 Initial 450K 86 38 NA NA 76.2 NA blood LSADT The Longitudinal Study of Aging Danish Twins European 3830 ES01607 Initial 850K 590 NA NA NA NA NA peripheral blood Not reported 3831 ES01608 Initial 450K 4689 NA NA NA NA NA peripheral blood Not reported 3832 ES01609 Initial 450K 437 NA NA NA NA NA bladder Not reported 3833 ES01610 Initial 850K 32 NA NA NA NA NA peripheral T cells Not reported 3834 ES01611 Initial 850K 8 NA NA NA NA NA blood Other admixed ancestry 3835 ES01612 Initial 850K 16 NA NA NA NA NA TOLF samples Other 3837 ES01614 Initial 450K 174 NA NA NA NA NA blood FRANCES European 3838 ES01614 Initial 450K 641 NA NA NA NA NA blood ARIES/ALSPAC European 3839 ES01615 Initial 850K 277 NA NA NA NA NA peripheral blood Not reported 3840 ES01616 Initial 850K 381 NA NA NA NA NA peripheral blood Not reported 3841 ES01617 Initial 450K 57 NA NA NA NA NA urothelium Not reported 3842 ES01618 Initial 450K 210 NA NA NA NA NA whole blood Not reported 3843 ES01619 Initial 450K 2325 41.5 NA NA NA NA blood Not reported 3844 ES01620 Initial 450K 12 NA NA NA NA NA skin fibroblasts Not reported 3845 ES01621 Initial 450K 7 NA NA NA NA NA primary human cells Not reported 3846 ES01622 Initial 850K 8 0 NA NA NA NA blood Asian unspecified 3847 ES01623 Initial 450K 968 NA NA NA NA NA blood BHS9 Adult cohort African American or Afro-Caribbean,European 3848 ES01623 Initial 450K 480 NA NA NA NA NA blood GSH European,African American or Afro-Caribbean 3849 ES01623 Initial 450K 512 NA NA NA NA NA blood DILGOM European 3850 ES01623 Initial 450K 218 NA NA NA NA NA blood ETS European 3851 ES01623 Initial 450K 173 NA NA NA NA NA blood EGCUT (Asthma) European 3852 ES01623 Initial 450K 100 NA NA NA NA NA blood EGCUT (Young_Old) European 3853 ES01623 Initial 450K 402 NA NA NA NA NA blood FTC European 3854 ES01623 Initial 450K 159 NA NA NA NA NA blood HBCS European 3855 ES01623 Initial 450K 96 NA NA NA NA NA blood JHS African American or Afro-Caribbean 3856 ES01623 Initial 450K 150 NA NA NA NA NA blood Lifelines European 3857 ES01623 Initial 450K 596 NA NA NA NA NA blood NTR European 3858 ES01623 Initial 450K 307 NA NA NA NA NA blood PREVEND Adult cohort European 3859 ES01623 Initial 450K 188 NA NA NA NA NA blood YFS European 3860 ES01623 Initial 450K 188 NA NA NA NA NA blood EpiGO Youth cohort African American or Afro-Caribbean 3861 ES01623 Initial 450K 283 NA NA NA NA NA blood LACHY Youth cohort African American or Afro-Caribbean 3862 ES01624 Initial 450K 20 NA NA NA NA NA biopsies Not reported 3863 ES01625 Initial 450K 3431 NA NA NA 54 6 blood ARIC European,African American or Afro-Caribbean 3864 ES01625 Initial 450K 3595 NA NA NA 58 13 blood FHS African American or Afro-Caribbean,European 3865 ES01625 Initial 450K 1082 NA NA NA NA NA blood GOLDN European 3866 ES01625 Initial 450K 971 49 NA NA 70 9 blood MESA African American or Afro-Caribbean,Hispanic or Latin American,European 3867 ES01625 Initial 450K 440 NA NA NA 58.3 7.6 blood RSIII-1 Not reported 3868 ES01625 Initial 450K 362 43 NA NA 70.8 3.2 blood RSII-3 Not reported 3869 ES01625 Initial 450K 149 NA NA NA 60.7 4.5 blood RSIII-2 Not reported 3870 ES01626 Initial 450K 269 NA NA NA NA NA soft tissue Not reported 3871 ES01627 Initial 450K 268 41.42 NA NA 66 NA lung TCGA African unspecified,Other admixed ancestry,European,Asian unspecified 3872 ES01627 Replication 450K 118 48.3 NA NA NA NA lung GEO European,East Asian,Asian unspecified,Other admixed ancestry,African unspecified 3873 ES01629 Initial 450K 30 NA NA NA NA NA whole blood Not reported 3874 ES01630 Initial 450K 30 NA NA NA NA NA whole blood Not reported 3875 ES01634 Initial 850K 87 NA NA NA NA NA blood Not reported 3876 ES01635 Initial 450K 125 NA NA NA NA NA whole blood Not reported 3877 ES01641 Initial 450K 653 NA NA NA NA NA blood Not reported 3878 ES01642 Initial 850K 681 NA NA NA NA NA blood NFBC Northern Finland birth cohort Not reported 3879 ES01642 Initial 850K 962 NA NA NA NA NA blood SAPALDIA Swiss study on air pollution and lung disease in adults European 3880 ES01643 Initial 450K 80 57.5 NA NA NA NA cancer tissues Asian unspecified,African unspecified,East Asian 3881 ES01644 Initial 450K 571 NA NA NA NA NA ovarian Not reported 3882 ES01645 Initial 450K 5858 NA NA NA NA NA whole blood Not reported 3883 ES01647 Initial 450K 5858 NA NA NA NA NA whole blood Not reported 3884 ES01648 Initial 450K 62 NA NA NA NA NA blood Other admixed ancestry 3885 ES01648 Initial 450K 142 NA NA NA NA NA blood Other admixed ancestry 3886 ES01649 Initial 850K 69 NA NA NA NA NA umbilical cord blood Other admixed ancestry 3887 ES01650 Initial 450K 54 NA NA NA NA NA whole blood Other 3888 ES01651 Initial 450K 62 NA NA NA NA NA whole blood Other 3889 ES01652 Initial 450K 63 NA NA NA NA NA nasal brushes Other 3890 ES01653 Initial 450K 78 NA NA NA NA NA nasal brushes Other 3891 ES01654 Initial 450K 726 39.5 NA NA 86.3 4.8 prefrontal cortex ROSMAP Other 3892 ES01654 Initial 450K 141 37.6 NA NA 85.8 7.8 prefrontal cortex Mt. Sinai Other 3893 ES01654 Initial 450K 107 50.2 NA NA 84.6 9 prefrontal cortex London Other 3894 ES01654 Initial 450K 56 48.2 NA NA 73.6 14.7 prefrontal cortex Gasparoni Other 3895 ES01654 Initial 450K 69 NA NA NA 83.6 6.2 whole blood London Other 3896 ES01665 Initial 450K 4355 0 NA NA 64 7.11 whole blood Other admixed ancestry 3897 ES01667 Initial 450K 157 NA NA NA NA NA cord blood Not reported 3898 ES01668 Initial 450K 2842 NA NA NA NA NA whole blood Not reported 3899 ES01669 Initial 450K 3371 NA NA NA NA NA whole blood Other 3900 ES01670 Initial 450K 4133 NA NA NA NA NA cord blood Other 3901 ES01671 Initial 450K 3295 NA NA NA NA NA cord blood Other 3902 ES01672 Initial 450K 36 44.4 NA NA 37.05 NA oesophageal Caucasian Other 3903 ES01673 Initial 450K 23 NA NA NA NA NA eye Not reported 3904 ES01674 Initial 850K 42 NA NA NA NA NA buccal cell Not reported 3905 ES01675 Initial 850K 72 NA NA NA 18 NA blood Not reported 3906 ES01676 Initial 450K 335 NA NA NA NA NA lung Not reported 3907 ES01677 Initial 450K 457 NA NA NA NA NA lung Not reported 3908 ES01678 Initial 450K 100 NA NA NA NA NA blood European 3909 ES01679 Initial 450K 82 NA NA NA NA NA brain Not reported 3910 ES01680 Initial 850K 184 NA NA NA NA NA blood East Asian 3911 ES01681 Initial 850K 24 1 NA NA NA NA prostate Not reported 3912 ES01682 Initial 850K 28 NA NA NA NA NA endothelial Not reported 3913 ES01683 Initial 450K 7463 NA NA NA NA NA blood Not reported 3914 ES01684 Initial 850K 128 NA NA NA NA NA blood Not reported 3915 ES01685 Initial 850K 542 NA NA NA NA NA blood Not reported 3916 ES01686 Initial 850K 13537 NA NA NA NA NA whole blood Not reported 3917 ES01687 Initial 450K 34 NA NA NA NA NA bone marrow Not reported 3918 ES01688 Initial 450K 130 NA NA NA NA NA breast Not reported 3919 ES01689 Initial 850K 242 NA NA NA NA NA whole blood East Asian 3920 ES01690 Initial 850K 2232 NA NA NA NA NA blood Not reported 3921 ES01691 Initial 850K 2232 NA NA NA NA NA blood Not reported 3922 ES01693 Initial 850K 912 NA NA NA NA NA blood Not reported 3923 ES01692 Initial 850K 1140 NA NA NA NA NA blood Not reported 3924 ES01694 Initial 850K 16 NA NA NA NA NA monocyte Not reported 3925 ES01695 Initial 850K 22 NA NA NA NA NA bone marrow Not reported 3926 ES01696 Initial 450K 163 NA NA NA NA NA B lymphoblastoid cell Not reported 3927 ES01697 Initial 450K 99 NA NA NA NA NA peripheral blood lymphocyte Not reported 3928 ES01698 Initial 850K 100 NA NA NA NA NA saliva African American or Afro-Caribbean 3929 ES01699 Initial 450K 47 NA NA NA NA NA NA Not reported 3930 ES01700 Initial 450K 47 NA NA NA NA NA NA Not reported 3931 ES01701 Initial 450K 47 NA NA NA NA NA NA Not reported 3932 ES01702 Initial 450K 325 NA NA NA NA NA whole blood Not reported 3933 ES01703 Initial 850K 855 NA NA NA NA NA blood Not reported 3934 ES01704 Initial 850K 697 NA NA NA NA NA blood Not reported 3935 ES01705 Initial 850K 138 NA NA NA NA NA peripheral blood Not reported 3936 ES01706 Initial 850K 21 NA NA NA NA NA CD4+ T cell Not reported 3938 ES01708 Initial 850K 94 NA NA NA NA NA cord blood Not reported 3939 ES01709 Initial 850K 374 NA NA NA NA NA blood Not reported 3940 ES01710 Initial 850K 12 NA NA NA NA NA whole blood Not reported 3941 ES01711 Initial 850K 20 NA NA NA NA NA liver Not reported 3942 ES01712 Initial 450K 13 NA NA NA NA NA bronchial epithelial Not reported 3943 ES01713 Initial 850K 46 NA NA NA NA NA blood Not reported 3944 ES01714 Initial 450K 7 NA NA NA NA NA peripheral blood Not reported 3945 ES01715 Initial 850K 293 NA NA NA NA NA whole blood Not reported 3946 ES01716 Initial 850K 213 NA NA NA NA NA whole blood Not reported 3947 ES01717 Initial 850K 308 NA NA NA NA NA whole blood Not reported 3948 ES01721 Initial 450K 158 46 NA NA 43.8 13.2 blood Amish European 3949 ES01721 Initial 450K 676 45 NA NA 42.8 4.5 blood BHS European 3950 ES01721 Initial 450K 186 45 NA NA 76 5 blood CHS European 3951 ES01721 Initial 450K 2648 46 NA NA 66.4 8.9 blood FHS European 3952 ES01721 Initial 450K 714 50 NA NA 48.5 15.9 blood GOLDN European 3953 ES01721 Initial 450K 1651 49 NA NA 61 8.9 blood KORA F4 European 3954 ES01721 Initial 450K 674 100 NA NA 72.4 6.8 blood NAS European 3955 ES01721 Initial 450K 963 50 NA NA 70.1 0.15 blood PIVUS European 3956 ES01721 Initial 450K 724 46 NA NA 59.9 8.2 blood RS European 3957 ES01721 Initial 450K 708 0 NA NA 58.1 9.3 blood TwinsUK European 3958 ES01721 Initial 450K 940 0 NA NA 68.3 6.25 blood WHI-BA23 European 3959 ES01721 Initial 450K 1072 0 NA NA 64.7 7.1 blood WHI-EMPC European 3960 ES01722 Initial 450K 1877 36 NA NA 56.5 5.9 blood ARIC African unspecified 3961 ES01722 Initial 450K 282 39 NA NA 42.7 4.7 blood BHS African unspecified 3962 ES01722 Initial 450K 189 33 NA NA 73 5.5 blood CHS African unspecified 3963 ES01722 Initial 450K 315 27 NA NA 61.1 7.6 blood GENOA African unspecified 3964 ES01722 Initial 450K 604 33 NA NA 48.4 11.2 blood HyperGEN African unspecified 3965 ES01722 Initial 450K 652 0 NA NA 62.8 6.6 blood WHI-BA23 African unspecified 3966 ES01722 Initial 450K 533 0 NA NA 62.7 6.9 blood WHI-EMPC African unspecified 3967 ES01725 Initial 450K 409 NA NA NA NA NA blood Asian unspecified 3968 ES01726 Initial 450K 409 NA NA NA NA NA blood Asian unspecified 3969 ES01736 Initial 450K 40 52.5 NA NA 48.7 4.7 peripheral blood mononuclear cell Chile study, PBMCs Not reported 3970 ES01736 Initial 450K 48 100 NA NA 39.7 8.1 peripheral blood mononuclear cell Bangladesh study Not reported 3971 ES01736 Initial 850K 32 100 NA NA 41.7 6.3 peripheral blood mononuclear cell Bangladesh study Not reported 3972 ES01737 Initial 450K 39 51.3 NA NA 48.7 4.7 buccal cell Chile study, buccal cells Not reported 3973 ES01739 Initial 850K 145 53.79 NA NA 0.74 0.05 cord blood Not reported 3974 ES01739 Initial 450K 103 58.25 NA NA 0.743 0.03 cord blood Not reported 3975 ES01740 Initial 450K 1266 54.9 NA NA 75 7 buffy coat Normative Aging Study Not reported 3976 ES01741 Initial 450K 1266 54.9 NA NA 75 7 buffy coat Normative Aging Study Not reported 3977 ES01742 Initial 450K 1266 54.9 NA NA 75 7 buffy coat Normative Aging Study Not reported 3978 ES01743 Initial 450K 1266 54.9 NA NA 75 7 buffy coat Normative Aging Study Not reported 3979 ES01744 Initial 450K 1266 54.9 NA NA 75 7 buffy coat Normative Aging Study Not reported 3980 ES01745 Initial 450K 1266 54.9 NA NA 75 7 buffy coat Normative Aging Study Not reported 3981 ES01746 Initial 450K 1266 54.9 NA NA 75 7 buffy coat Normative Aging Study Not reported 3982 ES01747 Initial 450K 1266 54.9 NA NA 75 7 buffy coat Normative Aging Study Not reported 3983 ES01748 Initial 450K 1266 54.9 NA NA 75 7 buffy coat Normative Aging Study Not reported 3984 ES01749 Initial 450K 1266 54.9 NA NA 75 7 buffy coat Normative Aging Study Not reported 3985 ES01750 Initial 450K 1266 54.9 NA NA 75 7 buffy coat Normative Aging Study Not reported 3986 ES01751 Initial 450K 1266 54.9 NA NA 75 7 buffy coat Normative Aging Study Not reported 3987 ES01752 Initial 450K 1266 54.9 NA NA 75 7 buffy coat Normative Aging Study Not reported 3988 ES01753 Initial 450K 1266 54.9 NA NA 75 7 buffy coat Normative Aging Study Not reported 3989 ES01760 Initial 450K 210 NA NA NA 28.12 10.11 whole blood STANISLAS Family Study SFS Not reported 3990 ES01766 Initial 450K 1453 NA NA NA NA NA brain Not reported 3991 ES01770 Initial 450K 1030 37.7 NA NA NA NA prefrontal cortex Female Not reported 3992 ES01771 Initial 450K 1030 37.7 NA NA NA NA prefrontal cortex Male Not reported 3993 ES01772 Initial 450K 179 NA NA NA NA NA cord blood Not reported 3994 ES01773 Initial 450K 229 NA NA NA NA NA placenta Not reported 3995 ES01774 Initial 450K 229 NA NA NA NA NA umbilical artery Not reported 3996 ES01775 Replication 450K 114 NA NA NA NA NA cord blood Not reported 3997 ES01776 Initial 450K 296 NA NA NA NA NA whole blood asbestos exposure Not reported 3998 ES01785 Initial 450K 305 48 19.75 29.75 24.75 NA whole blood Other 3999 ES01787 Initial 450K 492 54.1 56 80 66 NA whole blood Not reported 4000 ES01794 Initial 450K 250 0 21 49 NA NA whole blood InterGEN The Intergenerational Impact of Genetic and Psychological Factors on Blood Pressure African American or Afro-Caribbean 4001 ES01795 Initial 450K 313 NA 40 58 51.7 NA whole blood Other admixed ancestry 4002 ES01798 Initial 450K 112 NA NA NA NA NA whole blood twin Not reported 4003 ES01802 Initial 450K 274 58 NA NA NA NA cord blood FUSION Not reported 4004 ES01802 Initial 450K 65 69.2 NA NA NA NA cord blood Gene SMART Not reported 4005 ES01802 Initial 450K 22 45.4 NA NA NA NA cord blood Not reported 4006 ES01807 Initial 450K 93 NA NA NA NA NA whole blood APrON Alberta pregnancy outcomes and nutrition Not reported 4007 ES01808 Initial 850K 2682 21.51 NA NA 57.1 NA whole blood Not reported 4008 ES01809 Initial 850K 303 NA NA NA NA NA whole blood GUHS Growing Up Healthy Study Not reported 4009 ES01810 Initial 850K 1945 0.5013 0 0 0 0 umbilical cord blood Not reported 4010 ES01811 Initial 850K 49 NA NA NA NA NA prostate Hispanic or Latin American 4011 ES01812 Initial 850K 680 NA NA NA NA NA whole blood Not reported 4012 ES01813 Initial 850K 671 NA NA NA NA NA whole blood Not reported 4013 ES01814 Initial 450K 108 0.423 NA NA NA NA colorectal tumour Other admixed ancestry 4014 ES01815 Initial 850K 57 NA NA NA NA NA blood Not reported 4015 ES01816 Initial 850K 58 NA NA NA NA NA blood Not reported 4016 ES01819 Initial 450K 529 NA NA NA NA NA kidney Not reported 4017 ES01820 Initial 450K 480 NA NA NA NA NA kidney Not reported 4018 ES01821 Initial 850K 20 0 NA NA NA NA whole blood East Asian 4019 ES01822 Initial 850K 17503 NA NA NA NA NA blood Other admixed ancestry 4020 ES01823 Initial 850K 17503 NA NA NA NA NA blood Other admixed ancestry 4021 ES01824 Initial 850K 17503 NA NA NA NA NA blood Other admixed ancestry 4022 ES01825 Initial 850K 1771 NA NA NA NA NA whole blood Not reported 4023 ES01826 Initial 850K 48 NA NA NA NA NA blood Other admixed ancestry 4024 ES01860 Initial 850K 14 NA 14 35 NA NA whole blood Not reported 4025 ES01861 Initial 850K 27 NA NA NA NA NA whole blood Not reported 4026 ES01862 Initial 450K 1207 NA NA NA NA NA CD14+ monocyte Other admixed ancestry 4027 ES01863 Initial 450K 1027 NA NA NA NA NA CD14+ monocyte Other admixed ancestry 4028 ES01864 Initial 450K 20 0.5 NA NA NA NA whole blood Not reported 4029 ES01865 Initial 850K 365 NA NA NA NA NA whole blood Not reported 4030 ES01866 Initial 850K 365 NA NA NA NA NA whole blood Not reported 4031 ES01867 Initial 850K 365 NA NA NA NA NA whole blood Not reported 4032 ES01869 Initial 850K 365 NA NA NA NA NA whole blood Not reported 4033 ES01868 Initial 850K 365 NA NA NA NA NA whole blood Not reported 4034 ES01870 Initial 850K 365 NA NA NA NA NA whole blood Not reported 4035 ES01871 Initial 850K 365 NA NA NA NA NA whole blood Not reported 4036 ES01872 Initial 850K 365 NA NA NA NA NA whole blood Not reported 4037 ES01873 Initial 850K 365 NA NA NA NA NA whole blood Not reported 4038 ES01874 Initial 850K 1135 NA NA NA NA NA saliva Not reported 4039 ES01875 Initial 850K 1135 NA NA NA NA NA saliva Not reported 4040 ES01876 Initial 850K 4107 NA NA NA NA NA blood Not reported 4041 ES01877 Initial 850K 266 NA NA NA NA NA cord blood Not reported 4042 ES01878 Initial 850K 266 NA NA NA NA NA cord blood Not reported 4043 ES01879 Initial 850K 266 NA NA NA NA NA cord blood Not reported 4044 ES01880 Initial 850K 266 NA NA NA NA NA cord blood Not reported 4045 ES01882 Initial 850K 24 NA NA NA NA NA colorectal tumour Not reported 4046 ES01883 Initial 450K 2200 NA NA NA NA NA blood Other admixed ancestry 4047 ES01884 Initial 850K 111 NA NA NA NA NA placenta Not reported 4048 ES01885 Initial 450K 2774 0 NA NA NA NA blood Not reported 4049 ES01886 Initial 850K 8 NA NA NA NA NA salivary gland Not reported 4050 ES01887 Initial 450K 2802 NA NA NA NA NA cord blood Not reported 4051 ES01888 Initial 850K 231 NA NA NA NA NA cord blood Not reported 4052 ES01889 Initial 850K 13 NA NA NA NA NA whole blood Not reported 4053 ES01890 Initial 850K 13 NA NA NA NA NA vastus lateralis muscle Not reported 4054 ES01891 Initial 850K 11 NA NA NA NA NA blood Not reported 4055 ES01892 Initial 850K 40 NA NA NA NA NA peripheral blood Not reported 4056 ES01893 Initial 450K 4671 NA NA NA NA NA admixed tissues Other admixed ancestry 4058 ES01895 Initial 850K 22 NA NA NA NA NA meningioma Not reported 4059 ES01896 Initial 850K 985 NA NA NA NA NA cord blood Other admixed ancestry 4060 ES01897 Initial 850K 112 0.625 NA NA NA NA blood Not reported 4061 ES01898 Initial 850K 54 1 30 62 NA NA peripheral blood Not reported 4062 ES01899 Initial 850K 34 NA NA NA NA NA whole blood Not reported 4063 ES01900 Initial 850K 119 0 NA NA NA NA cord blood Not reported 4064 ES01901 Initial 450K 553 NA NA NA NA NA circulating tumor cell Not reported 4065 ES01902 Initial 450K 383 NA NA NA NA NA circulating tumor cell Not reported 4066 ES01903 Initial 450K 296 NA NA NA NA NA circulating tumor cell Not reported 4067 ES01904 Initial 850K 240 NA NA NA NA NA blood clots Not reported 4068 ES01905 Initial 850K 88 NA NA NA NA NA blood European 4069 ES01906 Initial 450K 2449 NA NA NA NA NA whole blood Not reported 4071 ES01908 Initial 850K 113 NA NA NA NA NA saliva Not reported 4072 ES01909 Initial 850K 14 NA NA NA NA NA blood Not reported 4073 ES01910 Initial 850K 96 NA NA NA NA NA cord blood Not reported 4074 ES01911 Initial 450K 642 NA NA NA NA NA whole blood Not reported 4075 ES01912 Initial 850K 414 NA NA NA NA NA blood European 4076 ES01913 Initial 450K 108 NA NA NA NA NA colorectal tumour Not reported 4077 ES01914 Initial 450K 301 NA NA NA NA NA placental Other admixed ancestry 4078 ES01915 Initial 850K 18 NA NA NA NA NA oral cancer tissue Not reported 4079 ES01916 Initial 850K 14 NA 38 74 NA NA blood Not reported 4080 ES01917 Initial 850K 126 81.7 NA NA 63.5 7.6 gastric tissue Not reported 4081 ES01918 Initial 850K 264 NA NA NA NA NA blood Not reported 4082 ES01919 Initial 450K 663 NA NA NA NA NA plasma the RODAM study African unspecified 4083 ES01920 Initial 850K 1200 NA NA NA NA NA salivary and peripheral blood InterGEN and GENOA African unspecified 4084 ES01921 Initial 850K 6 NA NA NA NA NA colorectal glands Not reported 4085 ES01922 Initial 850K 299 NA NA NA NA NA peripheral blood Hispanic or Latin American 4086 ES01923 Initial 850K 252 NA NA NA NA NA peripheral blood Native American 4087 ES01924 Initial 450K 291 NA NA NA NA NA blood Not reported 4088 ES01925 Initial 850K 192 100 NA NA NA NA placental Not reported 4089 ES01926 Initial 850K 1060 NA NA NA 49.9 12.15 peripheral blood leukocytes Not reported 4090 ES01928 Initial 850K 1060 NA NA NA 49.9 12.15 peripheral blood leukocytes Not reported 4091 ES01930 Initial 850K 1060 NA NA NA 49.9 12.15 peripheral blood leukocytes Not reported 4092 ES01927 Initial 850K 948 NA NA NA 50.56 7.48 peripheral blood leukocytes Not reported 4093 ES01929 Initial 850K 948 NA NA NA 50.56 7.48 peripheral blood leukocytes Not reported 4094 ES01931 Initial 850K 948 NA NA NA 50.56 7.48 peripheral blood leukocytes Not reported 4095 ES01932 Initial 850K 961 NA NA NA 51.2 7.52 blood Other admixed ancestry 4096 ES01933 Initial 850K 114 NA NA NA NA NA saliva Not reported 4097 ES01934 Initial 850K 114 NA NA NA NA NA saliva Not reported 4098 ES01935 Initial 850K 114 NA NA NA NA NA saliva Not reported 4099 ES01936 Initial 850K 114 NA NA NA NA NA saliva Not reported 4100 ES01937 Initial 450K 68 NA NA NA NA NA plasma African Migrants (RODAM) study Other 4101 ES01938 Initial 450K 68 NA NA NA NA NA plasma African Migrants (RODAM) study Other 4102 ES01939 Initial 450K 68 NA NA NA NA NA plasma African Migrants (RODAM) study Other 4103 ES01940 Initial 850K 60 NA NA NA NA NA cord blood Not reported 4104 ES01941 Initial 850K 48 NA NA NA NA NA meningiomas tumor Not reported 4105 ES01942 Initial 450K 667 NA NA NA NA NA whole blood Not reported 4106 ES01943 Initial 850K 971 NA NA NA NA NA whole blood Not reported 4107 ES01944 Initial 850K 172 NA NA NA NA NA cord blood European 4108 ES01945 Initial 450K 26 NA NA NA NA NA lung Not reported 4109 ES01946 Initial 850K 14 0 NA NA NA NA cfDNA Not reported 4110 ES01947 Initial 450K 47 NA NA NA NA NA peripheral blood cells East Asian 4111 ES01948 Initial 850K 1277 NA NA NA NA NA white blood Not reported 4112 ES01949 Initial 850K 79 NA NA NA NA NA gliomas tissue Not reported 4113 ES01950 Initial 850K 82 NA 0 0 0 0 neonatal blood spots the California Biobank Program Other admixed ancestry 4114 ES01951 Initial 850K 918 NA NA NA NA NA blood Not reported 4115 ES01952 Initial 850K 24 NA NA NA NA NA synovial tissue Shanghai Guanghua Hospital of Integrated Traditional Chinese and Western Medicine Not reported 4116 ES01953 Initial 850K 25 0.48 21 53 30.5 NA peripheral blood leukocytes Other admixed ancestry 4117 ES01954 Initial 450K 645 NA NA NA NA NA cord blood Other admixed ancestry 4118 ES01955 Initial 450K 645 NA NA NA NA NA cord blood Other admixed ancestry 4119 ES01956 Initial 450K 645 NA NA NA NA NA cord blood Other admixed ancestry 4120 ES01957 Initial 850K 366 0 NA NA NA NA whole blood European 4121 ES01958 Initial 850K 32 NA NA NA NA NA placenta Not reported 4122 ES01959 Initial 850K 32 NA NA NA NA NA placenta Not reported 4123 ES01960 Initial 850K 63 51.5 0 0 0 0 cord blood cells Other admixed ancestry 4124 ES01961 Initial 850K 101 NA NA 10.9 NA NA peripheral blood CLUES California Lupus Epidemiology Study Other admixed ancestry 4125 ES01962 Initial 450K 40 50 NA NA 17.95 NA peripheral leukocyte EPICOM Not reported 4126 ES01963 Initial 850K 133 NA NA NA NA NA peripheral blood APCFS the Australian Prostate Cancer Family Study Not reported 4127 ES01964 Initial 850K 268 79.9 NA NA 57.2 NA white blood EPIC European Prospective Investigation into Cancer and Nutrition Not reported 4128 ES01965 Initial 850K 88 32 NA NA NA NA peripheral blood Not reported 4129 ES01966 Initial 850K 68 38 NA NA 38 2 peripheral blood mononuclear cell Not reported 4130 ES01967 Initial 850K 97 NA NA NA NA NA whole blood European 4131 ES01967 Replication 850K 60 NA NA NA NA NA whole blood Not reported 4132 ES01968 Initial 450K 22774 NA NA NA NA NA blood Other admixed ancestry 4133 ES01969 Initial 450K 3237 NA NA NA NA NA blood CHS and ARIC Other admixed ancestry 4134 ES01970 Initial 450K 9732 NA NA NA NA NA whole blood Other admixed ancestry 4135 ES01971 Initial 450K 467 NA NA NA NA NA blood Veterans Aging Cohort Study Biomarker Cohort (VACS-BC) Other admixed ancestry 4136 ES01972 Initial 450K 875 NA NA NA NA NA blood Veterans Aging Cohort Study Biomarker Cohort (VACS-BC) Other admixed ancestry 4137 ES01973 Initial 850K 984 NA NA NA NA NA endometrium Other admixed ancestry 4138 ES01974 Initial 850K 180 0.65 NA NA 59.1 8 whole blood KNOW-CKD East Asian 4139 ES01975 Initial 850K 64 NA NA NA NA NA peripheral blood MDA MD Anderson Other admixed ancestry 4140 ES01976 Initial 450K 39 NA NA NA NA NA peripheral blood FHS Framingham Heart Study Other admixed ancestry 4141 ES01977 Initial 450K 768 0.497 NA NA 7.45 NA blood ALSPAC children Avon Longitudinal Study of Parents and Children Other admixed ancestry 4142 ES01978 Initial 850K 34 NA NA NA NA NA endometrium Other admixed ancestry 4143 ES01979 Replication 850K 49 NA NA NA NA NA endometrium Other admixed ancestry 4144 ES01980 Initial 850K 74 0 NA NA NA NA endometrium Other admixed ancestry 4145 ES01981 Initial 850K 296 NA NA NA NA NA rectal mucosal biopsies Other admixed ancestry 4146 ES01983 Initial 850K 30 NA NA NA NA NA invasive tumor front of aggressive uterine adenocarcinoma Other admixed ancestry 4147 ES01984 Initial 850K 13 NA NA NA NA NA invasive tumor front of uterine leiomyosarcoma Other admixed ancestry 4148 ES01985 Initial 850K 32 NA NA NA NA NA whole blood African unspecified 4149 ES01986 Initial 850K 4 NA NA NA NA NA HCC827 cells Other admixed ancestry 4150 ES01987 Initial 850K 40 0 NA NA 60.8 NA peripheral blood Other admixed ancestry 4151 ES01988 Initial 450K 12 NA NA NA NA NA gastric tissue Other admixed ancestry 4152 ES01989 Initial 850K 42 NA NA NA NA NA peripheral blood Other admixed ancestry 4153 ES01990 Initial 450K 46 0.5 NA NA 44 NA peripheral blood leukocytes Other admixed ancestry 4154 ES01991 Initial 850K 970 0 NA NA NA NA cord blood Other admixed ancestry 4155 ES01992 Initial 850K 975 1 NA NA NA NA cord blood Other admixed ancestry 4156 ES01994 Initial 850K 20 NA NA NA 57.6 NA skeletal muscle Other admixed ancestry 4157 ES01993 Initial 850K 13 0 NA NA 61.7 NA skeletal muscle Other admixed ancestry 4158 ES01995 Initial 850K 111 NA NA NA NA NA peripheral blood Other admixed ancestry 4159 ES01996 Initial 450K 323 NA NA NA NA NA peripheral blood leukocytes Other admixed ancestry 4160 ES01999 Initial 450K 456 NA NA NA NA NA peripheral blood leukocytes Other admixed ancestry 4161 ES02000 Initial 450K 449 NA NA NA NA NA peripheral blood leukocytes Other admixed ancestry 4162 ES02001 Initial 850K 27 0.59 NA NA 60.25 NA left ventricle myocardial samples Not reported 4163 ES02002 Initial 850K 47 23 NA NA 40.9 NA whole blood Other admixed ancestry 4164 ES02003 Initial 850K 903 NA NA NA 28.28 NA cord blood boston birth cohort Other 4166 ES02004 Initial 850K 32 NA NA NA 34 NA peripheral blood Not reported 4167 ES02005 Initial 850K 104 0.75 NA NA 8.6 NA peripheral blood COG Children’s Oncology Group (COG) study ALTE03N1 Native American 4168 ES02006 Initial 850K 31 NA NA NA NA NA peripheral blood Not reported 4169 ES02007 Initial 850K 358 53.07 14 44 29 NA placenta ELGAN cohort extremely low gestational age newborn cohort Not reported 4170 ES02008 Initial 850K 30 NA NA NA 40 NA buffy coat African American or Afro-Caribbean 4171 ES02009 Initial 850K 1210 NA 2.6 8.2 3.5 NA buccal mucosa multicentre PEPaNIC randomised controlled trial and its 2- and 4-year follow-up studies (ClinicalTrials.gov, NCT01536275) Not reported 4172 ES02010 Initial 850K 3725 NA NA NA NA NA cord blood European 4173 ES02011 Initial 850K 358 53.07 14 44 29 NA placenta ELGAN cohort extremely low gestational age newborn cohort Not reported 4174 ES02012 Initial 450K 641 0.327 NA NA 48.67 NA buffy coat HyperGEN African American or Afro-Caribbean 4175 ES02013 Replication 450K 602 0.431 NA NA 44.01 NA CD4+ T cell GOLDN MetS- Not reported 4176 ES02013 Replication 450K 393 0.547 NA NA 56.16 NA CD4+ T cell GOLDN MetS+ Not reported 4177 ES02014 Initial 850K 80 75 NA NA 65.6 NA blood CATIS China Antihypertensive Trial in Acute Ischemic Stroke East Asian 4180 ES02015 Initial 850K 1771 54 NA NA 61.8 NA blood PMMS East Asian 4181 ES02021 Initial 850K 16 NA NA NA NA NA umbilical cord blood Not reported 4182 ES02022 Initial 850K 16 NA NA NA NA NA gastric cardia tissues Not reported 4183 ES02023 Initial 850K 19 NA NA NA NA NA gastric cardia tissues Not reported 4184 ES02024 Initial 850K 20 NA NA NA NA NA gastric cardia tissues Not reported 4185 ES02025 Initial 850K 17 NA NA NA NA NA gastric cardia tissues Not reported 4186 ES02029 Initial 450K 619 NA NA NA NA NA whole blood European 4187 ES02029 Initial 850K 380 NA NA NA NA NA whole blood European 4188 ES02030 Replication 450K 29 NA NA NA NA NA whole blood Not reported 4189 ES02030 Replication 850K 63 NA NA NA NA NA whole blood Not reported 4190 ES02032 Initial 850K 30 0.23 NA NA 51.9 8.9 fasting blood Not reported 4191 ES02033 Initial 850K 7 0.43 NA NA 48 16 peripheral blood mononuclear cell patients with Lyme neuroborreliosis (LNB) Not reported 4192 ES02033 Initial 850K 7 0.29 NA NA 51 21 peripheral blood mononuclear cell patients without Lyme neuroborreliosis (LNB) Not reported 4193 ES02034 Initial 850K 139 0.53 NA NA 27.7 7.3 whole blood-derived leukocytes EDC Epidemiology of Diabetes Complications patients with Proliferative Retinopathy Not reported 4194 ES02034 Initial 850K 126 0.51 NA NA 26.5 8.2 whole blood-derived leukocytes EDC Epidemiology of Diabetes Complications patients without Proliferative Retinopathy Not reported 4195 ES02035 Initial 450K 10329 NA NA NA NA NA peripheral blood leukocytes ARIC,WHI,JHS,MEC,FHS Other admixed ancestry 4196 ES02036 Initial 850K 454 NA NA NA 42.2 NA whole blood Greater Middle Eastern 4197 ES02037 Replication 850K 381 NA NA NA 44.2 NA whole blood Greater Middle Eastern 4198 ES02038 Initial 850K 685 NA NA NA 5.8 NA peripheral blood cells MMNP South Asian 4199 ES02039 Replication 450K 2079 NA NA NA NA NA peripheral blood cells MPC;PMMST;ENID;ALSPAC Other admixed ancestry 4200 ES02040 Initial 450K 423 NA NA NA NA NA blood Veterans Aging Cohort Study Biomarker Cohort (VACS-BC) African American or Afro-Caribbean 4201 ES02041 Initial 850K 388 NA NA NA NA NA blood Veterans Aging Cohort Study Biomarker Cohort (VACS-BC) African American or Afro-Caribbean 4202 ES02042 Replication 450K 3104 NA NA NA NA NA peripheral blood leukocytes AMISH, CHS, GENOA, MESA Other admixed ancestry 4203 ES02043 Initial 450K 3471 NA NA NA NA NA whole blood FHS Framingham Heart Study Other admixed ancestry 4204 ES02044 Initial 450K 4152 NA NA NA NA NA peripheral blood WHI;FHS;REGICOR-450 European 4205 ES02044 Initial 850K 1122 NA NA NA NA NA peripheral blood REGICOR-EPIC;AIRWAVE European 4206 ES02046 Initial 450K 4152 NA NA NA NA NA peripheral blood WHI;FHS;REGICOR-450 European 4207 ES02046 Initial 850K 1122 NA NA NA NA NA peripheral blood REGICOR-EPIC;AIRWAVE European 4208 ES02047 Initial 450K 4152 NA NA NA NA NA peripheral blood WHI;FHS;REGICOR-450 European 4209 ES02047 Initial 850K 1122 NA NA NA NA NA peripheral blood REGICOR-EPIC;AIRWAVE European 4210 ES02045 Initial 850K 2334 NA 40 78 NA NA whole blood KARE, HEXA Asian unspecified 4211 ES02048 Initial 850K 1520 52.88 47 78 58 NA whole blood KERA Asian unspecified 4212 ES02049 Replication 850K 814 75.5 40 60 52 NA whole blood HEXA Asian unspecified 4213 ES02050 Initial 450K 79 NA NA NA NA NA whole blood low-risk, medium-risk, high-risk European 4214 ES02051 Initial 450K 2432 NA NA NA NA NA whole blood ARIC African unspecified 4215 ES02052 Initial 450K 1378 NA NA NA NA NA whole blood KORA European 4216 ES02053 Replication 450K 586 NA NA NA NA NA whole blood BSGS European 4217 ES02054 Replication 450K 827 NA NA NA NA NA whole blood LBC1936 European 4218 ES02055 Initial 450K 422 NA NA NA NA NA peripheral blood leukocytes African American or Afro-Caribbean 4219 ES02056 Initial 450K 422 NA NA NA NA NA peripheral blood leukocytes African American or Afro-Caribbean 4222 ES02060 Initial 850K 9 NA NA NA NA NA peripheral blood Not reported 4223 ES02061 Initial 850K 60 NA NA NA NA NA peripheral blood cells Not reported 4224 ES02064 Initial 850K 29 NA 2 15 NA NA peripheral blood Not reported 4225 ES02067 Initial 850K 11 NA 12 46 NA NA fibroblast cells Not reported 4226 ES02062 Initial 450K 618 48.7 NA NA NA NA cord blood ALSPAC Avon Longitudinal Study of Parents and Children European 4227 ES02062 Initial 450K 137 56.9 NA NA NA NA cord blood EDEN Etude des D eterminants pr e et post natals du d eveloppement et de la sant e de l’ Enfant European 4228 ES02062 Initial 450K 188 52.1 NA NA NA NA cord blood ENVIRONAGE 450K the ENVIRonmental influence ON early AGEing European 4229 ES02062 Initial 850K 345 48.7 NA NA NA NA cord blood ENVIRONAGE EPIC the ENVIRonmental influence ON early AGEing European 4230 ES02062 Initial 450K 1171 50.4 NA NA NA NA cord blood Generation R The Generation R Study European 4231 ES02062 Initial 450K 357 50.7 NA NA NA NA cord blood INMA Infancia y Medio Ambiente European 4232 ES02062 Initial 850K 172 51.2 NA NA NA NA cord blood Piccolipiù Piccolipiù cohort European 4233 ES02065 Initial 450K 618 48.7 NA NA NA NA cord blood ALSPAC Avon Longitudinal Study of Parents and Children European 4234 ES02065 Initial 450K 137 56.9 NA NA NA NA cord blood EDEN Etude des D eterminants pr e et post natals du d eveloppement et de la sant e de l’ Enfant European 4235 ES02073 Initial 450K 682 47.8 NA NA 7.4 NA child blood ALSPAC Avon Longitudinal Study of Parents and Children European 4236 ES02074 Initial 450K 682 47.8 NA NA 7.4 NA child blood ALSPAC Avon Longitudinal Study of Parents and Children European 4237 ES02073 Initial 450K 440 47.7 NA NA 6 NA child blood Generation R The Generation R Study European 4238 ES02073 Initial 450K 727 55.2 NA NA 8.5 NA child blood HELIX Human Early-Life Exposome project European 4239 ES02074 Initial 450K 440 47.7 NA NA 6 NA child blood Generation R The Generation R Study European 4240 ES02074 Initial 450K 727 55.2 NA NA 8.5 NA child blood HELIX Human Early-Life Exposome project European 4241 ES02076 Initial NA 159 56 NA NA 76.6 NA brain stage 1 Not reported 4242 ES02077 Initial NA 159 56 NA NA 76.6 NA brain stage 2 Not reported 4243 ES02065 Initial 450K 188 52.1 NA NA NA NA cord blood ENVIRONAGE 450K the ENVIRonmental influence ON early AGEing European 4244 ES02078 Initial NA 159 56 NA NA 76.6 NA brain stage 3 Not reported 4245 ES02065 Initial 850K 345 48.7 NA NA NA NA cord blood ENVIRONAGE EPIC the ENVIRonmental influence ON early AGEing European 4246 ES02065 Initial 450K 357 50.7 NA NA NA NA cord blood INMA Infancia y Medio Ambiente European 4247 ES02065 Initial 850K 172 51.2 NA NA NA NA cord blood Piccolipiù Piccolipiù cohort European 4248 ES02066 Initial 450K 618 48.7 NA NA NA NA cord blood ALSPAC Avon Longitudinal Study of Parents and Children European 4249 ES02079 Initial NA 159 56 NA NA 76.6 NA brain stage 4 Not reported 4250 ES02066 Initial 450K 137 56.9 NA NA NA NA cord blood EDEN Etude des D eterminants pr e et post natals du d eveloppement et de la sant e de l’ Enfant European 4251 ES02066 Initial 450K 188 52.1 NA NA NA NA cord blood ENVIRONAGE 450K the ENVIRonmental influence ON early AGEing European 4252 ES02066 Initial 450K 1171 50.4 NA NA NA NA cord blood Generation R The Generation R Study European 4253 ES02066 Initial 450K 357 50.7 NA NA NA NA cord blood INMA Infancia y Medio Ambiente European 4254 ES02080 Initial NA 159 56 NA NA 76.6 NA brain stage 5 Not reported 4255 ES02081 Initial NA 159 NA NA NA 56 NA brain stage 6 Not reported 4256 ES02071 Initial 450K 618 48.6 NA NA NA NA cord blood ALSPAC Avon Longitudinal Study of Parents and Children European 4257 ES02071 Initial 450K 1171 50.4 NA NA NA NA cord blood Generation R The Generation R Study European 4258 ES02071 Initial 450K 357 50.7 NA NA NA NA cord blood INMA Infancia y Medio Ambiente European 4259 ES02071 Initial 850K 172 51.2 NA NA NA NA cord blood Piccolipiù Piccolipiù cohort European 4260 ES02072 Initial 450K 618 48.7 NA NA NA NA cord blood ALSPAC Avon Longitudinal Study of Parents and Children European 4261 ES02072 Initial 850K 172 51.2 NA NA NA NA cord blood Piccolipiù Piccolipiù cohort European 4262 ES02068 Initial 450K 618 48.7 NA NA NA NA cord blood ALSPAC Avon Longitudinal Study of Parents and Children European 4263 ES02068 Initial 450K 137 56.9 NA NA NA NA cord blood EDEN Etude des D eterminants pr e et post natals du d eveloppement et de la sant e de l’ Enfant European 4264 ES02068 Initial 450K 188 52.1 NA NA NA NA cord blood ENVIRONAGE 450K the ENVIRonmental influence ON early AGEing European 4265 ES02068 Initial 850K 345 48.7 NA NA NA NA cord blood ENVIRONAGE EPIC the ENVIRonmental influence ON early AGEing European 4266 ES02068 Initial 450K 1171 50.4 NA NA NA NA cord blood Generation R The Generation R Study European 4267 ES02068 Initial 450K 357 50.7 NA NA NA NA cord blood INMA Infancia y Medio Ambiente European 4268 ES02068 Initial 850K 172 51.2 NA NA NA NA cord blood Piccolipiù Piccolipiù cohort European 4269 ES02069 Initial 450K 618 48.7 NA NA NA NA cord blood ALSPAC Avon Longitudinal Study of Parents and Children European 4270 ES02069 Initial 450K 137 56.9 NA NA NA NA cord blood EDEN Etude des D eterminants pr e et post natals du d eveloppement et de la sant e de l’ Enfant European 4271 ES02069 Initial 450K 188 52.1 NA NA NA NA cord blood ENVIRONAGE 450K the ENVIRonmental influence ON early AGEing European 4272 ES02069 Initial 850K 345 48.7 NA NA NA NA cord blood ENVIRONAGE EPIC the ENVIRonmental influence ON early AGEing European 4273 ES02069 Initial 450K 1171 50.4 NA NA NA NA cord blood Generation R The Generation R Study European 4274 ES02069 Initial 450K 357 50.7 NA NA NA NA cord blood HELIX Human Early-Life Exposome project European 4275 ES02070 Initial 450K 618 48.7 NA NA NA NA cord blood ALSPAC Avon Longitudinal Study of Parents and Children European 4276 ES02070 Initial 450K 137 56.9 NA NA NA NA cord blood EDEN Etude des D eterminants pr e et post natals du d eveloppement et de la sant e de l’ Enfant European 4277 ES02070 Initial 450K 188 52.1 NA NA NA NA cord blood ENVIRONAGE 450K the ENVIRonmental influence ON early AGEing European 4278 ES02070 Initial 450K 1171 50.4 NA NA NA NA cord blood Generation R The Generation R Study European 4279 ES02070 Initial 450K 357 50.7 NA NA NA NA cord blood INMA Infancia y Medio Ambiente European 4280 ES02082 Initial 850K 29 NA NA NA NA NA breast breast cancer Asian unspecified 4281 ES02083 Initial 850K 60 60 NA NA NA NA whole blood Not reported 4282 ES02084 Initial 850K 333 NA NA NA NA NA colon Asian unspecified 4283 ES02085 Initial 850K 32 NA NA NA NA NA thyroid Not reported 4284 ES02086 Initial 850K 12 25 50 84 66.83 NA oral mucosal PVL patients Proliferative verrucous leukoplakia Not reported 4285 ES02086 Initial 850K 8 37.5 54 82 65.62 NA oral mucosal HL patients homogeneous leucoplakia Not reported 4286 ES02087 Initial 450K 796 50.6 NA NA 9 NA saliva age 9 Other admixed ancestry 4287 ES02088 Replication 450K 796 50.6 NA NA 15 NA saliva age 15 Other admixed ancestry 4288 ES02089 Initial NA 12 NA NA NA NA NA peripheral blood mononuclear cells Asian unspecified 4289 ES02090 Initial 850K 19 63.16 NA NA 60.2 NA peripheral blood monocytes Discovery Set Cancer Not reported 4290 ES02090 Initial 850K 19 63.16 NA NA 60 NA peripheral blood monocytes Discovery Set Control Not reported 4291 ES02091 Initial NA 77 NA 50 60 NA NA whole blood European 4292 ES02092 Initial 850K 63 0 NA NA NA NA whole blood intermediate term night shift workers vs non-shift workers European 4293 ES02093 Initial 850K 60 0 NA NA NA NA whole blood intermediate term night shift workers vs short-term night shift workers European 4294 ES02094 Initial 850K 59 0 NA NA NA NA whole blood short-term night shift workers vs non-shift workers European 4295 ES02095 Initial 850K 48 100 NA NA NA NA whole blood short-term night shift workers vs non-shift workers European 4296 ES02096 Initial 850K 50 100 NA NA NA NA whole blood intermediate term night shift workers vs non-shift workers European 4297 ES02097 Initial 850K 50 100 NA NA NA NA whole blood intermediate term night shift workers vs short-term night shift workers European 4298 ES02075 Initial 450K 4 NA NA NA NA NA whole blood advanced Nasopharyngeal Carcinoma Asian unspecified 4299 ES02098 Initial 450K 975 NA NA NA NA NA purified monocytes Light Absorption Coefficient-MESA metaanalysis Other admixed ancestry 4300 ES02099 Initial 450K 975 NA NA NA NA NA purified monocytes Nitrogen oxides-MESA metaanalysis Other admixed ancestry 4301 ES02101 Initial 850K 29 NA NA NA NA NA whole blood-derived leukocytes Septic shock vs critically ill Not reported 4302 ES02102 Initial 850K 25 NA NA NA NA NA whole blood-derived leukocytes Sepsis vs critically ill Not reported 4303 ES02103 Initial 850K 28 NA NA NA NA NA whole blood-derived leukocytes septic shock vs Sepsis Not reported 4304 ES02105 Initial 850K 8 NA NA NA NA NA tumor and adjacent nontumor FFPE tissues DMPs between non-tumors and tumors Not reported 4313 ES02114 Initial 850K 138 NA NA NA NA NA whole blood Alzheimer’s Disease Not reported 4314 ES02115 Initial 450K 217 47.3 NA NA 61 NA whole blood-derived leukocytes Significant DMPs related to current smoking from total 5mC+5hmC methylation dataset Not reported 4315 ES02118 Initial 450K 719 53.5 NA NA 64 NA whole blood-derived leukocytes Significant DMPs related to former smoking from total 5mC+5hmC methylation dataset Not reported 4316 ES02119 Initial 850K 414 NA NA NA NA NA whole blood-derived leukocytes CYP2D6 methylation from genetic variation Other admixed ancestry 4317 ES02123 Initial NA 27 NA 2 47 NA NA whole blood Chung–Jansen syndrome, Börjeson–Forssman–Lehmann syndromes and White–Kernohan syndromes Not reported 4318 ES02124 Initial NA 31 NA NA NA NA NA whole blood Chung-Jansen syndrome Not reported 4319 ES02125 Initial 850K 214 NA NA NA NA NA whole blood Not reported 4320 ES02126 Initial 850K 461 NA NA NA NA NA whole blood Not reported 4321 ES02128 Initial 850K 21 NA NA NA NA NA whole blood Not reported 4322 ES02129 Initial 850K 225 49.41 NA NA 1.31 NA placenta INMA INfancia y Medio Ambiente-Environment and Childhood European 4323 ES02130 Initial 850K 223 69.5 NA NA 56.1 NA lung GTEx The genotype-tissue expression project Other 4324 ES02130 Initial 850K 223 71.1 NA NA 55.2 NA colon GTEx The genotype-tissue expression project Other 4325 ES02130 Initial 850K 157 0 NA NA 50.5 NA ovary GTEx The genotype-tissue expression project Other 4326 ES02130 Initial 850K 119 100 NA NA 54.3 NA prostate GTEx The genotype-tissue expression project Other 4327 ES02130 Initial 850K 54 83.3 NA NA 50.3 NA whole blood GTEx The genotype-tissue expression project Other 4328 ES02130 Initial 850K 50 100 NA NA 54.2 NA testis GTEx The genotype-tissue expression project Other 4329 ES02130 Initial 850K 47 59.6 NA NA 57.1 NA muscle GTEx The genotype-tissue expression project Other 4330 ES02130 Initial 850K 38 0 NA NA 50 NA breast GTEx The genotype-tissue expression project Other 4331 ES02130 Initial 850K 50 78 NA NA 59.7 NA kidney GTEx The genotype-tissue expression project Other 4332 ES02131 Initial 850K 285 53.7 NA NA 2 NA cord blood East Asian 4333 ES02132 Initial 850K 17 53 67.71 NA NA NA frontal lobe MSA Multiple system atrophy Not reported 4334 ES02133 Initial 850K 17 47 NA NA 68.06 NA frontal lobe PD Parkinson’s disease Not reported 4335 ES02134 Initial 850K 16 NA NA NA NA NA frontal lobe PSP progressive supranuclear palsy Not reported 4336 ES02132 Initial 850K 15 NA NA NA NA NA frontal lobe neurologically healthy controls Not reported 4337 ES02133 Initial 850K 15 NA NA NA NA NA frontal lobe neurologically healthy controls Not reported 4338 ES02134 Initial 850K 15 NA NA NA NA NA frontal lobe neurologically healthy controls Not reported 4339 ES02135 Initial 850K 17 53 NA NA 67.71 NA frontal lobe MSA Multiple system atrophy Not reported 4340 ES02135 Initial 450K 17 47 NA NA 68.06 NA frontal lobe PD Parkinson’s disease Not reported 4341 ES02136 Initial 850K 17 53 NA NA 67.71 NA frontal lobe MSA Multiple system atrophy Not reported 4342 ES02136 Initial 850K 16 NA NA NA NA NA frontal lobe PSP progressive supranuclear palsy Not reported 4343 ES02137 Initial 850K 17 47 NA NA 68.06 NA frontal lobe PD Parkinson’s disease Not reported 4344 ES02137 Initial 850K 16 NA NA NA NA NA frontal lobe PSP progressive supranuclear palsy Not reported 4345 ES02138 Initial 850K 885 49.2 NA NA 68.8 NA whole blood East Asian,African unspecified,South Asian,European 4346 ES02139 Initial 850K 235 NA NA NA 31.31 5.77 saliva Hispanic or Latin American 4347 ES02140 Initial 850K 119 80 NA NA 52 NA dorsolateral prefrontal cortex Not reported 4348 ES02141 Initial 850K 119 80 NA NA 52 NA nucleus accumbens Not reported 4349 ES02142 Initial 450K 154 100 NA NA NA NA cord blood birth Not reported 4350 ES02142 Initial 450K 70 100 NA NA NA NA cord blood age 9 Not reported 4351 ES02142 Initial 850K 67 100 NA NA NA NA cord blood age 14 Not reported 4352 ES02143 Initial 450K 155 0 NA NA NA NA cord blood birth Not reported 4353 ES02143 Initial 450K 86 0 NA NA NA NA cord blood age 9 Not reported 4354 ES02143 Initial 850K 83 0 NA NA NA NA cord blood age 14 Not reported 4355 ES02144 Initial 450K 309 NA NA NA NA NA cord blood birth Not reported 4356 ES02144 Initial 450K 156 NA NA NA NA NA cord blood age 9 Not reported 4357 ES02144 Initial 850K 150 NA NA NA NA NA cord blood age 14 Not reported 4358 ES02145 Initial 850K 358 41.9 NA NA 61.2 7.29 peripheral blood East Asian 4359 ES02146 Initial 850K 358 41.9 NA NA 61.2 7.29 peripheral blood East Asian 4360 ES02147 Initial 850K 358 41.9 NA NA 61.2 7.29 peripheral blood East Asian 4361 ES02148 Initial 850K 352 15 NA NA 44 NA whole blood East Asian 4362 ES02149 Initial 850K 575 48.2 NA NA 46.3 14.8 blood European 4363 ES02150 Initial 850K 9 33.3 27.5 65.5 55.5 NA blood LOBB Leipzig Obesity BioBank Not reported 4364 ES02151 Initial 850K 9 33.3 27.5 65.5 55.5 NA subcutaneous adipose tissue LOBB Leipzig Obesity BioBank Not reported 4365 ES02152 Initial 850K 9 33.3 27.5 65.5 55.5 NA omental visceral adipose tissue LOBB Leipzig Obesity BioBank Not reported 4366 ES02153 Initial 850K 319 48.3 13 77 35.8 NA whole blood European 4367 ES02154 Initial 850K 182 NA NA NA NA NA whole blood European 4368 ES02155 Initial 850K 43 69.8 NA NA 70.5 10.7 whole blood Epigenetics of Delirium 1 EOD1 delirium Not reported 4369 ES02156 Initial 850K 17 NA NA NA 80.8 5.1 whole blood Tottori surgery TSG East Asian 4370 ES02155 Initial 850K 44 NA NA NA 69.9 9.8 whole blood Epigenetics of Delirium 1 EOD1 non-delirium Not reported 4371 ES02157 Initial 850K 106 46.2 44 65 56 NA liver tissue East Asian 4372 ES02158 Initial 850K 2740 49.7 NA NA NA NA cord blood Hyperglycemia and Adverse Pregnancy Outcome HAPO South East Asian,Hispanic or Latin American,European,East Asian 4373 ES02160 Initial 850K 385 48.31 26.34 50.26 35.69 NA Peripheral whole blood the Personalised Anti-TNF Therapy in Crohn’s Disease study PANTS Not reported 4374 ES02161 Initial 450K 77 NA NA NA NA NA peripheral blood TCGA LAML The Cancer Genome Atlas [TCGA] AML [LAML] Not reported 4375 ES02180 Initial 27K 77 NA NA NA NA NA peripheral blood TCGA LAML The Cancer Genome Atlas [TCGA] AML [LAML] Not reported 4376 ES02181 Initial 27K 79 NA NA NA NA NA primary bone marrow Not reported 4377 ES02182 Initial 850K 30 50 NA NA 10.8 2.9 peripheral blood Family therapy European 4378 ES02182 Initial 850K 32 62.5 NA NA 9.9 4.4 peripheral blood Waitlist control European 4379 ES02183 Initial 850K 32 31.3 NA NA 56.9 14.3 whole blood Not reported 4380 ES02184 Initial 850K 32 31.3 NA NA 56.9 14.3 whole blood Not reported 4381 ES02185 Initial 850K 32 31.3 NA NA 56.9 14.3 whole blood Not reported 4382 ES02186 Initial 850K 22 0 NA NA NA NA whole blood Not reported 4383 ES02187 Initial 850K 22 0 NA NA NA NA whole blood Not reported 4384 ES02188 Initial 850K 22 0 NA NA NA NA whole blood Not reported 4385 ES02190 Initial 850K 29 NA 31.9 84.1 65.7 NA tumor tissue HGSOC Not reported 4386 ES02190 Initial 850K 15 NA 20.5 82.5 56.6 NA tumor tissue Benign Not reported 4387 ES02190 Initial 850K 5 NA 39 86.2 61.9 NA tumor tissue Borderline Not reported 4388 ES02191 Initial 850K 32 0 NA NA 31 4.7 placental +Opioids/+NOWS European 4389 ES02191 Initial 850K 32 0 NA NA 28 4.9 placental +Opioids/-NOWS European 4390 ES02191 Initial 850K 32 0 NA NA 32.5 40.2 placental -Opioids/-NOWS, control European 4391 ES02192 Initial 850K 289 NA 21 69.5 29.2 NA cervical samples African American or Afro-Caribbean,Asian unspecified 4392 ES02193 Initial 850K 14 100 NA NA 50.43 3.16 whole blood the underground miners East Asian 4393 ES02193 Initial 850K 9 100 NA NA 50 2.92 whole blood the controls East Asian 4394 ES02194 Initial 850K 10 30 NA NA 47.7 5.49 peripheral blood MetS Responder Not reported 4395 ES02195 Initial 850K 10 10 NA NA 49.7 10.29 peripheral blood MetS Non-Responder Not reported 4396 ES02196 Initial 850K 242 51.7 NA NA 14 3.7 blood African Americans (SAGE) Asthma cases African American or Afro-Caribbean 4397 ES02196 Initial 850K 218 50 NA NA 16.3 3.6 blood African Americans (SAGE) Controls African American or Afro-Caribbean 4398 ES02196 Initial 850K 158 44.9 NA NA 13.8 3.8 blood Mexican Americans (GALA II) Asthma cases Hispanic or Latin American 4399 ES02196 Initial 850K 201 50.2 NA NA 13.8 4.2 blood Mexican Americans (GALA II) Controls Hispanic or Latin American 4400 ES02196 Initial 850K 252 56 NA NA 12.9 3.1 blood Puerto Ricans (GALA II) Asthma cases Hispanic or Latin American 4401 ES02196 Initial 450K 155 44.5 NA NA 13.7 3.3 blood Puerto Ricans (GALA II) Controls Hispanic or Latin American 4402 ES02199 Initial 850K 97 52.6 11.9 15.6 13.9 NA nasal cells Hispanic or Latin American 4403 ES02200 Initial 850K 149 21.48 NA NA 57.54 12 blood Responders Not reported 4404 ES02200 Initial 850K 96 25 NA NA 58.1 13.54 blood Non-responders Not reported 4405 ES02201 Initial 850K 24 83.3 NA NA NA NA placenta sFGR Not reported 4406 ES02202 Initial 850K 86 0 NA NA 37.7 NA whole blood RHCC-AC the Reproductive Health of Childbearing Couples—Anhui Cohort Not reported 4407 ES02203 Initial 850K 13 46.2 NA NA 33.54 NA whole blood responders Not reported 4408 ES02203 Initial 850K 17 47.1 NA NA 33.88 NA whole blood non-responders Not reported 4409 ES02204 Initial 850K 24 84 NA NA 42 15 whole blood Response Not reported 4410 ES02204 Initial 850K 60 64 NA NA 44 15 whole blood Non-response Not reported 4411 ES02205 Initial 850K 21 33 NA NA 42 16 whole blood Longitudinal response Not reported 4412 ES02206 Initial 850K 18 33 NA NA 43 16 whole blood Longitudinal remission Not reported 4413 ES02207 Initial 850K 4261 0 NA NA NA NA blood Not reported 4414 ES02208 Initial 850K 3258 100 NA NA NA NA blood Not reported 4415 ES02209 Initial 850K 20 20 NA NA 82.6 8.4 white blood cells AD Alzheimer’s disease East Asian 4416 ES02209 Initial 850K 20 15 NA NA 60.2 5.3 white blood cells CHCs cognitively healthy controls East Asian 4417 ES02210 Initial 850K 20 50 NA NA 65.7 4.2 white blood cells MCI mild cognitive impairment East Asian 4418 ES02210 Initial 850K 20 20 NA NA 82.6 8.4 white blood cells AD Alzheimer’s disease East Asian 4419 ES02211 Initial 850K 20 50 NA NA 65.7 4.2 white blood cells MCI mild cognitive impairment East Asian 4420 ES02211 Initial 850K 20 15 NA NA 60.2 5.3 white blood cells CHCs cognitively healthy controls (CHCs) East Asian 4421 ES02212 Initial 850K 46 56.5 NA NA 70.5 8.7 whole blood NSAIDs (+) European 4422 ES02212 Initial 850K 125 69.6 NA NA 75.8 9.7 whole blood NSAIDs(-) European 4423 ES02213 Initial 450K 48 NA NA NA NA NA peripheral blood Not reported 4424 ES02214 Initial 450K 436 100 NA NA NA NA umbilical cord blood ALSPAC Not reported 4425 ES02215 Initial 850K 60 47 49 63 56 NA blood Individuals for marker screening East Asian 4426 ES02216 Initial 450K 368 0 NA NA 51 10.7 FFPE tumor Black Not reported 4427 ES02216 Initial 450K 326 0 NA NA 52.3 10.3 FFPE tumor White Not reported 4428 ES02217 Initial 850K 67 46.3 23 56 43.3 9 CD19+ B cells Smokers Smokers Other,African American or Afro-Caribbean 4429 ES02218 Initial 850K 67 46.3 23 56 43.3 9 CD15+ granulocytes Smokers Smokers Other,African American or Afro-Caribbean 4430 ES02219 Initial 850K 67 46.3 23 56 43.3 9 CD14+ monocytes Smokers Smokers Other,African American or Afro-Caribbean 4431 ES02220 Initial 850K 67 46.3 23 56 43.3 9 CD56+ natural killer cells Smokers Smokers Other,African American or Afro-Caribbean 4432 ES02221 Initial 850K 67 46.3 23 56 43.3 9 CD4+ T cells Smokers Smokers African American or Afro-Caribbean,Other 4433 ES02222 Initial 850K 67 46.3 23 56 43.3 9 CD8+ T cells Smokers Smokers African American or Afro-Caribbean,Other 4434 ES02217 Initial 850K 74 44.6 19 55 39 10.5 CD19+ B cells Non-smokers African American or Afro-Caribbean,Other 4435 ES02218 Initial 850K 74 44.6 19 55 39 10.5 CD15+ granulocytes Non-smokers Other,African American or Afro-Caribbean 4436 ES02219 Initial 850K 74 44.6 19 55 39 10.5 CD14+ monocytes Non-smokers Other,African American or Afro-Caribbean 4437 ES02220 Initial 850K 74 44.6 19 55 39 10.5 CD56+ natural killer cells Non-smokers Other,African American or Afro-Caribbean 4438 ES02221 Initial 850K 74 44.6 19 55 39 10.5 CD4+ T cells Non-smokers Other,African American or Afro-Caribbean 4439 ES02222 Initial 850K 74 44.6 19 55 39 10.5 CD8+ T cells Non-smokers Other,African American or Afro-Caribbean 4440 ES02223 Initial 850K 1133 34.25 6 95 60.79 NA peripheral blood RLS Not reported 4441 ES02223 Initial 850K 1150 34.61 34 88 60.34 NA peripheral blood controls Not reported 4442 ES02224 Initial 850K 40 39.34 63 96 85.24 NA Caudate Nucleus RLS Not reported 4443 ES02225 Initial 850K 40 39.34 63 96 85.24 NA Putamen RLS Not reported 4444 ES02226 Initial 850K 40 39.34 63 96 85.24 NA Parietal Cortex RLS Not reported 4445 ES02224 Initial 850K 21 61.9 19 89 68.17 NA Caudate Nucleus controls Not reported 4446 ES02225 Initial 850K 21 61.9 19 89 68.17 NA Putamen controls Not reported 4447 ES02226 Initial 850K 21 61.9 19 89 68.17 NA Parietal Cortex controls Not reported 4448 ES02227 Initial 850K 94 NA NA NA NA NA blood Not reported 4449 ES02228 Initial 850K 11 0.09 NA NA 50.55 9.67 peripheral blood Not reported 4450 ES02228 Initial 850K 9 0.33 NA 46.44 NA 5.34 peripheral blood Not reported 4451 ES02229 Initial 450K 1113 0.448 NA NA 58 14 whole blood Not reported 4452 ES02229 Initial 450K 338 0.544 NA NA 65 14 whole blood Not reported 4453 ES02229 Initial 450K 245 0.592 NA NA 67 10 whole blood Not reported 4454 ES02229 Initial 850K 1262 0.439 NA NA 54.5 16 whole blood Not reported 4455 ES02229 Initial 850K 304 0.566 NA NA 63 16 whole blood Not reported 4456 ES02229 Initial 850K 239 0.594 NA NA 68 13.5 whole blood Not reported 4457 ES02230 Initial 850K 14 NA 14 17 NA NA peripheral blood Not reported 4458 ES02232 Initial 850K 80 0.45 NA NA NA NA placental ART European 4459 ES02232 Initial 850K 77 0.545 NA NA NA NA placental control European 4460 ES02233 Initial 850K 19 0.0526 NA NA 40.68 13.64 whole blood Other admixed ancestry 4461 ES02233 Initial 850K 40 0.15 NA NA 35.88 12.2 whole blood Other admixed ancestry 4462 ES02234 Initial 850K 19 0.0526 NA NA 40.68 13.64 whole blood Other admixed ancestry 4463 ES02234 Initial 850K 40 0.15 NA NA 35.88 12.2 whole blood Other admixed ancestry 4464 ES02236 Initial 450K 93 NA NA NA 71.16 5.32 frontal cortex grey matter tissue FTLD Not reported 4465 ES02236 Initial 450K 70 NA NA NA 76.17 7.93 frontal cortex grey matter tissue Controls Not reported 4466 ES02235 Initial 450K 1113 0.448 NA NA 58 14 whole blood Not reported 4467 ES02235 Initial 450K 338 0.544 NA NA 65 14 whole blood Not reported 4468 ES02235 Initial 450K 245 0.592 NA NA 67 10 whole blood Not reported 4469 ES02235 Initial 850K 1262 0.439 NA NA 54.5 16 whole blood Not reported 4470 ES02235 Initial 850K 304 0.566 NA NA 63 16 whole blood Not reported 4471 ES02235 Initial 850K 239 0.594 NA NA 68 13.5 whole blood Not reported 4472 ES02237 Initial 450K 1113 0.448 NA NA 58 14 whole blood Not reported 4473 ES02237 Initial 450K 338 0.544 NA NA 65 14 whole blood Not reported 4474 ES02237 Initial 450K 245 0.544 NA NA 67 10 whole blood Not reported 4475 ES02237 Initial 850K 1262 0.439 NA NA 54.5 16 whole blood Not reported 4476 ES02237 Initial 850K 304 0.566 NA NA 63 16 whole blood Not reported 4477 ES02237 Initial 850K 239 0.594 NA NA 68 13.5 whole blood Not reported 4478 ES02238 Initial 450K 1113 0.448 NA NA 58 14 whole blood Not reported 4479 ES02238 Initial 450K 338 0.544 NA NA 65 14 whole blood Not reported 4480 ES02238 Initial 450K 245 0.592 NA NA 67 10 whole blood Not reported 4481 ES02238 Initial 850K 1262 0.439 NA NA 54.5 16 whole blood Not reported 4482 ES02238 Initial 850K 304 0.566 NA NA 63 16 whole blood Not reported 4483 ES02238 Initial 850K 239 0.566 NA NA 68 13.5 whole blood Not reported 4484 ES02239 Initial 450K 245 0.592 NA NA 67 10 whole blood Not reported 4485 ES02239 Initial 850K 239 0.594 NA NA 68 13.5 whole blood Not reported 4486 ES02240 Initial 450K 1113 0.448 NA NA 58 14 whole blood Not reported 4487 ES02240 Initial 450K 338 0.544 NA NA 65 14 whole blood Not reported 4488 ES02240 Initial 450K 245 0.592 NA NA 67 10 whole blood Not reported 4489 ES02240 Initial 850K 1262 0.439 NA NA 54.5 16 whole blood Not reported 4490 ES02240 Initial 850K 304 0.566 NA NA 63 16 whole blood Not reported 4491 ES02240 Initial 850K 239 0.594 NA NA 68 13.5 whole blood Not reported 4495 ES02242 Initial 850K 77 0.545 NA NA NA NA placental control European 4496 ES02245 Initial 850K 32 0 NA NA NA NA inflammatory breast cancer tissue Not reported 4497 ES02245 Initial 850K 6 0 NA NA NA NA normal breast frozen tissues Not reported 4498 ES02246 Initial 850K 162 23 NA NA 15.16 1.45 whole blood BEAR Civilian European,African unspecified,Other 4499 ES02246 Initial 850K 423 40 NA NA 54.54 16.87 whole blood DNHS-1 Civilian Other,European,African unspecified 4500 ES02246 Initial 850K 95 0 NA NA 26.81 5.2 whole blood DCHS Civilian European 4501 ES02246 Initial 850K 479 29 NA NA 42.22 12.25 whole blood GTP-1 Civilian Other,European,African unspecified 4502 ES02246 Initial 450K 140 0 NA NA 26.01 1.74 whole blood NIU Civilian Other,European,African unspecified 4503 ES02246 Initial 850K 120 29 NA NA 43.15 10.77 whole blood Shared Roots Civilian African unspecified 4504 ES02246 Initial 850K 206 25 NA NA 39.24 14.17 whole blood AURORA Civilian Other,European,African unspecified 4505 ES02246 Initial 850K 73 0 NA NA 45.54 7.29 whole blood H3A_Rwanda Civilian African unspecified 4506 ES02246 Initial 450K 100 40 NA NA 53.6 14.01 whole blood DNHS-2 Civilian European,African unspecified 4507 ES02246 Initial 450K 265 29 NA NA 41.95 12.37 whole blood GTP-2 Civilian African unspecified,European 4508 ES02246 Initial 450K 180 100 NA NA 49.72 8.25 whole blood WTC Civilian European,African unspecified,Oceanian 4509 ES02246 Initial 850K 96 100 NA NA 68.67 4.36 whole blood GMRFQUT Military European 4510 ES02246 Initial 850K 127 100 NA NA 23.07 2.18 whole blood MRS-1 Military European,African unspecified,Other 4511 ES02246 Initial 850K 89 90 NA NA 27.51 8.63 whole blood PRISMO-1 Military European,African unspecified,Other 4512 ES02246 Initial 850K 216 100 NA NA 25.13 4.82 whole blood Army STARRS-1 Military Other,European,African unspecified 4513 ES02246 Initial 850K 140 90 NA NA 34.77 8.33 whole blood PROGrESS Military Other,European,African unspecified 4514 ES02246 Initial 850K 1028 78 NA NA 44.06 13.7 whole blood NCPTSD/TRACTS Military African unspecified,Other,European 4515 ES02246 Initial 450K 126 100 NA NA 22.2 3.04 whole blood MRS-2 Military African unspecified,Other,European 4516 ES02246 Initial 450K 62 100 NA NA 27.1 9.23 whole blood PRISMO-2 Military European 4517 ES02246 Initial 450K 102 100 NA NA 23.79 4.25 whole blood Army STARRS-2 Military European 4518 ES02246 Initial 450K 303 66 NA NA 34.09 11.68 whole blood INTRuST Military Other,European,African unspecified 4519 ES02246 Initial 450K 369 50 NA NA 38.36 9.36 whole blood VA-M-AA Military African unspecified 4520 ES02246 Initial 450K 176 78 NA NA 34.87 9.89 whole blood VA-M-EA Military European 4521 ES02243 Initial 850K 12 0.67 NA NA NA NA placental IUI European 4522 ES02243 Initial 850K 77 0.545 NA NA NA NA placental control European 4523 ES02244 Initial 850K 80 0.45 NA NA NA NA placental ART European 4524 ES02244 Initial 850K 77 0.545 NA NA NA NA placental control European 4525 ES02242 Initial 850K 12 0.67 NA NA NA NA placental IUI European 4526 ES02243 Initial 850K 11 0.454 NA NA NA NA placental SF European 4527 ES02244 Initial 850K 12 0.67 NA NA NA NA placental IUI European 4528 ES02244 Initial 850K 11 0.454 NA NA NA NA placental SF European 4529 ES02247 Initial 850K 77 0.545 NA NA NA NA placental control European 4530 ES02247 Initial 850K 50 0.48 NA NA NA NA placental IVF European 4531 ES02248 Initial 850K 77 0.545 NA NA NA NA placental control European 4532 ES02248 Initial 850K 30 0.4 NA NA NA NA placental ICSI European 4533 ES02249 Initial 850K 77 0.545 NA NA NA NA placental control European 4534 ES02249 Initial 850K 25 0.4 NA NA NA NA placental IVF-FRESH European 4535 ES02249 Initial 850K 17 0.235 NA NA NA NA placental ICSI-FRESH European 4536 ES02250 Initial 850K 135 NA NA NA NA NA whole blood Not reported 4537 ES02251 Initial 850K 153 NA NA NA NA NA whole blood Not reported 4538 ES02252 Initial 450K 912 NA NA NA NA NA Blood and fecal European 4539 ES02253 Initial 450K 232 NA NA NA 31 4.5 cord blood TOP Treatment of Obese Pregnant Women Not reported 4540 ES02254 Initial 850K 736 NA 50 75 61 NA blood Subset I ESTHER Study Subset I European 4541 ES02254 Initial 850K 1027 NA 50 75 62 NA blood Subset II ESTHER Study Subset II European 4542 ES02254 Initial 450K 997 NA 50 75 63 NA blood Subset III ESTHER Study Subset III European 4543 ES02254 Replication 450K 312 NA 50 75 64 NA blood Subset IV ESTHER Study Subset IV European 4544 ES02255 Initial 850K 266 NA NA NA NA NA whole blood cancer Not reported 4545 ES02255 Initial 850K 268 NA NA NA NA NA whole blood Benign Not reported,East Asian 4546 ES02256 Initial 850K 429 NA NA NA 51.27 NA blood PAH UK PAH Cohort Not reported 4547 ES02256 Initial 850K 226 NA NA NA NA NA blood PPMI Parkinson's Progression Markers Initiative Not reported 4548 ES02256 Initial 850K 141 NA NA NA NA NA blood ADNI Alzheimer's Disease Neuroimaging Initiative Not reported 4549 ES02256 Initial 450K 694 NA NA NA NA NA blood NFBC1966 Northern Finland Birth Cohort 1966 Not reported 4550 ES02257 Initial 450K 9881 NA NA NA NA NA cord blood PACE Consortium Pregnancy And Childhood Epigenetics Consortium Other admixed ancestry 4551 ES02257 Initial 450K 2017 NA NA NA NA NA peripheral blood PACE Consortium Pregnancy And Childhood Epigenetics Consortium Other admixed ancestry 4552 ES02257 Initial 450K 2740 NA NA NA NA NA peripheral blood PACE Consortium Pregnancy And Childhood Epigenetics Consortium Other admixed ancestry 4553 ES02258 Initial 850K 539 NA NA NA NA NA umbilical cord blood Gen3G Genetics of Glucose Regulation in Gestation and Growth Other admixed ancestry 4554 ES02258 Initial 450K 440 NA NA NA NA NA cord blood Gen3G Genetics of Glucose Regulation in Gestation and Growth Other admixed ancestry 4555 ES02258 Replication 850K 293 NA NA NA NA NA peripheral blood Gen3G Genetics of Glucose Regulation in Gestation and Growth Other admixed ancestry 4556 ES02259 Initial 850K 774 44 NA NA 60 8.8 blood Generation Scotland Generation Scotland: The Scottish Family Health Study (GS) Other 4557 ES02259 Replication 850K 1065 NA NA NA 59.9 9.6 blood Generation Scotland Generation Scotland: The Scottish Family Health Study (GS) Other 4558 ES02260 Initial 850K 8898 40.9 NA NA 49.8 13.7 whole blood GS Generation Scotland: Scottish Family Health Study European 4559 ES02260 Initial 850K 4757 38.5 NA NA 48.5 14 whole blood Set 1 Generation Scotland: Scottish Family Health Study European 4560 ES02260 Replication 850K 4141 43.66 NA NA 51.4 13.2 whole blood Set 2 Generation Scotland: Scottish Family Health Study European 4561 ES02260 Replication 450K 1330 45.15 NA NA NA NA blood LBC Lothian Birth Cohort European 4562 ES02260 Replication 450K 719 0 NA NA 47.2 4.6 peripheral blood ALSPAC Mothers Avon Longitudinal Study of Parents and Children European 4563 ES02260 Replication 450K 423 41 NA NA 17.1 1.1 peripheral blood ALSPAC Children Avon Longitudinal Study of Parents and Children European